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Abstract 
Biocatalysis is a field rapidly expanding to meet a demand for green and sustainable 
chemical processes.  As the use of enzymes for synthetic chemistry becomes more 
common, the construction of multistep enzyme reactions is likely to become more 
prominent providing excellent cost and productivity benefits.  However, the design 
and optimisation of multistep reactions can be challenging.  An enzyme toolbox of 
well-characterised enzyme parts is critical for the design of novel multistep reactions.  
Furthermore, while whole-cell biocatalysis offers an excellent platform for multistep 
reactions, we are limited to the use of mesophilic host organisms such as 
Escherichia coli.  The development of a thermophilic host organism would offer a 
powerful tool allowing whole-cell biocatalysis at elevated temperatures.   
This study aimed to investigate the construction of a multistep enzyme reaction from 
well-characterised enzyme parts, consisting of an esterase, a carboxylic acid 
reductase and an alcohol dehydrogenase.   
A novel thermostable esterase Af-Est2 was characterised both biochemically and 
structurally.  The enzyme shows exceptional stability making it attractive for industrial 
biocatalysis, and features what is likely a structural or regulatory CoA molecule 
tightly bound near the active site. 
Five carboxylic acid reductases (CARs) taken from across the known CAR family 
were thoroughly characterised.  Kinetic analysis of these enzymes with various 
substrates shows they have a broad but similar substrate specificity and that electron 
rich acids are favoured.  The characterisation of these CARs seeks to provide 
specifications for their use as a biocatalyst. 
The use of isolated enzymes was investigated as an alternative to whole-cell 
biocatalysis for the multistep reaction.  Additional enzymes for the regeneration of 
cofactors and removal of by-products were included, resulting in a seven enzyme 
reaction.  Using characterised enzyme parts, a mechanistic mathematical model was 
constructed to aid in the understanding and optimisation of the reaction, 
demonstrating the power of this approach. 
Thermus thermophilus was identified as a promising candidate for use as a 
thermophilic host organism for whole-cell biocatalysis.  Synthetic biology parts 
	 3	
including a BioBricks vector, custom ribosome binding sites and characterised 
promoters were developed for this purpose.  The expression of enzymes to complete 
the multistep enzyme reaction in T. thermophilus was successful, but native T. 
thermophilus enzymes prevented the biotransformation from being completed. 
In summary, this work makes a number of contributions to the enzyme toolbox of 
well-characterised enzymes, and investigates their combination into a multistep 
enzyme reaction both in vitro and in vivo using a novel thermophilic host organism.   
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Preface 
 
Chapters 3, 4 and 5 of this thesis are reformatted manuscripts of papers which have 
been published, submitted or are intended for submission respectively.  Each of 
these chapters includes a preface which explains the contributions of various authors 
to these works, and their publication status. 
An extended introduction has been included as chapter 1, which introduces the 
areas these papers cover, and how they are related in the context of this thesis.   
However some repetition of this material may be present due to the need to 
introduce each paper in its own right. 
A general materials and methods chapter has been included as chapter 2, to try and 
give more detail on the core techniques used throughout this thesis which may not 
have been covered in detail in the work intended for publication.  Again some 
repetition of material is likely with the materials and methods sections of the 
individual chapters. 
The manuscripts for these papers have been reformatted to match the formatting of 
this thesis, with figures renumbered accordingly.  Also the bibliographies have been 
combined for a final bibliography at the end of the thesis. 
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1.1 Biocatalysis 
1.1.1 Biocatalysis for green chemistry 
In response to growing public concern and regulatory pressure, there is an ever 
increasing demand for the development of chemical manufacturing processes which 
“reduce or eliminate the use or generation of hazardous substances in the design, 
manufacture and application of chemical products”, which is the definition of green 
chemistry (Anastas and Warner, 1998).  Sustainability and recycling are integral 
parts of the circular economy and biological methods are an excellent starting point 
in designing green processes (Banner et al., 2011).  Biocatalysis, the use of 
enzymes to carry out chemical reactions, offers a solution in meeting the green 
chemistry challenge. Recently increasing numbers of processes are employing 
biocatalysis, which ranges from the production of speciality to bulk chemicals 
(Wenda et al., 2011).  One of the greatest advantages enzymes have over their 
chemical counterparts is their often exquisite enantio- and regio- selectivity (Pollard 
and Woodley, 2007).  This makes them particularly attractive for the production of 
pharmaceuticals and indeed this is where enzymes have seen the most use.  In 
2009, 72 % of drugs were chiral (not including protein drugs), a number that is likely 
to increase, therefore driving the uptake of biocatalysis further (Wells and Meyer, 
2014).   
As well as possessing excellent selectivity, enzymes are considered as a green 
alternative as they:  I. can act as non-toxic catalysts, II. result in a decrease in waste 
production, III. are able to operate in mild reaction conditions such as at ambient 
temperature, pressure and pH, which can result in lower energy consumption, IV. 
work in aqueous media, V. may offer shorter synthesis routes, VI. prevent the large 
scale use of metals and organic solvents, and VII. are catalysts from a renewable 
feedstock (Wenda et al., 2011).   
The first biocatalysis reaction was carried out nearly a century ago when scientists 
realised that components of living cells could be used for chemical transformations 
(Bornscheuer et al., 2012).  More recent examples include the use of proteases in 
laundry detergents (Estell, Graycar and Wells, 1985), glucose isomerase to convert 
glucose into the sweeter tasting fructose (Bhosale, Rao and Deshpande, 1996) and 
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penicillin G acylase to make semisynthetic antibiotics (Bruggink, Roos and de 
Vroom, 1998).  The first processes that were developed using enzymes found 
stability to be the major challenge.   Enzyme immobilisation techniques were used to 
tackle this problem, also facilitating the reuse of the enzyme.  Since then enzyme 
structures have allowed rational enzyme engineering for extended substrate scope 
and stability. More recently directed evolution approaches are rapidly modifying 
biocatalysts to meet industrial specifications (Bornscheuer et al., 2012). 
The field of biocatalysis is gaining increasing momentum with tools such as 
bioinformatics, rapid gene synthesis, access to enzyme structures and high 
throughput screening, which facilitate further development (Aldridge, 2013). 
1.1.2 Enzymes 
Enzymes are proteins that selectively catalyse biochemical reactions through the 
stabilisation of reaction transition states, offering a new reaction pathway for which 
the free energy of the transition state is lowered, decreasing the Gibbs free energy of 
activation (∆G‡) (Figure 1-1) (Voet and Voet, 2004).  The Gibbs free energy of 
activation is the difference in free energy between the transition state and the 
substrate (Stryer, 1995). 
The first step in an enzyme catalysed reaction is the binding of substrates to the 
active site of an enzyme, forming an enzyme-substrate complex, with the substrates 
bound in a favourable orientation for a reaction to occur (Cook and Cleland, 2007).  
Active sites are generally formed of a cleft or crevice in the enzyme, and take up a 
relatively small part of the total volume of the enzyme .  Amino-acid residues that 
come from different parts of the linear amino-acid chain come together in three-
dimensions to form the active site .  Much of the catalytic power of enzymes comes 
from their bringing together of substrates in favourable orientations in the enzyme-
substrate complex (Stryer, 1995).   
The substrate specificity of an enzyme is determined by the precise arrangements of 
atoms in the active site.  The metaphor of a lock and key describing substrate 
binding was made in 1980 by Emil Fisher (Fischer, 1890).  However, many enzymes 
have been shown to assume shapes complementary to their substrates only after 
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binding, leading to the induced fit model of interaction between substrate and 
enzyme (Koshland, 1995).   
Like chemical catalysts, enzymes only accelerate reactions and cannot alter reaction 
equilibria.  However, most reactions in biological systems do not occur at perceptible 
rates in the absence of enzymes.  Enzymes are controlled in a number of ways 
including by feedback inhibition, by other regulatory proteins or by covalent 
modification such as phosphorylation (Stryer, 1995).   
 
Figure 1-1 – Enzymes lower the Gibbs free energy of activation 
Enzymes catalyse reactions by lowering the Gibbs free energy of activation.  They offer a 
new reaction pathway whose transition state is lower, allowing a faster reaction to occur.  
Free-energy profiles of a reaction without enzyme (A), and with enzyme (B) is shown to 
demonstrate this.  This figure is adapted from (Stryer, 1995).  
1.1.3 Michaelis-Menten kinetics 
For many enzymes, the rate of an enzyme catalysed reaction varies with substrate 
concentration.  The classic equation describing the effect of changing substrate 
concentration on the velocity of an enzyme catalysed reaction is the Michaelis-
Menten equation (Stryer, 1995).  The use of the equation requires the use of the 
steady-state assumption, which is true for similar equations describing the effects of 
two or more substrates.  The assumption states that the concentration of the 
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enzyme-substrate complex (ES in Figure 1-2) quickly reaches a steady state 
following the start of a reaction.  It is also assumed that the substrate concentration 
(S) is greatly in excess of enzyme concentration (E), and that there is an absence of 
products (P).  Using these assumptions the Michaelis-Menten equation (Figure 1-3) 
can be derived from the rate constants in Figure 1-2 (Cook and Cleland, 2007). 
 
Figure 1-2 - A reaction scheme for a simple one-substrate enzyme catalysed reaction 
The reaction scheme utilising first order rate constants for a one substrate enzyme reaction 
is shown in which the enzyme (E) and substrate (S) bind reversibly (k1 and k-1), forming an 
enzyme-substrate complex (ES).  The enzyme catalysed reaction occurs and the product (P) 
is released.  This is assumed to be the rate limiting step and is described by kcat. 
 
A. 	" = $%&' ∙ [*],-.[*] 
B. $%&' = /0&1 ∙ [E3] 
C. 45 = 	 678.69:;68  
Figure 1-3 – The Michaelis-Menten equation 
A.  The Michaelis-Menten equation describing the rate of a reaction (v) in terms of Vmax, 
KM, and substrate concentration [S]. 
B.  Vmax is the maximum velocity that reaction can achieve if substrate concentration is 
extrapolated towards infinity.  It is proportional to the kcat multiplied by the total 
enzyme concentration [ET]. 
C.  KM is often referred to as the Michaelis constant.  It is an aggregate constant 
describing the rate of ES breakdown (k-1 + kcat in Figure 1-2) divided by the rate of ES 
formation (k1 in Figure 1-2).  KM is described in units of substrate concentration and is 
equal to the substrate concentration which yields a rate (v) of half Vmax. 
 
 
 
E + S ES E + P
k1
k-1
kcat
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Similar equations can be constructed to describe the effects of two substrates, 
although this also depends on the reaction mechanism (random sequential, ordered 
sequential or ping-pong), shown in Table 1-1.  Sequential steady state, ordered 
sequential rapid equilibrium and ping-pong equations are most commonly used 
(Cook and Cleland, 2007).  For three of more substrates, the method of King-Altman 
may be used to derive an equation (King and Altman, 1956).   
  
Table 1-1 - Equations describing bi-substrate enzyme catalysed reactions 
Ordered sequential 
steady state and 
Random 
sequential 
 
" = $%&' ∙ [A] ∙ [B](4?@ ∙ 45A) + (45@ ∙ [B]) + (45A ∙ [A]) + ([A] ∙ [B]) 
Ordered sequential 
rapid equilibrium 
" = $%&' ∙ [A] ∙ [B](4?@ ∙ 45A) + (45A ∙ [A]) + ([A] ∙ [B]) 
Ping-Pong 
 
" = $%&' ∙ [A] ∙ [B](45@ ∙ [B]) + (45A ∙ [A]) + ([A] ∙ [B]) 
The three most commonly used rate equations for bi-substrate reactions.  Substrate 
concentrations are shown as [A] and [B].   
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1.1.5 The six classes of enzyme 
All of the enzymes identified to date have been classified according to six Enzyme 
Commission numbers (EC numbers), according to the reactions they catalyse 
(Schomburg et al., 2013).  These are detailed in Table 1-2 (Meyer, Ghisalba and 
Leresche, 2014). 
 
Table 1-2 – Six enzyme classes  
EC number and name Reaction catalysed 
EC 1. Oxidoreductases Oxidation or reduction reactions.  This involves the 
transfer of electrons from an electron donator to an 
electron acceptor, typically involving cofactors such as 
NAD(P)H or NAD(P)+, which must be regenerated for 
industrial use. 
EC 2. Transferases Transfer of a specific group from one substance to 
another, including methyl, acyl, amino, glycosyl or 
phosphate groups. 
EC 3. Hydrolases Hydrolysis of a substrate with water to form two 
products.  This reaction can be made to work in the 
reverse direction when water is excluded from the 
reaction mixture. 
 
EC 4. Lyases Cleavage of various chemical bonds by means other 
than hydrolysis or oxidation.  Can be made to work in 
the reverse direction. 
EC 5. Isomerases The conversion of one isomer of a molecule to another. 
EC 6. Ligases The linking of two molecules generally coupled with the 
hydrolysis of ATP or other NTP. 
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1.1.6 Enzyme discovery 
Theoretically, almost any organic chemical reaction could be carried out by 
enzymes.  However, we are limited by the enzyme activities known to us currently 
(Meyer et al., 2013).  Of the six enzyme classes, hydrolases have received by far the 
most attention in the past.  Recently substantially more interest has been shown in 
oxidoreductases and to a lesser extent transferases, as shown in Figure 1-4 (Meyer 
et al., 2013). 
 
Figure 1-4 - Overview of the enzyme classes presented as oral or poster presentations 
at previous Biotrans Symposia. 
Data are presented at a % of the total in each year – taken from (Meyer et al., 2013). 
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1.1.7 The enzyme toolbox for synthetic chemistry 
Most industrial biotransformations are performed by chemists.  For enzymes to be 
routinely used by chemists for the synthesis of new molecules, a toolbox full of 
different enzymes capable of carrying out a range of reactions and accepting a range 
of substrates is required (Meyer, Ghisalba and Leresche, 2014).  Some enzymes in 
particular have secured their place in the enzyme toolbox for synthetic chemistry 
(Table 1-3), with many well-characterised enzymes available commercially, and a 
host of case studies demonstrating their uses (Woodley, 2008).  Often a panel of 
enzymes of the same class is required to allow a broad range of substrates to be 
accepted, or to function over a range of conditions.  Where a panel of well-
characterised enzymes is available, it allows chemists to consider these reactions 
with more confidence when designing new synthetic routes to target molecules.  
Described in Table 1-3 are a number of enzymes considered part of the enzyme 
toolbox for synthetic chemistry, a toolbox which is expanding rapidly as sustainable 
chemistry becomes increasingly prevalent  (Pollard and Woodley, 2007; Turner and 
O’Reilly, 2013).  
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Table 1-3 - The enzyme toolbox for synthetic chemistry. 
(Pollard and Woodley, 2007; Turner and O’Reilly, 2013). 
Enzyme class Description Reactions 
Esterases, 
lipases, 
proteases, 
amidases and 
nitrilases 
Hydrolases are probably the most widely 
used biocatalyst industrially and are 
especially attractive for the resolution of 
chiral compounds.   Esterases and lipases 
catalyse the hydrolysis of ester bonds, with 
lipases catalysing the hydrolysis of longer 
acyl chain compounds such as fats and 
oils.  Proteases or amidases catalyse the 
hydrolysis of amide bonds (Meyer, 
Ghisalba and Leresche, 2014).  Nitrilase 
enzymes have also been gaining attention 
recently for the hydrolysis of nitriles into 
carboxylic acids and ammonia (DeSantis et 
al., 2002).  Hydrolase enzymes can also be 
made to work in the reverse direction when 
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they are used in the absence of water 
(Meyer, Ghisalba and Leresche, 2014).   
Halohydrin 
Dehalogenases 
(HHDHs) 
Halohydrin dehalogenases (HHDHs) are 
lyases which can catalyse the ring closure 
of halohydrins producing epoxide rings, or 
the ring opening of epoxides via the 
addition of nucleophiles such as cyanide, 
azide or nitrite ions (Van Hylckama Vlieg et 
al., 2001).   
 
Ketoreductases 
(KREDs) and 
Alcohol 
Dehydrogenases 
(ADHs) 
 
Ketoreductases and alcohol 
dehydrogenase are enzymes that 
reversibly catalyse the reduction of 
aldehydes and ketones to primary or 
secondary alcohols.  Various enzymes 
have been shown to accept a wide range of 
substrates including both aliphatic and 
cyclic compounds.  They can also be used 
in the oxidative direction for the oxidation of 
alcohols to aldehyde and ketones, or even 
 
R
OH
X
R O R S
R
OH
OH / NO2 / CN / N3
O
O
NH
HHDH HHDH
HH
DH
HHDH
nuc
leop
hile
nucleophile
nucleophile
R1
O
R2
NAD(P)H+
R1
OH
R2
NAD(P)++
R1
O
H
NAD(P)++
R1
O
OH
NAD(P)H+
KRED
ADH
KRED
ADH
Basic
	36	
aldehydes to carboxylic acids (Kaluzna, 
David Rozzell and Kambourakis, 2005).  
NAD(P)+ or NAD(P)H are used as cofactors 
by these enzymes which must be 
regenerated for industrial use. 
Transaminases 
(ATAs) 
Transaminases, also known as 
aminotransferases, catalyse the conversion 
of ketones to primary amines via the 
addition of an amine donor such as 
alanine, resulting in a ketone by-product.  
The reaction is dependent on pyridoxal 5ʹ-
phosphate (PLP) and is equilibrium driven.  
Transaminases allow the production of 
enantiomerically pure primary amines, 
which are valuable chiral intermediates for 
the preparation of pharmaceutical products 
(Green, Turner and O’Reilly, 2014). 
 
Carboxylic acid 
reductases 
(CARs) 
Carboxylic acid reductases are a relatively 
new class of enzyme for biocatalysis which 
catalyses the reduction of carboxylic acids  
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to aldehydes via an NADPH and ATP 
dependent reaction.  The reduction of 
carboxylic acids chemically is difficult 
requiring harsh chemicals and carboxylic 
acid reductases represent a much greener 
alternative (Napora-Wijata, Strohmeier and 
Winkler, 2014). 
Enoate reductase 
(EREDs) 
Enaote reductases, members of the “old 
yellow enzyme” family, catalyse the 
stereoselective reduction of alkenes 
featuring an electron withdrawing group.  
The use of enoate reductases in whole-cell 
reactions can be challenging due to 
undesired carbonyl reduction (Stuermer et 
al., 2007). 
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Monoamine 
oxidase (MAOs) 
Monoamine oxidases catalyse the 
oxidation of monoamines into imines.  
Typically the imine is hydrolysed by water 
to produce a carbonyl and ammonia, 
although a reducing agent can be used to 
reduce the imine which is useful for kinetic 
resolution of amines (Edmondson et al., 
2003). 
 
Cytochrome P450 
(P450 
Monooxygenases) 
Cytochrome P450’s are heme-containing 
proteins which are generally the terminal 
oxidase enzymes in electron transfer 
chains, as well as having other key roles in 
primary and secondary metabolism or drug 
degradation.  They are useful enzymes 
industrially for the oxy-functionalization of 
carbon-hydrogen bonds.  However, they 
can also catalyse a range of reactions via a 
similar mechanism including, epoxidation, 
sulfoxidation and dealkylation, although 
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hydroxylation is the most common (O’Reilly 
et al., 2011; Urlacher and Girhard, 2012).  
Baeyer-Villiger 
Monooxygenases 
(BVMOs) 
Baeyer-Villiger Monooxygenases (BVMOs) 
are flavin-containing, O2 and NAD(P)H 
dependent enzymes.  They catalyse the 
oxidation of ketone or heteroatom 
containing molecules for Baeyer-Villiger 
oxidations and sulfoxidations (Torres 
Pazmino, Dudek and Fraaije, 2010). 
 
Aldolase Aldolases catalyse asymmetric carbon-
carbon bond formation between a 
nucleophilic carbonyl such as 
acetaldehyde, dihydroxyacetone or pyruvic 
acid, and a broad range of different 
electrophilic aldehydes (Turner and 
O’Reilly, 2013).  They exhibit excellent 
specificity and recently attempts at tailoring 
substrate and stereospecificity de novo 
have been carried out (Windle et al., 2014). 
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1.1.8 Expanding the enzyme toolbox 
The total number of microbial species on Earth is estimated to be 1012 (Locey and 
Lennon, 2016), offering a huge wealth of protein diversity (Guazzaroni, Silva-Rocha 
and Ward, 2015).  Vast numbers of bacterial genomes are now being sequenced 
with third generation sequencing potentially able to produce a finished genome in a 
few hours (Land et al., 2015).  Bioinformatics tools such as the commonly used basic 
alignment search tool (BLAST) allow genomes to be mined for protein sequences of 
interest (Altschul et al., 1990).  However, whilst between 103-105 microbial species 
are estimated to be present in just 1 g of soil, less than 1 % can be cultured using 
existing methodologies.  Metagenomics avoids the need to isolate and cultivate 
individual microorganisms and has been proven as a powerful tool in identifying 
novel enzymes with potential for industrial applications (Guazzaroni, Silva-Rocha 
and Ward, 2015).  
Natural enzymes are generally not optimised for industrial purposes.  Biocatalysts 
with increased turnover numbers and lower KM values for their industrial substrate 
are highly desirable.  Increased catalytic efficiency on insoluble substrates, 
increased stability at both higher temperature at extremes of pH, higher tolerance to 
end production inhibition and stability in various solvents are all desirable attributes 
which can be engineered into an enzyme depending on the requirements (Dalby, 
2007). 
Two main approaches to enzyme engineering have been used previously.  The first 
enzyme engineering attempts used rational design requiring detailed knowledge of 
the enzyme structure.  Subsequently, random mutagenesis has been used to 
generate libraries of enzyme variants which are then screened in a process 
commonly referred to as directed evolution.  Screening approaches are required to 
test all of the enzyme variants created, often with subsequent rounds of evolution 
towards a directed target.  Currently, this is the most problematic part of a directed 
evolution process, with some types of reaction particularly difficult to screen for, 
especially when multiple traits are required.  In recent years some library sizes have 
become much larger requiring high throughput screening technologies to be used 
(Woodley, 2013).   
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Structural knowledge, catalytic insight and multiple sequence alignment of protein 
sequence datasets can allow the construction of much smaller high-quality libraries 
with a greater chance of success, requiring fewer variants to be screened (Woodley, 
2013).  Recent trends have also seen the use of computational tools such as 
molecular modelling or even de novo design to complement structural analysis and 
directed evolution (Damborsky and Brezovsky, 2014). 
1.1.9 Using enzymes - isolated enzymes or whole-cells 
Enzymes may be used as isolated enzymes or maintained within the host cells 
expressing the enzyme for use as a whole-cell biocatalyst, as shown in Figure 1-5.  
The use of enzymes in whole cell systems have a number of advantages such as 
including cofactor regeneration utilising host metabolic pathways, improved stability 
of the enzyme inside the cell and no requirement for isolation of the enzyme from the 
host resulting in a less complex upstream process (Ladkau, Schmid and Bühler, 
2014).  However, whilst whole-cell biocatalysis can offer an easier upstream 
process, it suffers from a greater complexity downstream as products must be 
isolated from cells once the reaction is complete, and unwanted side reactions can 
occur resulting in a less pure product (Duetz, Van Beilen and Witholt, 2001).  
Furthermore, achieving a high productivity can be challenging as diffusion across cell 
membranes is often rate limiting, and high substrate concentrations can be hard to 
achieve due to toxicity effects.  Furthermore, the reaction itself is more difficult to 
control as any changes must be engineered into the microorganism (Schrewe et al., 
2013; Ladkau, Schmid and Bühler, 2014). 
Isolated enzymes allow the downstream processing of a reaction to be much 
cheaper and simpler (du Preez et al., 2015).  Side reactions are reduced and a high 
purity product can be easily isolated.  Possibly the biggest advantage is the ability to 
simply control these reactions.  Changing the concentrations of enzyme, substrate, 
co-solvent, pH and temperature can allow the most efficient process possible to be 
designed (Fessner, 2015).  However, the use of isolated enzymes also comes with a 
number of challenges and problems.  Isolated enzymes can be less stable than they 
are inside the cell, and there is no possibility of producing more enzyme as there is 
in a whole-cell system.  Therefore stability is an important factor for the use of 
isolated enzymes, with high stability necessary for an economical process.  Cofactor 
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regeneration systems can also be necessary (Oroz-Guinea and García-Junceda, 
2013).  Furthermore, to properly optimise an in vitro reaction enzymes must be 
properly characterised (Vasić-Rački, Findrik and Vrsalović Presečki, 2011).  A 
comparison of the advantages and disadvantages of whole-cell and isolated enzyme 
biocatalysis is shown in Table 1-4. 
 
Figure 1-5 - Whole-cell vs Isolated enzymes.     
A comparison of the use of whole-cells and isolated enzymes for biocatalysis.  An example 
reaction is shown consisting of a reversible reaction catalysed by enzyme E1, and an 
oxidoreductase enzyme E2 using NADH.  In this example NADH can be regenerated by the 
host metabolism using whole-cell biocatalysis, or can be regenerated using a third enzyme 
E3 if isolated enzymes are used.  Whole-cell biocatalysis offers a simpler upstream process 
in that enzymes do no need to be purified, and cofactors can be regenerated.  However side 
reactions can occur and diffusion across the cell membrane, as shown in the figure, can be 
rate limiting.  The use of isolated enzymes overcomes some of these problems but the 
addition of a cofactor regeneration system is often needed, and enzymes must be isolated 
and purified before use. 
 
 
 
 
 
 
DE
Host Metabolism
A B C
NADH NAD+
A C
ø ø ø
E1 E2
A B C
NADH NAD+
E1 E2
E3
Transcription
Translation
Transcription
Translation
Whole-cell Isolated enzyme 
	 43	
Table 1-4 - A comparison of whole-cell and isolated enzyme biocatalysis 
(Oroz-Guinea and García-Junceda, 2013; Fessner, 2015) 
Whole-cell advantages 
• No need to isolate enzymes. 
• Enzymes are generally more 
stable in the cellular 
environment. 
• Cofactors can be regenerated 
using the host metabolism. 
 
Isolated enzymes advantages 
• Processes can be controlled and 
optimised simply by changing 
parameters such as enzyme or 
substrate concentration. 
• Faster rates as no cellular membrane. 
• Few side reactions occur. 
• High substrate concentrations and 
solvents are better tolerated. 
• Product purification easier. 
Whole-cell disadvantages 
• Diffusion of the substrate or 
product across the cell 
membrane can be rate limiting. 
• Side reactions can occur 
resulting in lost substrate or 
product. 
• Cells may be less robust against 
high substrate concentrations or 
the use of solvents. 
• Process is difficult to control. 
Isolated enzymes disadvantages 
• Cofactor regeneration is needed for 
some enzymes. 
• Enzymes may be less stable and are 
not regenerated. 
• Enzyme isolation is required. 
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1.1.10 Are enzymes always green? 
Whilst enzymes do have a number of attractive properties, they are often cited as a 
green alternative without an evaluation of the economic feasibility or environmentally 
friendliness taking place.  For example, many synthetically interesting substrates are 
hydrophobic, possessing poor solubility in aqueous media which is generally used 
for enzyme reactions (Domínguez de María and Hollmann, 2015).  To overcome this, 
reactions must be carried out in the millimolar range resulting in large volumes of 
aqueous media being used.  Once the reaction is complete this is considered waste 
which must be further treated, requiring energy and reagents to do so resulting in a 
poor environmental (E) factor (defined as the ratio of the mass of the waste per mass 
of product) overall (Leuchs, Na’amnieh and Greiner, 2013).  Furthermore diluted 
biocatalysis with low substrate loadings is economically quite inefficient and can only 
be profitable if the product is of high value.  As a rule of thumb for fine chemicals, 
processes should run at a minimum of > 50 - 100 g substrate L−1 (Woodley, 2013).   
To overcome these solubility challenges some reactions can be run with water-
miscible co-solvents such as methanol, ethanol, tert-butanol or iso-propanol.  Whilst 
this can allow higher substrate concentrations to be used it also results in higher 
product concentrations which can result in undesirable product inhibition 
(Stepankova, Damborsky and Chaloupkova, 2013).  Hydrophobic co-solvents can 
also be used for a two liquid phase system, acting as both a substrate reservoir and 
product sink.  Solvents such as butyl acetate, tert-butyl methyl ether or 2-methyl 
tetrahydrofuran have been used for this purpose (Woodley and Lilly, 1990).  Other 
interesting approaches include the use of ionic liquids (Yang and Pan, 2005).  
1.1.11 Industrial Biocatalysis  
According to a recent review of biocatalysis by the Swiss Industrial Biocatalysis 
Consortium (SIBC), the industries using biotechnology in terms of value added can 
be ranked as 1.  Pharmaceuticals, 2.  Food industry, 3.  Agrochemicals, 4.  
Cosmetics, 5.  Polymers and 6.  Others.  While biocatalysis is most widely used in 
the production of pharmaceuticals, unfortunately timeline compressions during 
development mean that biocatalysis often represents the second generation process 
choice.  Where enzymes are employed in the production of pharmaceuticals, 
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oxidoreductases followed by hydrolases are by far the most commonly used enzyme 
classes (Meyer et al., 2013). 
A number of enzymes were also identified by the consortium as being a priority in 
the development of new enzymes for biocatalysis.  NAD(P)H dependent 
dehydrogenases for the reduction of ketones, ketoacids, olefins and other chemicals, 
and the oxidation of alcohols by alcohol dehydrogenases were identified as the top 
enzyme reactions which would ideally be developed (Meyer et al., 2013). 
In 2012 biotechnology as a whole generated at least $324 billion in the US alone, 
with industrial products (biofuels, enzymes, biomaterials and biochemicals) 
representing at least $104 billion of this.  Biotechnology continues to grow more 
quickly than other industries although it is difficult to predict for how long this may 
continue (Carlson, 2016).   
The opportunity for combining bio-bio or bio-chemo catalysis steps has been 
identified as having great potential, especially as multiple enzyme steps may be 
combined utilising the same reaction conditions.  However commercial processes 
utilising more than one enzyme step are still rare (Wells and Meyer, 2014).   
1.1.12 Multistep biocatalysis 
Reactions in which multiple catalysts work together for one-pot reactions are 
becoming increasingly popular.  Combining reactions into one process removes the 
need to isolate substrates and products at each step, which gives excellent cost and 
productivity benefits (Turner and Truppo, 2013).  Multistep pathways can also allow 
reversible processes to become irreversible, or remove inhibitory products (Oroz-
Guinea and García-Junceda, 2013). 
Enzymes are well suited to integration into multi-step pathways and indeed this is 
how they function in nature, catalysing complex metabolism networks (Ravasz et al., 
2002).  In contrast chemical steps will often have differing reaction conditions making 
multi-step one pot reactions challenging to achieve (Wells and Meyer, 2014).  
Enzymes are particularly attractive for the conversion of simple and cheap starting 
materials into high value enantiomerically pure products (Turner and Truppo, 2013). 
	46	
Synthetic biology concepts offer an excellent framework from which to consider the 
development of multi-step biocatalysis pathways.  Synthetic biology aims to allow the 
rational design of complex biological systems: if biocatalysis is to become a widely 
adopted technology for sustainable chemical synthesis this is something that should 
be embraced (Bujara et al., 2010).    
1.2 Thermophiles  
1.2.1 Thermophiles in Biocatalysis 
Enzyme stability can be a critical parameter in the development of effective 
biocatalytic processes (Bujara et al., 2010).  Enzymes from thermophiles offer an 
excellent starting point in overcoming this problem in that they have increased 
stability not only at high temperatures but also against organic solvents, extremes of 
pH or proteolytic enzymes (Atomi, Sato and Kanai, 2011).  Enzymes from 
thermophiles can also be used at ambient temperatures and “thermozymes” will 
often have a much longer half-life at these temperatures than their mesophilic 
counterparts, giving them a higher total turnover number (TTN) and making them 
very attractive for industrial use (Rogers and Bommarius, 2011).   
Thermozymes can be over expressed in a mesophilic host such as Escherichia coli.  
This gives advantages such as allowing easy purification by differential thermal 
stability with respect to most of the proteins from the host, as well as a good 
understanding of the genetic tools and fermentation technology for these organisms 
(Demirtas, Kolhatkar and Kilbane, 2003).   
On the other hand, production in a mesophilic host has its disadvantages.  
Thermophilic proteins can often be insoluble in mesophilic bacterial cells, forming 
inclusion bodies (Peng et al., 2012).  Sometimes thermozymes that form oligomers, 
require post-translational modification, proteolytic cleavage or suitable chaperones, 
are difficult to express in mesophilic hosts (Cava, Hidalgo and Berenguer, 2009).  
However, most notably there is no opportunity for thermophilic whole-cell 
biocatalysis while using a mesophilic host, an area which is widely anticipated yet 
has remained largely undeveloped (Taylor et al., 2011).  
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1.2.2 Thermophile classification, identification and their place in 
the tree of life 
Thermophiles are organisms which grow at high temperatures, classified as 50 oC 
and above. The theoretical limit for life is 150 oC (Van Dover, 2000) although to date 
life has only been found at a maximum temperature of 121 oC (Kashefi and Lovley, 
2003).  Thermophiles are further categorised into moderate thermophiles, which 
grow between 40 and 60 oC, extreme thermophiles between 60 and 85 oC, and 
hyperthermophiles for organisms that can live at greater than 85 oC (Madigan et al., 
2012). 
Thermophiles have been identified from a variety of natural and man-made sources 
including geothermal and volcanic areas, deep-sea hydrothermal vents, 
geothermally heated oil and petroleum reserves, solar-heated soils or sediments, 
acid mine drainage and acidic effluents, biological wastes and waste treatment 
plants and self-heated compost piles (Mehta and Satyanarayana, 2013). 
Many hyperthermophiles are located on short branches near the base of rooted 
phylogenetic trees based on 16S rRNA sequences (Glansdorff and Xu, 2004).  This 
observation has led to the hypothesis that the last common ancestor of all extant 
organisms was possibly a hyperthermophile, and that life originated at high 
temperatures.  However, there is still much debate around this (Stetter, 1996; 
Farmer, 1998).   
For a microbe to grow at high temperature, major components such as proteins, 
nucleic acids and lipids must be able to resist heat.  Thermophiles have various 
adaptions allowing them to survive and thrive at high temperatures (Mehta and 
Satyanarayana, 2013) 
1.2.3 DNA stabilisation in thermophiles 
Several techniques are employed by thermophiles in order to stabilise their DNA at 
high temperatures.  Many hyperthermophiles possess a reverse gyrase, which is a 
type I DNA topoisomerase that catalyses the positive super coiling of closed circular 
DNA.  Positive supercoiling of DNA is thought to be an important factor in stabilising 
DNA at high temperatures (Heine and Chandra, 2009).    
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Other proteins have also been shown to be active in maintaining DNA in 
hyperthermophiles at high temperature.  For example some Euryarchaeotes contain 
histone-like proteins, which act in a similar way to the core histones of Eukaryotes, 
winding and compacting DNA into nucleosome like structures allowing DNA to be 
maintained in a double stranded form at high temperatures (Sandman, Pereira and 
Reeve, 1998).  Other small DNA-binding proteins can bind to the minor groove of 
DNA non-specifically, increasing the melting temperature of DNA by up to 40 oC 
(Robinson et al., 1998).   
Compatible solutes such as polyamines can also stabilise DNA, in addition to other 
molecules (Kurz, 2008).  Monovalent and divalent salts are able to enhance the 
stability of DNA as they can screen the negative charge of the phosphate backbone.  
Salts such as KCl and MgCl2 have also been shown to protect DNA from 
depurination and hydrolysis (Marguet and Forterre, 1998). 
Some thermophilic bacteria show a higher than average GC content (Marashi and 
Ghalanbor, 2004).  G-C pairs are to be more thermostable due to an additional 
hydrogen bond, and it has been considered that thermophiles are using a higher GC 
content to stabilise their DNA (Galtier, Tourasse and Gouy, 1999).  However there 
are also many examples of mesophiles with a high GC content (Dillon et al., 2015), 
and thermophiles with a more average GC content (Rozanov, Logacheva and 
Peltek, 2014).  An analysis of the GC content of a number of different prokaryotes 
did not detect a significant correlation of GC content with optimum growth 
temperature, although a correlation of GC content in structural RNAs with optimum 
growth temperature was detected (Hurst and Merchant, 2001).   
The GC content of an organism has a strong effect on the amino acid composition of 
their proteins.  High GC content may be a result of a preference for certain amino 
acid residues, which may be involved in coping with elevated temperatures (Wu et 
al., 2012).  For example Thermus thermophilus, which has a GC content of 70 %, 
uses many proline residues to help stabilize its proteins, and these are coded by 
CCT, CCC, CCA, CCG (Imada et al., 1991; Littlechild et al., 2013).   
	 49	
1.2.4 Lipid bilayer stabilization in thermophiles 
Membrane lipid composition is a major factor in determining growth temperature, and 
because of this the maximum span of temperatures possible for an organism to grow 
at is 40 oC.  At lower temperatures lipids become more rigid, while at higher 
temperatures they become more disordered and crystalline.  Thermophilic bacteria 
and archaea have different methods of altering their membrane lipid composition to 
meet their growth temperature (Mehta and Satyanarayana, 2013). 
The lipids of thermophilic bacteria are all ester linked, with the fluidity of the 
membrane due to the fatty acid chain composition.  As temperature is increased, 
chain length increases, saturation increases and there is an increase in branching 
(Koga, 2012). 
The lipids of archaea are ether linked.  These are either diethers forming a bilayer 
membrane, or tetraethers forming a monolayer membrane. The hydrocarbon chain 
lengths are always fixed at either 20 or 40 carbons.  All hyperthermophiles have a 
tetraether membrane, and at very high temperatures cyclisation of the acyl chains 
can be introduced.  The failure of bacteria to grow above 80 oC is thought to be due 
to a lack of tetra ether lipids (Koga, 2012). 
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Figure 1-6 – Examples of the lipids of bacteria and archaea. 
A. The lipids of bacteria have ester linkages.  A phospholipid is shown as an example.  
They form bilayers with the fluidity of the membrane determined by the fatty acid 
composition. 
B. The lipids of archaea have ether linkages.  They form either diethers forming a 
bilayer, or tetraethers, as shown in the figure, forming a monolayer.  Tetraether lipids 
allow the membranes of hyperthermophiles to be stable at higher temperatures 
(Koga, 2012). 
R is used to represent functional groups that might be incorporated as part of the head 
group. 
1.2.5 Stabilisation of thermophilic proteins 
When proteins are denatured by insults such as elevated temperature, the 
combination of non-covalent forces holding the protein in its tertiary structure, which 
includes hydrogen bonds, ion pairs, hydrophobic bonds and Van der Waals 
interactions, are disrupted.  The protein unfolds and is prone to aggregation as 
exposed hydrophobic residues interact with the hydrophobic residues of other 
proteins.  Chemical modifications such as cysteine oxidation, deamination of 
asparagine and glutamine residues and peptide bond hydrolysis also can occur 
(Littlechild et al., 2013). 
The proteins of thermophilic organisms must also be adapted to function at high 
temperature.  Generally, these adaptions result in much more stable proteins overall, 
giving resistance against other factors such as solvents or extremes of pH (Gomes 
and Steiner, 2004).  This makes the enzymes of thermophiles (sometimes called 
thermozymes) very attractive for industrial processes (Littlechild, 2015).  These 
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adaptions are often unpredictable.  However some trends can be observed and are 
summarised in Table 1-5 (Li, Zhou and Lu, 2005). 
Some amino acids are more prone to chemical modification while others have 
advantageous properties conferring thermostability.  Comparisons between proteins 
from thermophiles and mesophiles show some trends for increases or decreases in 
certain amino acids, although these adaptions vary between proteins which is not 
surprising given their different environments and tertiary structures.  An increasing 
frequency of charged residues in thermophilic proteins has been observed, along 
with a decrease in polar, uncharged residues.  This likely increases the number of 
ionic interactions available to stabilise the structure (Littlechild et al., 2013).   
There is a trend for the replacement of glycine with alanine possibly stabilising a-
helices, and lysine with arginine which is less susceptible to chemical attack at high 
temperatures (Vieille, Zeikus and Vieille, 2001).  Cysteine residues are also less 
common in thermophilic proteins, except where they are required for activity, as they 
are susceptible to oxidation at high temperatures.  Increased frequencies of aromatic 
and proline residues can offer greater rigidity, conferring thermostability (Fleming 
and Littlechild, 1997; Korkhin et al., 1999) 
Hyper-thermophilic proteins have been shown to have substantially more ion pairs 
than mesophilic proteins (Aguilar et al., 1997).  The ion pairs in thermophiles are 
often observed clustered together, forming extended ionic networks offering even 
greater stability than the action of the ionic bonds alone (Isupov et al., 1999).   
Proteins fold so as to bury their hydrophobic residues within their core, and this is 
known to play a major role in protein stability.  An average increase in stability of 1.3 
kcat mol-1 has been calculated for each additional methyl group buried in protein 
folding (Pace, 1992).   
Hydrophobic interactions are thought to be key to the thermostability of a number of 
thermophilic proteins, and increased hydrophobic interactions are observed at 
subunit interfaces in the crystal structures of many hyperthermophilic proteins.  
Furthermore, thermophilic proteins are often found to adopt a higher oligomeric state 
than their mesophilic counterparts (Singleton, Isupov and Littlechild, 1999; Littlechild 
et al., 2013).   
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Often a reduction in the frequency and length of external loops is observed in 
thermophilic proteins (Vieille, Zeikus and Vieille, 2001).  In addition to this loops can 
be better anchored to the rest of the structure through interactions such as ion pairs, 
hydrogen bonding or hydrophobic interactions.  Often N- or C- termini can be seen 
anchored to the core or even interacting with each other increasing stability 
(Auerbach et al., 1997; Littlechild et al., 2013).   
Table 1-5 - Adaptions that can increase thermostability (Littlechild et al., 2013). 
• Increased hydrogen bonding. 
• An increase in ionic interactions.  Networks of ionic interactions can give 
greater stability than the sum of the ionic interactions alone.  
• Increased hydrophobicity in the core. 
• Stabilisation of a-helices. 
• Increased packing to fill internal cavities such as C-terminal extensions and 
additional secondary structure. 
• Binding of metal ions. 
• Shorter surface loops, or loops stabilised by interactions with metal ions. 
• More rigidity, less flexibility.  For example by increased proline content.   
• Increased usage of disulphide bonds. 
 
1.3 Whole-cell biocatalysis at elevated temperatures 
1.3.1 The potential for whole-cell biocatalysis at elevated 
temperatures. 
While the enzymes of thermophiles are often employed for industrial biocatalysis, 
whole-cell biocatalysis in a thermophilic host is an area which is widely anticipated, 
yet fairly undeveloped (Taylor et al., 2011).  Carrying out processes at high 
temperatures have a number of advantages, yet there are also a number of 
challenges and these are summarised in Table 1-6 (Frock and Kelly, 2012).  
Thermophiles are thought to be especially well suited for the consolidated 
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bioprocessing of lignocellulose and the production of fuels such as bioethanol 
(Taylor et al., 2011). 
Table 1-6 - Advantages and disadvantages of whole-cell biocatalysis at 
elevated temperatures.  
(Frock and Kelly, 2012). 
Advantages 
• Reduced risk of contamination. 
• Recovery of volatile products. 
• Lower risk of release of viable 
genetically modified organisms. 
• Higher mass transfer rates. 
• Improved solubility of some 
substrates. 
• High temperatures more 
consistent with some chemical 
processes, allowing integration. 
• Do no need to cool the reactor. 
• Some evidence that 
thermozymes produced 
homogenously can work better 
as biocatalysts (Mei et al., 2012). 
 
Disadvantages 
• Energy burden of heating 
reactor. 
• Currently lower yields of 
biomass. 
• Genetic stability of hosts 
unknown. 
• Lower gas solubilities. 
• Substrate or product lability at 
elevated temperatures. 
• Less known about microbial 
physiology. 
• Genetic tools are undeveloped. 
 
Many of the disadvantages in Table 1-6 relate to the undeveloped nature of whole-
cell biocatalysis at elevated temperatures and more work is needed in order to 
overcome these.  The major challenge is the lack of genetic tools and these must be 
developed in order for a thermophile to be considered for whole-cell biocatalysis 
(Taylor et al., 2011). 
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1.3.2 Potential thermophilic host organisms as cell factories for 
whole-cell biocatalysis 
Several thermophiles have been identified as model organisms at elevated 
temperatures and these are excellent starting points for developing a host chassis 
for thermophilic whole-cell biocatalysis.  Methodologies for gene inactivation and 
genetic complementation have been established for several hyperthermophilic 
archaea, including the euryarchaeon Pyrococcus furiosus and a number 
crenarchaeotic Sulfolobus species (Taylor et al., 2011).  The thermophilic bacterium 
Thermus thermophilus and a range of Geobacillus species are also very promising 
options with genetic systems available (Cava, Hidalgo and Berenguer, 2009; 
Kananavičiute and Čitavičius, 2015). 
P. furiosus, a hyperthermophilic anaerobic archaeon with an optimum growth 
temperature of 98 oC, is able to take up DNA efficiently by electroporation (Farkas et 
al., 2012).  DNA can be integrated into the chromosome utilising the presence or 
absence of pyrF as a marker (Farkas et al., 2012).  An interesting use of P. furiousus 
has been the use of a temperature regulated promoter PcipA, which allows the use 
of resting cells at 72 oC for the expression of heterologous proteins (Basen, Sun and 
Adams, 2012).  P. furiosus has also been shown to be useful for carboxylic acid 
reduction utilising the native aldehyde ferredoxin oxidoreductases and a ferredoxin 
pool pushed towards the reduced form through the use of hydrogen and 
hydrogenase enzymes (Hollmann et al., 2012). 
Sulfolobus species grow in volcanic springs with an optimal growth temperature of 
75 – 80 oC at pH 2.0 to 3.0.  They can be transformed by electroporation and a 
number of genetic tools have been developed for various species.  The best studied 
Sulfolobus species are S. islandicus, S. acidocaldarius and S. solfataricus (Berkner 
and Lipps, 2008).  The deletion of the lacS or pyrF genes has allowed genome 
insertions or deletions to be carried out in these organisms, and would facilitate their 
use of a host organism for whole-cell biocatalysis (Atomi, Imanaka and Fukui, 2012; 
Wagner et al., 2012).   
Geobacilli are Gram-positive, aerobic or facultative anaerobic thermophilic bacteria 
with an optimum growth temperature between 50 and 60 oC.  However, growth 
temperatures can range from 37 to 80 oC.  Similar to Bacillus species they are able 
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to utilise various carbon sources making them an attractive host for biotechnological 
applications.  Electroporation is a common transformation technique for Geobacilli 
although other methods are possible.  Plasmid vectors are available for Geobacilli as 
well as thermostable antibiotic resistance cassettes, most commonly kanamycin, 
which have been used for selection (Kananavičiute and Čitavičius, 2015). 
Thermus thermophilus is a particularly attractive choice as it is naturally competent, 
aerobic and able to grow quickly on complex media such as yeast extract and 
trypticase (Cava, Hidalgo and Berenguer, 2009).  Thermus is one of the most widely 
distributed genera of thermophilic bacteria and many of its isolates carry genes for 
enzymes of great biotechnological potential (Moreno et al., 2005).  Strains HB27 and 
HB8 of T. thermophilus have been widely used as laboratory models due to efficient 
and natural competence and the ability to grow at good rates under laboratory 
conditions (Koyama et al., 1986).  This has allowed the development of a number of 
genetic tools that are able to function at 60-70 oC, including selectable genes, 
cloning and expression plasmids, reporter genes and fluorescent localisation 
markers (Cava, Hidalgo and Berenguer, 2009).  T. thermophilus has been 
investigated as a host organism for whole-cell biocatalysis in this study. 
1.4 In vitro cascade reactions and the application of 
mathematical modelling 
1.4.1 The use of isolated enzymes for biocatalysis in vitro. 
The use of isolated enzymes for cell free biocatalysis have a number of advantages 
as discussed in Section 1.1.9.  Pathways of multiple enzymes for the construction of 
artificial metabolisms in vitro is an exciting concept, often called Systems 
Biocatalysis.  Systems Biocatalysis offers the freedom to design the most 
appropriate sequence of reactions to the target product, free from competing 
metabolic pathways, kinetic restrictions of physical barriers and regulatory circuits, 
toxicity problems (Fessner, 2015).  In vitro biosynthetic systems could surpass the 
constraints of whole cells or cell lysates, with the potential to become a disruptive 
bio-manufacturing platform (Zhang, 2015).  Well defined enzyme modules might be 
used to construct new reactions using synthetic biology approaches, with models of 
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each module allowing quick evaluation of new processes in silico (Ladkau, Schmid 
and Bühler, 2014). 
For the use of isolated enzymes to compete with whole-cell biocatalysis enzyme 
stability is key.  The total turnover number (TTN) of an enzyme can be calculated as 
its turnover number (kcat) divided by its half-life at the process temperature, giving an 
indication of the best enzyme for a process (Rogers and Bommarius, 2011).  Higher 
TTN’s allow much more economically efficient processes to be constructed, with the 
cost of enzyme production relative to the product yield decreasing (Zhang, 2015).  
The use of enzymes from thermophiles is an excellent starting point in greater 
enzyme stability, and engineering and immobilization techniques may be used to 
improve this (Hickey et al., 2007; Woodley, 2013).    As the stability of enzymes is 
improved and the cost per kg of enzyme production is decreased, the use of 
enzymes not only for high value pharmaceuticals or specialty chemicals, but also for 
the production bulk chemicals from renewable feedstocks using isolated enzymes 
becomes feasible (Zhang, 2015).    
However, enzyme production cost is not the only factor in considering a process 
using isolated enzymes.  Oxidoreductases which catalyse many industrially relevant 
reactions typically require cofactors such as NAD(P)H.  For these reactions to be 
economically competitive a method for cofactor regeneration is essential.  
Regeneration can also help drive a reaction to completion and allow the removal of 
inhibitory cofactor by-products.  For cofactor regeneration to be economical and 
practical the total turnover number (TTN) of the cofactor must also be high.  TTNs of 
103 to 105 are often enough to make a process economically viable, although this 
depends on the cost of the cofactor and the value of the product.  Chemical and 
electrochemical strategies generally lack the high selectivity needed to reach high 
TTN’s, and for this reason enzymatic reactions are usually the method of choice for 
cofactor regeneration (Woodyer, Johannes and Zhao, 2003). 
Generally NAD(H) functions in reactions involved in biodegradation while NADP(H) 
is commonly involved in biosynthesis.  However, both are involved in a wide range of 
synthetically useful redox reactions (Woodyer, Johannes and Zhao, 2003).  ATP 
regeneration is also possible but this is an area which is much less developed (Zhao 
and Van Der Donk, 2003). 
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1.4.2 Cofactor regeneration 
Enzymes such as formate dehydrogenase (Berríos-Rivera, Bennett and San, 2002), 
glucose dehydrogenase (Wong and Whitesides, 1980) and isopropanol alcohol 
dehydrogenase have successfully been employed for the regeneration of NADH.  
NADPH-dependent systems are less developed but approaches using glucose 6-
phosphate dehydrogenase or an engineered formate dehydrogenase have been 
used (Kragl et al., 1996; Tishkov et al., 1999; Van Der Donk and Zhao, 2003; 
Woodyer, Zhao and Van Der Donk, 2005).  One of the most promising systems for 
both NADH and NADPH regeneration is the use of phosphite dehydrogenase 
(PTDH) from Pseudomonas stutzeri utilising phosphite as a sacrificial substrate.  
This enzyme has been engineered to accept both NAD+ and NADP+ as substrates 
as well as for improved thermostability (Woodyer, Van der Donk and Zhao, 2003; 
McLachlan, Johannes and Zhao, 2007). 
Another approach for cofactor regeneration is to exploit the reversible nature of the 
reactions catalysed by some oxidoreductases for the regeneration of the cofactor.  A 
sacrificial substrate for a reaction in the reverse direction is used to regenerate the 
cofactor for the reaction of interest (Robins and Osorio-Lozada, 2012).  For example, 
the reduction of ketones to optically active alcohols by ADHs or KREDs can be 
driven by the use of a sacrificial substrate such as 2-propanol being oxidised in the 
opposite direction (Schrewe et al., 2013). 
Techniques for the regeneration of ATP are less well developed (Zhao and Van Der 
Donk, 2003), but four enzymes have been employed for the regeneration of ATP 
from ADP.  Phosphoenolpyruvate coupled with pyruvate kinase (Zhao and Van Der 
Donk, 2003), acetylphosphate coupled with acetate kinase (Yan et al., 2014), 
creatine phosphate coupled with creatine kinase (Wei and Goux, 1992) and 
polyphosphate coupled with polyphosphate kinase (PPK) (Restiawaty et al., 2011).  
Of these, the sacrificial substrate polyphosphate is by far the cheapest while being 
highly stable, although Mg2+ chelation remains a challenge (Kameda et al., 2001).  
For regeneration from AMP, an adenylate kinase or polyphosphate-AMP 
phosphotranferase may also be used (Resnick and Zehnder, 2000; Woodyer, 
Johannes and Zhao, 2003).  
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1.4.3 Using isolated enzymes 
Isolated enzymes can be used as a crude lysate or can be purified further.  Isolated 
enzymes can be used with no further preparation in a simple batch reaction, 
however, operational stability and the ability to re-use enzymes can be greatly 
improved through immobilisation techniques.  Enzymes can be bound to a supports 
or carriers such as synthetic resins, biopolymers or inorganic solids such as silicas 
(Cau, 2006).  Enzymes or carriers can be trapped inside membrane devices such a 
hollow fibre reactors to facilitate their reuse (Kragl et al., 1996).  Alternatively 
enzymes can be entrapped in a polymer network such as polyacrylamide or silica 
sol-gel (Sheldon and Van Pelt, 2013).  Increasingly there is interest in the use of 
carrier-free immobilised enzymes using cross-linked enzyme crystals or aggregates 
(CLECs or CLEAs) (Roy and Abraham, 2004; Sheldon, 2011).  This allows for more 
highly concentrated enzyme activity with high stability and low production costs, 
making this an attractive option.  However every enzyme is different and there no 
“one size fits all” solution to enzyme immobilisation.  Often enzyme immobilisation 
can depend on the type of reactor to be used such as stirred tank, fixed bed, 
fluidised bed reactors, different types of membrane reactors or flow reactors 
(Sheldon and Van Pelt, 2013). 
1.4.4 The use of process modelling in reaction engineering 
Reaction engineering using process models of chemical reactions has for a long time 
been an efficient and effective method for the design of reaction systems 
(Charpentier, 2002).  In moving from the lab to the process plant a process model 
can be invaluable allowing decisions to be made on a firm foundation.  Often 
biocatalysis processes do not make this transition well.  One of several reasons is 
the complexity of enzyme kinetics and the lack of available models (Ringborg and 
Woodley, 2016).   
Equations such as those above may be used to construct mechanistic models of a 
biocatalysis process.  The process of building a model can facilitate a fuller 
understanding the dynamics of a reaction, and uncover phenomena that might 
otherwise be missed.  It can be used as a summary of the available process 
information (Tufvesson et al., 2013).  Furthermore, a validated model can be 
exploited to optimise a reaction or explore other process options (Rios-Solis et al., 
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2015).  The construction of a model early in the development process can be an 
invaluable asset in determining the feasibility of a reaction in terms of cost and 
benefit, or to highlight specifically where enzyme engineering could give substantial 
gains (Sin, Woodley and Gernaey, 2009).  Changes to the process can be simulated 
in silico allowing processes decisions to be well informed (Ringborg and Woodley, 
2016).   
An alternative to building a mechanistic model for the optimisation of a process is 
data driven modelling (Solomatine and Ostfeld, 2008).  A good example of this is the 
use of design of experiments methodologies allowing the generation of a response 
surface.  This is a powerful tool and one which is gaining popularity within the 
synthetic biology community in general (Kennedy and Krouse, 1999).  However, it 
operates as a black box, offering little information on the intricacies of the reaction 
itself which may offer substantial insight or improvements to a process (Vasić-Rački, 
Findrik and Vrsalović Presečki, 2011).    
Good modelling practice should be used for the construction of process models.  
Uncertainty and sensitivity analysis can be used to show the confidence in the 
model’s predictions, and to understand which parameters are the most sensitive to 
error, giving greater uncertainty in the final model prediction (Sin, Gernaey and 
Lantz, 2009).  Where standard errors or 95 % confidence intervals have been 
reported for a parameter these may be used in the uncertainty analysis.  In other 
cases parameters can be placed into categories of low, medium or high uncertainty 
with bounds of ± 5 %, ± 25 % and ± 50 % of the parameter value used respectively 
(Sin, Woodley and Gernaey, 2009). 
1.4.5 Genetic algorithms for optimisation 
Genetic algorithms are a technique for the optimisation of a system towards an 
object or objectives.  The concept was developed in the 1960s and 1970s by Holland 
and colleagues (Holland, 1975).  The idea is based on the theory of evolution, in 
which weak and unfit species are faced with extinction by natural selection while 
strong species have more opportunity to pass on their genes to future generations by 
reproduction (Konak, Coit and Smith, 2006).  Genetic algorithms are particularly well 
suited to multi-objective problems and are good at avoiding local minima or maxima 
(Deb et al., 2000). 
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In a genetic algorithm a population of solutions, known as individuals, is ranked 
against an objective function, with the best performing individuals allowed to survive 
or reproduce.  New individuals are generated by the crossover of successful 
individuals and by the introduction of mutations.  Multiple rounds of selection and 
reproduction can be carried out to reach an optimised solution (Konak, Coit and 
Smith, 2006). 
Genetic algorithms represent a useful option for the optimisation of process models 
towards a particular objective function.  Examples include achieving a certain level of 
productivity while minimising cost, minimising the formation of an intermediate or by-
product, or achieving a certain yield of product in a specified time frame with 
minimised cost (Kuhn et al., 2010).   
1.5 Carboxylic acid reductase enzymes and their use in the 
construction of enzymatic cascade reactions 
1.5.1 Carboxylic acid reductases. 
The reduction of carboxylic acids is challenging.  Thermodynamically, COOH is in an 
energetically favourable state and so shows little reactivity, needing a high level of 
energy for activation to participate in chemical reactions (Napora-Wijata, Strohmeier 
and Winkler, 2014).  Chemical reductions of carboxylic acids mostly proceed by the 
formation of an activated derivative via a reaction with complex metal hydrides such 
as lithium aluminium hydride and sodium borohydride used in stoichiometric 
amounts, in the absence of water (Nystrom and Brown, 1947). Since aldehydes are 
more reactive than carboxylic acids, generally the reduction of carboxylic acids 
proceeds through to the respective alcohol (Bhaskar Khant and Periasamy, 1991).   
In contrast carboxylic acid reductase (CAR) enzymes offer a green and regio-
selective alternative without the use of harsh reducing agents in stoichiometric  
amounts (Akhtar, Turner and Jones, 2013).  These are large, multi-domain enzymes 
of approximately 130 kDa in size.  They feature an N-terminal adenylation domain, a 
C-terminal thioester reductase domain that likely adopts a Rossman fold, and a 
central phosphopantetheine binding domain (Marchler-Bauer et al., 2015).  A 
phosphopantetheine arm must be covalently attached to a conserved serine in this 
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central domain through the action of a phosphopantetheine transferase for the 
production of an active enzyme (Venkitasubramanian, Daniels and Rosazza, 2007). 
In our study (Chapter 4) on the characterisation of five CAR enzymes, we show that 
the first step in the proposed reaction mechanism, attack on the alpha phosphate of 
ATP by a negatively charged oxygen of a carboxylic acid substrate, is likely rate 
determining.  The substrate specificity is broad but similar for each of the CARs 
tested with electron rich acids favoured substrates.  We define operational windows 
in terms of pH and temperature for each CAR enzyme.  We also show that each of 
the products of the CAR reaction (PPI, NADP+ and AMP) act as inhibitors and that 
inhibition by PPI gives insight into the ordered binding of substrates at the 
adenylation domain. 
1.5.2 Carboxylic acid reductases (CARs) are well suited for the 
construction of multi-step cascade reactions. 
CARs connect many of the enzymes in the enzyme toolbox (Table 1-3), and so allow 
the construction of attractive multi-step one-pot reactions.  Many hydrolase enzymes 
produce carboxylic acids as one of their products allowing them to be used 
effectively ahead of CARs, with a range of enzymes accepting aldehydes as one of 
their substrates (Turner and O’Reilly, 2013).  This allows CARs to be used in the 
construction of a range of multi-step pathways allowing a large combination of 
reactions to be constructed (France et al., 2016), as shown in Figure 1-7. 
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Figure 1-7 - CARs connect many enzyme reactions allowing a host of multi-step 
reactions to be constructed. 
ADH: alcohol dehydrogenase, ATA: amino transferase, IRED: imine reductase, CAR: 
carboxylic acid reductase.  Cofactors and additional substrates are not shown for clarity. 
 
CARs are well suited for multi-step reactions featuring hydrolase enzymes such as 
esterases.  Nevertheless, chemically the hydrolysis of esters is relatively 
straightforward, typically catalysed using dilute alkali or acid with heating under reflux 
(Girard, 1980).  However a one-pot chemical multistep pathway for the hydrolysis of 
an ester followed by the reduction of the resulting carboxylic acid as is unfeasible, as 
the addition of lithium aluminium hydride does not allow the presence of water 
(Nystrom and Brown, 1947).  In contrast, CARs may be combined with an esterase 
allowing a one-pot reaction.  The addition of an alcohol dehydrogenase to this 
reaction after the CAR step creates a reaction which demonstrates well the potential 
of CARs for multi-step biocatalysis, as detailed in Figure 1-8. 
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Figure 1-8 - Reaction scheme for an enzymatic cascade reaction for the hydrolysis 
and reduction of an ester through to an alcohol 
A carboxylic acid reductase (CAR) may be combined with an esterase (Est) and an alcohol 
dehydrogenase (ADH) for an attractive one-pot process for the hydrolysis and subsequent 
reduction of an ester through to its derivative alcohol.  R and R’ represent any functional 
group, although substrate specificity is limited by the enzymes used. 
1.5.3 Esterases 
Esterases (EC 3.1.1.1) and their cousins the lipases (EC 3.1.1.3) have received 
generous attention in the past as they are widespread throughout nature and are 
very useful for chemical synthesis.  Both esterases and lipases catalyse the 
cleavage of an ester into a carboxylic acid and an alcohol.  Esterases can hydrolyse 
water soluble esters with short acyl chains, while lipases have a preference for 
insoluble esters with an acyl chain of greater than ten carbons in length (Ferrer et al., 
2016). 
Most esterases and lipases belong to the α/β hydrolase protein fold superfamily, 
although examples of enzymes with esterase activity that do not have this fold have 
been found (Upton and Buckley, 1995; Wagner et al., 2002).  Lipases are further 
differentiated from esterases in that they undergo the processes of interfacial 
activation in which a hydrophobic lid domain moves away from the activity site in the 
presence of a minimum concentration of a lipid substrate.  Esterases do not show 
this characteristic and obey classical Michaelis-Menten kinetics (Ferrer et al., 2016).   
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Figure 1-9 - The reaction mechanism of α/β hydrolase enzymes. 
A.  Acylation step.  
1. Histidine and aspartate/glutamate residues deprotonate the catalytic serine promoting nucleophilic attack by the serine oxygen on the 
carbonyl carbon of the ester. 
2.  A tetrahedral intermediate is formed, stabilised by an oxyanion hole. 
3, 4.  An alcohol product is liberated by general acid catalysis by the aspartate/glutamate activated histidine, and the formation of an 
acyl-enzyme intermediate. 
B. Deacylation step. 
5.  A water activated by the histidine residue undergoes nucleophilic attack of the carbonyl carbon of the acyl-enzyme intermediate 
6.  A second tetrahedral intermediate is formed. 
7.  The carboxylic acid product is liberated. 
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Catalysis by esterases which have the classic α/β hydrolase fold generally proceeds 
via a mechanism similar to that of serine proteases, via a catalytic triad of serine, 
histidine and aspartate/glutamate in which an acyl-enzyme intermediate is formed, 
and the alcohol product is released (Kraut, 1977).  The acylation step (Figure 1-9A) 
proceeds via nucleophilic attack on the carbonyl carbon by a catalytically active 
serine, activated by a histidine and an acidic aspartate or glutamate residue, 
resulting in a tetrahedral intermediate.  An oxyanion hole is crucial in stabilising the 
carbonyl oxygen in this intermediate.  An acyl-intermediate is formed with the release 
of the alcohol group (Berg, Tymoczko and Stryer, 2010). 
The second is known as the deacylation step (Figure 1-9B) in which the acyl-enzyme 
intermediate is hydrolyzed releasing the carboxylic acid product.  Generally, the 
deacylation step is much slower than the first step and is considered to be rate 
limiting.  The deacylation step proceeds via hydrolysis of the acyl-intermediate by a 
water molecule, again with the formation of a tetrahedral intermediate before the 
release of the carboxylic acid product (Voet and Voet, 2004). 
Esterases have been used for a variety of biotechnology applications (Levisson, van 
der Oost and Kengen, 2009), including the synthesis of optimally pure compounds 
for food, agriculture and pharmaceutical industries (Romano et al., 2015).  They also 
have found uses in the degradation of natural materials, pollutants, plastics and 
other waste (Gomes and Steiner, 2004).  Esterases are often shown to possess 
excellent stability in organic solvents (Klibanov, 2001) , and to have a broad 
substrate specificity with high region- and stereo- selectivity, making them attractive 
for industrial use (Somers and Kazlauskas, 2004; Yang et al., 2015).   
1.5.4 Alcohol dehydrogenases 
Alcohol dehydrogenases  (ADHs, (EC 1.1.1.1) and keto-reductases (KREDs, EC 
1.1.1.2), catalyse the conversion of ketones or aldehydes to alcohols, or vice versa 
(Kaluzna, David Rozzell and Kambourakis, 2005).  While ADHs and KREDs catalyse 
similar reactions, they are different classes with different overall folds (Hyndman et 
al., 2003; Knoll, 2008).   This is one of the most common redox reactions in organic 
chemistry, however synthetic chemical methods require the use of toxic metals and 
complex hydrides (Brown and Chaikin, 1949).  In contrast, biotransformations offer 
mild reaction conditions with excellent specificity making this an attractive class of 
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enzyme for use in synthetic chemistry (Goldberg et al., 2007).  The majority of the 
dehydrogenases or reductases that can be used for these biotransformations require 
nicotinamide cofactors, and so their regeneration must be considered for the use of 
these enzymes (Kroutil et al., 2004).   
ADHs are distributed widely in nature and have been isolated from species 
throughout the three domains of life (Guy, Isupov and Littlechild, 2003).  The ADH’s 
can be classified according to three classes.  Type I ADHs, or medium chain ADHs 
are dimers or tetramers with each subunit containing approximately 370 amino acid 
residues (Reid and Fewson, 1994).  These ADH’s may also be split into non-zinc 
dependent and zinc dependent, where often both a structural zinc and a catalytic 
zinc is present (Knoll, 2008).  Type II ADH’s, or short chain ADH’s, are generally 
around 250 amino acid residues in length and generally do not contain metals.  Type 
III ADH’s, or long chain ADH’s, are between 380 and 900 amino acids in length and 
are generally iron dependent.  The type III ADH’s show little sequence homology to 
either of the other two classes of ADH (Reid and Fewson, 1994). 
Classic examples of ADH’s include horse liver ADH (HLADH) and yeast ADH1 
(YADH1).  Both of these enzymes are medium chain zinc dependent ADH’s and are 
fairly homologous to each other, except for a deletion of 21 amino acid residues from 
the catalytic domain of yeast ADH1, as well as some other sequence gaps and 
insertions (Raj, Ramaswamy and Plapp, 2014).  Medium chain zinc-dependent 
ADH’s have a conserved tertiary structure made up of two domains, a cofactor 
binding domain and a catalytic domain.  Most are active as dimers or tetramers, with 
a loop segment in the catalytic domain mediating the formation of the quaternary 
structure (Knoll, 2008).  
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The reaction mechanism of HLADH is generally agreed to proceed as follows 
(Agarwal, Webb and Hammes-Schiffer, 2000), as is shown in Figure 1-10. 
1. Binding of NAD+ 
2. Binding of alcohol by coordination with the catalytic zinc 
3. Deprotonation of the alcohol via a proton relay in which the proton is 
transferred via a hydrogen bonded system of hydroxyl groups on Ser48 and 
NAD before reaching His51.  The proton is then transferred to the aqueous 
solvent.  This leads to a zinc bound alkoxide ion 
4. Hydride transfer from the alkoxide ion to NAD+, leading to a NADH and a zinc 
bound aldehyde or ketone 
5. Release of the aldehyde 
6. Release of NADH 
HLADH and YADH1 have been shown to follow a Theorell-Chance mechanism 
(which is a specific case of an ordered bi-bi reaction), in which there is no significant 
build up of EAB or EPQ intermediates (Kuby, 1991).  This occurs as there is direct 
hydride transfer between the substrate and NAD+ (Agarwal, Webb and Hammes-
Schiffer, 2000).   
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Figure 1-10 - Mechanism of horse liver alcohol dehydrogenase. 
The mechanism of alcohol oxidation in the active site of horse liver alcohol dehydrogenase.  
Benzyl alcohol is shown as the substrate in black, with NAD+ in blue and the key residues of 
the protein in green.  The catalytic zinc, coordinated by two cysteines and a histidine is 
shown in orange, and a water molecule in light blue. PT1 to 3 refers to the proton transfer 
relay to His51.  Adapted from (Agarwal, Webb and Hammes-Schiffer, 2000). 
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1.6 Aims and objectives  
As discussed in section 1.1.12, multistep biocatalysis is an attractive prospect 
industrially.  This work aims to investigate the use of a multistep enzymatic cascade 
reaction featuring an esterase, a carboxylic acid reductase and an alcohol 
dehydrogenase for the hydrolysis and subsequent reduction of an ester through to 
an alcohol. 
Enzymes which can take a proof of concept industrially relevant chemical (methyl p-
toluate) to its derivative alcohol will be identified for the construction of this cascade.  
In the process new enzymes are to be explored and characterised to determine their 
potential for biocatalysis.  Carboxylic acid reductases are of particular interest 
industrially and a thorough biochemical characterisation of these enzymes from 
available genomes will be carried out (Chapter 4).  Novel thermophilic esterases will 
also be investigated, with the possibility of collaborations with other work being 
carried out at the University of Exeter (Chapter 3).   Where possible the use of 
thermostable enzymes will be explored offering high operational stability and 
allowing their expression in a thermophilic bacterium.  
As discussed in section 1.3, whole-cell biocatalysis at elevated temperatures is an 
attractive yet undeveloped prospect.  A synthetic biology approach will be used in 
developing the use of the thermophilic bacterium T. thermophilus for whole-cell 
biocatalysis.  This will include the design and characterisation of parts such as 
expression vectors, promoters, ribosome binding sites and optimised protein coding 
sequences.  Utilising this approach enzymes to carry out the cascade reaction will be 
expressed in T. thermophilus to evaluate its use as a host organism for whole-cell 
biocatalysis (Chapter 6). 
Following the characterisation of the enzymes utilised in the construction of the 
cascade reaction, this knowledge can used in the design of an in vitro reaction.  In 
combination with characterised enzymes for cofactor regeneration, mathematical 
modelling of the cascade reaction will be used to understand the dynamics of the 
multi-enzyme system, as discussed in section 1.4.  The model can then be used to 
optimise the process and explore potential reaction configurations (Chapter 5).   
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In summary, this works seeks to characterise novel enzymes for inclusion into the 
enzyme toolbox for synthetic chemistry (Chapters 3 and 4), and combine them into a 
multistep cascade reaction to investigate both the use of isolated enzymes (Chapter 
5), and the use of a thermophilic host organism for whole cell biocatalysis (Chapter 
6). 
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Chapter 2 - General Materials and 
Methods 
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2.1 Materials 
2.1.1 Bacterial strains 
The bacterial strains used in this study are shown in Table 2-1. 
Table 2-1 – Bacterial strains used in this study 
Strain Use 
5-alpha E. coli (NEB) High transformation efficiency cloning strain 
BL21(DE3) E. coli (NEB) Expression strain 
Rosetta 2 E. coli (Novagen) Expression strain derived from BL21(DE3) 
RipL E. coli (Agilent Technologies) Expression strain derived from BL21(DE3) 
Thermus thermophilus HB27::nar T. thermophilus HB27::nar, a strain of HB27 
with the addition of the nar element 
transferred from T. thermophilus HB8, was 
used in all T. thermophilus work.  This strain 
was kindly gifted by José Berenguer, and is 
required for the use of the Pnar promoter in 
an HB27 strain. 
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2.1.3 Media 
The components of media not described in other places is shown in Table 2-2 
(Sambrook and Russell, 2012).   
Table 2-2 - Growth media used in this study. 
Name Components 
LB media (Luria-Bertani Broth) 10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract 
SOC (Super Optimal broth with 
Catabolite repression) 
20 g/L tryptone, 5 g/L yeast Extract, 4.8 g/L 
MgSO4, 3.603 g/L glucose, 0.5 g/L NaCl, 0.186 
g/L KCl 
 
2.1.4 Antibiotics 
Antibiotics were prepared at 1000x concentration in distilled water, except 
chloramphenicol which was prepared in ethanol.  Stocks were stored at -20 oC and 
fully defrosted before use.  Final working concentrations are shown in Table 2-3. 
Table 2-3 - Antibiotics used in this study.  
Antibiotic Working concentration 
Kanamycin 50 µg / ml 
Kanamycin for use with T. 
thermophilus 
30 µg / ml 
Chloramphenicol 50 µg / ml 
Ampicillin 100 µg / ml 
Streptomycin 50 µg / ml 
Spectinomycin 50 µg / ml 
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2.1.5 Chemicals 
Unless otherwise specified, all chemicals were purchased from Sigma-Aldrich 
(Gillingham, UK), and were of the highest purity available.   
2.1.6 Antibodies 
Antibodies used in western blots in this study are shown in Table 2-4.  All were used 
at a 1:1000 dilution. 
 
Table 2-4 – Antibodies used in this study 
Primary Antibodies 
Chicken Anti-DDDDK (FLAG) tag antibody 
(Abcam) 
Mouse anti-c-Myc Monoclonal Antibody (Life 
Technologies) 
Mouse anti-penta-His Antibody (Qiagen) 
Secondary Antibodies 
IRDye 680RD Goat anti-Mouse IgG (H+L) (LI-
COR Biosciences) 
IRDye 800CW Donkey anti-Chicken IgG (H + 
L) (LI-COR Biosciences) 
 
2.2 DNA methods 
2.2.1 Plasmid preparation and isolation 
Plasmids were prepared from overnight cultures of E. coli grown in 10 ml LB media 
with the appropriate antibiotics (Table 2-3).  A QIAprep Spin Miniprep Kit (Qiagen) 
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was used for plasmid purification following the manufacturer’s instructions.  DNA was 
eluted in 50 µl distilled water. 
2.2.2 High fidelity PCR 
For PCR reactions requiring high fidelity, where the PCR product would be 
incorporated into a vector, high fidelity PCR using Phusion polymerase (Fermentas) 
was performed.  A general recipe is shown in Table 2-5. 
 
Table 2-5 – PCR recipe for use with Phusion 
polymerase 
Component Vol per reaction (µl) 
5x High GC buffer 4 
Distilled water 11.2 
dNTPs at 2.5 mM 1.6 
Primer Fwd (10 µM) 1 
Primer Rev (10 µM) 1 
DMSO 0.6 
Template 0.5 
Phusion polymerase (1 
U/µL) 
0.1 
Total 20 
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Where appropriate a master mix was made for multiple PCR reactions.  PCR 
reactions were performed in an Eppendorf Nexus GSX1 or Biorad thermocycler 
T100 using the following program: 
• 98 oC for 1 minute 
• 35 cycles of: 
o 98 oC for 30 seconds  
o 55 oC for 30 seconds (other annealing temperatures were used where 
appropriate) 
o 72 oC for 30 seconds per 1 kb 
• 72 oC for 5 minutes 
 
2.2.3 PCR for cloning confirmation  
For analytical PCR reactions where the resulting product would only be analysed by 
agarose gel electrophoresis, such as colony PCR, DreamTaq Green PCR Master 
Mix (Thermo Scientific) was used.  A general recipe is shown in Table 2-6. 
Table 2-6 – PCR recipe for use with DreamTaq 
Green PCR Master Mix 
Component Vol per reaction (µl) 
2x DreamTaq Green PCR 
Master Mix 
5 
Distilled water 3.6 
Primer Fwd (10 µM) 0.5 
Primer Rev (10 µM) 0.5 
DMSO 0.3 
Template (or water for 
colony PCR) 
0.1 
Total 10 
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Where appropriate a master mix was made for multiple PCR reactions.  For colony 
PCR reactions, colonies were added directly to the PCR reaction.  PCR reactions 
were performed in an Eppendorf Nexus GSX1 or Biorad thermocycler T100 using 
the following program: 
• 94 oC for 1 minute (5 minutes for colony PCR) 
• 40 cycles of: 
o 94 oC for 30 seconds  
o 55 oC for 30 seconds (other annealing temperatures were used where 
appropriate) 
o 68 oC for 1 minute per 1 kb 
• 68 oC for 5 minutes 
 
2.2.4 Agarose gel electrophoresis 
DNA fragments were analyzed using agarose gel electrophoresis, separating DNA 
by size.  Generally 1.0 % agarose gels were prepared by heating 0.6 g of agarose in 
100 ml 1x TAE buffer until dissolved.   1x TAE buffer was prepared from a 50x TAE 
buffer stock.  50x TAE buffer was made up of: 142 g/L Tris base, 57 ml/L acetic acid 
and 19 g/L EDTA. 
2.5 µl of Midori Green Advance (Nippon Genetics) was added while cooling the 
agarose before pouring the agarose into a gel tray with a comb, where it was allowed 
to set.  DNA samples were loaded onto the gel with an appropriate DNA ladder.  The 
gel was run in a Sub-Cell GT Cell (Bio-Rad) at 100 V in 1x TAE buffer for 45 minutes 
before visualization under UV light using a Bio-Rad BioDoc-It imaging system.   
2.2.5 Gel extraction or DNA purification 
Where required, DNA fragments from PCR or restriction digests were extracted from 
agarose gels and purified using a QIAquick Gel Extraction kit (Qiagen) following the 
manufacturer’s instructions.  Elution was carried out in 30 µl distilled water.  For the 
purification of DNA from PCR reactions, SureClean (Bioline) was used following 
manufacturer’s instructions, with DNA suspended in the same volume of distilled 
water.  
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2.2.6 Restriction digests 
Restriction digests were carried out using up to 1000 ng of purified DNA in a 20 µl 
reaction volume.  1 µl each of FastDigest enzymes (Fermentas) were used, and 
where required 1 µl of FastAP Thermosensitive Alkaline Phosphatase (Fermantas) 
or 1 µl DpnI FastDigest (Fermentas).  Reactions were carried out at 37 oC for 30-60 
minutes, followed by 10 minutes at 80 oC.  Digests were analysed on agarose gels 
followed by gel extraction of the desired fragment, or used directly. 
2.2.7 Ligations 
Restriction digested vector and insert fragments were ligated at a standard molar 
ratio of 1:3 vector to insert, with between 10-100 ng of vector DNA.  Ligation 
reactions were carried out in a volume of 10 µl using T4 DNA Ligase (Thermo 
Scientific).  Reactions contained 1 µl 10X ligase buffer, 0.1 µl T4 ligase and a total of 
8.9 µl of distilled water, vector and insert.  Ligations were carried out for 20 minutes 
at room temperature before being placed on ice ready for transformation into a 
chemically competent cloning strain of E. coli. 
2.2.8 E. coli transformation 
Chemically competent strains were prepared by laboratory technicians or purchased 
ready to use.  Competent cells were stored at -80 oC and defrosted on ice. 1-5 µl of 
ligation mixture was then added to 50 µl of competent cells and incubated on ice for 
30 minutes.  Cells were heat-shocked in a water bath at 42 oC for 30 seconds before 
cooling on ice for 2 minutes.  200 µl of LB media or SOC was added and cells were 
incubated at 37 oC with shaking at 220 RPM for one hour.  Cells were plated out 
onto LB plates containing the appropriate antibiotic, and where pNIC28-BSA4 was 
used as the cloning vector the addition of 5 % (w/v) sucrose. 
2.3 Protein purification and analysis 
2.3.1 General protocol for protein expression in E. coli 
Expression plasmids were transformed into the BL21(DE3) strain or other derivative 
strains of E. coli, and glycerol stocks produced.  A 10 ml overnight culture was set up 
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in LB media with the appropriate antibiotics added at 50 µg / ml, and incubated at 30 
oC with shaking at 220 rpm.  2 ml of overnight culture was used to inoculate 1 L of 
LB with the addition of 50 µg / ml of the relevant antibiotics, in a 2 L Erlenmeyer 
flask, incubated at 37 oC with shaking at 220 rpm.  OD600 nm readings were taken 
periodically after the first 3 hours of incubation until OD600 nm reached between 0.4 
and 0.8.  At this point temperature was dropped to 20 or 30 oC with the addition of 
100 µM IPTG.  Cultures were left overnight for approximately 18 hours before 
harvesting the cells by centrifugation at 4,700 g for 30 minutes at 4oC, and re-
suspended in 25 ml of nickel column wash buffer (25 mM Tris-HCl pH 7.5, 500 mM 
NaCl, 20 mM imidazole) per 0.5 L of culture.  Cell suspensions were either frozen at 
-20 oC or processed immediately for purification. 
2.3.2 Cell lysis by sonication 
Cells were lysed by sonication on ice using a Soniprep 150 sonicator (MSE, London, 
UK), by six cycles of 25 seconds sonication at an amplitude of 10 µm, followed by 35 
seconds resting.  The insoluble fraction of the cell lysis sample was removed by 
centrifugation at 20,000 g for 30 minutes at 4oC.   
2.3.3 Protein purification 
Soluble cell extract was loaded onto 1 ml HisTrap-FF columns (GE Healthcare), pre-
equilibrated with nickel column wash buffer, using an ÄKTApurifier system.  Columns 
were washed with 20 ml of wash buffer before elution of bound protein by raising the 
concentration of imidazole from 20 mM to 250 mM over a 10 ml gradient, with 1.5 ml 
fractions collected throughout.   
Fractions were analysed by SDS-PAGE, and those shown to contain the protein of 
interest were concentrated to less than 2 ml by ultrafiltration, using a Vivaspin 20 
(Sartorius) with a 10 kDa MW cut off.  Up to 2 ml was then loaded and run through a 
HiLoad 16/600 Superdex 200 gel filtration column, pre-equilibrated with GF buffer 
(25 mM Tris-HCl pH 7.5, 100 mM NaCl), again using an ÄKTApurifier system.  
Fractions were collected throughout a 120 ml elution in GF buffer, and those thought 
to contain the protein of interest analysed by SDS-PAGE, before being pooled and 
concentrated to between 1 mg/ml and 8 mg/ml by ultrafiltration as previously.   
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2.3.4 Protein quantification 
Protein concentration was determined by measuring OD280 nm using a Nanodrop 
2000c (Thermo Scientific), blanked against GF buffer, and utilizing an extinction 
coefficient and MW calculated by protein sequence analysis by the Expasy 
ProtParam tool (Gasteiger et al., 2005) (http://web.expasy.org/protparam/). 
2.3.5 SDS-PAGE 
SDS-PAGE was used to separate proteins by size for visualization. ExpressPlus 
PAGE Gels (GenScript) were used with Tris-MOPS (SDS) running buffer consisting 
of: 6.06 g/L Tris base, 10.46 g/L MOPS, 1 g/L SDS and 0.3 g/L EDTA.  Samples 
were prepared for analysis by dilution in an equal volume of 2X-SDS-PAGE buffer 
(100 mM Tris-HCl pH 6.8, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue, 20% (w/v) 
glycerol, 2% (v/v) b-mercaptoethanol), and heated at 100oC for 10 minutes.  1 – 20 
µl of each sample was loaded onto the gel.  10 µl of a protein ladder such as Spectra 
Multicolor Broad Range Protein Ladder (Thermo Scientific) was also included.  Gels 
were using a Mini-Protean Electrophoresis System (Bio-Rad), at 150 V for 1 hour.  
Gels were stained with InstantBlue stain (Expedeon) for 1 hour, and washed with 
water.   
2.3.6 Western blot 
Western blots were carried out following SDS-PAGE electrophoresis without 
staining, using a Pierce G2 Fast Blotter (Thermo Scientific) and an iBind Western 
System (Thermo Scientific).  Nitrocellulose (0.22 µm pore size, Sartorius Stedim) 
was cut to size and soaked in 1-Step Transfer Buffer (Thermo Scientific) for 30 
minutes with four Western Blotting Filer Papers (7 cm by 8.4 cm, 0.83 mm thickness, 
Thermo Scientific). 
A “sandwich” was constructed of two filter papers, nitrocellulose sheet, SDS-PAGE 
gel (plastic casing removed) and finally two more filter papers.  This was placed onto 
the Pierce G2 Fast Blotter and the lid attached.  Transfer was carried out at 25 V, 1.3 
A, for 30 minutes.  During the transfer the iBind mix and antibodies were prepared.  
Following the transfer the nitrocellulose sheet was removed and soaked in 6 ml of 
iBind mix, ready for the next step. 
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iBind mix was prepared consisting of 6 ml iBind buffer, 300 µl iBind additive and 23.7 
ml distilled water.  Antibody solutions were prepared at a 1 in 1000 dilution in 2 ml of 
iBind mix for both primary and secondary antibodies.   
An iBind card was placed into the iBind system, and 5 ml of iBind mix pipetted 
covering the card.  1 ml was pipetted into the center of the card.  The nitrocellulose 
membrane was placed facing down onto the center of the card.  The iBind system 
was clipped shut, and iBind solutions added in slots 1 to 4 as follows:   
1. 2 ml primary antibody solution, 
2. 2 ml iBind mix, 
3. 2 ml secondary antibody solution, 
4. 6 ml iBind mix. 
 
The iBind system was left for 2.5 hours before visualization using an Odyssey CLx 
Imaging System (LI-COR). 
2.4 Other methods 
2.4.1 HPLC method for separation of methyl p-toluate, p-toluic acid, 
p-tolualdehyde, and p-tolyl alcohol 
An Eclipse Plus C18 column with a particle size of 3.5 µm, measuring 4.6 x 100 mm, 
was used.  The column was run at 60 oC on the following method using two buffers, 
buffer A: 95 % H2O, 5 % (v/v) acetonitrile, 0.1 % (v/v) trifluoroacetic acid, and buffer 
B: 5 % H20, 95 % (v/v) acetonitrile, 0.1 % (v/v) trifluoroacetic acid.  3 µl of sample 
was injected and eluted on a gradient from 0 to 100 % buffer B over 10 minutes.  
Buffer B was maintained at 100 % for a further 2 minutes before the column was re-
equilibrated with buffer A for 2 minutes before the next run. 
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Chapter 3 - Structural and biochemical 
characterisation of Archaeoglobus 
fulgidus esterase reveals a bound CoA 
molecule in the vicinity of the active 
site.  
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3.1 Authors 
Christopher Sayer1, William Finnigan1, Michail N. Isupov1, Mark Levisson2, Servé W. 
M. Kengen2, John van der Oost2, Nicholas J. Harmer1, Jennifer A. Littlechild1* 
1The Henry Wellcome Building for Biocatalysis, Biosciences, University of Exeter, 
Stocker Road, Exeter EX4 4QD, UK 
2 Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708WE, 
Wageningen, The Netherlands 
3.2 Preface for inclusion in this thesis 
This chapter is made up of the reformatted manuscript for a paper published in 
Scientific Reports in April 2016, volume 6.  The esterase in this paper, AF-Est2, 
makes up the first step in the enzymatic cascade reaction investigated throughout 
this thesis, shown in Figure 1-1.  It was chosen for the cascade due to its ability to 
accept methyl p-toluate as a substrate, and its good thermostability allowing its use 
in Thermus thermophilus.  A thorough biochemical characterisation was an important 
step in developing this cascade reaction, and was combined with the structural work 
on AF-Est2 carried out by Chris Sayer for publication. 
All biochemical work was performed by William Finnigan, except assays for activity 
against acetyl-CoA and succinyl-CoA which were performed by Chris Sayer.  
Sections 3.5.1 to 3.5.6 including all relevant figures and tables, and 3.6.1 to 3.6.8 
written by William Finnigan, edited by all authors.  Other sections were written by 
Chris Sayer or Michail N. Isupov, edited by all authors. 
The manuscript has been formatted to match the formatting of this thesis.  
References have been combined with those in the other chapters of this thesis for a 
final reference chapter.  Figure and table numbers have also been edited for 
inclusion in the thesis.  
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3.3 Abstract  
A new carboxyl esterase, AF-Est2, from the hyperthermophilic archaeon 
Archaeoglobus fulgidus has been cloned, over-expressed in Escherichia coli and 
biochemically and structurally characterized. The enzyme has high activity towards 
short- to medium-chain p-nitrophenyl carboxylic esters with optimal activity towards 
the valerate ester. The AF-Est2 has good solvent and pH stability and is very 
thermostable, showing no loss of activity after incubation for 30 min at 80 °C. The 1.4 
Å resolution crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the 
vicinity of the active site. Despite the presence of CoA bound to the AF-Est2 this 
enzyme has no CoA thioesterase activity. The pantetheine group of CoA partially 
obstructs the active site alcohol pocket suggesting that this ligand has a role in 
regulation of the enzyme activity. A comparison with closely related α/β hydrolase 
fold enzyme structures shows that the AF-Est2 has unique structural features that 
allow CoA binding. A comparison of the structure of AF-Est2 with the human 
carboxyl esterase 1, which has CoA thioesterase activity, reveals that CoA is bound 
to different parts of the core domain in these two enzymes and approaches the 
active site from opposite directions.  
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3.4 Introduction 
Archaeoglobus fulgidus is an anaerobic heterotrophic sulfate reducing archaeon 
(Klenk et al., 1997) that grows at temperatures between 60 and 95 °C, with optimal 
growth at 83 °C. The enzymes from thermophilic microorganisms have high potential 
for use as new industrial biocatalysts due to their naturally high stability to 
temperature and organic solvents (Littlechild et al., 2007; Littlechild, 2015). 
The esterases are a class of enzymes that catalyse the cleavage of ester bonds and 
have been extensively used in many important biotechnology applications (Levisson, 
van der Oost and Kengen, 2009). These include the synthesis of optically pure 
compounds in the agriculture, food and pharmaceutical industries (Romano et al., 
2015) and the degradation of natural materials and pollutants, plastics and other 
industrial waste products (Gomes and Steiner, 2004; Wei, Oeser and Zimmermann, 
2014). Features such as high stability in organic solvents (Klibanov, 2001), broad 
substrate specificity (Yang et al., 2015) and high regio- and stereo-selectivity 
(Somers and Kazlauskas, 2004) make these enzymes attractive biocatalysts. 
Specific examples include the use of aryl esterases in the development of flavours in 
the food and beverage industries (Lomolino et al., 2003), and the use of the Bacillus 
carboxyl esterase NP for the production of the nonsteroidal drug naproxen (Quax 
and Broekhuizen, 1994). 
The lipolytic enzymes are made up from two main groups (Schrag and Cygler, 
1997): the true lipases (EC 3.1.1.3; triacylglycerol lipases) and the esterases (EC 
3.1.1.1; carboxylesterases). Enzymes of both groups catalyse the cleavage of an 
ester into a carboxylic acid and an alcohol. The esterases hydrolyse water soluble 
esters with a short fatty acid chain, while lipases show preference for insoluble fatty 
acid esters with a chain length greater than ten carbon units. The esterases obey 
classical Michaelis-Menten kinetics and have a relatively open active site. In 
contrast, the lipases use the process of interfacial activation where a hydrophobic lid 
domain moves away from the active site in the presence of a minimum concentration 
of a lipid substrate. Most lipolytic enzymes belong to the α/β hydrolase protein fold 
superfamily. However, esterase activity has been reported for enzymes with a β 
lactamase fold (Wagner et al., 2002) and an α/β/α hydrolase fold (Upton and 
Buckley, 1995) or as a side activity for the carbonic anhydrase enzymes (Host, 
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Martensson and Jonsson, 2006). The ESTHER database (Lenfant et al., 2013) 
divides the α/β hydrolase enzymes into over 140 families and superfamilies which 
are further assigned to groups C, H, L, and X. 
The proposed mechanism of catalysis by the α/β hydrolase lipolytic enzymes 
resembles the serine protease mechanism (Blow, Birktoft and Hartley, 1969). This 
involves the substrate binding with the carbonyl oxygen adjacent to the oxyanion 
hole. The catalytic acidic residues and histidine activate the catalytic serine hydroxyl 
which performs nucleophilic attack on the carbonyl carbon of the scissile bond to 
produce the tetrahedral intermediate. Subsequently the alcohol product is released 
and an acyl-enzyme complex is formed. After an attack by a water molecule another 
tetrahedral intermediate is formed which resolves to release the carboxyl product 
and the free enzyme. The catalytic serine residue in the α/β hydrolase fold esterases 
is usually located in a tight nucleophilic elbow with the consensus sequence Gly-X-
Ser-X-Gly, although deviations from this consensus have been reported (Bourne, 
Isupov and Littlechild, 2000). 
Many examples of thermophilic esterases have previously been described, including 
enzymes from Thermotoga maritima (Levisson, van der Oost and Kengen, 2007; 
Levisson et al., 2012), Geobacillus stearothermophilus (Liu et al., 2004, 2007), 
Alicyclobacillus acidocaldarius (Mandrich et al., 2008), Thermobifida fusca (Billig et 
al., 2010), Sulfolobus tokadaii (Angkawidjaja et al., 2012), Rhizomucor miehei (Yang 
et al., 2015), amongst others. To date two esterases and a lipase from A. fulgidus 
have been reported. The AFEST (Manco et al., 2000) (locus tag: AF1716) is a 
member of the hormone-sensitive-lipase family and has a preference for the 
substrate pNP-caprylate. The crystal structure of this enzyme (PDB: 1JJI) revealed 
several thermophilic adaptations with an increased secondary structure content, 
reduction in loop extensions and an increase in intramolecular ion pairs compared to 
a mesophilic homologue (De Simone et al., 2001). The second esterase Est-AF 
(Kim, Lee and Ryu, 2008) (locus tag: AF2336) showed optimal activity towards pNP-
butyrate and no activity for substrates with a carboxyl group larger than caprylate. 
This enzyme has been applied in the resolution of ketoprofen ethyl esters. Extensive 
mutagenesis of Est-AF resulted in an enzyme with improved activity for the 
production of the S-enantiomer of ketoprofen (Kim et al., 2015). The biocatalytic 
synthesis of poly(δ-valerolactone) using AFEST has also recently been 
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demonstrated (Cao et al., 2012). The alkaliphilic A. fulgidus lipase (Chen et al., 
2009) (locus tag: AF1763) is also thermostable at 70-90 °C. 
Here, we report the biochemical and structural characterisation of a third esterase 
from the A. fulgidus genome, named AF-Est2 (locus tag: AF1537). This belongs to 
the α/β hydrolase 6 family and the X group of the ESTHER classification. This 
enzyme was biochemically characterised and shown to be highly thermostable and 
stable in organic solvents and at extremes of pH.  The X-ray structure of the AF-Est2 
was determined and reveals the presence of a molecule of Coenzyme A (CoA). This 
is bound in a unique position in the vicinity of the enzyme active site groove, partially 
obstructing the alcohol binding pocket. AF-Est2 shows a novel utilisation of CoA 
where the pantetheine moiety could act as a regulatory function for enzyme activity.   
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3.5 Results and Discussion 
3.5.1 Substrate specificity 
The AF-Est2 enzyme was successfully cloned and over-expressed in Escherichia 
coli and purified using a nickel affinity column and size exclusion chromatography. 
AF-Est2 was tested against a range of p-nitrophenyl (pNP) esters and was shown to 
be active against small to medium acyl chain length esters (C2 to C8), which is 
consistent with its classification as an esterase rather than a lipase. AF-Est2 showed 
optimum activity against pNP-valerate with a kcat of 58.9 ± 0.2 s-1 and a KM of 19 ± 1 
µM (Table 3-1). The kcat values are close for the whole range of acyl ester chain 
lengths and differences in the catalytic efficiency of the enzyme are due to large 
differences in the KM for these different substrates. AF-Est2 was also active against 
the substrate methyl p-toluate which other tested carboxyl esterases are inactive 
against. Kinetic constants were determined using a phenol red assay giving a KM of 
1500 ± 100 µM with kcat of 1.23 ± 0.07 s-1, 0.94 ± 0.02 s-1 and 0.08 ± 0.006 s-1 at 70 
oC, 50 oC and 30 oC respectively. This shows the enzyme is able to accommodate 
industrially relevant bulky aromatic carboxylate groups 
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Table 3-1 – The kinetic characterisation of AF-Est2 using pNP-esters with 
varying acyl chain length and pNP- benzoate as substrates. 
 k cat (s-1) K M (μM) k cat / K M (s-1 μM-1) 
C2 21.5 ± 0.2 620 ± 10 0.0349 ± 0.0007 
C3 47.8 ± 0.5 254 ± 8 0.189 ± 0.006 
C4 55.5 ± 0.5 92 ± 3 0.61 ± 0.02 
C5 58.9 ± 0.2 19 ± 1 3.1 ± 0.2 
C8 46.0 ± 0.3 120 ± 10 0.37 ± 0.03 
C12 0 N/A 0 
Benzoate 0 N/A 0 
No activity was detected for substrates with an acyl chain length of twelve carbons or 
more. 
 
3.5.2 Enzyme stability and activity at elevated temperatures  
To test the temperature tolerance of AF-Est2, it was incubated at elevated 
temperatures for 30 min and then cooled to room temperature before being assayed. 
No loss of activity was observed after incubation at temperatures up to 80 °C. This is 
close to the optimum growth temperature of A. fulgidus. As the incubation 
temperature was increased past this point the enzyme became progressively 
denatured, retaining no activity after incubation at 95 °C (Figure 3-1a). The 
temperature optimum for activity of AF-Est2 was determined by performing the assay 
at increasing temperatures. The activity increased with temperature following the 
Arrhenius equation up to a maximum of 80°C. A high level of spontaneous substrate 
hydrolysis prevented measurement of activity beyond 80 °C. 
Activity was also measured whilst incubating AF-Est2 at 70 °C, 50 °C and 30 °C for 
an extended time period. AF-Est2 was able to retain over 50 % activity for one week 
at 70 oC showing the enzyme would be an excellent choice for applications where an 
elevated temperature may be required for solubilisation of industrial substrates or 
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where enzyme stability under reactions conditions is an issue. At 30 °C and 50 °C an 
excess of 50 % activity remained after 20 days. 
3.5.3 Enzyme stability and activity at different pHs 
Features adopted by proteins for stability at high temperatures often allow them to 
withstand other denaturing conditions such as extremes of pH, presence of organic 
solvents and proteolysis. We therefore tested the activity of AF-Est2 at pH 7.5 after 
incubation for one hour at a range of different pH values. No significant change in 
activity was observed for all incubation pH values between 3.0 and 12.0, showing 
that the enzyme is stable across an unusually wide range of pH values (Figure 3-1b). 
Incubation at pH 2.0 caused inactivation of the enzyme. Activity assays for AF-Est2 
at different pHs showed that the enzyme is active over a broad range of pH values 
from 5.0 to 11.0 with optimum activity at pH 9.0.  
3.5.4 Solvent stability 
The residual activity of the AF-Est2 was tested after incubation in a range of 
common organic solvents. The enzyme retained activity in nearly all of the solvent 
conditions after incubation for 1 hour in buffer containing 25 mM Tris-HCl pH 7.5, 
100 mM NaCl, and either 10 %, 25 % or 50 % of methanol, ethanol, isopropanol, 
DMSO, acetonitrile and acetone. Only incubation in 50 % isopropanol was 
significantly detrimental to the enzyme activity resulting in 23 % relative activity when 
compared to the control. As with the stability of AF-Est2 at extremes of pH, 
adaptions for thermal stability allow the enzyme to withstand the denaturing effects 
of a range of organic solvents. 
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Figure 3-1 – Effects of temperature and pH on AF-Est2 
a) The effects of temperature on AF-Est2. Blue triangles  show the relative activity of 
AF-Est2 with increasing temperature, relative to a maximum activity at 80°C. Red 
circles  show the relative activity of AF-Est2 incubated for half an hour at various 
temperatures, against a control kept at room temperature.  The insert shows the 
linearity of the Arrhenius plot of the relative activity with increasing temperature. 
b) The effects of pH on AF-Est2.  Blue triangles  show the relative activity of AF-Est2 
at various pH values, relative to its maximum activity at pH 9.0.  Red circles  show 
the activity of AF-Est2 after incubation at various pH values for hour, before assaying 
under standard conditions. 
3.5.5 Inhibitors 
To assist in determining the mechanism of AF-Est2, the effect of common hydrolase 
inhibitors on the enzyme was tested. The serine protease inhibitors 
phenylmethysulfonyl fluoride (PMSF) and benzamidine and the carboxylesterase 
inhibitor benzil were used in a range of concentrations up to 2 mM. Both reversible 
inhibitors benzamidine and benzil showed no effect on the reaction rate of AF-Est2 
after incubation for half an hour. To fully inhibit AF-Est2, incubation with 100 μM 
PMSF for 30 min was required. When PMSF was added during the enzymatic 
reaction a significantly lower inhibition of the enzyme was observed. This would 
suggest that the substrates or products compete with the PMSF for binding in the 
active site of the enzyme. 
Investigating the kinetics of the enzyme inhibition with different concentrations of 
PMSF (Figure 3-2a) revealed the mode of inhibition to be mixed, with a KI of 1.0 ± 
0.3 µM and an Alpha value of 0.3 ± 0.1. A small Alpha value suggests PMSF acts 
more as an uncompetitive inhibitor than a competitive inhibitor, again suggesting an 
unusual mode of inhibition for this enzyme (Copeland, 2013).  
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Figure 3-2 – Inhibition of AF-Est2 
a) Inhibition of AF-Est2 by PMSF.  The effect of increasing concentrations of PMSF on the 
kinetics of AF-Est2 with pNP-valerate. Initial rates with varying concentrations of PMSF are 
displayed as follows:  0 μM PMSF by , 0.1 μM PMSF by , 0.2 μM PMSF by  , 0.4 
μM PMSF by  and 0.8 μM PMSF by . The data has been fitted to the mixed model 
inhibition equation and the following parameters calculated.  KCAT = 59 ± 0.7 s-1, KM = 18 ± 1 
μM, KI = 1.0 ± 0.3 μM and α = 0.3 ± 0.1 μM.   A small alpha value suggests PMSF acts more 
as an uncompetitive inhibitor, which is reflected when the data is shown as a Lineweaver-
Burk plot.  
b) Effect of diamide on AF-Est2 activity.  The relative activity of AF-Est2 after incubation with 
various concentrations of diamide over time, shown as 100 mM , 10 mM  and 1 mM 
. The activity is relative to a control sample with no diamide. Error bars show the 
standard error of three replicates. 
3.5.6 Structural determination 
AF-Est2 was crystallized in the space group P212121 with cell dimensions of a=55.6 
Å, b=67.6 Å, c=139.5 Å, a=b=g=90o. The asymmetric unit contains two protein 
monomers each with a molecular mass of 28.1 kDa giving a solvent content of 46 %. 
The structure has been isotropically refined to a resolution of 1.4 Å with a final Rfree 
of 17.5 (Table 3-2). Several data sets were collected in an attempt to get protein-
ligand complexes from crystals soaked or co-crystallised with pNP esters, benzyl, 
benzamidine and PMSF. Data for putative pNP-valerate and PMSF complexes were 
collected to high resolution, but contained no density for the bound ligand. 
The structure reveals, as expected, a canonical a/b hydrolase fold core domain 
(Asp1-Arg117 and Asp176-His254), and a cap domain (Leu118-Phe175) formed by 
helices a5-a8 (Figure 3-3). Six helices of the core domain surround an eight 
stranded b-sheet of mixed type with connectivity 1,2,-1x,2x,1x,1x,1x with direction +-
++++++ . The catalytic Ser89 residue in both molecules of AF-Est2 is an outlier on 
the Ramachandran plot. The strained conformation of the catalytic serine residue is 
observed in the structures of most other a/b hydrolase fold enzymes(Ollis et al., 
1992). There are no residues in a cis conformation in AF-Est2. The structure also 
contains two CoA molecules at full occupancy, several ordered PEG molecules and 
a single citrate molecule bound at a crystal contact. This citrate ligand originates 
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from the crystallisation solution and could have contributed to the formation of more 
ordered crystals. 
Although the asymmetric unit of AF-Est2 contains two monomers, these do not form 
oligomers in the crystal. This is in agreement with the chromatography results where 
the protein eluted as a monomer from a calibrated size exclusion column. 
 
Figure 3-3 - A cartoon representation of the AF-Est2 structure. 
Showing the core and cap domains in dark green and light green respectively, with the 
bound CoA molecule shown as a stick model.  The catalytic triad residues are shown as 
stick models and the active site is highlighted as a yellow box. Figure 3-3 to Figure 3-6 were 
prepared using PyMOL Molecular Graphics System (Schrödinger LLC). 
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3.5.7 Ligand assignment 
When most of the AF-Est2 model was built using the original 2.1 Å resolution data, a 
significant stretch of continuous density became apparent on both the 2Fo-Fc and the 
Fo-Fc maps in the proximity of the AF-Est2 catalytic triad in both monomers. 
Modelling of a bound polypeptide did not produce a convincing match to the 
observed density. A molecule of CoA provided the best fit for the un-assigned 
density. Refinement at the higher resolution of 1.4 Å confirmed the full occupancy of 
this CoA ligand in the AF-Est2 structure (Figure 3-4a).  
3.5.8 The CoA binding groove 
The pantetheine group of the CoA points directly into the active site. The remainder 
of the CoA molecule is bound in a groove on the surface of the enzyme (Figure 3-4b, 
c). This groove is formed by the loop region consisting of residues 116-121, 
preceding α5 on one side and the loop region of residues 202-207 which precedes 
α9 on the other side. There is an ion pair formed by the diphosphate moiety of the 
CoA and the guanidinium group of Arg117. The residues Arg119 and Arg182 could 
also form ion pairs with the diphosphate and phosphate groups of CoA, respectively, 
but do not do so in this structure. The CoA also forms several specific H-bonds and 
hydrophobic interactions. The adenine ring of CoA is stacked in a pocket between 
the side chains of Tyr207 and Leu178 (Figure 3-4b) and its N6A atom makes a H-
bond to the main chain oxygen of Arg117. The side chain of Lys206 is H-bonded to 
O2B of the ribose ring of CoA. The N4P and O5P of the pantetheine group of the 
CoA are H-bonded to main chain oxygen of Leu202 and the main chain nitrogen of 
Leu121, respectively.  It appears that the CoA has a high affinity for the enzyme and 
is tightly bound since no CoA was added during expression or purification of the 
enzyme. Extensive dialysis of the purified enzyme did not remove the CoA molecule 
which may contribute to the high thermostability observed for this enzyme.  
The NCBI reference sequence database contains about twenty protein sequences 
from both archaeal and bacterial sources with higher than 35 % sequence identity to 
AF-Est2 over more than 90 % of its length. Residues that are involved in CoA 
binding in AF-Est2 are either conserved or conservatively replaced in the majority of 
these enzymes. This suggests that these other enzymes could also bind CoA, 
however, in the absence of their biochemical or structural characterization this 
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cannot be determined. The structure of the AF-Est2 described in this paper is the 
first example to show the binding of CoA to an esterase enzyme in this conformation. 
Since the AF-Est2 binds CoA this enzyme could have a role in reversible hydrolysis 
of CoA esters. However, no activity was observed towards the common CoA esters, 
acetyl-CoA and succinyl-CoA (data not shown) confirming that AF-Est2 does not 
function as a thioesterase. If CoA esters were a substrate for AF-Est2 they would 
have moderate affinity for the enzyme to allow the rapid dissociation of the product 
CoA which would not bind as tightly to the enzyme as observed in these studies. It 
therefore appears that the tightly bound CoA acts as an integral part of the enzyme. 
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Figure 3-4 - The interactions of the CoA ligand bound to AF-Est2.  
a) A stereo diagram showing the electron density maps in the region of the CoA binding to 
AF-Est2. The 2Fo-Fc (blue) is contoured at 1.2 σ and the Fo-Fc map is contoured at 3.5 σ 
(green) and -3.2 σ (red). The ligand and amino acid residues are shown as stick models. 
Solvent molecules are shown as red crosses, a Cl- ion is shown as a green cross.  
b) A stereo diagram showing the CoA binding site of AF-Est2. The CoA molecule is shown 
as a stick model with carbon atoms coloured in green. Amino acid side chains of residues 
implicated in the ligand binding are coloured in light blue with hydrogen bonds shown as 
black dashes. The figure was prepared using CCP4mg (McNicholas et al., 2011).  
c) The electrostatic potential surface of the AF-Est2 CoA complex. The positive charge is 
shown in blue and the negative charge is shown in red. The ligand molecule was not used in 
the surface calculation and is shown as a stick model. 
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3.5.9 Active site 
The active site is located at the interface of the core and the cap domains with the 
conserved catalytic triad composed of Ser89, His228 and Asp200. The catalytic 
serine is in a strained conformation and is located in a tight nucleophilic elbow at the 
end of strand b5 with the conserved esterase signature sequence Gly-His-Ser-Leu-
Gly. 
A comparison of the structure of AF-Est2 with structures of the ligand complexes of 
other proteins of the α/β hydrolase family 6, allows prediction of its active site 
pockets. The carboxyl binding pocket of AF-Est2 is likely to be formed by the loop 
region between β3 and α1, and helices α5, α6 and α7. The side chains of residues 
Met229, Lys154, Phe158, Leu140, Met139 and Ser32, with Phe158 and Lys154, are 
responsible for defining the size of the carboxyl ester group to be hydrolysed. This 
largely hydrophobic pocket defines the enzyme’s optimal activity towards pNP-
valerate (Table 3-1). The residues Lys154 and Phe158 (helix α7), at the far end of 
the carboxyl binding pocket, restrict the chain length of the substrate that can be 
hydrolysed. It appears that movement of these side chains would be required for the 
binding of the caprylate chain, which would explain the lower levels of affinity of AF-
Est2 towards this pNP-ester (Table 3-1). The enzyme’s affinity towards the pNP-
acetate and pNP-propionate is also relatively low, which appears to be due to the 
reduced binding interactions available in the active site for these substrates. 
3.5.10 CoA obstructs the alcohol binding pocket of the active 
site 
The hydrophobic alcohol pocket is formed by the side chains of residues Leu118, 
Val120, Leu169 and Cys172, and is partially obstructed by the pantetheine group of 
the CoA. The alcohol pocket is responsible for binding the pNP moiety of the 
associated substrates. The predicted binding of the pNP moiety is thought to be 
provided by the main chain region of helix α6 between the side chains of Val120 and 
Leu169. For successful pNP ester hydrolysis, displacement of the pantetheine group 
of the CoA would be required, since modelling has shown it to be a major steric 
hindrance for the binding of the relatively large pNP group in the alcohol pocket. 
However high activity of AF-Est2 towards the pNP esters suggests that the flexible 
CoA pantetheine group is displaced from the alcohol pocket upon substrate binding. 
	104	
3.5.11 Thiol oxidation inhibits AF-Est2 activity towards pNP 
esters 
The thiol group of CoA is located around 4 Å away from the thiol group of Cys172 in 
AF-Est2 and would form a disulfide bond with Cys172. The necessity of the CoA 
pantetheine group displacement for pNP ester hydrolysis was confirmed by 
incubation of the AF-Est2 with the disulfide inducing agent diamide which enforces 
the formation of a covalent bond between the thiol groups of CoA and Cys172 
(Figure 3-4b). This oxidised enzyme shows no activity towards pNP-valerate 
demonstrating that this enzyme is inhibited by the formation of the disulfide. 
Modelling studies suggest that hydrolysis of substrate esters with small alcohol 
groups (methyl or ethyl) may not be inhibited by the disulfide formation. 
Since the AF-Est2 does not have a signal sequence it is assumed to be a cytosolic 
protein, with reduced disulfides. It would appear that the CoA ligand may control the 
levels of activity of AF-Est2 towards carboxyl esters since activity towards esters with 
larger alcohol groups will be reduced due to the partial obstruction of the active site 
by the CoA. It is possible that AF-Est2 could have evolved from an ancestral protein 
with CoA thioesterase activity. 
3.5.12 Comparison of AF-Est2 with related enzymes of the α/β 
hydrolase family 
The AF-Est2 belongs to the α/β hydrolase family 6 in the Pfam classification (Finn et 
al., 2014). The enzymes of this family are reported to catalyse a variety of different 
reactions. Examples include a Pseudomonas fluorescens esterase (De Yin et al., 
2010), bacterial non-heme haloperoxidases (Hofmann et al., 1998), the Burkholderia 
xenovorans 3-oxodipate enol lactonase (Bains et al., 2011) and Aureobacterium (-) 
γ-lactamase (Line, Isupov and Littlechild, 2004). Depending on the features of the 
active site and the type of reaction that is catalysed, some of the enzymes have 
esterase activity.  
The closest sequence homologues of AF-Est2 in the structural database are the C-C 
bond hydrolases such as the tetrameric Mhcp (Dunn et al., 2005) from E. coli (PDB 
1U2E) and the tetrameric meta-cleavage product (MCP) hydrolase (Hsad) from 
Mycobacterium tuberculosis (Lack et al., 2007) (PDB 2VF2). The latter enzyme (with 
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only 27 % identity to AF-Est2 over 95 % of the amino acid sequence) catalyses the 
hydrolytic cleavage of a C-C bond in an intermediate of cholesterol metabolism and 
is also capable of catalysing ester bond hydrolysis in vitro (Lack et al., 2007). The 
active site Ser114Ala mutation of Hsad has allowed elucidation of the conformational 
changes of the enzyme structure which accompany the substrate binding(Lack et al., 
2010) (PDB 2WUF). The relative positions of the cap and core domains differ 
between Hsad and AF-Est2 which causes a shift of the helix α8 by 6.5 Å towards the 
catalytic triad in AF-Est2 (Figure 3-5a). The helices α5, α6 and α7 of the cap domain 
of AF-Est2 are shifted by approximately 3 Å in relation to their equivalent helices in 
the Hsad structure. The loop region between the core and the cap domain is 
involved in the CoA binding in AF-Est2. This loop is significantly longer in Hsad and 
occupies the space of the CoA groove in AF-Est2. The differences of the cap domain 
positions would prevent the binding of the MCP substrates to AF-Est2. In Hsad, the 
active site entrance on the interface of the domains is open in the absence of ligand 
and partially closes in its presence (Lack et al., 2010). However, it is much more 
closed in AF-Est2, even when the obstructing CoA molecule is not taken into 
account. The shorter loop region between helices α8 and α9 in AF-Est2 would 
restrict the relative secondary structure movements observed in the Hsad enzyme. 
The MCP hydrolases have two conserved sub-sites: a hydrophilic polar sub-site 
binding a substrate dienoate moiety, and a non-polar sub-site binding the 
hydrophobic part of the molecule. The different position of helix α8 and the loops 
connecting the core and the cap domains would not allow AF-Est2 to form such a 
non-polar binding site. The polar binding site responsible for MCP hydrolase activity 
also shows low conservation of both the positioning of the main chain backbone and 
the amino acid sequence in this region. Therefore, it is not expected that AF-Est2 
would have C-C hydrolase activity.  
AF-Est2 also shares 27 % identity (over 79 % of the amino acid sequence) with the 
monomeric E. coli BioH carboxyl esterase (Sanishvili et al., 2003) (PDB 1M33), an 
enzyme involved in biotin biosynthesis. The enzyme has a preference for carboxyl 
esterase activity towards short acyl chain substrates and has weak thioesterase 
activity (Sanishvili et al., 2003). Whilst the core domains of the two enzymes 
superimpose closely, there is a relative movement of the helices α5-α8 that comprise 
the cap domain. The relative movement of the core and the cap domains between 
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the model and the target could be the reason why an MR solution could not be found 
for AF-Est2 using Hsad and BioH as models, despite their greater sequence 
similarity.   
AF-Est2 and BioH display little structural conservation in the active site region. One 
of the two helices in BioH which define the carboxyl pocket (α5) is displaced 5 Å 
away from the active site in AF-Est2 and the other (α6), which defines the far edge of 
the pocket, is in a different orientation. BioH shows optimal activity towards pNP-
acetate and pNP-propionate with lower activities observed for pNP-butyrate and 
pNP-caprylate. In contrast, AF-Est2 shows a similar activity towards acetate and a 
much greater activity towards pNP-propionate and optimal activity towards pNP-
valerate. The side chains of Gln147 (equivalent Ala143 in AF-Est2), Trp81 (His88) 
and Leu24 (Ser32) give BioH a more restrictive carboxyl binding pocket compared to 
AF-Est2, thereby explaining the difference in substrate specificity between the two 
enzymes.  
Using the DaliLite server (Holm and Rosenstrom, 2010), AF-Est2 shows best 
structural alignment to an enol lactonase (Bains et al., 2011) (RMSD 2.2 Å; PDB 
2XUA) and a carboxyl esterase from a newly isolated thermophilic Planctomyces 
species, Thermogutta terrifontis (TtEst; RMSD 2.5 Å) recently described by our 
group (Sayer et al., 2015). The core domains between TtEst and AF-Est2 
superimpose closely and the relative positions of the core and the cap domains are 
similar (Figure 3-5b). However, helices α5 and α8 are displaced in AF-Est2 
compared to the TtEst.  
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Figure 3-5 - A comparison of the overall fold of AF-Est2 with that of related proteins. 
a) A stereo diagram showing the superposition of AF-Est2 (green) with the open form of 
Hsad (magenta; PDB 2VF2). The core domains are shown as transparent cartoon models 
and the cap domains are shown as full colour cartoon models. The AF-Est2 cap domain 
restrains the size of the ligand capable of binding to the enzyme active site. The CoA ligand 
is shown as a stick model.  
b) A stereo diagram showing the superposition of AF-Est2 (green) with the malate complex 
of the TtEst (PDB 4UHE). The core domains are shown as transparent cartoon models and 
the cap domains are shown as full colour cartoon models. The relative positions of the core 
and cap domains are more similar between AF-Est2 and TtEst, than between AF-Est2 and 
Hsad. The ligands CoA and the malate which maps the alcohol binding pocket in TtEst are 
shown as stick models. 
 
A
B
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The carboxyl binding pocket in AF-Est2 occupies a larger volume than that in TtEst. 
This is consistent with AF-Est2’s preference towards larger butyrate and valerate 
esters for which the TtEst shows limited activity (Sayer et al., 2015). Mutagenesis 
studies in TtEst have confirmed that Leu37 hinders the binding of esters with side 
chains larger than propionate. The corresponding Ser32 in AF-Est2 allows binding of 
the larger carboxyl side chains. Although most of the residues in the carboxyl pocket 
are not conserved between AF-Est2 and TtEst, they both are predominantly 
hydrophobic.  
The 3-oxodipate enol lactonase and (-) γ-lactamase, which both are active only 
towards pNP-acetate, have bulky Trp side chains obstructing the binding of the 
longer chain substrates in the carboxyl pocket. 
The alcohol pocket in AF-Est2 is significantly smaller than that of TtEst and the 3-
oxodipate enol lactonase. This is due to obstruction by the panthotheine group of the 
CoA molecule and to the different position of helix α5. 
3.5.13 Comparison of CoA binding with another α/β hydrolase 
fold thioesterase 
Since the results presented in this paper suggest that the AF-Est2 has inherited the 
CoA binding from an ancestral protein with thioesterase activity, it is interesting to 
compare this ligand binding in AF-Est2 with other proteins of the α/β hydrolase fold 
family. Since only a relatively small proportion of CoA thioesterases have the α/β 
hydrolase fold, a search of the PDB revealed a single enzyme of this family which 
also binds CoA. This human carboxyl esterase 1 (PDB 2DQZ and 2H7C) is involved 
in cholesterol ester hydrolysis, fatty acyl CoA hydrolysis, acyl-CoA:cholesterol acyl 
transfer, and fatty acyl ethyl ester synthesis (Bencharit et al., 2006). The monomer of 
the hexameric human enzyme is twice as large as AF-Est2; however, the core 
domains of the two proteins superimpose well. In contrast, the cap domain of the 
human esterase has no similarity to the cap domain of AF-Est2 and contains three 
distinct ligand binding sites. The mode of binding of the CoA ligand to one of these 
sites in the human carboxyl esterase shares little similarity to that observed in AF-
Est2 (Figure 3-6). In AF-Est2, the CoA molecule is bound in the groove on the 
surface between the C-terminal part of the core domain and the cap domain. In the 
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human carboxyl esterase the CoA binds between the N-terminal part of the core 
domain and the extended cap domain. This results in the pantetheine groups of CoA 
coming into the enzyme active sites of AF-Est2 and human carboxyl esterase 1 from 
opposite directions. These differences confirm that AF-Est2 shows an entirely novel 
form of CoA binding and suggests that this enzyme has evolved to utilise the 
pantetheine group of CoA as an integral part of its active site. 
 
 
 
Figure 3-6 - A comparison of the CoA binding to both AF-Est2 (cyan) and human 
carboxylesterase 1 (magenta) shown as cartoon models in the same orientation.  
The core domains are shown as transparent models and the cap domains are shown in full 
colour. The CoA ligands bound to the two proteins are shown as ball-and-stick models with 
carbon atoms coloured in grey. The CoA molecules bind to different parts of the core domain 
in these two proteins and their panthetheine groups come into the enzyme active site from 
the different directions. 
3.5.14 Conclusions 
The AF-Est2 esterase structure has shown a novel binding mode for a CoA molecule 
which is located in a groove overlapping the active site of the enzyme where the 
pantetheine moiety is partially obstructing the alcohol binding pocket.  This suggests 
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that the CoA may have a role in reducing activity towards esters with a large alcohol 
group. The AF-Est2 does not appear to be related to the α/β hydrolase fold 
eukaryotic carboxyl esterases that also bind CoA. The structures of AF-Est2 and 
human carboxyl esterase reveal that the pantetheine group approaches the active 
site from opposite directions between the two enzymes. The AF-Est2 enzyme is so 
far unique in its mode of binding of CoA and could represent the first example of a 
new group of esterases. The AF-Est2 reported here shows no thioesterase activity 
despite the fact that it could have evolved from an ancestral protein with CoA 
thioesterase activity. 
The detailed biochemical and structural comparisons of AF-Est2 with other related 
Pfam family 6 α/β hydrolase enzymes as reported in this paper is of general interest 
from the aspect of natural enzyme evolution which has occurred within this large 
enzyme family.  
The AF-Est2 esterase from the thermophilic archaeon Archaeoglobus has potential 
applications in industrial biocatalysis due to its overall stability to high temperature, a 
broad pH range and tolerance to organic solvents.  
3.6 Methods 
3.6.1 Expression and purification 
The gene encoding AF-Est2 (locus tag: AF1537; Uniprot accession number: 
O28735) was PCR-amplified, without its stop codon, using chromosomal DNA of A. 
fulgidus as a template and the two primers 5ʹ- 
GCGCCATGGACCTGGAGAGAGTATTCATCG-3ʹ and 5ʹ 
GGGCTCGAGAACCCCAACTTTTTTGAGAAACTTTTCAAGCGC-3ʹ, introducing 
respectively a NcoI and XhoI restriction site. The generated PCR product was 
digested by NcoI and XhoI and the product was purified and ligated into the protein 
expression vector pET24d (EMD Millipore) digested with the same restriction 
enzymes, resulting in the plasmid pWUR365 for the expression of the C-terminal  6x-
His-tag AF-Est2 protein. 
The pWUR365 vector was transformed into the E. coli strain BL21-CodonPlus 
(DE3)-RIPL (Agilent) cells which were grown on Luria-Bertani (LB) medium 
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containing 50 µg/ml each of kanamycin, chloramphenicol and streptomycin for 
protein expression. Cultures were grown at 37 °C, 225 rpm until approximately OD600 
0.6, at which point protein expression was induced by the addition of 1 mM IPTG. 
The cultures were left shaking at 30 °C for a further 18 hours.  Cells were harvested 
by centrifugation and resuspended in 20 mM Tris-HCl pH 8.0, 10 mM imidazole. Cell 
lysis was achieved by sonication on ice followed by centrifugation. AF-Est2 was 
purified using a 1 ml His-Trap FF crude column (GE Healthcare) using an elution 
gradient from 20 to 500 mM imidazole in 20 mM Tris-HCl pH 8.0, 0.5 M NaCl. The 
enzyme was then applied to a calibrated Superdex 200 HiLoad 16/60 size exclusion 
column (GE Healthcare) and was eluted with one column volume of a buffer of 25 
mM Tris-HCl, pH 7.5, 0.1 M NaCl.  
3.6.2 Standard assays 
Assays were carried out using pNP ester substrates as previously described 
(Armstrong et al., 1966). A 50 mM stock of each substrate in DMSO was prepared 
and stored at -80 °C until required. Unless otherwise specified, each reaction was 
performed in assay buffer containing 50 mM Tris-HCl pH 7.5, 1 mM substrate, 0.125 
µg/ml of enzyme and carried out in triplicate in standard 96-well microplates (Greiner 
655101).  Reactions were started by the addition of substrate after pre-incubation at 
30 °C for 5 min, and monitored by following the absorbance at 405 nm over 10 min 
in a Tecan Infinite M200 PRO plate reader. All activity measurements included a 
reading for the blank rate of hydrolysis which was subtracted from the observed 
activity, compensating for any autohydrolysis of the pNP esters.  
The molar extinction coefficient of pNP was determined for every condition prior to 
measurements.  One Unit of esterase activity was defined as the amount of protein 
releasing 1 μmol/min of pNP.  
To measure the CoA thioesterase activity a DTNB-based assay (Riddles, Blakeley 
and Zerner, 1983), which measures the level of free thiols (and hence formed CoA) 
was performed following incubation of the enzyme with acetyl-CoA and succinyl-
CoA. 
	112	
3.6.3 Substrate specificity and kinetics 
Kinetic analysis of substrate specificity was carried out by measuring the activity of 
AF-Est2 against a range of pNP esters (C2 to C12 and pNP-benzoate) over a range 
of ten substrate concentrations from 5 to 2500 µM. The initial reaction rates were 
fitted to the Michaelis-Menten equation by non-linear least squares regression using 
GraphPad Prism v. 5.0. 
Phenol red was used to monitor the change in pH as a result of the hydrolysis of the 
industrial substrate methyl p-toluate by the change in absorbance at 540 nM. The 1 
ml assay was prepared using 20 µg/ml phenol red, 1 mM HEPES pH 8.0 at each 
assay temperature. A spectrophotometer with a Peltier temperature controller was 
used for assays at 50oC and 70oC with 13.6 µg / ml of enzyme.  Assays at 30oC 
were carried out in a standard 96-well microplate reader in a 200 µl volume with 25.0 
µg / ml of enzyme.  All assays were carried out for 10 min after addition of the 
substrate.  A standard curve from 0 to 300 µM of p-toluic acid was generated for 
each assay temperature.  Activity was measured at eight concentrations of methyl p-
toluate between 0 and 5000 µM and the initial reaction rates were fitted as described 
above. 
3.6.4 Effects of temperature 
The thermostability of AF-Est2 was assessed by incubating samples at a range of 
temperatures for half an hour using the temperature gradient function of a T100 
thermocycler (Bio-Rad). Following incubation samples were cooled to 4° C before 
assaying activity against pNP-valerate, relative to a control sample kept at room 
temperature. 
To examine the effect of temperature on the activity of AF-Est2, a standard assay 
buffer was prepared and titrated to the correct pH at temperatures from 20 °C to 80 
°C. Using an Evolution 300UV-Vis spectrophotometer (Thermo Scientific) with a 
Peltier heater, 970 µl of assay buffer was equilibrated to temperature in a 1 ml quartz 
cuvette. The blank rate with 0.5 mM pNP-valerate was measured before the addition 
of 0.125 µg of enzyme. A 10 min continuous assay was performed and the data 
analysed to use only initial linear rates. 
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To measure the stability of AF-Est2 at 70oC, 50oC and 30oC aliquots of AF-Est2 were 
prepared at 1 mg/ml in 25 mM HEPES pH 7.5, 100 mM NaCl and 0.01 % sodium 
azide. Every few days 0.2 µg of enzyme was taken from each aliquot was used to 
measure activity against 0.5 mM pNP-valerate in triplicate, with rates calculated 
relative to those at the beginning of the experiment. 
3.6.5 Effects of pH 
To test the stability of AF-Est2 at various pHs, AF-Est2 was incubated for one hour 
at room temperature in the following buffers covering a range of pH values from 2 to 
12: 100 mM KCl-HCl pH 2.0, 100 mM glycine-HCl pH 3.0, 100 mM sodium acetate 
pH 4.0 and pH 5.0, 100 mM sodium phosphate pH 6.0, 100 mM Tris-HCl pH 7.0, pH 
8.0 and pH 9.0, 100 mM glycine-NaOH pH 10.0, 100 mM sodium dihydrogen 
orthophosphate-NaOH pH 11.0 and pH 12.0. The enzyme was then diluted 250 fold 
into 50 mM Tris-HCl pH 7.5, to a final concentration of 2.5 µg/ml, and assayed 
against pNP-caprylate (C8). 
To access the effect of pH on enzyme activity, reactions were carried out using the 
buffers described above in place of the standard reaction buffer. The pNP-caprylate 
was used as the substrate to reduce spontaneous hydrolysis at alkaline pHs. 
Readings were taken at 348 nm, the isobestic point of pNP, to remove the effect of 
pH on the readings.   
3.6.6 Effect of solvents 
To examine the stability of AF-Est2 in various solvents, the enzyme was incubated 
for 1 hour in buffer containing 25 mM Tris-HCl pH 7.5, 100 mM NaCl, and either 10 
%, 25 % or 50 % solvent. Methanol, ethanol, isopropanol, DMSO, acetonitrile and 
acetone were tested. A control sample was incubated with no solvent to compare 
relative activity. Samples were then diluted 1 in 2000 in assay buffer to measure 
enzyme activity. 
3.6.7 Effect of inhibitors 
The inhibitors PMSF, benzamidine and benzil at concentrations in the 0 – 2 mM 
range were incubated with enzyme at 9 nM for 30 min before measuring enzyme 
activity by the addition of the substrate, 0.5 mM pNP-valerate.   
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The mode of PMSF inhibition was determined using Michaelis-Menten kinetics with 
eight different pNP-valerate concentrations in the presence of five inhibitor 
concentrations. The best equation to describe the inhibition data was selected by 
fitting a non-linear least squares regression in GraphPad Prism 5.0.  
3.6.8 Diamide treatment 
0.25 mg / ml enzyme was incubated in a 1, 10 or 100 mM diamide, 25 mM Tris-HCl 
pH 7.5, 100 mM NaCl solution for 1 hour before a 1 in 250 dilution into 25mM Tris-
HCl pH 7.5, 100 mM NaCl was made. A control incubation was also performed 
without the addition of diamide. Enzyme assays were performed as specified 
previously against pNP-valerate.  Activity was calculated as relative to the control 
sample. 
3.6.9 Crystallization 
AF-Est2 was concentrated to ~12 mg/ml using a 10 kDa membrane Vivaspin 
(Vivaproducts) and microbatch crystallization trials were set up using an Oryx6 
crystallization robot (Douglas Instruments) using the JCSG Screen+™ (Molecular 
Dimensions). The droplet contained a 50:50 ratio of protein solution to screen and 
was covered with Al’s oil (50:50 mix of silicon and paraffin oils) before being stored 
at 20 °C.  
Native crystals appeared within one week in 100 mM ammonium chloride and 10 % 
(w/v) PEG3350 and were cooled in liquid N2 using a cryoprotectant consisting of 100 
mM ammonium chloride, 10 % (w/v) PEG3350, 35 % (v/v) PEG400, 25 mM Tris pH 
7.5 and 100 mM NaCl. Multiple attempts of inhibitor and substrate co-crystallisation 
produced crystals in conditions related to those of native crystals. Additionally, native 
crystals were soaked for 30-300 sec in the cryoprotectant containing variable 
concentrations of ligands. 
3.6.10 X-ray data collection and structure solution 
Native AF-Est2 data were collected to 2.1 Å and later to 1.4 Å on beamline I03, at 
the Diamond Synchrotron light source (Didcot, UK) at 100 K in a stream of gaseous 
nitrogen using a Pilatus detector (Dectris). Data were processed and scaled using 
XDS(Kabsch, 2010) and AIMLESS(Evans and Murshudov, 2013) in the Xia2(Winter, 
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Lobley and Prince, 2013) pipeline. All further data and model manipulation was 
carried out using the CCP4 suite of programs (Winn et al., 2011).  
Phases for the initial structure were determined using these 2.1 Å resolution data by 
the molecular replacement method implemented in the MORDA pipeline (Vagin and 
Lebedev; http://www.biomexsolutions.co.uk/morda). The best solution was found 
with the bromoperoxidase A1 monomeric model(Hofmann et al., 1998) (PDB 1A8Q) 
which shares 27 % sequence identity to AF-Est2. Two monomers of the search 
model were positioned in the AF-Est2 unit cell with a Z-score of 9.6 and in the course 
of initial refinement Rfree was reduced from 57.6 % to 51.9 %. MORDA has estimated 
the probability of the resulting solution to be correct at 81 %. 
The phases were improved by two fold NCS averaging using DM(Cowtan, 2010). 
The averaged phases were used in phased refinement implemented in the 
REFMAC5(Murshudov et al., 2011). The combined partial model and averaged 
phases produced a good quality map that allowed re-building of AF-Est2 structure in 
COOT(Emsley et al., 2010). The unknown ligand was identified as CoA at this stage. 
Refinement with both anisotropic and isotropic B-factors was attempted since for 1.4 
Å the ratio of independent reflections to refined atoms (including alternative 
conformations) is 20, which is a borderline case for anisotropic B-factor refinement 
according to PDB REDO(Joosten et al., 2014). After the map inspection isotropic B-
factor refinement was selected. 
The statistics of the data processing and parameters of the final refined models are 
given in Table 3-2. The dictionary definitions for pNP ester ligands used for docking 
were prepared using JLIGAND (Lebedev et al., 2012) and the manual docking of 
ligands was performed in COOT.  
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Table 3-2 - The AF-Est2 data processing and structural refinement 
statistics. 
Crystal COA complex 
Beamline (Diamond) I03 
Resolution (Å) 70.29-1.40 (1.44-1.40)a 
Wavelength (Å) 0.9763 
Space group P212121 
Cell dimensions  a, b, c= 55.1, 67.2, 140.6 Å; α, β, γ = 90º  
No. of  protomers in A.U. 2 
Solvent content (%); VM (Å3 
Da-1)  
46.4; 2.31 
Unique reflections 102188 
Redundancy 5.6 (2.5) 
Completeness 98.9 (89.6) 
<(I)/ σ (I)> 18.9 (2.0) 
Rsym (%) 4.4 (46.1) 
Wilson B factor (Å2) 24.5 
Overall R-factor (%) 15.6 
Rfree (5 % total data) % 17.3 
Residues refined 508 
No. of waters modelled 514 
RMSD bond length (Å) 0.011 [0.019] b 
RMSD bond angle (º) 1.6 [2.0] 
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Occupancy of ligand 1.0 
Average B factor  
Protein (Å2) 22.8 
Water (Å2) 35.5 
Ligand 24.8 
Ramachandran analysis (% of 
residues) 
 
     Most favoured 88.7 
     Additionally allowed 10.9 
     Generously allowed 0.0 
     Disallowed 0.4 
G-factor 0.1 
a Values for the outer resolution shell are given in parentheses. 
b Target values are given in brackets. Rsym=∑h∑J|<Ih>-IJ(h) |/∑h∑J IJ(h), where 
I(h) is the intensity of the reflections h, ∑h is the sum over all the reflections 
and ∑J is the sum over J measurements of the reflections. The individual 
atomic B-factors were refined isotropically. Rcryst =∑||Fo|-|Fc||/∑|Fo|. Wilson B-
factor was estimated by SFCHECK(Vaguine, Richelle and Wodak, 1999). The 
Ramachandran plot analysis and G-factor calculation were performed by 
PROCHECK (Laskowski et al., 1993). 
 
3.6.11 Accession codes 
The coordinates and structure factors for AF-Est2 have been deposited in the 
Protein Data Bank with code: 5FRD. 
 
  
	118	
3.7 Acknowledgments and Other Information 
3.7.1 Acknowledgements 
This work was supported by the Hotzyme project (grant agreement no. 265933) 
financed by the European Union 7th Framework Programme FP7/2007-2013. WF is 
funded by a BBSRC PhD studentship. MI would like to thank the BBSRC funded 
ERA-IB grant BB/L002035/1 and the University of Exeter for support. The authors 
would like to thank the Diamond Synchrotron Light Source for access to beamline 
I03 (proposals No. MX8889 and No. MX11945) and the beamline scientists for 
assistance. The work of ML was funded by the Graduate School VLAG Wageningen, 
the Netherlands.  
3.7.2 Author contributions 
SVWK and ML identified and cloned the gene within the group of JvdO at 
Wageningen University. CS over-expressed and crystallised the protein. The protein 
was biochemically characterised by CS, WF and NH. The structure was determined 
by CS and MNI.  JAL coordinated the project and wrote the manuscript with input 
from all other authors.  
3.7.3 Competing interests 
There are no competing financial or other competing interests. 
 
	 119	
 
 
 
 
 
 
 
Chapter 4 - Characterization of 
carboxylic acid reductases as enzymes 
in the toolbox for synthetic chemistry  
	120	
4.1 Authors 
William Finnigan [a], Adam Thomas[a], Holly Cromar[a], Ben Gough[a], Radka 
Snajdrova[b], Joseph P. Adams[b], Jennifer A. Littlechild[a], Nicholas J. Harmer*[a]  
[a]  W. Finnigan, A. Thomas, H. Cromar, B. Gough, J.A. Littlechild, N. J. Harmer 
Biosciences, College of Life and Environmental Sciences, University of Exeter, 
Stocker Road, Devon, Exeter EX4 4QD, UK 
[b] R. Snajdrova, J. Adams 
Synthetic Chemistry, AC - API Chem – UK, GlaxoSmithKline R&D Ltd, Medicines 
Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK 
 
  
	 121	
4.2 Preface for inclusion in this thesis 
This chapter is made up of the reformatted manuscript for a paper initially submitted 
for publication in ChemCatChem in May 2016, and again in September 2016 after 
responding to reviewer comments.  mpCAR is used to fill the second step in the 
enzymatic cascade reaction investigated in subsequent chapters, shown inFigure 
1-8.  It was chosen for the cascade due to its superior thermostability allowing better 
operational stability and with the hope of expression in T. thermophilus. 
All biochemical work was performed by William Finnigan, with the exception of the 
kinetic characterisation of msCAR which was performed by Holly Cromar.  Ben 
Gough also carried out preliminary work on niCAR and tpCAR.  Phylogenetic 
analysis was performed by Adam Thomas. 
All text and figures relating to the phylogenetic analysis of the CAR enzymes, 
including discussions on similarities with members of the ANL superfamily, was 
written by Adam Thomas, and edited by all authors. 
All other text and figures were written by William Finnigan with editing and 
contributions by Nicholas Harmer.  Final edits were carried out by all authors. 
The manuscript has been formatted to match the formatting of this thesis.  
References have been combined with those in the other chapters of this thesis for a 
final reference chapter.  Figure and table numbers have also been edited for 
inclusion in the thesis.  
 
This manuscript was accepted by ChemCatChem in November 2016, after 
responding to further reviewer comments.  DOI: 10.1002/cctc.201601249.  The 
accepted version has only minor differences to this thesis version. 
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4.3 Abstract 
Carboxylic acid reductase enzymes (CARs) meet the demand in synthetic chemistry 
for a green and regio-specific route to aldehydes from their respective carboxylic 
acids.  However, relatively few of these enzymes have been investigated. Sequence 
alignments with members of the ANL superfamily of enzymes shed light on CAR 
functional dynamics. From a phylogenetic analysis of known and hypothetical CARs, 
four unstudied enzymes were selected, and for the first time, a thorough biochemical 
characterization carried out.  Kinetic analysis of these enzymes with various 
substrates shows they have a broad but similar substrate specificity.  Electron rich 
acids are favored, suggesting that the first step in the proposed reaction mechanism, 
attack by the carboxylate on the a-phosphate of ATP, is the step determining 
substrate specificity and reaction kinetics.  Effects of pH and temperature provide a 
clear operational window for these enzymes, while investigation of product inhibition 
by NADP+, AMP and pyrophosphate (PPi) indicates that binding of substrates at the 
adenylation domain is ordered with ATP binding first.  This paper consolidates CARs 
as important and exciting enzymes in the toolbox for sustainable chemistry, providing 
specifications for their use as a biocatalyst.  
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4.4 Introduction 
The demand for 'green chemistry' is of increasing global importance, driven by the 
need to balance sustainable and efficient resource utilization with the demands and 
increasing consumption of a rising population (Zhang, 2015).  Biological solutions to 
chemistry challenges are a critical component in meeting this demand. The use of 
isolated enzymes and cell-based systems that produce negligible dangerous waste, 
often with higher yields, offers an alternative to traditional chemical processes.  In 
some cases, biological alternatives are more rapid and cost effective than their 
chemical counterpart (Littlechild, 2011).  Despite these potential advantages, 
enzymes are still under-used in chemistry.  Expanding the toolbox of available 
enzymes is essential for the successful development of new synthetic routes and 
sustainable manufacturing processes (Meyer et al., 2013). 
An important opportunity that is ripe for exploitation is synthetic routes based on 
organic acids. These compounds have a long history of production by fermentation 
(Kertes, King and Blanch, 2009).  Indeed, multiple carboxylic acids were identified to 
be “Top Value Added Chemicals From Biomass” (Erickson, Nelson and Winters, 
2012), many of which are now being produced industrially. Reduced products of 
these organic acids, especially optically pure aldehydes and alcohols, are essential 
building blocks for use in the chemical, pharmaceutical and food industries (He et al., 
2004).  However, chemical methods for the reduction of carboxylic acids are limited, 
and require chemicals such as lithium aluminium hydride and sodium borohydride in 
stoichiometric amounts (Napora-Wijata, Strohmeier and Winkler, 2014). 
Two enzyme classes are capable of reduction of organic acids to aldehydes, and a 
review of the biocatalytic reductions possible by organisms harboring them published 
(Napora-Wijata, Strohmeier and Winkler, 2014).   The aldehyde oxidoreductases 
(AORs) reversibly oxidize organic aldehydes to their respective acids. The oxidized 
product is more thermodynamically favorable, and so the equilibrium tends towards 
this product. AORs are therefore more useful for syntheses that require the oxidation 
of aldehydes (Heider, Ma and Adams, 1995; Hollmann et al., 2012).  In contrast, the 
carboxylic acid reductases (CARs) catalyze the reduction of a carboxylic acid to an 
aldehyde at the expense of ATP and NADPH, producing AMP, PPi and NADP+ as 
by-products (He et al., 2004).  The reduction of carboxylic acids into aldehydes by 
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CARs has been confirmed by a number of studies previously, using GC-MS analysis.  
Products other than the aldehyde have not been detected (Akhtar, Turner and 
Jones, 2013; Moura et al., 2015).  The hydrolysis of ATP makes the reduction of 
acids to aldehydes by CARs strongly thermodynamically favorable, making them an 
attractive green route to optically pure aldehydes (Napora-Wijata, Strohmeier and 
Winkler, 2014).  This synthesis can be coupled to other enzymes such as an alcohol 
dehydrogenase which can provide a complete route to the alcohol product (Akhtar, 
Turner and Jones, 2013). 
Indeed, CARs have been employed in a number of synthetic pathways. These 
include the production of the flavor vanillin by yeast (Hansen et al., 2009), and a 
synthetic pathway for the production of propane in Escherichia coli (Kallio et al., 
2014).  These examples both highlight the potential of CARs as part of a toolbox for 
synthesis of fine chemicals from non-oil-based chemical precursors (Erickson, 
Nelson and Winters, 2012). 
CARs are relatively large, multidomain enzymes of around 130 kDa.  They feature 
an N-terminal adenylation domain, a C-terminal thioester reductase domain that 
likely adopts a Rossmann fold, and a central phosphopantetheine binding domain 
(Figure 4-1) (Marchler-Bauer et al., 2015).  A phosphopantetheine arm must be 
covalently attached to a conserved serine in this central domain through the action of 
a phosphopantetheine transferase for the production of an active enzyme 
(Venkitasubramanian, Daniels and Rosazza, 2007).  Fungal α-aminoadipate 
reductases, which are responsible for the reduction of α-aminoadipate to α-
aminoadipate semialdehyde in lysine biosynthesis, share this domain architecture, 
also with the requirement for the loading of a central phosphopantetheine prosthetic 
group (Ehmann, Gehring and Walsh, 1999).  However these enzymes have been 
shown to have a different substrate specificity from CARs (Moura et al., 2015). 
Phosphopantetheine arms are most commonly associated with acyl carrier proteins 
where they maintain an acyl chain in a energetically active thioester bond, with the 
length and flexibility of the arm allowing access to spatially distinct active sites (Chan 
and Vogel, 2010).  In CARs, the phosphopantetheine arm is believed to act in much 
the same way, shuttling an attached acyl chain between the N- and C-terminal 
domains (Venkitasubramanian, Daniels and Rosazza, 2007). 
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The proposed mechanism of CAR enzymes has four main steps (labelled 1 to 
4;Figure 4-1).  In the first two steps, the relatively unreactive carboxylic acid is 
activated to form a thioester with the phosphopantetheine arm at the N-terminal 
adenylation domain, in a mechanism possibly similar to that of the ANL superfamily 
of adenylating enzymes such as long chain fatty acid CoA ligases (Hisanaga et al., 
2004; Gulick, 2009).  (1) ATP and a carboxylic acid enter the active site of the 
adenylation domain where the α-phosphate of ATP is attacked by an oxygen from 
the carboxylic acid, forming an AMP-acyl phosphoester with the release of 
pyrophosphate (Hisanaga et al., 2004). (2) The thiol group of the 
phosphopantetheine arm can then nucleophilically attack the carbonyl carbon of the 
AMP-acyl phosphoester intermediate, releasing AMP and forming an acyl thioester 
with the phosphopantetheine arm.  (3) The phosphopantetheine arm transfers to the 
C-terminal reductase domain (4) where the thioester is reduced by NADPH, 
releasing the aldehyde and NADP+, and regenerating the thiol of the 
phosphopantetheine arm in the process (Napora-Wijata, Strohmeier and Winkler, 
2014). 
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Figure 4-1 – Proposed mechanism of CAR enzymes.   
1: ATP and a carboxylic acid enter the adenylation domain where a phosphoester 
intermediate is formed releasing pyrophosphate in the process.   
2: the thiol of the phosphopantetheine arm nucleophilically attacks the carbonyl carbon of 
this intermediate forming a thioester intermediate with the phosphopantetheine arm, 
releasing AMP.   
3: the phosphopantetheine arm transfers to the reduction domain where,  
4: the thioester bond is reduced by NADPH releasing an aldehyde product, regenerating the 
phosphopantetheine thiol group and producing NADP+.   
  
	128	
Relatively few CARs have been explored to date.  CARs were first described in 
Neurospora crassa as an aryl-aldehyde: NADP+ oxidoreductase (Gross and Zenk, 
1969).  Subsequently, CARs were characterized from Nocardia asteroides JCM 
3016 (Kato et al., 1991) and later Nocardia iowensis (Li and Rosazza, 1997) 
(referred to as niCAR here) when they were reclassified as carboxylic acid 
reductases (Li and Rosazza, 1997).  Characterization of the Nocardia asteroides 
JCM 3016 CAR was performed by comparing the relative activity of this enzyme 
towards various aromatic substrates (1 mM concentration).   This CAR was reported 
to prefer 3-substituted benzoates and aliphatic acids that were substituted with a 
phenyl group.  No reaction of this CAR with simple aliphatic acids was reported.  The 
optimum pH for activity of this enzyme was pH 7.5, and the optimum temperature for 
activity was 40 °C (Kato et al., 1991). 
The relative activities of the Nocardia iowensis CAR (niCAR) against various 
aromatic substrates have also been reported. The highest activity was achieved with 
indole-5-carboxylic acid, which was the most activated carboxylic acid tested.  
Substrates with 2-substituted benzoates or ring-deactivating groups showed no or 
very low levels of activity.  The reduction of racemic ibuprofen by whole Nocardia 
iowensis cells gave a enantiometic excess (ee) of 61.2 %, which has been attributed 
to enantio-selectivity by niCAR based on kinetic data for its reduction of (S)-(+)-
Ibuprofen and (R)-(-)-Ibuprofen enantiomers (Li and Rosazza, 1997).  The 
requirement for the presence of a phosphopantetheine transferase for the loading of 
a phosphopantetheine group onto the CAR enzyme was shown for niCAR and is 
presumed to be the case for all the CAR enzymes (Li and Rosazza, 1997).  
A CAR from Mycobacterium marinum has also been described and its application for 
the reduction of fatty acids to fatty alcohols explored. This CAR is active against fatty 
acids between two and eighteen carbons in length (Akhtar, Turner and Jones, 2013).  
CAR activity has also been reported in the zygomycete fungus Syncephalastrum 
racemosum, although a responsible gene has yet to be identified (Brenna et al., 
2015). 
Recently a characterization of CARs from Nocardia iowensis, Nocardia brasiliensis, 
Mycobacterium marinum and Mycobacterium smegmatis showed CARs to prefer 
substrates where the carboxylic acid was the only polar or charged group, giving a 
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useful insight into the substrate specificity of these enzymes.  Also, a model was 
developed for the prediction CAR reactivity using this and previous CAR data (Moura 
et al., 2015).  It is worth noting that the msCAR characterized by Moura et al. is 
distinct from msCAR used in this study. 
Here, we have produced a detailed phylogeny of the CARs and identified four 
previously undescribed CARs for further study that are broadly spread across this 
phylogeny.  With the addition of niCAR for comparison to earlier work, a thorough 
biochemical characterization was carried out on each. We investigated the effects of 
temperature and pH to identify suitable conditions for the use of CARs in biocatalytic 
reactions.  We further performed a full kinetic analysis on a range of aromatic and 
aliphatic substrates with these CARs to look for potential differences in their 
substrate specificity and to examine the effects of various functional groups on their 
kinetic parameters.  Finally, we describe potential issues of product inhibition with 
the CAR enzymes. Our investigation provides a more thorough description of the 
factors to be considered when using the CAR enzymes in industrial biocatalysis. 
4.5 Results 
4.5.1 Alignment and phylogenetic analysis 
CAR adenylation domains were aligned with a firefly luciferase, a fatty acyl-CoA 
ligase and a reductase domain from a non-ribosomal peptide synthetase, all from the 
ANL superfamily (Supplementary Figure 4-1). CARs share ~20% sequence 
homology with other ANL superfamily members.  Members of the ANL super family 
catalyze the initial adenylation of a carboxylic acid to form an acyl-AMP intermediate, 
which is generally followed by the formation of a thioester.  The family name is based 
on three of its sub families: Acyl-CoA synthetases, the non-ribosomal peptide 
synthase (NRPS) adenylation domain, and the Luciferase enzyme (Gulick, 2009). 
Previous alignment and crystallography studies have identified nine motifs that are 
conserved within the superfamily. Of the nine, five are strongly conserved within the 
CARs, including the active site ppxTSGSTGxPK, rGxTE and TGD motifs (where 
p=aliphatic and r=aromatic residues). These motifs are considered “signature” to the 
ANL superfamily, and are involved in the hydrolysis of ATP (Marahiel, Stachelhaus 
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and Mootz, 1997). The remaining four motifs are also present albeit with lower 
conservation. 
A total of 48 unique sequences showing homology to known CAR proteins were 
gathered using pBLAST, or mined directly from GenBank by raw text searches 
(Supplementary Figure 4-2). All sequences identified were solely from Subclass 
actinobacteridae. Within this Subclass, sequences were obtained from families 
Streptomycetaceae and Corynebacterinae.  
A masked multiple sequence alignment of the dataset was shown to be best fit to the 
Whelan and Goldman model of amino acid substitution, with a discrete gamma 
distribution of mutation rates and an assumed presence of invariant sites 
(WAG+I+G). This model was implemented into a Bayesian phylogenetic 
reconstruction (Figure 4-2). According to 16S data, the Streptomycetaceae are 
thought to have evolved before the Corynebacterinae. However, rooting the tree on 
the streptomycetes has poor parsimony as numerous gene loss events would have 
had to have occurred for this to be the case (Lodders and Kämpfer, 2007).  Instead, 
due to an outgroup being unobtainable for this dataset, we opted to root the tree on 
its midpoint. The tree is extremely well supported, with all nodes possessing a 
confidence score of >0.75, and only four of forty-six biologically relevant nodes being 
scored at below the highest possible confidence score of 1. 
In order to better understand how CAR functionality differs across clades, we 
selected sequences for characterization from a range of host organisms that broadly 
cover distinct areas of the phylogenetic tree.  
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Table 4-1– Carboxylic acid reductases chosen for this study. 
Abbreviation Source NCBI Reference: 
mpCAR Mycobacterium phlei WP_003889896.1 
msCAR Mycobacterium smegmatis AFP42026.1 
niCAR Nocardia iowensis Q6RKB1.1 
noCAR Nocardia otitidiscaviarum WP_029928026.1 
tpCAR Tsukamurella paurometabola WP_013126039.1 
Five carboxylic acid reductases were chosen for a through biochemical 
characterization from a range of host organisms containing putative 
CAR’s.  CAR abbreviations have been chosen to reflect their source.  
NCBI ascension numbers are shown which may be used to access the 
protein sequences. 
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Figure 4-2 - Phylogenetic tree of CAR enzymes.  
A midpoint rooted phylogeny of a masked alignment of 48 carboxylic acid reductase 
sequences retrieved from GenBank. Phylogeny was constructed with MrBayes and 
visualized in FigTree. Node labels represent Bayesian posterior probabilities describing 
node reliability (with 1 being unequivocal) computed by MrBayes. Coloured branches 
represent CARs that have been studied: Blue – in previous research, Red – in this paper, 
Purple – in both this paper and previous research.   
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4.5.2 Expression and Purification 
CAR enzymes (Table 4-1) were expressed in E. coli and purified from the cell lysates 
by nickel affinity chromatography followed by gel filtration in order to obtain a high 
level of purity (Supplementary Figure 4-3).  The optimum conditions for the 
expression of Mycobacterium phlei CAR (mpCAR) in E. coli in LB media were 
determined to be induction at OD600 0.6 with 150 µM IPTG, followed by incubation 
for approximately 18 hours at 20 °C, with orbital shaking at 225 rpm (data not 
shown).  Similar conditions were assumed to be suitable for the expression of the 
other CAR enzymes and indeed all CARs were well expressed. CARs were co-
expressed with the Sfp phosphopantetheinyl transferase from Bacillus subtilis on a 
separate plasmid, as the loading of a phosphopantetheine group onto CAR enzymes 
has been shown to be essential for activity (Venkitasubramanian, Daniels and 
Rosazza, 2007). 
4.5.3 Kinetic characterization of CAR enzymes 
The CAR enzymes were characterized in terms of their substrate specificity towards 
a range of aromatic carboxylic acids, a range of aliphatic unsaturated fatty acids, and 
the cofactors ATP and NADPH.  A list of the substrates with their chemical structure 
can be found in Figure 4-3 and Supplementary Figure 4-4.  For each CAR, an initial 
assay at high substrate concentration (5 mM) was carried out to identify compounds 
for which CAR had activity. For those compounds where activity was detected, a full 
kinetic analysis was performed (Supplementary Figure 4-5 to Supplementary Figure 
4-9).  All the CARs that were tested showed similar KM values for NADPH and ATP.  
For NADPH the KM was between 24 and 36 µM, whilst for ATP KM values of between 
64 and 84 µM were observed. These values are both well within the physiological 
ranges for these cofactors and in good agreement with previous studies. (Li and 
Rosazza, 1997; He et al., 2004; Akhtar, Turner and Jones, 2013)  Production of 
benzaldehyde and 4-methylbenzaldehyde from the derivative acids was confirmed 
by HPLC, with no other products observed.  NADPH consumption was also 
confirmed as a good measure of aldehyde production (Supplementary Figure 4-10 
and Supplementary Figure 4-11). 
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4.5.4 Investigating the effects of electronic density on aryl 
substituted carboxylic acid substrates  
All of the enzymes that we tested showed strong activity against the classical CAR 
substrate benzoic acid (compound 1, Figure 4-3A, Table 4-2), which all previously 
studied CARs have shown activity against. (He et al., 2004; Akhtar, Turner and 
Jones, 2013; Moura et al., 2015)  A series of substituents of varying electronic 
configuration were tested (compounds 2-5, Figure 4-3A, Table 4-2). Compounds with 
more electron rich systems generally lowered KM giving increased catalytic efficiency 
compared to benzoic acid.  Minimal activity was detected with 2-methoxy benzoic 
acid.   
In contrast, compounds that incorporated an electron withdrawing nitro group in the 
benzene ring (compounds 6-8, Figure 4-3B, Table 4-2) resulted in a large decrease 
in the turnover number of the CARs, in most cases inhibiting activity all together.  
Again, there was no detectable activity with a nitro group in the 2 position; whilst in 
the para position only tpCAR showed a low level of activity.  However, all the CARs 
tested were active against 3-nitrobenzoic acid but with a lower kcat than benzoic acid.  
Absorbance at OD340nm by nitro compounds was shown not to interfere with the 
assay (Supplementary Figure 4-12) 
4.5.5 Investigating the effect of the aromatic unit on catalytic 
activity 
3-phenylpropionic acid (compound 9, Figure 4-3C, Table 4-3) has a carboxylate 
group out of conjugation from the aryl ring, extended away from the aryl ring by two 
carbons giving the carboxylate group greater flexibility.  When tested with the CARs, 
this change caused a reduction in KM, with a similar or slightly lower kcat. (E)-3-
phenylprop-2-enoic acid (cinnamic acid; compound 10, Figure 4-3C, Table 4-3), 
being a conjugated system, was expected to have activity between 9 and the model 
compound 1, benzoic acid. The CAR activity against (E)-3-phenylprop-2-enoic acid 
showed a substantial reduction in kcat compared to 3-phenylpropionic acid or benzoic 
acid, with a slight further reduction in KM.  The cognate compound with a triple bond 
(phenylpropynoic acid; compound 11, Figure 4-3C, Table 4-3) showed very low or no 
detectable activity in the CAR reaction.  
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Two other compounds were tested: firstly, the b-keto acid 3-oxo-3-phenylpropanoic 
acid (compound 12, Figure 4-3C, Table 4-3) showed an increase in KM with mpCAR, 
msCAR and tpCAR, but a decrease in KM with noCAR and niCAR in comparison to 
3-phenylpropionic acid.  However, in all cases, the kcat was reduced when compared 
to 3-phenylpropionic acid or benzoic acid, as it was for (E)-3-phenylprop-2-enoic 
acid.  Finally, trans-2-phenylcyclopropane-1-carboxylic acid (compound 13, Figure 
4-3C, Table 4-3) features a cyclopropane ring between the benzene ring and 
carboxylate group.  For all the CARs this modification resulted in much lower KM 
values, and a much lower kcat, compared to 3-phenylpropionic acid or benzoic acid. 
4.5.6 Heterocycles 
Heterocycles containing nitrogen, oxygen or sulfur were tested (compounds 14-17, 
Figure 4-3D, Table 4-4).  Generally, weak activity was observed, with decreasing KM 
values for increasing heteroatom size.  Where there was activity, kcat was generally 
lower than benzoic acid.  Possibly, in cases where no activity was detected, the KM 
was outside the range of detection of the assay. 
4.5.7 Fatty acids 
All the CARs showed very high catalytic efficiency for fatty acids between eight and 
twelve carbons in length, with low KM values compared to benzoic acid (compound 
18-21, Figure 4-3E, Table 4-4).  Octadecanoic acid (21), with a carbon chain length 
of 18 carbons, showed a similarly low KM but a greatly reduced kcat.  All CARs except 
mpCAR were active against butanoic acid (compound 18, Figure 4-3E, Table 4-4) 
but with a very large KM, in most cases too large to characterize accurately. In 
general, mpCAR was much less efficient with fatty acids than the other CARs.
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Figure 4-3 – CAR activity for various benzoic acid derivatives, heterocycles and fatty 
acids.   
The kcat (min-1) determined for each enzyme against each substrate displayed as follows:  
mpCAR , msCAR , tpCAR , noCAR  and niCAR .  Below each substrate is its 
chemical structure.  Error bars show the standard error.  A:  Benzoic acid and derivatives 
with electron donating groups.  B:  Derivatives with an electron withdrawing groups.  C:  
Derivatives with various substituents between the carboxylate group and benzene ring.  D:  
Heterocycles containing either an oxygen, sulfur or nitrogen.  E:  Fatty acids between four 
and eighteen carbons in length. 
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Table 4-2 – CAR activity against benzoic acid and its derivatives with electron donating and withdrawing groups 
  
		
1. Benzoic 
acid 
2. 4-methyl-
benzoic acid 
3. 4-
Methoxy-
benzoic 
acid 
4. 3-
Methoxy-
benzoic 
acid 
5. 2-
Methoxy-
benzoic 
acid 
6. 4-Nitro-
benzoic 
acid 
7. 3-Nitro-
benzoic 
acid 
8. 2-Nitro-
benzoic 
acid 
  Hammet sigma constants: [26] 0 -0.17 -0.27 0.12 - 0.71 0.78 - 
mpCAR 
kcat (min-1) 140 ± 20* 122 ± 3 132 ± 4 104 ± 3 NA NA 3.7 ± 0.5 NA 
KM (mM) 20 ± 4* 3.7 ± 0.2 2.8 ± 0.2 3.0 ± 0.2 NA NA 0.3 ± 0.1 NA 
kcat / KM (min-1 mM-1) 7 ± 1* 33 ± 2 48 ± 5 35 ± 3 NA NA 11 ± 4 NA 
msCAR 
kcat (min-1) 197 ± 4 154 ± 6 179 ± 6 18 ± 1* NA NA 40 ± 10 NA 
KM (mM) 3.4 ± 0.2 0.16 ± 0.02 0.19 ± 0.02 12 ± 1* NA NA 0.5 ± 0.2 NA 
kcat / KM (min-1 mM-1) 57 ± 4 900 ± 100 930 ± 80 1.4 ± 0.2* NA NA 100 ± 50 NA 
tpCAR 
kcat (min-1) 142 ± 3 152 ± 2 130 ± 2 186 ± 2 19 ± 3 13 ± 1 33 ± 2 NA 
KM (mM) 2.0 ± 0.1 0.69 ± 0.03 0.45 ± 0.02 0.56 ± 0.02 9 ± 3 0.6 ± 0.1 0.7 ± 0.1 NA 
kcat / KM (min-1 mM-1) 72 ± 6 220 ± 10 290 ± 10 334 ± 10 2.2 ± 0.7 22 ± 6 44 ± 8 NA 
noCAR 
kcat (min-1) 183 ± 6 135 ± 5 138 ± 4 136 ± 5 NA NA 59 ± 2 NA 
KM (mM) 2.1 ± 0.2 1.2 ± 0.2 1.1 ± 0.1 0.9 ± 0.1 NA NA 2.5 ± 0.3 NA 
kcat / KM (min-1 mM-1) 89.1 ± 8 110 ± 20 130 ± 10 150 ± 10 NA NA 24 ± 3 NA 
niCAR 
kcat (min-1) 98 ± 7 94 ± 2 49 ± 1 93 ± 1 NA NA 18 ± 1 NA 
KM (mM) 0.9 ± 0.1 1.0 ± 0.1 0.25 ± 0.01 0.68 ± 0.03 NA NA 5.6 ± 0.7 NA 
kcat / KM (min-1 mM-1) 103 ± 9 97 ± 6 200 ± 10 137 ± 6 NA NA 3.2 ± 0.4 NA 
NA: no activity was detected with that substrate.  *: KM was unusually large and substrates concentrations could not reach a high enough concentration to 
accurately determine kinetic constants. Errors represent the standard error.  No Hammett constants for ortho positions as steric effects cannot be properly 
accounted for. 
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Table 4-3 – CAR activity against benzoic acid derivatives with the carboxylic acid group extended from the ring. 
    
9. 3-
Phenylpropionic 
acid 
10. (E)-3-
phenylprop-2-
enoic acid 
11. 
Phenylpropynoic 
acid 
12. 3-oxo-3-
phenylpropanoic 
acid   
13. trans-2-
Phenylcyclopropane-
1-carboxylic acid 
mpCAR 
kcat (min-1) 21.5 ± 0.7 67 ± 2 NA 18 ± 2 20 ± 1 
KM (mM) 3.0 ± 0.3 0.3 ± 0.02 NA 3.8 ± 0.8 1.8 ± 0.2 
kcat / KM (min-1 mM-1) 7.2 ± 0.7 240 ± 2 NA 5 ± 1 12 ± 1 
msCAR 
kcat (min-1) 184 ± 9 118 ± 2 NA 75 ± 2 2.2 ± 0.1 
KM (mM) 0.16 ± 0.02 0.075 ± 0.004 NA 0.27 ± 0.02 0.006 ± 0.0001 
kcat / KM (min-1 mM-1) 1200 ± 200 1600 ± 500 NA 280 ± 20 380 ± 20 
tpCAR 
kcat (min-1) 158 ± 2 38 ± 1 6 ± 4 85 ± 2 43 ± 1 
KM (mM) 0.32 ± 0.01 0.310 ± 0.002 0.09 ± 0.02 0.55 ± 0.04 0.061 ± 0.005 
kcat / KM (min-1 mM-1) 500 ± 20 120 ± 2 70 ± 40 150 ± 10 700 ± 60 
noCAR 
kcat (min-1) 140 ± 4 105 ± 3 NA 63 ± 2 48 ± 1 
KM (mM) 2.7 ± 0.2 0.72 ± 0.07 NA 0.29 ± 0.03 1 ± 0.1 
kcat / KM (min-1 mM-1) 52 ± 4 147 ± 15 NA 210 ± 20 46 ± 3 
niCAR 
kcat (min-1) 85.8 ± 0.9 7.7 ± 0.7 7 ± 0.4 37.1 ± 0.5 10.8 ± 0.3 
KM (mM) 0.97 ± 0.03 0.05 ± 0.02 1.3 ± 0.2 0.39 ± 0.02 0.21 ± 0.02 
kcat / KM (min-1 mM-1) 88 ± 3 170 ± 70 5 ± 1 94 ± 4 51 ± 5 
NA: no activity was detected with that substrate.  Errors represent the standard error. 
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Table 4-4 – CAR activity against heterocycles and fatty acids 
    
14. Pyridine-
2-carboxylic 
acid 
15. 1H-
Pyrrole-2-
carboxylic 
acid 
16. Furan-2-
carboxylic 
acid 
17. 
Thiophene-
2- 
carboxylic 
acid 
18. C4 – 
Butanoic 
acid 
19. C8 – 
Octanoic 
acid 
20. C12 – 
Dodecanoic 
acid 
21. C18 – 
Octadecanoic 
acid 
mpCAR 
kcat (min-1) NA NA NA 50 ± 20* NA 58 ± 1 55 ± 2 3.7 ± 0.3 
KM (mM) NA NA NA 50 ± 20* NA 2.0 ± 0.1 0.09 ± 0.01 0.09 ± 0.02 
kcat / KM (min-1 mM-1) NA NA NA 1.1 ± 0.6* NA 29 ± 2 600 ± 70 39 ± 9 
msCAR 
kcat (min-1) NA NA 50 ± 10 123 ± 4 129 ± 7* 296 ± 8 131 ± 5 46 ± 4 
KM (mM) NA NA 13 ± 4 3.3 ± 0.3 7.9 ± 0.8* 0.1 ± 0.01 0.05 ± 0.01 0.6 ± 0.09 
kcat / KM (min-1 mM-1) NA NA 4 ± 2 37 ± 3 16 ± 2* 3000 ± 300 2700 ± 400 80 ± 10 
tpCAR 
kcat (min-1) 23 ± 3 NA 19 ± 1 82 ± 3 82 ± 3* 219 ± 3 157 ± 5 15 ± 1 
KM (mM) 24 ± 7 NA 4.7 ± 0.5 3.3 ± 0.3 5.0 ± 0.4* 0.2 ± 0.01 0.04 ± 0.01 0.12 ± 0.03 
kcat / KM (min-1 mM-1) 0.9 ± 0.3 NA 4.0 ± 0.4 25 ± 3 17 ± 2* 1140 ± 50 3600 ± 400 120 ± 30 
noCAR 
kcat (min-1) 76 ± 4 NA NA 135 ± 4 170 ± 20* 141 ± 2 99 ± 3 11 ± 1 
KM (mM) 20 ± 2 NA NA 2.6 ± 0.2 50 ± 8* 0.2 ± 0.01 0.04 ± 0.01 0.02 ± 0.01 
kcat / KM (min-1 mM-1) 3.9 ± 0.4 NA NA 52 ± 4 3.4 ± 0.7* 750 ± 30 2500 ± 300 500 ± 300 
niCAR 
kcat (min-1) NA NA NA 60.8 ± 0.9 260 ± 30* 233 ± 5 157 ± 9 68 ± 7 
KM (mM) NA NA NA 1.00 ± 0.05 32 ± 4* 0.2 ± 0.01 0.02 ± 0.01 0.7 ± 0.1 
kcat / KM (min-1 mM-1) NA NA NA 58 ± 3 8 ± 1* 1350 ± 90 7000 ± 2000 100 ± 20 
NA: no activity was detected with that substrate.  *: KM was unusually large and substrates concentrations could not reach a high enough concentration to accurately 
determine kinetic constants. Errors represent the standard error. 
	 141	
4.5.8 Effects of pH 
The activity of an enzyme at different pH values is an important consideration for an 
industrial enzyme. Therefore, the effect of pH on CAR activity was examined by 
measuring activity against benzoic acid at different pH values.  mpCAR, niCAR, 
noCAR and tpCAR all showed optimum activity at pH 7.5, whilst msCAR showed an 
optimum activity at pH 7.8 (Figure 4-4).  Both niCAR and tpCAR show a sharp peak 
of activity around pH 7.5, with activity quickly decreasing as the pH moved away 
from this point.  In contrast, mpCAR and noCAR show a slightly broader optimum 
around pH 7.0 to 7.6.  msCAR behaves very differently from the other CARs.  At 
more acidic pH values between pH 5.5 and 6.8 it shows very low activity where the 
other CARs are more active.  However, it is also more active at more alkaline pH 
values where the other CARs are less active. 
4.5.9 Effects of temperature 
Thermostability was investigated by incubating the CAR enzymes at various 
temperatures for half an hour and measuring residual activity against 4-
methylbenzoic acid relative to a control kept on ice.  tpCAR was the least 
thermostable CAR tested, being completely inactive after half an hour at 42 °C 
(Figure 4-5A).  In contrast, mpCAR, a CAR from the moderate thermophile M. phlei, 
retains 92% of its activity following the same incubation at 42 °C.  mpCAR was able 
to retain residual activity up to 50 °C making it the most thermostable CAR identified 
to date.  Both niCAR and noCAR showed intermediate thermostability, denaturing at 
temperatures beyond 44 °C, while msCAR is marginally more thermostable and is 
able to retain some activity until 47 °C. 
Activity at temperature was tested in a 10 minute reaction.  The more thermostable 
CARs, mpCAR, msCAR and niCAR all showed an optimum activity of 42 °C (Figure 
4-5B).  Activity decreased past this temperature at various degrees relative to the 
thermostability of each enzyme.  noCAR showed a slightly lower optimum at 38 °C 
while tpCAR had a much lower optimum still, at only 31 °C. 
The half-life and degradation constant at 30 °C were calculated by measuring activity 
at various time points over 120 hours.  The data were fitted to a one phase decay 
equation by non-linear least squares regression.  mpCAR, a CAR from a moderate 
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thermophile, showed by far the longest half-life at 30 °C at 123.2 hours (Table 4-5).  
In contrast, tpCAR has a much shorter half-life of only 25.0 hours.  The half-lives of 
msCAR, niCAR and noCAR fell between these extremes at 53.7, 42.9 and 35.3 
hours respectively.  Total turnover numbers (TTN) for the three best substrates were 
calculated as kcat / KD (Table 4-5). 
4.5.10 Product inhibition 
mpCAR was tested for product inhibition with AMP, NADP+ and PPi.  NADP+ showed 
competitive inhibition with NADPH with a KI of 143 ± 8 µM (Supplementary Figure 
4-13) and AMP was a competitive inhibitor of ATP with a KI of 8200 ± 900 µM 
(Supplementary Figure 4-14).  PPi showed mixed inhibition with ATP with a KI of 220 
± 50 µM, and an a of 2.5 ± 1.4.  Surprisingly, PPi also showed competitive inhibition 
with 4-methylbenzoic acid with a KI of 340 ± 40 µM (Supplementary Figure 4-15 and 
Supplementary Figure 4-16). 
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Figure 4-4 – The activity of CAR enzymes in response to pH.  
Overlapping buffers were used to cover a range from pH 5.6 to pH 9.0 in intervals of 
0.2 and are displayed as follows:  MES-NaOH  PIPES-NaOH , MOPS-NaOH  , 
HEPES-NaOH , Tris-HCl  Activity against  4-methylbenzoic acid acid is shown 
relative to the highest activity at 100%.  Errors bars show the combined standard 
deviation of three readings and three blank readings (with no enzyme) at each pH 
values.  
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Figure 4-5 – The effects of temperature on CAR enzymes.   
A – Thermostability of CAR enzymes.  The residual activity of CAR enzymes against 4-
methylbenzoic acid after a 30-minute incubation at different temperatures is displayed.  
Activity is shown relative to a control sample kept at 4 oC with errors bars showing the 
standard deviation of three readings.  B – Activity of CAR enzymes at different 
temperatures.  Activity is relative to the fastest rate at 100%.  Error bars show the combined 
standard deviation of three readings and three blank reading (with no substrate) at each 
temperature.  
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Table 4-5 – Half-life and degradation constant KD of CAR enzymes when incubated at 
30 oC. 
Enzyme Halflife 
(hours) 
KD (hrs -1) TTN benzoic 
acid 
TTN 4-
methylbenzoic 
acid 
TTN 4-
methoxybenzoic 
acid 
mpCAR 123.2 0.0056 ± 0.004 30000 ± 
20000 
20000 ± 20000 20000 ± 20000 
msCAR 53.7 0.013 ± 0.001 15000 ± 
1000 
10000 ± 1000 14000 ± 1000 
niCAR 25 0.28 ± 0.002 350 ± 30 336 ± 8 175 ± 4 
noCAR 35.3 0.02 ± 0.002 9000 ± 1000 6800 ± 700 6900 ± 700 
tpCAR 42.9 0.016 ± 0.002 9000 ± 1000 6000 ± 1000 8000 ± 1000 
The half-life, KD and TTN for the three best substrates of CAR enzymes calculated from activity after 
incubation at 30 °C over time, fitted to Y=Y0*e-K*X.  Standard error for KD is shown.  TTN has been 
calculated as kcat / KD, with the combined error shown. 
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4.6 Discussion 
The CAR enzymes offer an excellent opportunity for green chemistry: they offer the 
opportunity to reduce carboxylic acids selectively to aldehydes, without the use of 
harsh reducing agents. CARs also have the clear advantage over other enzymes 
capable of carrying out this reaction of the reduced product being thermodynamically 
favored, due to the hydrolysis of ATP. Although previous studies have identified a 
few CARs from different species, and demonstrated that they have activity against 
diverse acids, none of these studies has provided a detailed, kinetic comparison of 
diverse CARs. We therefore aimed to thoroughly characterize example CARs from 
across the known CAR family, together with the best-characterized CAR from N. 
iowensis. Our aim was to demonstrate the similarities and differences between these 
CARs, learn more about the CAR mechanism, and highlight the potential of these 
enzymes for biocatalysis. 
4.6.1 The effect of the addition of electron donating or withdrawing 
groups 
The reduction of carboxylic acids to aldehydes typically involves a transfer of a 
‘hydride’ to the carbonyl unit. We therefore initially expected that electron 
withdrawing groups, which make this carbon more electrophilic, would be preferred 
substrates. However, our observation was that, contrary to our expectation, electron 
donating groups were preferred substrates (Figure 4-3, Table 4-2). The addition of 
electron donating groups to benzoic acid resulted in a reduction in KM, and so an 
increase in catalytic efficiency. We reasoned that these groups would drive electrons 
into the p-system, making the first step of the reaction (attack by the negatively 
charged carboxylate group on the a phosphate of ATP) more favorable. As two of 
the other steps (2 and 4) involve nucleophilic attacks on the acid group carbon atom 
of the carboxyl group (which should favor electron withdrawing groups), this strongly 
suggests that the first step in the reaction has the greatest impact on substrate 
specificity and selection. It is possible that the reduced KM with electron donating 
substituents is a consequence of the acyl-AMP intermediate forming more readily, 
although very detailed studies of the kinetics of this individual step would be required 
to confirm this. In long-chain fatty acid ligases, the acyl-AMP intermediate has been 
shown to be unable to leave the active site (Hisanaga et al., 2004), so the addition of 
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a group which likely improves the formation of this intermediate might be expected to 
cause a lower KM and greater catalytic efficiency.  Moreover, when benzyl-AMP was 
used as a substrate with a CAR from Nocardia asteroides it showed a KM of 70 nM, 
compared to 260 nM for benzoic acid, suggesting that this intermediate binds more 
tightly to the enzyme (Kato et al., 1991).  Furthermore, the phosphopantetheine 
binding and C-terminal reductase domains shows high sequence identity to that of 
other ANL superfamily members that process very different substrates.  For example 
a NRPS from Mycobacterium intracellulare, WP_014382786.1, has an average of 58 
% identity to the CARs in Figure 4-2 for this C-terminal region). This strongly 
suggests that substrate specificity must be determined in the adenylation domain, 
likely at the formation of the first intermediate. 
In the 3-position, the methoxy group has no resonance effect on the carboxylic acid 
and so is actually slightly electron withdrawing by induction, as indicated by the 
Hammett sigma constants in Table 4-2.  In many of the CARs, the kcat of 3-
substituted benzoic acids shows a small reduction compared to 4-substituted acids, 
with msCAR showing greatly reduced activity. However, these are still good 
substrate for most of the CARs.  It is likely that there are further interactions between 
the substrate and the active site binding pocket, and that electronic effects alone 
cannot account for all differences in activity. 
Very low or no activity was found with a 2-methoxy substituent of benzoic acid. This 
suggests that there is a steric interference by the methoxy group on the binding of 
the nearby carboxylate group to the relevant area of the active site.  This effect has 
been reported for other CARs examined to date with other 2-substituents.  However, 
some cases suggest there is activity, but at a low level (Kato et al., 1991; Li and 
Rosazza, 1997).  No structure of a CAR enzyme has yet been described, and this 
would be highly beneficial in understanding the effects of groups in the 2-position. 
All substrates with an electron withdrawing group showed much lower kcat values 
than benzoic acid, in most cases inhibiting activity all together.  These groups should 
increase the propensity of the carbonyl carbon to nucleophilic attack in steps 2 and 4 
of the reaction. Therefore, this strongly suggests again that these two steps are of 
limited relevance for substrate specificity. Only 3-nitrobenzoic acid showed activity 
with all the CAR enzymes, likely as in this position the electron withdrawing group 
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has no resonance effect on the carboxylate group.  As is the case with the methoxy 
group, it is possible that a 2-nitro substituent inhibits activity due to a steric hindrance 
because of its close proximity to the carboxylate group.   
Previously it has been reported that 2-substituted benzoic acids are poor substrates 
for niCAR, in good agreement with our data (Li and Rosazza, 1997).  However very 
low activity was observed with 2-methoxybenzoic acid previously, which we did not 
detect.  Substrates with the addition of electron donating groups to benzoic acid 
were previously shown to be good substrates for niCAR, in agreement with our 
results.  The activity of niCAR with electron withdrawing chloro and bromo 3-
substituted benzoic acids supports our reasoning that in the meta position the 
absence of a resonance effect allows better activity with these substrates than in the 
other positions (Li and Rosazza, 1997). 
4.6.2 Modifications between the benzene ring and the carboxylic 
acid group. 
3-Phenylpropionic acid disrupts the influence of the aryl unit on the carboxylic acid 
compared to benzoic acid, and also makes a less sterically rigid substrate.  This 
difference seems to have made the carboxylic acid group more accessible, as the KM 
is much lower than benzoic acid in most cases.  The inclusion of a double bond in 
(E)-3-phenylprop-2-enoic acid, should withdraw electrons from the carboxylic acid 
group.  This would be beneficial for nucleophilic attack on the carbonyl in steps 2 and 
4 of the reaction, but detrimental to the initial attack by the oxygen of the carboxylate 
group on ATP.  The inclusion of the double bond causes a significant drop in kcat.  
The double bond also makes the molecule more rigid, in an apparently favorable 
conformation, as the KM is even smaller than for 3-phenylpropionic acid. 
When a triple bond is added to the structure (phenylpropynoic acid), the molecule is 
very rigid and flat, with a more electron deficient carboxylic acid group.  These 
effects together removed activity in nearly all the CARs.  The presence of a b-ketone 
group into the b-carbon of 3-phenylpropionic acid will have a similar effect to the 
inclusion of a double bond in (E)-3-phenylprop-2-enoic acid, very weakly withdrawing 
electrons from the carboxylic acid group. Indeed, the kcat values for phenylpropynoic 
acid and (E)-3-phenylprop-2-enoic acid are similar.  The ketone group had mixed 
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effects on the KM for the various CARs, suggesting differing interactions taking place 
with the ketone group within the active sites of the enzymes.  These observations all 
agree with the hypothesis that the first step of the proposed reaction mechanism is 
rate limiting. 
4.6.3 Heterocycles 
The CARs generally showed less activity towards heterocycles as towards a 
benzene ring. They showed a preference for heterocycles containing a larger 
heteroatom, or with a less aromatic nature.  In Thiophene-2- carboxylic acid, the lone 
pairs of electrons in the sulfur atom are more dispersed and less available for 
bonding, which possibly results in the lower KM. In contrast, the nitrogen atom in 1H-
pyrrole-2-carboxylic or pyridine-2-carboxylic acid has lone pairs more available for 
bonding, which may result in the very large KM values, or lack of activity observed.  
Furan-2-carboxylic acid, with an oxygen atom in the heterocycle, sits between these 
substrates in both respects.   
4.6.4 Fatty acids 
Fatty acids make interesting substrates, since fatty alcohols can be used as biofuels, 
in detergents, surfactants and polymers (Napora-Wijata, Strohmeier and Winkler, 
2014).  As was observed for the CAR from Mycobacterium marinum (mmCAR), most 
of the CARs tested were active against fatty acids between C4 and C18, with similar 
kinetics to previous work observed (Akhtar, Turner and Jones, 2013).  Catalytic 
efficiency with butyric acid was very poor, primarily due to large KM‘s for this 
substrate suggesting it might be too small to make the necessary interactions in the 
active site of the adenylation domain.  However, larger fatty acids showed much 
lower KM’s, with high turnover numbers resulting in catalytic efficiencies higher than 
any of the aromatic substrates tested in many cases.  As the acyl chain length 
increased past octanoic acid (with an eight carbon chain length), kcat decreased, 
reaching a low residual level for stearic acid.  Both niCAR and msCAR showed a 
better turnover number with the longer steric acid than the other CARs, suggesting 
these enzymes might be better suited to larger substrates.  Recently two other 
CARs, in combination with niCAR and mmCAR have been shown to have activity 
against ethanoic, butanoic, 2-methyl butanoic and 2-oxobutanoic acids, highlighting 
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that CARs can accept small fatty acids and that they can tolerate the addition of 
groups such as a methyl or carbonyl group onto the alpha carbon.  However, 2-
aminobutanoic acid was also tested but showed no activity (Moura et al., 2015). 
4.6.5 Effects of pH and temperature 
The operating pH and temperature range of an enzyme is an important consideration 
for a potential biocatalyst.  Stability at extremes of pH and in solvents are 
characteristics often found in thermostable proteins, as the mechanisms stabilizing 
these proteins against high temperature can also be stabilizing against these other 
conditions.  We observed an optimum pH of 7.5 for four of the five CARs tested, with 
a general tolerance to acidic pH, consistent with previously reported data on the 
activity of other CARs (Kato et al., 1991).  In particular, both mpCAR and noCAR 
were able to tolerate pH 6 with only a small loss of activity (whilst other CARs 
showed a much narrower optimum).  In contrast to this, msCAR is clearly better 
suited to more alkaline pH values (Figure 4-4). This therefore offers a CAR suitable 
for use in biocatalysis in conjunction with other enzymes favoring a similarly alkaline 
pH.  
mpCAR showed by far the best thermostability of any characterized CAR (Figure 5, 
Table 6). We also observed that it shows a much lower catalytic efficiency in general 
than the other CARs at 30 °C (Tables 2-4).  Possibly, there has been a trade-off 
between the rigidity of the enzyme (providing thermostability) and flexibility to allow a 
broader substrate range. It was notable that the rate enhancement in mpCAR at its 
optimum temperature compared to 30 °C was little greater than that for other CARs 
(Figure 4-5B).  In contrast, tpCAR shows very poor thermostability (Figure 4-5A), but 
is active with many of the substrates that the others CARs could not turn over (e.g. 
compounds 5, 6, 11, 14).  A possible compromise enzyme is msCAR, which shows 
the next best thermostability, and also has generally good catalytic efficiency.  When 
choosing an enzyme for industrial use, the lifespan of the enzyme can be an 
important consideration.  TTN can be calculated as a measure of how effective an 
enzyme will be over its lifetime, which we have demonstrated with three of the best 
CAR substrates (Table 4-5).  In this respect the most thermostable CARs have an 
obvious advantage in that the total turnover number of these enzymes will be much 
greater (Rogers and Bommarius, 2011).  We observed that the lifespan of the 
	152	
enzyme at 30 °C (Table 4-5) mirrored the thermostability of the enzymes exactly 
(Figure 4-5), suggesting that a test of thermostability will be a good predictor of 
lifespan for CARs. 
4.6.6 Product inhibition and reaction mechanism 
mpCAR was shown to be inhibited by most of its reaction products and it is assumed 
that the other CARs share this inhibition.  It is unsurprising that NADP+ acts as a 
competitive inhibitor of NADPH (Supplementary Figure 4-13) as NADP+ is likely also 
able to bind to the Rossmann fold of the reductase domain.  AMP acts as a 
competitive inhibitor against ATP (Supplementary Figure 4-14), likely as they are 
very similar molecules.  AMP has also been shown to be a competitive inhibitor of 
ATP in long-chain fatty acid CoA synthetases, in which the adenylation domain 
shows significant homology to the CAR adenylation domain (Li et al., 2007). 
PPi showed mixed inhibition against ATP but competitive inhibition against 4-
methylbenzoic acid (Supplementary Figure 4-15 and Supplementary Figure 4-16).  
This pattern of inhibition is characteristic for ordered sequential bisubstrate reactions 
(Cook and Cleland, 2007).  This indicates that ATP is first to bind to the adenylation 
domain and is then followed by a carboxylic acid.  Long-chain fatty acid CoA 
synthetases show the same ordered binding of these substrates (Hisanaga et al., 
2004).  We therefore propose a model for the ordered binding of substrates and 
inhibitors to the CAR enzyme based on these results (Figure 4-6).  It is also 
interesting that whilst PPi is a product of ATP, its activity as an inhibitor shows that it 
preferentially binds to the carboxylic acid binding site. CARs might therefore need to 
be combined with other enzymes such as phosphite dehydrogenase (Zou et al., 
2012) or inorganic pyrophosphatase (Lahti, 1983) to overcome product inhibition in 
an industrial process.    
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Figure 4-6 – Model for binding of substrates and inhibitors to the CAR enzyme.   
A: binding and release of substrates, products and inhibitors in the adenlyation domain. The 
final result is the formation of a thioester intermediate with the phosphopantetheine arm, 
represented by CAR-CA.  The phosphopantetheine arm can then transfer CA to the 
reduction domain, B, where it is reduced by NADPH, releasing the aldehyde product.  
CAR
ATP
CAR-ATP
Carboxylic acid
CAR-ATP-CA CAR-AMP-CA
Ppi AMP
CAR-CA
CAR-Ppi
AMP
CAR-AMP
Ppi
ATP
CAR-Ppi-ATP
Ppi
CAR-CA
A
NADPH
CAR-CA-NADPH
NADP+
Aldehyde + CAR
CAR-CA-NADP+
NADP+B
	154	
4.6.7 CAR phylogeny 
Here we have provided the first glimpse of CAR evolution within the Actinomycetes. 
From the phylogeny it can be hypothesized that the CARs may have propagated 
through the Nocardia and Mycobacteria by a series of early horizontal transfer 
events. This is most apparent in M. smegmatis, which possesses three CAR 
paralogues that cluster in two distinct Mycobacterial clades. Additionally, it is 
apparent that a large amount of change has occurred within the Tsukamurella. This 
could reflect the slightly more promiscuous substrate range of tpCAR.  
4.6.8 Insight into the adenylation step from the ANL superfamily of 
enzymes. 
We have presented evidence that the adenylation domain of the CARs belongs to 
the ANL superfamily of enzymes due to the presence of conserved hallmark motifs. 
This placement is further supported by nonribosomal peptide synthetases (NRPSs) 
and the acyl-CoA synthetases both using an acyl group to form a thoiester between 
a substrate and a pantetheine thiol. Furthermore, the NPRSs mobilize their substrate 
following thiolation of a phosphopantetheine arm that is bound to a holo-acyl carrier 
protein domain. Parallels can be drawn between both above reactions and the 
proposed mechanism of CAR activity in Figure 4-1. Due to the lack of crystal 
structure, previous evidence for the functional dynamics of carboxylic acid reduction 
in CARs was based on its substrate properties and overall sequence structure 
(Napora-Wijata, Strohmeier and Winkler, 2014).  It follows that knowledge of the 
extensively studied ANL superfamily can be used to offer insight into the finer details 
of the mechanism of carboxylic acid reduction employed within the CAR family. 
ANL superfamily members, which the CAR adenylation domain shows homology to, 
are further partitioned into two subdomains – a large (~450 aa) N-terminal domain 
and a small (~100 aa) C-terminal domain, connected by a flexible linker. Crystal 
structures show the substrate binding pocket is formed by the N- and C-domain 
interface. Substrate adenylation progresses in a two-step manner, where following 
the formation of an acyl-bound intermediate and the release of PPi, the active site 
undergoes massive conformational changes due to a ~140° rotation of the C-
terminal domain. Within the NRPSs and the acyl-CoA synthetases, the second 
domain architecture facilitates thiolation of the phosphopantetheine. Lysines that are 
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required within each active site are positioned on opposing faces of the C-terminal 
domain, and are conserved within the CARs (Supplementary Figure 4-1).(Sundlov et 
al., 2012)  This suggests that the CARs also undergo characteristic ANL superfamily 
domain-alteration between steps 1 and 2 (Figure 4-1) to catalytically isolate the 
adenylation and thioester forming reactions (Gulick, 2009). 
Within the NRPSs, the ~140° rotation of the adenylation domain C-terminal further 
serves to move the holo-acyl carrier protein domain such that the 
phosphopantetheine arm can interact with the adenylation domain active site in its 
thioester forming conformation (Mitchell et al., 2012).  Substrate loading induces a 
curl in phosphopantetheine arm architecture, forcing the substrate to disassociate 
from the adenylation domain and be held in a position favorable for a second domain 
to interact (Goodrich, Harden and Frueh, 2015). 
4.6.9 Summary 
The place of CARs in the ANL superfamily gives support to the current model of 
multi-step carboxylic acid reduction, and provide tantalizing details about the 
potential mechanistic processes that have to be undertaken by the CARs in order to 
activate their somewhat unreactive substrate. The conserved functional motifs 
characteristic of the ANL superfamily identified in the CARs suggest that major 
conformational changes facilitate the formation of the phosphopantetheine-substrate 
thioester, as well as the movement of this intermediate to the reductase domain. 
Previous work has primarily focused on screening for CAR activity with different 
substrates at only one substrate concentration, with data provided as relative activity 
or simply a binary determination of activity (Li and Rosazza, 1997; Moura et al., 
2015).  Our comparative enzyme kinetic analysis across the CAR family allows 
substrate preference to examined in greater depth, and allows some predictions to 
be made about the likely substrates that these enzymes could usefully turnover 
industrially.  Our data indicates that the CARs have similar substrate preferences, 
with some orthologues being more promiscuous than others.   The substrate 
preferences strongly suggest that the first step in the proposed reaction mechanism, 
during which an AMP-carboxylic acid phosphoester intermediate is formed with the 
release of PPi, is critical for determining suitable substrates. Consequently, the 
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addition of groups that donate electrons, making the oxygen of the carboxylic acid 
more electronegative, will be better substrates.   Inhibition studies suggest that this 
first step is an ordered sequential Bi Bi reaction, with ATP being loaded before the 
carboxylic acid.  
The CAR enzymes in this study show only moderate thermostability. To date no 
CAR enzymes have been identified in any thermophilic organisms.  A thermostable 
CAR enzyme would be attractive for use industrially as this enzyme would likely be 
resistant to other denaturing forces such as extremes of pH or solvent and likely offer 
a higher total turnover number for use in vitro reactions. 
All of the by-products produced in the reaction (PPi, AMP and NADP+) appear to be 
inhibitors, and so for the use of CARs in vitro there is a need to remove or 
regenerate all these by-products.   
For the application of CAR enzymes in a cascade reaction with other enzymes, pH 
optimum is also an important consideration.  Whilst some of the CARs showed 
activity across a broader range of pH values than others, various CARs are available 
to cover reactions with good activity between pH 6-9 at least.      
Our results have validated CARs as a useful tool for novel biocatalysis and could be 
integrated with other enzymes for efficient reduction of carboxylic acids to aldehydes 
in vitro.  
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4.7 Methods 
4.7.1 Alignments and Phylogeny Construction 
Unless specified, all algorithms were performed under default settings. 48 
sequences were retrieved by homology search in BLAST to the N. iowensis CAR. 
Alignments were performed using the MUSCLE plug-in within Geneious version 9.1 
(http://www.geneious.com) (Kearse et al., 2012).  Sequence masking was conducted 
with the Gblocks algorithm within the Phylogeny.fr online tool 
(http://www.phylogeny.fr) (Dereeper et al., 2008).  ProtTest (version 3.4)(Abascal, 
Zardoya and Posada, 2005) analysis of the aligned dataset was performed in the 
command line. MrBayes (version 3.2.6)(Ronquist et al., 2012) was run in the 
command line as follows: The amino acid substitution model was fixed to WAG with 
a gamma-distributed rate variation across a proportion of invariable sites and 8 
gamma categories. The analysis was run for 1,000,000 MCMCMC generations, 
sampling every 100 generations with two parallel runs and four chains (containing 
one heated chain of temperature 0.2), with a burn-in of 25%. Trees were visualised, 
midpoint rooted and modified in FigTree version 1.4 
(http://tree.bio.ed.ac.uk/software/figtree/). 
It must be noted that a more complete list of 124 CAR homologues was retrieved 
(Supplementary Figure 4-17 and Supplementary Figure 4-18), however a reduced 
set of sequences was used as this allowed the construction of a more reliable 
phylogeny.  
4.7.2 Expression and purification 
CAR genes (except niCAR) were cloned into expression vectors pNIC28-Bsa4 
(Hansch et al., 1977) or obtained from Prozomix, cloned into pET28a (Novagen). A 
pET plasmid for the expression of niCAR was obtained from Andrew Hill (University 
of Manchester).  All contained a N-terminal 6x histidine tag (Hansch et al., 1977).  
Vectors were transformed into BL21 (DE3) E. coli along with a pCDF-Duet1 vector 
containing a phosphopantetheine transferase from Bacillus subtilis for its co-
expression with the CARs.  Expression was carried out in LB media with the addition 
of 50 µg/µl each kanamycin and spectinomycin.  Cells were grown to approximately 
0.6 OD600nm at 37 °C with shaking at 225 rpm, at which point IPTG was added to a 
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concentration of 150 µM and temperature was dropped to 20 °C for protein 
expression overnight.  Cells were harvested by centrifuging and re-suspended in 25 
mM Tris-HCl pH 8.0, 0.5 M NaCl.  Cell lysate was prepared by sonication on ice 
followed by centrifugation to remove the insoluble fraction. 
CARs were purified from the cell lysate using a 1 ml His-Trap FF crude column (GE 
Healthcare) using an elution gradient from 10 to 250 mM imidazole in 25 mM Tris-
HCl pH 8.0, 0.5 M NaCl.  The purified sample was then applied to a Superdex 200 
HiLoad 16/60 gel filtration column (GE Healthcare) and eluted in 25 mM HEPES, pH 
7.5, 0.1 M NaCl at 1.0 ml/min.  Eluted fractions were analyzed by SDS-PAGE before 
being pooled and concentrated to approximately 2 mg/ml.  To calculate protein 
concentration from OD280nm, an extinction coefficient and molecular weight for each 
enzyme was calculated using the ExPaSy ProtParam tool, and are shown in 
Supplementary Figure 4-19.  Yields of approximately 2 – 10 mg purified protein per 
liter of culture were obtained, with 2 – 4 L of culture prepared per batch.  Single use 
aliquots of protein were stored at -80 °C. 
4.7.3 Standard enzyme assay 
Unless otherwise specified, assays were carried out in 100 mM Tris-HCl pH 7.5 
prepared at 30 °C, 1 mM ATP, 0.25 mM NADPH, 10 mM MgCl2, 2-6 µg of purified 
CAR enzyme and 5 mM carboxylic acid substrate in a total volume of 200 µl.  
Carboxylic acid substrates were prepared in DMSO at 500 mM.  The oxidation of 
NADPH was used to monitor the reactions by measuring the absorbance of NADPH 
at 340 nm.  Reactions were performed in triplicate in a 96-well microtitre plate using 
a Tecan M200 plate reader at 30 °C over the course of 5 or 10 minutes, after a 5 
minute preincubation at 30 °C.  Where convenient, an EpMotion 7050 (Eppendorf) 
liquid handling robot was used to set up the assays. 
4.7.4 Kinetic analysis of substrate specificity. 
Kinetic analysis was performed by picking eight appropriate substrate concentrations 
around an approximate KM value for each substrate, and measuring initial rates as 
described previously.  Rates were fitted to the Michaelis-Menten equation by non-
linear least squares regression using GraphPad Prism v. 5.0. To calculate constants 
for ATP and NADPH, 5 mM (E)-3-phenylprop-2-enoic acid was used as the 
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carboxylic acid substrate, except for niCAR where 5 mM 4-methylbenzoic acid was 
used. 
4.7.5 pH vs activity. 
Buffers were prepared and titrated to the correct pH using NaOH or HCl whilst at 30 
°C, covering pH values in intervals of 0.2.   The buffers 50 mM MES pH 5.6 to 6.6, 
50 mM PIPES pH 6.4 to 7.4, 50 mM MOPS pH 6.6 to 7.8, 50 mM HEPES pH 7.0 to 
pH 8.0 and 50 mM Tris pH 7.8 to pH 9.0 were used. Reactions were carried out as 
standard with 1 mM ATP, 0.25 mM NADPH, 10 mM MgCl2 2-6 µg of purified CAR 
enzyme and 5 mM 4-methylbenzoic acid.  Blanks containing no enzyme were used 
to subtract a blank rate at each pH value.  Initial rates were calculated as relative 
activity against the fastest result at 100 %.    
4.7.6 Thermostability 
A solution containing 2 µg of purified enzyme, 0.25 mM NADPH, 1 mM ATP, 10 mM 
MgCl2, 100 mM Tris-HCl pH 7.5 was incubated across the temperature gradient of a 
Biorad thermocycler from 30 °C to 50 °C for 30 minutes. The sample was cooled and 
assayed for CAR activity against 4-methylbenzoic acid, in comparison to a control 
sample that remained on ice. 
4.7.7 Degradation at 30 °C 
2 ml samples at 2 mg/ml in 25 mM HEPES, pH 7.5, 0.1 M NaCl were incubated at 30 
°C over a 120 hour period.  At specified time intervals, samples were taken and 
assayed for enzyme activity against 4-methylbenzoic acid.  Rates were calculated 
relative to the first reading at 100 %, and fitted to a model of first order thermal 
deactivation using the equation Y = Y0 * e-K*X where Y is the relative activity and X is 
the time in hours. 
4.7.8 Temperature vs activity 
100 mM Tris-HCl pH 7.5 was prepared at assay temperatures between 30 and 50 
°C.  Assays were performed as for the thermostability experiment using the 
temperature gradient of a Biorad thermocycler from 30 °C to 50 °C over the course 
of 10 minutes, before rapidly cooling on ice with the addition of 10 mM NaOH.  A 
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blank reaction with no substrate was used to calculate the NADPH used in the 
reaction.  Activity was calculated relative to the maximum rate at 100 %.  
4.7.9 Product inhibition 
Potential inhibitors were titrated across a broad range of concentrations to determine 
whether inhibition occurred and to give an idea of an approximate KI.  Kinetic 
analysis then was performed as described above using substrates that each inhibitor 
was likely competitive against, with the addition of the inhibitors at a range of 
concentrations based around the approximate KI.  Data were fitted using GraphPad 
Prism 5.0 by non-linear least squares regression to different models of enzyme 
inhibition.  The model with the best fit for the data was used to determine the mode 
of inhibition.  Where inhibition was not competitive, additional analysis was carried 
out with other substrates
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4.9 Supporting Information 
CLUSTAL multiple sequence alignment by MUSCLE (3.8) 
Conserved motifs between adenylating domains of Actinomycete CARs, FadD13 
and NPRS 
p=medium aliphatic amino acid. r=aromatic amino acid. x=any amino acid.  
Firefly_Luciferase|BAL46512.1         ---------------------MEDAKNIKKGPAPFYPLEDGTAGEQLHKAMK-------- 
FadD13|NP_217605.1                    --------------------------------------------------MKNIGWMLRQ 
NRPS|WP_014382786.1                   ----------------------------------------------------SIPALFAA 
Tsukamurella_paurometabola            ---MSIET------------------VQNGVPAEGSVPPADQQTERLPQVIARIFAQFAD 
Mycobacterium_smegmatis1              ---MTSDVHDEQSTRRIAELYATDPEFAAAAPLPAVVDAAHKPGLRLAEILQTLFTGYGD 
Mycobacterium_genavense               ---MTSDNRDERTARRVAELFNNDPQFRAAAPLPEVIEAACAPGLRLTEVLARLVEGYAD 
Mycobacterium_marinum                 MSITCVDTRAQRSARRIEQLYSTDAQFAAARPSTAVGIAISKSGLGLPQIIQTVMDGYPQ 
Nocardia_asteroides                   ---MTVEVDADRLADRIRALYAQDAQIRAATPIPEAHARVTTPGTPLARIVSTVMTAYAD 
Nocardia_paucivorans                  ---MSVDTRESRLERRIAELYATDEQFAAARPDVAVTAEVERAGRRSARVVHAVAKGYAH 
Mycobacterium_fortuitum               ---MSFDTRDEQLATRIADLTATDPQFAAAIPSDTVTASVDVPGLLLPEIVQRVLEGYAE 
Mycobacterium_smegmatis2              ---MTIETREDRFNRRIDHLFETDPQFAAARPDEAISAAAADPELRLPAAVKQILAGYAD 
Mycobacterium_vaccae                  ---MSTDTREGRLARRIADLFATDPQFAAAVPDETVAAAVEEHAAHLPDIMRTVLDGYAD 
Mycobacterium_obuense                 ---MPTDTREERLAHRIDDLSATDTQFAAALPDEAIAEAIEDPQLRLPQIIATVLDGYAD 
Nocardia_seriolae                     ---MVEDTARAEIHRRIAERVLADEQVRVAMPLPEVSEAARQPGLGLARAVEVLMVGYAE 
Nocardia_otitidiscaviarum             ---MLDDARAERRERRIADALADD-QVREAAADAAVSESVRRVEVRLARIVDAVMSGYGD 
Nocardia_iowensis                     ---MAVDSPDERLQRRIAQLFAEDEQVKAARPLEAVSAAVSAPGMRLAQIAATVMAGYAD 
Nocardia_transvalensis                ---MEITDAQAQLIRRATELIEGDEQVRAALPDEAVAKAVQAPGLGLASVVATIMEGYAD 
                                                                                                   
     p(S/T)rx(E/Q)p N-terminal helix cap (A1) 
Firefly_Luciferase|BAL46512.1         RYALVPGTIAFTDAH-----------IEVNITYAEYFEMSVRLAEAMKRYGLN-TNHRIV 
FadD13|NP_217605.1                    RATVSPRLQAYVEPS-----------TDVRMTYAQMNALANRCADVLTALGIA-KGDRVA 
NRPS|WP_014382786.1                   QVARGPGAVAITCGG-------------RSFTYRHLYEATNRLAHLLVERGAG-PGQRVA 
Tsukamurella_paurometabola            RPAFATREAGPGTP-------------YATVSYREIWRRVTALVASWQSE-VA-PGDFVA 
Mycobacterium_smegmatis1              RPALGYRARELATDE-GGRTVTRLLPRFDTLTYAQVWSRVQAVAAALRHNPIY-PGDAVA 
Mycobacterium_genavense               RPALGERVRELVTDA-DGRTVLRLRPRFETISYRDVWDRVRAIATAWSSDPVT-AGDVVA 
Mycobacterium_marinum                 RPALGQRATRVVTDPNTGRSSAQLLAEFETITYRELWNRTNALTNAFAAEALADRGQRVC 
Nocardia_asteroides                   RPALGVRRTELVVEA--GRATRRLLPEFELLTYGEVWERARALAASWYAEGLA-AGEFVA 
Nocardia_paucivorans                  RPALGQRAVDYITDPRTGRTSMELLPRYETLTYREVWERAGAIASALAGNPVR-AGDRVC 
Mycobacterium_fortuitum               RPALGERALEFVADPATGRTTARLLPRFDTISYGQVWDRVRALAAALHASGVA-AGDRVA 
Mycobacterium_smegmatis2              RPALGKRAVEFVTDE-EGRTTAKLLPRFDTITYRQLAGRIQAVTNAWHNHPVN-AGDRVA 
Mycobacterium_vaccae                  RPALARRAVRFVEDA-TGRTVAELLPHFETITYAELAHRIHGVTAALTD--VH-PGDRVA 
Mycobacterium_obuense                 RPALGQRAVRLVADPHTERTEAQLLPHFDTITYGELSTRIHHLLTALTD--VD-PGDRVA 
Nocardia_seriolae                     RPAIGERAAEIVTGA-DGRRIRRLLPEYRTITYAELWSRAGAIAAAWQHDPLR-AGDFLC 
Nocardia_otitidiscaviarum             RAALAWRRSELVDGA------VRLLPEYSTMTYRELWRQAGAVAAEWGADPVR-AEDFVC 
Nocardia_iowensis                     RPAAGQRAFELNTDDATGRTSLRLLPRFETITYRELWQRVGEVAAAWHHDPLR-AGDFVA 
Nocardia_transvalensis                RPAAGRRAVEFVADD-SGRRHARLLPRYDTITYGELWERVRALMAAWHHDPTR-AGDFVA 
 
  structural element (R/K/F)pGp poorly conserved with ANL superfamily (A2) 
Firefly_Luciferase|BAL46512.1         VCSENSLQFFMPVLGALFIGVAVAPANDIYNERELLNSMNISQPTVVFVSKKGLQKILNV 
FadD13|NP_217605.1                    LLMPNSVEFCCLFYGAAKLGAVAVPINTRLAAPEVSFILSDSGSKVVIYGAPSAP----- 
NRPS|WP_014382786.1                   VAVPRSAEAIVAILAVLKTGAAYVPIDPSVPAARVQFVLGDAAPIAAVTTAEV------- 
Tsukamurella_paurometabola            ILGFTSSDFVTVDLATTLLGAPNVPLQAGAPAARIATILDETRPKILAVSADQVDLAQEA 
Mycobacterium_smegmatis1              TIGFASPDYLTLDLVCAYLGLVSVPLQHNAPVSRLAPILAEVEPRILTVSAEYLDLAVES 
Mycobacterium_genavense               TVGFSSADYLVVDLVCAYLGLVTVPLQHNAPPARLRPIIEECEPKIVAVSAEYLDLAAES 
Mycobacterium_marinum                 VLGFASIDYATIDLALMLLGAVSVPLPTNAARAQLCHIVSETQPSLIASSTENLPDAISL 
Nocardia_asteroides                   TLGFTGADYTVLDLATIHLGAVAVPLQAGASATQLRSILDETAPRVLAVDTANLAVALDV 
Nocardia_paucivorans                  ILGFASVDYTTIDMALTRLAAVSVPLQTGAPAERLRPIIAETEPTVLAASIDHLDDAVTA 
Mycobacterium_fortuitum               ILGFTSADYTVIDTALGQIGAVSVPLQTSSSPEALAPIVTETEPRVIAASVDHLADAVEL 
Mycobacterium_smegmatis2              ILGFTSVDYTTIDIALLELGAVSVPLQTSAPVAQLQPIVAETEPKVIASSVDFLADAVAL 
Mycobacterium_vaccae                  LLGFTSVDYTTVDMALSMLGAVLVPLQTSAPLSTLRPIIAETEPVLIASSVDTLDDAVAL 
Mycobacterium_obuense                 ILGFTSVDYTVIDTTLVLRGAVSVPLQTSAPAATLRPIVAETEPVVFAASVDHLSDAVDL 
Nocardia_seriolae                     VLGFGSGDFAALEIAAIRQGLVTVPLQANAAAAQWRSIIEETGARTLAVSLELLDSALDV 
Nocardia_otitidiscaviarum             TLGFTSPDYTVVDLALMRLAAVAVPLQASASVAQWRSIMAETEPRMLAASAETLPAAVEA 
Nocardia_iowensis                     LLGFTSIDYATLDLADIHLGAVTVPLQASAAVSQLIAILTETSPRLLASTPEHLDAAVEC 
Nocardia_transvalensis                ILGFTGIDYTVVDLACACLGAVSVPLQAGASLAQLTPIAAETEPRVLATDIEQLGAGVDL 
 
 
 
 
 
 
 
 
 
Firefly_Luciferase|BAL46512.1         QKKLPIIQKIIIMDSKTDYQGFQSMYTFVTSHL--PPGFNEYDFVPESFDRDKTI----- 
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FadD13|NP_217605.1                    ------------------------VIDAIRAQADPPGTVTDWIGADSLAERLRSA-AADE 
NRPS|WP_014382786.1                   ---------------RPQLGGF-------------AGQIIDIDDPAVVRQPATGL-PVPS 
Tsukamurella_paurometabola            LAESAATPRVVVFD----------------------GERDGYEGIEADILSGSAL-PAPE 
Mycobacterium_smegmatis1              VRDVNSVSQLVVFDHHPEVDDHRDALARAREQL--AGKGIAVTTLDAIADEGAGL-PAEP 
Mycobacterium_genavense               ALTSTSLRQLMVFDYRAEVDEQRENFEQTRVRLQGSGTRVAVTTVDEVVARGRRL-PAVA 
Mycobacterium_marinum                 VLSHRAPHRVVVFDYRPELDAHREALEAARARL--AAIPVTVETLTAIIARGRTVRPAEA 
Nocardia_asteroides                   VLAGAAPRALVVFDHHADDDNDREVLAAARARLRAANSPIVLSTVAEVIDRGRLA-DPAP 
Nocardia_paucivorans                  VLAGHLPARLIVFDYHPRVDDQREAFAAATEKLAEAGGPVVIETLAEVIDRGTAL-PPVP 
Mycobacterium_fortuitum               ALTAHAPAQLVVFDHHPEIDDHREAVASAAERITAAGASIAVDTLAGLLDRGSNL-PAPE 
Mycobacterium_smegmatis2              VESGPAPSRLVVFDYSHEVDDQREAFEAAKGKL--AGTGVVVETITDALDRGRSL-ADAP 
Mycobacterium_vaccae                  ALDAPDAARLVVFDHRAEVDDHRDALTSATARLRAAGSPLEIETLAEVIARGSTM-PARE 
Mycobacterium_obuense                 VADAESVGRLIVFDYRAEVDDHRDAIADARARLADAGRSIEIVTLSEVLAHGATL-PAAQ 
Nocardia_seriolae                     VLDGSPVTSIVVFDFEPEEDRQAEILVGARDRIAASGSTITLESLAAVLERGATL-PAVP 
Nocardia_otitidiscaviarum             VLGGFAPRRVLVFDYRPELEAHRSAVDSARERLAEVG--CTVATVADAVDRGANL-P-AP 
Nocardia_iowensis                     LLAGTTPERLVVFDYHPEDDDQRAAFESARRRLADAGSLVIVETLDAVRARGRDL-PAAP 
Nocardia_transvalensis                VLSGDSVRSVVVFDYYAEDDDHRAALESARARL--ADSPVTVDTLDEVLARGRDL-PAAP 
 
    Phosphate binding loop ppx(S/T)(S/T/G)G(S/T)TGxPK (A3) 
Firefly_Luciferase|BAL46512.1         ----------ALIMNSSGSTGLPKGVALPHRTA---CVRFSHARDPI-FGNQIIPDTAIL 
FadD13|NP_217605.1                    PAVECGGDDNLFIMYTSGTTGHPKGVVHTHESVHSAASSWASTIDVR-YRDRLLLP---- 
NRPS|WP_014382786.1                   A------DSIAYIIYTSGTTGTPKGVAVTHSNV---TQLLESIDAQL------DVGQVWT 
Tsukamurella_paurometabola            FFAEPGTDPLVTLIYTSGSTGTPKGAMYTEQLV---RDAWLKVDSIV---DIDMPAESLL 
Mycobacterium_smegmatis1              IYTADHDQRLAMILYTSGSTGAPKGAMYTEAMV---ARLWTMSFITG-----DPTPVINV 
Mycobacterium_genavense               ACADGDDQRLAMIMYTSGSTGTPKGAMYTERTV---TTVWTTMRFLA-----PGLPVINA 
Mycobacterium_marinum                 DCGAQSADAPALLIYTSGSTGAPKGVVYTRNRV---ADFWRTSKAEVEATEQRTAPSITL 
Nocardia_asteroides                   LVPAPQDDPLAMLIYTSGSTGTPKGAMYTDRLV---AAGWQPAR---------PVAVLNV 
Nocardia_paucivorans                  LAPAEEPDSLALLIYTSGSTGAPKGAMITDRMV---AEHWRAATAER-WGQRGTEPSIVL 
Mycobacterium_fortuitum               APKADGSDPLALLIYTSGSTGAPKGAMYLQSAV---AKFWRRNSKAW---LGPVSSAINL 
Mycobacterium_smegmatis2              LYVPDEADPLTLLIYTSGSTGTPKGAMYPESKT---ATMWQAGSKAR-WDETGVMPSITL 
Mycobacterium_vaccae                  QF-SPDADTLMLLIYTSGSTGAPKGAMYTERLV---ATTWRRSSRSF-WGDHGPLPSITL 
Mycobacterium_obuense                 PFTSPDDDPLLLLIYTSGSTGAPKGAMYPERLI---TNAWRRSGRSA-WGGEQTTPSITL 
Nocardia_seriolae                     LHVPADEDEVALLIYTSGSTGTPKGAIYPHRLV---TGMWLGPNV-------IPAPVMNF 
Nocardia_otitidiscaviarum             LRIPSDRERLALLIYTSGSTGAPKGAMYTDRLV---AGLWLSANEIR-------VPALTM 
Nocardia_iowensis                     LFVDTDDDPLALLIYTSGSTGTPKGAMYTNRLA---ATMWQGNSMLQ---GNSQRVGINL 
Nocardia_transvalensis                LHTDGDEDELSLLIYTSGSTGTPKGAIYPARLL---TRMWRSGGD-------RPMPVLGF 
 
  possible active site aromatic residue (A4) 
Firefly_Luciferase|BAL46512.1         SVVPFHHGFGMFTTLGYLICGFRVVLMYRFEEELFLRSLQDYKIQSALLVPTLFSFF--- 
FadD13|NP_217605.1                    --LPMFHVAALTTVIFSAMRGVTLISMPQFDATKVWSLIVEERVCIGGAVPAILNFMRQ- 
NRPS|WP_014382786.1                   QCHSLAFDFSVWEVFGALLHGGRLVVVPDDVVRSPDDLRALLVREQVSVLSQTPSAFY-- 
Tsukamurella_paurometabola            HFLPMSHMYGRNWLIAGLASGGTGYFAGASDMSTLFDDLAAARPTAIGLVPRVCELIHQR 
Mycobacterium_smegmatis1              NFMPLNHLGGRIPISTAVQNGGTSYFVPESDMSTLFEDLALVRPTELGLVPRVADMLYQH 
Mycobacterium_genavense               NFMPLNHLGGRLPLASAFLSGGTSYFVPESDLSTLFEDWALVRPTEAAMVPRVVEMLYQH 
Mycobacterium_marinum                 NFMPMSHANGRQVLYGTLSNGGTAYFTARSDLSTLFDDLALVRPTELGFPPRIWDMLLER 
Nocardia_asteroides                   NFLPMSHIAARLTLNGVLARGGTAYFTAAADMSTLFEDIALVRPTEIFLVPRVCDMLLHR 
Nocardia_paucivorans                  GFMPMSHILGRAICWMALGSGGTVYFAAKSDLSTLLDDLALVRPTQLTFVPRVWEMLFQR 
Mycobacterium_fortuitum               SFMPMSHVMGRGILYASLAAGGTCYFAARSDLSTLLEDLALTRPTELNFVPRVWEMIHSE 
Mycobacterium_smegmatis2              NFMPMSHVMGRGILCSTLASGGTAYFAARSDLSTFLEDLALVRPTQLNFVPRIWDMLFQE 
Mycobacterium_vaccae                  NFLPMSHVMGRGLLYATLGAGGTAYFAAKSDLSTFLEDLALVRPTQLSFVPRIWDIIFAE 
Mycobacterium_obuense                 NFMPMSHMMGRGVLYGTLGAGGTAYFAARSDLSTFLDDLALVRPTQLSFVPRIWDTIAAE 
Nocardia_seriolae                     CYMPLSHVAGRMVLSGTFARGGTAYFAASSDMSTLFEDIALVRPTEVFFVPRVCDMLFQR 
Nocardia_otitidiscaviarum             NYMPLSHIAGRMSLYGTLMRGGTAYFAAASDMSTLLDDFGLARPTELFLVPRVCELLHQR 
Nocardia_iowensis                     NYMPMSHIAGRISLFGVLARGGTAYFAAKSDMSTLFEDIGLVRPTEIFFVPRVCDMVFQR 
Nocardia_transvalensis                SYMPMSHVAGRGSLISALSLGGTVYFAARSDMSTLFDDITLCRPTMVFFVPRVCDMVFQR 
 
 
Firefly_Luciferase|BAL46512.1         ----------------AKSTLIDKYDLSNLHEIASGG---------APLSKEV-GEAVAK 
FadD13|NP_217605.1                    ------------VPEFAELDAP------DFRYFITGG---------APMPEALIKIYAAK 
NRPS|WP_014382786.1                   ------------ALQSADALAPEVGEQLKLQTVVFGGEALE--------PHRL-STWLHH 
Tsukamurella_paurometabola            YLA---------VEADTDAET----ARVELRDRVLGGRLQAAMCGSAALSSEL-QTFMEW 
Mycobacterium_smegmatis1              HLATVDRL----VTQGADELTAEKQAGAELREQVLGGRVITGFVSTAPLAAEM-RAFLDI 
Mycobacterium_genavense               YRGAVDRG----IAEGADPATAEHDAATEMREQVLGGRVLGGFVGSAPLATEM-KAFLDS 
Mycobacterium_marinum                 FGREVDRRLRDGTAEGADPGALKARVAADLRQVLLGGRYALAMMGSAPISEQM-KASVES 
Nocardia_asteroides                   FRREVDRR----ADAGVDPEVLAEEVRGELRERVLGGRLLTVLCGSAPIAPEL-RRFVES 
Nocardia_paucivorans                  FQSEMYRR----AADGREQAEVAAEVTAELRRNLLGGRFLSATTGSAPMSAEM-KVWVED 
Mycobacterium_fortuitum               YQSRVDQR----LAEGRDREAVEAEVLAEVRDKVLGGRFVAAMTGSAPISAEL-KTWTQD 
Mycobacterium_smegmatis2              YQSRLDNR----RAEGSE-DRAEAAVLEEVRTQLLGGRFVSALTGSAPISAEM-KSWVED 
Mycobacterium_vaccae                  VAKELERR----TADAAD-------VLADLRQSLLGGRYVSAMTGSAPLSAEM-ESFVEQ 
Mycobacterium_obuense                 VAKEVDRR----PDDLAD-------VYADLRQSLLGGRHVMAMSGSAPLSPEM-RTFVED 
Nocardia_seriolae                     CQSEVQRR----TAAGESVEDADAAVKTALREEFLGGRLVRVMVGSAPVSAEM-KEFMRS 
Nocardia_otitidiscaviarum             YQSELDRR----VVAGEDAETAATNVKAELRERVLGGRYLTALSGSAPLAAEM-KTFMES 
Nocardia_iowensis                     YQSELDRR----SVAGADLDTLDREVKADLRQNYLGGRFLVAVVGSAPLAAEM-KTFMES 
Nocardia_transvalensis                YRSEVDRR----LAAGGDREQVEREVKTELREHFLGGRFLLALVGSAPLSPEM-RAFMES 
 
        
   active site and mg2+ binding a(G/W)x(A/T)E (A5) 
Firefly_Luciferase|BAL46512.1         RFHLPGIRQGYGLTETT--SAILITPEGDDKPG-AVGKVVPFFEAKVVDLDTG---KTLG 
FadD13|NP_217605.1                    NIE---VVQGYALTESCGGGTLLLSEDALRKAG-SAGRATMFT--DVAVRGDDGVIREHG 
NRPS|WP_014382786.1                   HPGLPRMINMYGITET---TVHASFREILRGDVDNNVSPIGVPLGNLAFFVLDGWLRPVP 
Tsukamurella_paurometabola            LLGID-IQIGYGSTEA---GGVIRDGVVVRPPV-TEYKLIDVP--ELGYFVTD---SPHP 
Mycobacterium_smegmatis1              TLGAH-IVDGYGLTET---GAVTRDGVIVRPPV-IDYKLIDVP--ELGYFSTD---KPYP 
Mycobacterium_genavense               MLDAH-ITDGYGLTET---GMLTRDNVVNRNRV-IDYKLIDVP--ELGYFLTD---RPYP 
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Mycobacterium_marinum                 LLDLD-VMEGYGSTEA---GTVIINNEVQRPQV-IDYKLVDVA--ELGYFLTD---RPYP 
Nocardia_asteroides                   VLRLR-LHDGYGSTET---GGVIFDTKVMRPPV-LDYKLVDVP--ELGYFSTD---KPYP 
Nocardia_paucivorans                  LLDLP-LRDGYGSTEA---GSITLDGRVRRPPV-IDYKLVDVP--ELGYFRTD---RPYP 
Mycobacterium_fortuitum               MLGIH-LLEGYGSTEA---GMALFDGVVQRPPV-IDYKLVDVP--DLGYFGTD---QPHP 
Mycobacterium_smegmatis2              LLDMH-LLEGYGSTEA---GAVFIDGQIQRPPV-IDYKLVDVP--DLGYFATD---RPYP 
Mycobacterium_vaccae                  LLDMH-LIDGYGSTEA---GAVLVDGQIQRPPV-IDYKLVDVP--DLGYFSTD---RPHP 
Mycobacterium_obuense                 LIDIH-LTDGYGSTEA---GAVFVDGQVQRPPV-IDYKLVDVP--DLGYFTTD---RPHP 
Nocardia_seriolae                     VMGQP-VIDGYGSTEA---GGILIDNEIRRPPV-IDYKLADVP--ELGYFSTD---KPHP 
Nocardia_otitidiscaviarum             LLDDE-LHDGYGSTEA---GSVLLDNRIKRPPV-LDYRLVDVP--ELGYFRTD---KPHP 
Nocardia_iowensis                     VLDLP-LHDGYGSTEA---GSVLLDNQIQRPPV-LDYKLVDVP--ELGYFRTD---RPHP 
Nocardia_transvalensis                VLEIG-MFDGYGATET---GGVLLNNELQRPPV-LDYRLEDVP--ELGYFGTD---KPYP 
 
         Distorted beta sheet GEx10-14GY (A6)     ATP binding (S/T)GD (A7) 
Firefly_Luciferase|BAL46512.1         VNQRGELCVRGPMIMSGYVNNPEATNALIDKDGW-------LHSGDIAYWDEDEHFFIVD 
FadD13|NP_217605.1                    ---EGEVVIKSDILLKEYWNRPEATRDAFD-NGW-------FRTGDI-GEIDDEGYLYIK 
NRPS|WP_014382786.1                   VGVVGELYVAGGGLATGYVGRPGLSATRFVACPFGAPGARMYRTGDLVRWSADGQLEYIG 
Tsukamurella_paurometabola            ---RGELLVKSTQLIPGYYNSDK---RIRDDEGF-------YRTGDVMAELGPDRLEYVD 
Mycobacterium_smegmatis1              ---RGELLVRSQTLTPGYYKRPEVTASVFDRDGY-------YHTGDVMAETAPDHLVYVD 
Mycobacterium_genavense               ---RGELLVKTDTMTPGYYKRPEVTAQVFDEDGF-------YKTGDVMAEIEPDHLVYVD 
Mycobacterium_marinum                 ---RGELLVKTRTLFSGYYRDPEDGAQVFDPDGF-------YRTGDIMAQVGPDRLAYLD 
Nocardia_asteroides                   ---RGELLLKTTTMISGYYRRPEVTAQVFDEDGF-------CRTGDVVAELGPDRVAYVD 
Nocardia_paucivorans                  ---RGELAVRSESLTPGYYRRPDVTAQVFDADGY-------YHTGDIFAEVAPDELVYVD 
Mycobacterium_fortuitum               ---RGELLIKTENLFPGYYKRPEVTASVFDEDGF-------YRTGDVVAEIGPDQLRYVD 
Mycobacterium_smegmatis2              ---RGELLVKSEQMFPGYYKRPEITAEMFDEDGY-------YRTGDIVAELGPDHLEYLD 
Mycobacterium_vaccae                  ---RGELLVRSETLFPGYYKRPDITAEMFDEDGY-------YRTGDIVAETAPDRLTYLD 
Mycobacterium_obuense                 ---RGELLVKSETLFPGYYKRPEVTAEMFDPDGY-------YRTGDVVAETGPDQLVYLD 
Nocardia_seriolae                     ---RGELLVKSTQQIPGYFKRPDVTAEIFDADGF-------YRTGDIVAEVRPDHLVFVD 
Nocardia_otitidiscaviarum             ---RGELLLKTESMFPGYYKRPEITAEMFDADGF-------YRTGDVVAELGPEQLVYVD 
Nocardia_iowensis                     ---RGELLLKAETTIPGYYKRPEVTAEIFDEDGF-------YKTGDIVAELEHDRLVYVD 
Nocardia_transvalensis                ---RGELLLKSETLVPGYYKRPELNAEIFDADGF-------YRTGDVMAEIGRDRLVYVD 
 
                      Hinge domain Rx(D/K)x6G modified to Rx4Kx3G in CARs (A8) 
Firefly_Luciferase|BAL46512.1         RLKSLIKY-KGYQVAPAELESILLQHPNIFDAGVAGLPDDDAGELPAAVVVLEHG----- 
FadD13|NP_217605.1                    DRLKDMIISGGENVYPAEIESVIIGVPGVSEVAVIGLPDEKWGEIAAAIVVAD------- 
NRPS|WP_014382786.1                   RADEQVKI-RGYRIELGEIRAALADVEGVEQAAVLVREDRAGEKRLVGYV---------- 
Tsukamurella_paurometabola            RRSNVIKLAQGEFVPIAQLEAIYAAGPDVHQIFLYGTSERSY--LIGVVVPAPGPDGET- 
Mycobacterium_smegmatis1              RRNNVLKLAQGEFVAVANLEAVFSGAALVRQIFVYGNSERSF--LLAVVVPTPEALEQD- 
Mycobacterium_genavense               RRNNVLKLAQGEFVAVANLESIYAGAPLVRQIFVYGNSERSN--LLAVIVPTPEALAEGN 
Mycobacterium_marinum                 RRNNVLKLSQGEFVAVSRLEAIFANSPLVRQIFVYANGARAY--PLAVVVPTQDAQSRHG 
Nocardia_asteroides                   RRNNVLKLSQGEFVTVSRLEAVFAGADLVRQIYVYGSSERAY--LLAVIVPTEAALAGP- 
Nocardia_paucivorans                  RRSFVLKLSQGEFVTVSKLEAVFARSPLVRQIYVYGNSTRSY--LLAVVVPTEEAQARGD 
Mycobacterium_fortuitum               RRNNVLKLAQGEFVTLAKLEAVFGNSPLVQQIYVYGNSAQPY--LLAVVVPTDPSVS--- 
Mycobacterium_smegmatis2              RRNNVLKLSQGEFVTVSKLEAVFGDSPLVRQIYVYGNSARSY--LLAVVVPTEEALSRWD 
Mycobacterium_vaccae                  RRNNVLKLSQGEFVTVSKLEAVFGDSPLIHQIYVYGNSARPY--LLAVVVPTDAALAR-- 
Mycobacterium_obuense                 RRNNVQKLSQGEFVTVSKLEAVFGDSPRVRQIYVYGNSARSY--LLAVVVPTEDVLGR-- 
Nocardia_seriolae                     RRNNVLKLSQGEFVAVSKLEAVYATSPLIAQIFVHGSGERSH--LLAVIVPTAAARALA- 
Nocardia_otitidiscaviarum             RRNNVLKLSQGEFVTVAALEAVYATSPLIRQIFVYGSSERAY--LLAVVVPTDAVLALP- 
Nocardia_iowensis                     RRNNVLKLSQGEFVTVAHLEAVFASSPLIRQIFIYGSSERSY--LLAVIVPTDDALRGRD 
Nocardia_transvalensis                RRNNVLKLSQGEFVAVSKLEALYTSSPLVRQIYVYGSSERAY--LLAVIVPTDDAVTAPE 
 
   adenylate forming motif Px4GKrx(R/K) poorly conserved apart from second active site lysine (A10) 
Firefly_Luciferase|BAL46512.1         ----KTMTEKEIVDYVASQVTTAKKLRGGVVFVDEVPKGLTGKL---DARKIREILIKAK 
FadD13|NP_217605.1                    ----QNEVSEQQIVEYCGTRLARYKLPKKVIFAEAIPRNPTGK----ILK---TVLREQY 
NRPS|WP_014382786.1                   ----TGAADPSEIRARLGRRLPTYMVPAAVVVLDVLPLTVNGKL---DTRALPAPE---- 
Tsukamurella_paurometabola            DAQTRTRVLDGLAAIARENDLAAYEVPRDVLI-ERDPFSQENGLRSGIGKLVRPALIARY 
Mycobacterium_smegmatis1              PAALKAALADSLQRTARDAELQSYEVPADFIV-ETEPFSAANGLLSGVGKLLRPNLKDRY 
Mycobacterium_genavense               SPALKTAIHQSLRQTAAAAQLQSYELPVDFIL-ETKPFTDENGLLSGLGKQLRPRLKERY 
Mycobacterium_marinum                 RAELKAELHTSLHRVAMSAGLAPYEIPRDFIV-ETTPFTPQNGLLTAIHKLARPHLTQRY 
Nocardia_asteroides                   AASLRAELGASLQRAAVAAELEPYEIPRDFLI-ESVPFSVDNGLLSGVSKLLRPALKQRY 
Nocardia_paucivorans                  VEALKPLIGRSLRQVAKTAGLQSYEIPRDLIV-DTTPFTLRNGLLTGSRKLARPKLEEHY 
Mycobacterium_fortuitum               ----KEAIAESLQEVAREADLQSYEIPRDFIV-ETTPFSLENGLLTGIRKLAWPKLKAHY 
Mycobacterium_smegmatis2              GDELKSRISDSLQDAARAAGLQSYEIPRDFLV-ETTPFTLENGLLTGIRKLARPKLKAHY 
Mycobacterium_vaccae                  -EDVKTAVAESLQDVARAADLQSYEIPRDFLI-ETTPFTLENGLLTGIRKLARPALKERY 
Mycobacterium_obuense                 -DDAKALVAESLQNVARAAGLQSYEIPRDFLI-EPTPFTLENGLLTGIRKLARPRLKEHY 
Nocardia_seriolae                     PAERTAAIAESLRQIARDAELESYEIPRDFIV-EDEPFTQENGLLSGIAKLLRPKLRERY 
Nocardia_otitidiscaviarum             AARARAEVSESLQRIAKESGLRPYEIPRDLII-ESEPFTIDNGLLSGIGKLLRPKLKEHY 
Nocardia_iowensis                     TATLKSALAESIQRIAKDANLQPYEIPRDFLI-ETEPFTIANGLLSGIAKLLRPNLKERY 
Nocardia_transvalensis                PAELKAAIGESLQRVARDAELESYEIPRDFLV-EPEAFSMANGLLSGIGKLLRPKLKQRY 
 
 
Firefly_Luciferase|BAL46512.1         KGGKSKL--------------------------------------------------- 
FadD13|NP_217605.1                    SATVPK---------------------------------------------------- 
NRPS|WP_014382786.1                   -------YSDVD----------RYRAPASAIEEILAGIYAQVLGAERVGV--DDSFFD 
Tsukamurella_paurometabola            GDRLHDLYAQADTRQREGLRALDASG---PIIDTVLGAAALTLGADIADFDADTRFGD 
Mycobacterium_smegmatis1              GQRLEQMYADIAATQANQLRELRRAAATQPVIDTLTQAAATILGT-GSEVASDAHFTD 
Mycobacterium_genavense               GEQLERLYSEIAAAQVDEIRVLREAAADRPAVETLAGACRALLGTSGADS--ESHFTD 
Mycobacterium_marinum                 GARLELLYTELADSQTRRLHRLRQTGGRLPALETIRRAAGALLGTETTEPRPEAHFKD 
Nocardia_asteroides                   GARLDALYDEVVREQEAELERLRREAPMLPVDEVVARAALAVLGCAAADLRPSARFGE 
Nocardia_paucivorans                  GPRLEQLYTELAEAGTDELRALRRDGADRPVLETVRRAVSALLGTTDGAPPPEAHFTD 
Mycobacterium_fortuitum               GERLEQLYAELAETQAAELRELRSASADAPVVETVSRAAGALLGAAASDLGPDAHFTD 
Mycobacterium_smegmatis2              GERLEQLYTDLAEGQANELRELRRNGADRPVVETVSRAAVALLGASVTDLRSDAHFTD 
Mycobacterium_vaccae                  GDRLEALYAELAEGQTDELRELRRSGAERPVQETVLRAAAALLGAAATDLQPDAHFTD 
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Mycobacterium_obuense                 GEQLEALYAELADGQADEMRTLRADGANRPMLETVGRAAAALLGTAATDVQPDAHFTD 
Nocardia_seriolae                     GARLEQMYDEQAQRQRDELATLRREAAELPVLETVCRAARAVLG--GTQPPPDAHFTD 
Nocardia_otitidiscaviarum             GERLEQLYAELAEQREDELTALRRGAHDRPILDTVTRAAGAVLDLTAGEVSPDAHFAD 
Nocardia_iowensis                     GAQLEQMYTDLATGQADELLALRREAADLPVLETVSRAAKAMLGVASADMRPDAHFTD 
Nocardia_transvalensis                GDRLEERYDELSREQQDELTALRTAAADLPVLETVSRAAKALLGCATTDLRPDAHFAD 
 
Supplementary Figure 4-1 - MUSCLE Alignment of adenylation domains of ANL 
superfamily members. 
MUSCLE Alignment between Mycobacteria, Tsukamurella and Nocardia CARs, Firefly 
Luciferase from Photinus pyralis, a long chain fatty acid CoA ligase (FadD13) from 
Mycobacterium tuberculosis, and an adenylating subunit from a non-ribosomal peptide 
synthase from Mycobacterium intracellulare suggests the CARs are a member of the ANL 
enzyme superfamily. Confidently conserved domains that confer the hallmark functions of 
the ANL family are highlighted blue. Potentially, or poorly conserved domains are highlighted 
yellow. ANL hallmark motifs were identified according to Gulick 2009 and Marahiel et al., 
1997. Accession numbers for the CARs are found in Supplementary Figure 2. 
 
 
 
CAR Sequences are included with associated data files due to space 
limitations 
Supplementary Figure 4-2 - All CAR sequences used in this study to build 
phylogenetic tree in figure 2.  
Sequences were retrieved from GenBank by homology search to the N. iowensis CAR It 
must be noted that the majority of CAR homologues identified are autoannotaded as 
oxidoreductases, and not carboxylic acid reductase.  
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Supplementary Figure 4-3 – SDS-PAGE analysis of the purification of mpCAR, 
msCAR, niCAR, noCAR and tpCAR.   
Each gel shows the soluble fraction of the cell lysate (Sol), the insoluble fraction (Insol), the 
unbound flow-through from the nickel column (Ni F/T) and the fractions which were collected 
from the subsequent gel filtration column (eg A2-A8).  SDS-PAGE analysis of the gel 
filtration fractions were used to select fractions for pooling for subsequent assays. 
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Supplementary Figure 4-4 – Carboxylic acid substrates  
The names and structures of all 20 carboxylic acid substrates tested are shown.  The effects 
of the addition of electron donating or withdrawing groups were tested (2 to 8), extending the 
carboxylic group away from the benzene ring with various modification (9-13), the inclusion 
nitrogen, sulfur or oxygen in the benzene ring (14-17) and fatty acids with chain lengths 
between four and sixteen carbons in length (18-21).   
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Supplementary Figure 4-5 – mpCAR kinetic data  
Initial rates of activity at changing substrate concentration for each substrate.  Appropriate 
substrate concentrations were calculated from preliminary experiments determining both 
which substrates the enzyme showed activity against and a rough estimate of the KM value 
from initial rates of activity over a wide range of substrate concentrations
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Supplementary Figure 4-6 – noCAR kinetic data 
Initial rates of activity at changing substrate concentration for each substrate.  Appropriate 
substrate concentrations were calculated from preliminary experiments determining both 
which substrates the enzyme showed activity against and a rough estimate of the KM value 
from initial rates of activity over a wide range of substrate concentrations. 
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Supplementary Figure 4-7 – tpCAR kinetic data 
Initial rates of activity at changing substrate concentration for each substrate.  Appropriate 
substrate concentrations were calculated from preliminary experiments determining both 
which substrates the enzyme showed activity against and a rough estimate of the KM value 
from initial rates of activity over a wide range of substrate concentrations. 
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Supplementary Figure 4-8– niCAR kinetic data  
Initial rates of activity at changing substrate concentration for each substrate.  Appropriate 
substrate concentrations were calculated from preliminary experiments determining both 
which substrates the enzyme showed activity against and a rough estimate of the KM value 
from initial rates of activity over a wide range of substrate concentrations. 
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Supplementary Figure 4-9 – msCAR kinetic data 
Initial rates of activity at changing substrate concentration for each substrate.  Appropriate 
substrate concentrations were calculated from preliminary experiments determining both 
which substrates the enzyme showed activity against and a rough estimate of the KM value 
from initial rates of activity over a wide range of substrate concentrations. 
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Supplementary Figure 4-10 – Comparison of NADPH consumption with aldehyde 
production 
Reactions containing 2 mM benzoic acid or p-toluic acid were set up and the consumption of 
NADPH monitored over 10 minutes at OD340nm.  Reactions were stopped by the addition of 
50 % acetonitrile and aldehyde concentration determined by HPLC.  The comparison shows 
slightly more aldehyde was produced in the reaction than the observed NADPH 
consumption.  This can be attributed to the reaction occurring before the monitoring of 
NADPH could begin.  This comparison shows that measuring NADPH consumption is a 
good measure of the CAR reaction. 
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Supplementary Figure 4-11 – Confirmation of benzaldehyde and p-tolualdehyde 
production by all the CARs tested. 
Reactions containing 2 mM benzoic acid or p-toluic acid were set up and allowed to run for 
10 minutes before being stopped by the addition of 50 % acetonitrile for analysis by HPLC.  
For all the CARs, the derivative aldehyde product was detected by HPLC.   
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Supplementary Figure 4-12 – Controls looking at the feasibility of using NADPH 
consumption to measure activity of CAR enzymes with nitro aromatic acid substrates. 
Substrate concentration was titrated from 10 mM and OD340nm plotted as a function of 
concentration.  The plate reader used is accurate up to OD340nm 3.0 as shown. 
Standard CAR reaction mix without CAR enzyme was assayed with the addition of 5 mM 
and 2.5 mM of the three nitro aromatic acids used.  NADPH can be measured accurately as 
additional absorbance despite the inclusion of the nitro aromatic compounds.  Error bars 
show the standard deviation of three readings. 
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Supplementary Figure 4-13 – Competitive inhibition of NADPH by NADP+   
Initial rates at changing concentrations of NADPH at various NADP+ concentrations were fit 
to Michaelis-Menten inhibition equations in Graphpad using non-linear least squares 
regression.  The best fit was shown to be competitive inhibition and the Lineweaver–Burk 
plot in the top right of the figure clearly shows this.  The KI was calculated as 143 ± 8 µM.   
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Supplementary Figure 4-14 – Competitive inhibition of ATP by AMP 
Initial rates at changing concentrations of ATP at various AMP concentrations were fit to 
Michaelis-Menten inhibition equations in Graphpad using non-linear least squares 
regression.  The best fit was shown to be competitive inhibition.  The KI was calculated as 
8200 ± 900 µM. 
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Supplementary Figure 4-15 – Competitive inhibition of p-toluic acid by PPI  
Initial rates at changing concentrations of p-toluic acid at various PPI concentrations were fit 
to Michaelis-Menten inhibition equations in Graphpad using non-linear least squares 
regression.  The best fit was shown to be competitive inhibition.  The KI was calculated as 
340 ± 40 µM. 
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Supplementary Figure 4-16 – Mixed model inhibition of ATP acid by PPI 
Initial rates at changing concentrations of p-toluic acid at various PPI concentrations were fit 
to Michaelis-Menten inhibition equations in Graphpad using non-linear least squares 
regression.  The best fit was shown to be mixed inhibition, with a KI of 220 ± 50 µM, and an 
a of 2.5 ± 1.4.   
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FASTA file is included with associated data files due to space limitations 
Supplementary Figure 4-17 – All 99 CAR sequences identified   
A FASTA file containing all 124 CAR protein sequences identified.  A subset were used for 
the tree in the main text.  An extended tree is shown in supplementary figure 15. 
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Supplementary Figure 4-18 - Unrooted maximum likelihood phylogeny of the 124 CAR 
homologues.  
CARs were aligned with MUSCLE, in Geneious, masked by eye, and had their phylogeny 
constructed in the PhyML plug-in for Geneious under the WAG+I+G model of amino acid 
substitution with 8 gamma rate categories. Node confidence scores are SH-like statistics 
computed by PhyML, with 1 being unequivocal. Coloured branches represent CARs that 
have been studied: Blue – in previous research, Red – in this paper, Purple – in both this 
paper and previous research. 
 
 
 
 Molecular 
Weight 
Extinction 
Coefficient 
mpCAR 129534.6 116800 
msCAR 131391.8 102235 
tpCAR 122207.3 108430 
niCAR 129519.6 102485 
noCAR 129087.2 114850 
 
Supplementary Figure 4-19 – Table of molecular weights and extinction coefficients 
calculated using ExPASY ProtParam. 
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Chapter 5  - Construction, modelling 
and optimisation of a seven enzyme, 
one-pot biotransformation 
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5.1 Preface for inclusion in this thesis 
This chapter is the first draft of a paper intended for submission to eLife.  The draft in 
this thesis is likely an extended version of what will be submitted, containing extra 
background information in the introduction and more discussion. 
All experiments and modelling were performed by William Finnigan.  All content 
written by William Finnigan and edited by Nicholas Harmer. 
The manuscript has been formatted to match the formatting of this thesis.  
References have been combined with those in the other chapters of this thesis for a 
final reference chapter.  Figure and table numbers have also been edited for 
inclusion in the thesis. 
eLife asks that supplementary figures are linked to figures in the text, and the 
labelling of the supplementary figures therefore follows this format. For example 
Figure 5-2 has a number of supplementary figures associated with it labelled Figure 
5-2 – Supplementary Figure 1 through to Figure 5-2 – Supplementary Figure 8.   
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5.2 Introduction 
5.2.1 Multi-step biocatalysis 
Biocatalysis, the use of isolated enzymes or whole cells, is increasingly the route of 
choice in the chemical and particularly the pharmaceutical industries (Pollard and 
Woodley, 2007).  Driven by a requirement for the sustainable use of limited 
resources, enzymes offer unrivalled selectivity at mild operating conditions making 
them an excellent choice in meeting these goals (Fessner, 2015).   
Recently, there has been an increasing interest in developing one-pot reactions, 
where multiple catalysts work together to complete chemical pathways.  These 
remove the need to isolate substrates and products at each step, giving great cost 
and productivity benefits (Turner and Truppo, 2013).  The use of multistep pathways 
can also drive reversible processes to completion and allow inhibitory or 
unproductive by-products to be eliminated (Oroz-Guinea and García-Junceda, 
2013).  
Enzymes are particularly well suited to multi-step reactions in that this mimics the 
use of enzymes in nature, where they carry out complex metabolic transformations in 
similar and mild conditions.  In contrast, the use of several chemical steps together 
will often have differing operational requirements, making this a more challenging 
approach (Wells and Meyer, 2014).  There is particular interest in implementing 
enzymatic pathways for the conversion of simple and inexpensive starting materials 
into high value, often enantiomerically pure, products (Turner and Truppo, 2013). 
The use of whole cells for these types of reactions has a number of advantages. 
These include a simpler upstream process, higher enzyme stability inside the cell, 
cofactor regeneration utilising host metabolic machinery, and avoiding enzyme 
isolation steps (De Carvalho, 2011; Schrewe et al., 2013).  However, whilst the use 
of whole cells can reduce the complexity of the upstream process, it suffers from 
more a difficult downstream process.  Moreover, maximising the conversion can be 
challenging. Diffusion across cell membranes can be rate limiting (Ni and Chen, 
2004), and unwanted side reactions can occur (Stuermer et al., 2007). High 
substrate concentrations can be difficult to achieve due to toxicity to the cells (De 
Bont, 1998).  Finally, the reaction itself is more difficult to control as changes in 
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enzyme concentration must be engineered into the microorganism, and this is 
frequently challenging (Oroz-Guinea and García-Junceda, 2013). 
The use of isolated enzymes rather than whole cells can significantly reduce the cost 
and complexity of downstream processing (du Preez et al., 2015).  As fewer 
catalysts and chemicals are present, fewer side reactions occur, and a higher purity 
product can be achieved (Bujara et al., 2010).  Furthermore, reactions are not limited 
by diffusion across a cell membrane (Hold and Panke, 2009).  Perhaps the most 
attractive feature of using isolated enzymes is the ability to finely control the reaction 
by changing the concentration of enzymes, substrate, co-solvent, pH or temperature. 
These allow the design of the most efficient system to meet the process need (Xue 
and Woodley, 2012).  To achieve this, the enzymes involved must be thoroughly 
characterised, the isolated enzymes must be sufficiently stable for the process to be 
economical, and cofactor regeneration systems may need to be employed (Oroz-
Guinea and García-Junceda, 2013). 
5.2.2 The enzyme toolbox for in vitro biocatalysis 
The concept of an enzyme toolbox is often invoked, together with a need for more 
well-defined enzyme building blocks (Wells and Meyer, 2014).  This correlates with 
the frequently lamented need for well characterised parts in synthetic biology (where 
the ultimate goal is the in silico design of novel microorganisms) (Kuhn et al., 2010; 
Ellis, Adie and Baldwin, 2011; Medema et al., 2012).  In synthetic biology, modelling 
of these parts is significantly complicated by the many confounding cellular factors of 
the cell (Purcell et al., 2013).  In contrast, modelling of enzymes in vitro can be fairly 
robust and offers solutions for reaction engineering (Vasić-Rački, Findrik and 
Vrsalović Presečki, 2011).  In order for a robust enzyme toolbox to be realised, well 
characterised and validated parts are needed (Wachtmeister et al., 2014), ideally 
with validated mathematical models so that new pathways can be engineered and 
tested in silico (Turner and Truppo, 2013).  
For enzymes to be used as part of an in vitro system, operational stability is a key 
factor (Polizzi et al., 2007).  Thermostable enzymes are an excellent starting point in 
achieving high operational stability (Littlechild, 2011).  Additional modifications such 
as enzyme immobilisation or enzyme engineering can be used to further increase 
enzyme lifespan (Keasling, 2012).  The use of thermostable enzymes also allows 
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purification by heat precipitation: recently a cocktail of nine thermostable enzymes 
were isolated in this way from a single E. coli strain, allowing a convenient one-pot 
biotransformation (Ninh et al., 2015). 
5.2.3 Carboxylic acid reductases join up separate enzyme 
reactions. 
Many critical chemicals for modern society are derived from reduced petrochemical 
based precursors.  The oxidation of these molecules is more chemically 
straightforward than reduction of the alternative, oxidised sustainable feedstocks.  A 
very relevant challenge is therefore the biocatalytic reduction of renewable 
feedstocks to provide useful products (Wells and Meyer, 2014). This will 
considerably assist in the move to a sustainable, bio-based economy whilst avoiding 
the use to potentially toxic reductants (Cherubini, 2010).  
An example of a recent addition to the enzyme toolbox for such reactions are the 
carboxylic acid reductases (CARs) (Akhtar, Turner and Jones, 2013).  CARs 
catalyse the reduction of carboxylic acids to aldehydes in mild conditions, and can 
connect many types of enzyme reaction allowing the construction of novel multi 
enzyme pathways (Figure 5-1) (Turner and O’Reilly, 2013).  Previously, we have 
shown CARs to be a fairly promiscuous class of enzyme, catalysing the reduction of 
both aliphatic and aromatic carboxylic acids.  Electron rich acids are favoured as the 
first step in the CAR reaction mechanism, attack by the carboxylate on the a-
phosphate of ATP, is limiting (Finnigan et al., 2016).  
Hydrolase enzymes are the most widely used class of enzyme industrially (Meyer et 
al., 2013), generally producing a carboxylic acid as one of their products (Panda and 
Gowrishankar, 2005).  These enzymes are well poised for inclusion into novel 
enzymatic cascade reactions with CARs.  Additionally many enzymes considered as 
established members of the enzyme toolbox accept aldehydes as their substrates 
(Turner and O’Reilly, 2013).  The use of CARs for multistep reactions opens up a 
large number of useful enzyme combinations for synthetic chemistry (Figure 5-1). 
CARs have been shown to be useful in the construction of pathways for in vivo use.  
Examples include the production of the flavor vanillin by yeast (Hansen et al., 2009) 
and a synthetic pathway for the production of propane in Escherichia coli (Kallio et 
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al., 2014).  The use of a CAR in E. coli as a whole-cell biocatalyst for the synthesis of 
the antioxidant 3-hydroxytyrosol has been explored (Napora-Wijata et al., 2014).  As 
well as having beneficial effects on human health it is a valuable building block in the 
synthesis of pharmaceuticals (Allouche, Fki and Sayadi, 2004).  Using a “design of 
experiments” approach, citrate was shown to be a suitable co-substrate for the 
regeneration of NADPH and ATP.  However, a preparative-scale bio-reduction gave 
much lower yields than expected, possibly due to mechanical stress or oxygen 
limitation at the larger scale (Napora-Wijata et al., 2014).  The use of CARs as an 
isolated enzyme, however, has not been explored, possibly due to the challenging 
and costly requirements for both ATP and NADPH regeneration (Zhang, 2015). 
 
 
Figure 5-1 – Potential for utilising CARs in multi-step enzyme reactions 
CARs join many industrially relevant enzyme reactions, making them useful for the 
construction of novel multi-step enzyme reactions.  Cofactors and additional substrates are 
not shown for clarity.  ADH: alcohol dehydrogenase, ATA: amino transferase, IRED: imine 
reductase, CAR: carboxylic acid reductase.  R: R-group, limited by enzyme substrate 
specificity. 
5.2.4 Cofactor regeneration 
Many oxidoreductases require cofactors, most commonly the comparatively 
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regeneration is essential.  While many enzyme systems have been developed for the 
regeneration of NAD(P)H, perhaps one of the most useful makes use of the 
phosphite dehydrogenase (PTDH) enzyme from Pseudomonas stutzeri.  The wild 
type enzyme regenerates NADH via the nearly irreversible oxidation of phosphite to 
phosphate. This enzyme has been engineered to also regenerate NADPH and 
improve thermostability (Woodyer, Van der Donk and Zhao, 2003; McLachlan, 
Johannes and Zhao, 2007). 
Techniques for the regeneration of ATP are less well developed, but enzymes such 
as pyruvate kinase (PK), creatine kinase (CK), adenylate kinase (AK) and 
polyphosphate kinase (PPK) have been used (Zhao and Van Der Donk, 2003).  Of 
these, polyphosphate kinase makes use of the cheapest and most stable substrate, 
polyphosphate.  Polyphosphate strongly chelates Mg2+, which is an essential 
cofactor for many enzymes that utilise ATP. This limits the concentration of 
polyphosphate that can be added to a reaction (Itoh and Shiba, 2004). 
Polyphosphate is also a substrate for polyphosphate-AMP phosphotransferase 
(PAP), which allows the regeneration of ADP from AMP (Woodyer, Johannes and 
Zhao, 2003). PAP can be combined with an ATP regenerating enzyme for complete 
regeneration of ATP from AMP.  This has demonstrated using both PAP and PPK 
(Kameda et al., 2001).  In an alternative approach, adenylate kinase (which 
catalyses the reversible conversion of two ADP molecules into one ATP and one 
AMP) was used in place of PPK.  PAP was again used, pushing the equilibrium 
towards the regeneration of ATP (Resnick and Zehnder, 2000). 
5.2.5 The application of process modelling  
In developing new biocatalytic processes the use of kinetic modelling is widely 
advocated, yet often not used in process development (Sin, Woodley and Gernaey, 
2009; Ringborg and Woodley, 2016).  However, recent literature shows there is 
increasing interest in this topic (Vasić-Rački, Findrik and Vrsalović Presečki, 2011).  
The development of a kinetic model early on in the development process can be 
invaluable in cost / benefit or feasibility analysis (Sin, Woodley and Gernaey, 2009). 
It can highlight where enzyme engineering could provide substantial gains, allow 
simulations of hypothetical change that can speed up process development, and 
allow evidence based decision-making (Rios-Solis et al., 2015).  Critically, a model 
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allows for the identification of bottlenecks and the quantification of process problems 
(du Preez et al., 2015).  For these reasons, the application of validated models is 
important in driving the field of biocatalytic process development forward (Ringborg 
and Woodley, 2016).  Despite these advantages, few models for multistep 
biocatalysis processes have been explored. The challenges of integrating kinetic 
models for multiple enzymes are evident, not least the number of kinetic parameters 
involved (Rios-Solis et al., 2015).  
Two general types of model have been constructed to describe enzyme reactions.  
“Data driven” empirical methods provide a model of the enzyme reaction without a 
need to understand the detailed mechanism of the reaction (Park, 2007).  Often 
these models are simpler, involve fewer parameters, and fit the data well, but at the 
expense of understanding the reaction (Vasić-Rački, Findrik and Vrsalović Presečki, 
2011).  In multi-enzyme systems where many components are present, protein 
interactions that could affect the reaction rate may occur. The use of a data driven 
model can be advantageous in these circumstances (Vasić-Rački, Findrik and 
Vrsalović Presečki, 2011).  Another approach is to use “mechanistic models”. These 
seek to describe enzyme mechanisms as accurately as possible: a classic example 
is the use of Michaelis-Menten equations (Peri et al., 2007).  As mechanistic models 
seek to understand a system as well as to predict it, they offer the opportunity to 
observe unanticipated phenomena, and so generate new hypotheses. These offer 
opportunities to develop substantial improvements or insight into the development 
process (Vasić-Rački, Findrik and Vrsalović Presečki, 2011). 
Irrespective of whether a pathway is to be applied as a whole-cell system, or as 
isolated enzymes, there is a need to understand the mechanisms of the enzymes 
involved and to model reaction kinetics to optimise overall yield (Rios-Solis et al., 
2015).  Whilst data driven empirical models can be powerful tools for the optimisation 
of isolated cases, they operate as “black boxes” that offer no further understanding 
of the system being studied.  Where pathways fail to meet the productivity expected 
of them, mechanistic models can be invaluable in understanding and troubleshooting 
where a bottleneck may lie (Ringborg and Woodley, 2016). 
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5.2.6 Aims and objectives. 
There are many industrially relevant enzymes that generate carboxylic acids or use 
aldehydes as their substrates (Figure 5-1).  The construction of multi-step reactions 
offers attractive one-pot processes with excellent cost and productivity benefits.  To 
demonstrate the use of CARs in multi-step cascade reactions, and investigate their 
use in vitro, we designed a reaction made up of an esterase, a CAR and an alcohol 
dehydrogenase (ADH) to hydrolyse and then reduce an ester to its derivative 
alcohol.  Methyl p-toluate was chosen as a trial substrate.  Enzymes for cofactor 
regeneration and by-product removal were added resulting in a synthetic seven 
enzyme system.    
To highlight the modular nature of the enzyme toolbox for designing multistep 
reactions, each enzyme in the system has been characterised individually and a 
mathematical model for each created. In addition, the effects of pH and temperature 
were assessed to define an operational window.  In constructing and testing the 
model for each step in the reaction we demonstrate the value of a model in 
identifying process problems. Specifically, we were able to predict the need for PPi 
removal, and to optimise the trial batch reaction for maximum productivity. 
With increasing numbers of enzymes becoming available from commercial sources 
or described in literature, the development of new cascades will the lay the base for 
artificial metabolisms and create enzyme catalyst networks allowing new reactions to 
be quickly assembled (Schrittwieser et al., 2011).  
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5.3 Results 
5.3.1 Expression and purification of enzymes 
All of the enzymes used in this study were recombinantly prepared from E. coli, as 
fusions with a polyhistidine-tag. All of the proteins were purified by nickel affinity 
chromatography followed by size exclusion chromatography. A high level of purity 
was achieved for each enzyme (Figure 5-2 - Supplementary Figure 1 to Figure 5-2 - 
Supplementary Figure 8).  
5.3.2 Designing a synthetic multi-step pathway 
Enzymes with the correct substrate specificity to fill the esterase, CAR and ADH 
steps were identified from the literature. Where possible, thermostable enzymes 
were chosen to provide maximum operational stability. In the case of the CAR step, 
only moderate thermostability was possible due to the limited number of organisms 
that use these enzymes.  An esterase from the hyperthermophile Archaeoglobus 
fulgidus (afEst2), a CAR from the moderate thermophile Mycobacterium phlei 
(mpCAR), and an ADH from the hyperthermophile Aeropyrum pernix (apADH) were 
chosen (Figure 5-2) (Guy, Isupov and Littlechild, 2003; Sayer et al., 2016).  The 
catalytic constants of these enzymes against the relevant substrates in the test 
pathway were determined (Table 5-2 - Supplementary Figure 1 to Table 5-2 - 
Supplementary Figure 20), or taken from relevant literature (references shown in 
Table 5-2).  
To allow cofactor regeneration, a thermostable mutant of PTDH, capable of 
regenerating both NADH and NADPH, was chosen given the need for both of these 
cofactors in the pathway.  For ADP regeneration from AMP, PAP enzymes from 
thermophilic organisms Thermodesulfobium narugense (tnPAP) and 
Thermanaerovibrio velox (tvPAP) were identified with 33 % and 34 % homology 
against the previously characterised PAP from Acinetobacter johnsonii (Bonting, 
Kortstee and Zehnder, 1991).  Both showed PAP activity (Figure 5-2 - 
Supplementary Figure 9).  tnPAP was used in the final pathway due to greater 
activity.   
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A thermostable PPT enzyme from Thermosynechococcus elongatus that had 
previously been characterised (Sato et al., 2007) was initially chosen to regenerate 
ATP from ADP. However, in our hands this enzyme gave very low activity.  In its 
place, a thermostable AK enzyme from Thermotoga neapolitana (tnAK) was used, 
which had previously been characterised with high activity (Vieille et al., 2003).  
Upon identifying a need for the removal of PPi from the reaction, a thermostable 
PPiase from Thermus thermophilus was also added (ttPPiase) and its activity 
determined (Table 5-2 - Supplementary Figure 15). 
 
 
Figure 5-2 - A schematic of the seven enzyme reaction 
The hydrolysis of methyl p-toluate to p-toluic acid, followed by reduction to p-tolualdehyde 
and further to p-tolylalcohol is shown.  The use or production of water is not shown.  afEst2: 
Esterase enzyme from Archaeoglobus fulgidus, mpCAR: Carboxylic acid reductase from 
Mycobacterium phlei, apADH: Alcohol dehydrogenase from Aeropyrum pernix, PTDH: 
Engineered phosphite dehydrogenase from Pseudomonas stutzeri, ttPPiase: Inorganic 
pyrophosphatase from Thermus thermophilus, tnPAP: Polyphosphate AMP 
phosphotransferase from Thermodesulfobium narugense, tnAK: Adenylate kinase from 
Thermotoga neapolitana. PolyPn: A polyphosphate molecule of with a chain length of n 
phosphates.    
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5.3.3 Identifying an operational window. 
Thermostability and activity at pH was determined for each enzyme to define an 
operational window for the reaction (Figure 5-3).  Data for afEst2(Sayer et al., 2016), 
mpCAR(Finnigan et al., 2016), apADH(Hirakawa, Kamiya and Kawarabayashi, 2004) 
and tnAK(Vieille et al., 2003) was adapted from previous work.  The effects of pH 
and temperature on the remaining enzymes were characterised (Figure 5-3 - 
Supplementary Figure 1 to Figure 5-3 - Supplementary Figure 6).  Taking a threshold 
of 25 % relative activity or more for each enzyme, a window between pH 6.8 and pH 
9.0 was identified. pH 7.5 was chosen as a compromise between all enzymes, and 
as ADH activity in the (undesired) oxidative direction was minimised.  As we 
expected, the operational window for temperature is primarily limited by the mpCAR 
enzyme, as this has only moderate thermostability.  A reaction temperature of 30 oC 
was chosen to ensure maximum activity of this enzyme.  
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Figure 5-3 - The operational window for temperature (A) and pH (B) for the seven 
enzyme reaction 
A.  Residual relative activity after incubation at various temperatures for 30 minutes.  
The operational window for temperature is shown by the dashed vertical line and 
arrow. 
B.  Relative activity at various pH values.  Values are relative to the maximum activity in 
each case.  The operational window is shown by two dashed vertical lines, and 
arrows pointing inwards.  
20 30 40 50 60 70 80 90 100
0
20
40
60
80
100
120
Temperature oC
R
el
at
iv
e 
ac
tiv
ity
 %
PTDH
ttPpiase
mpCAR
afEst2
apADH
tnPAP
tnAK
apADH 
oxid.
4 5 6 7 8 9 10 11 12
0
20
40
60
80
100
120
pH
R
el
at
iv
e 
ac
tiv
ity
 %
A
B
	206	
5.3.4 Reaction modelling. 
Mathematical models utilising kinetics based on the steady state approximation were 
developed in isolation for each section of the multi-step reaction, and validated 
before being combined into a multi-step process. These models were developed 
using Python scripts (Supplementary File 1) following a single approach, with 
equations appropriate for each enzyme. The rate equations are summarised in Table 
5-1, which were used to construct a full set of differential equations (Table 1 - 
Supplementary Figure 1).  Kinetic parameters were either identified from available 
literature or calculated experimentally.  An uncertainty analysis was carried out for 
each model, where possible using bounds equal to the 95 % confidence intervals of 
each parameter (Table 5-2).  In some cases where uncertainty was judged to be 
large due to incomplete knowledge, bounds of ± 50 % of the parameter were used.  
Starting concentrations were given bounds of ± 5 %, except in the case of 
polyphosphate where the length of the polyphosphate chain is unknown.  In this case 
± 25 % was used with the upper bound equal to the absolute concentration of 
phosphate units.  For more information on the use of uncertainty and sensitivity 
analysis in process modelling please see the following references (Sin, Gernaey and 
Lantz, 2009; Price et al., 2013).   Model predictions were tested by running small 
scale reactions in a thermomixer, with samples taken every 30 minutes into 
acetonitrile for analysis by HPLC.  
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Table 5-1 – Kinetic equations 
The rationale for the kinetic equations chosen for each enzyme and interacting partner are 
discussed in detail below. Aldehyde degradation was modelled as a first order process. 
afEst2 !1 = $%&' ∙ )*+'%&' ∙ *,-./0*,-./0123,-./0  
mpCAR 45678 = 45678 ∙ 91 :;;<=>;;>?@:<A91 :;;<B;;>∙=>;;>?@:<A ∙ (1 + *@3;2>@3;) ∙ (1 + *@F;2>@F;)   45G6H8I = 45G6H8I ∙ (1 + *J@F;K2>J@F;K)  456*LM = 456*LM ∙ (1 + $88L4N88LO6*LM) )*+'P6Q = R:S.T@U91 :;;<B;;>∙=>;;>?@:<A  !2 = $P6Q ∙ )*+'P6Q ∙ *@:<A∙*@W;(2>@W;∙23@:<A)1(23@:<A∙*@W;)1(23@W;∙*@:<A)1(*@W;∙*@:<A) ∙ *J@F;X*J@F;X12YJ@F;X  
apADH !3 = 	 $6HI ∙ )*+'6HI\]M ∙ *@^A/_`A/∙*J@FX(2>J@FX∙23@^A/_`A/)1(23@^A/_`A/∙*J@FX)1(23J@FX∙*@^A/_`A/)1(*J@FX∙*@^A/_`A/)  !4 = 	 $6HI ∙ )*+'6HIQbc ∙ *@^:d_d^∙*J@FK(2>J@FK∙23@^:d_d^)1(23@^:d_d^∙*J@FK)1(23J@FK∙*@^:d_d^)1(*J@FK∙*@^:d_d^)  
PTDH 45G6H1 = 	45G6H1 ∙ (1 + *J@F;K2>J@F;K)  45G6H81 = 	45G6H81 ∙ (1 + *J@FK2>J@FK)  !5 = 	 $87HI ∙ )*+'87HIOG6H1 ∙ *J@FK*J@FK123J@FK  !6 = 	 $87HI ∙ )*+'87HIOG6H81 ∙ *J@F;K*J@F;K123J@F;K  
 
PPiase !7 = $88L+&b ∙ )*+'88L+&b ∙ *;;<*;;<123;h<  
PAP !8 = 	 $887 ∙ )*+'887 ∙ *;d^`;*;d^`;123;d^`; ∙ *@3;*@3;123@3;  
AK !9 = 	 $62 ∙ )*+'62O\]M ∙ *@F;*@F;123@F; ∙ *@F;*@F;123@F;  !10 = 	 $62 ∙ )*+'62OQbc ∙ *@3;*@3;123@3; ∙ *@W;*@W;123@W;  
Aldehyde degradation !11 = )+M ∙ $6lMbmnMb  
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Table 5-2 – Kinetic parameters used in the model. 
 
afEst2 (Sayer et al., 2016) 
 
kcat (Sayer et al., 2016) 6 ± 1 min-1 
KM-Ester (Sayer et al., 2016) 1,500 ± 200 µM 
 
mpCAR (Finnigan et al., 2016) 
 
kcat 200 ± 20 min-1 
KM-Acid 1,500 ± 320 µM 
KM-ATP 100 ± 28 µM 
KI-ATP 40 ± 34 µM 
KM-NADPH 30 ± 8 
KI-AMP (Finnigan et al., 2016) 10,000 ± 1,800 
KI-ADP 11,000 ± 4,000 
KI-NADP+ (Finnigan et al., 2016) 143 ± 16 
KI-PPi-Acid (Finnigan et al., 2016) 340 ± 80 µM 
KI-PPi-ATP (Finnigan et al., 2016) 220 ± 100 µM 
a-PPi-ATP (Finnigan et al., 2016) 2.6 ± 2.8 
 
apADH 
 
kcat-Fwd 1.7 ± 0.2 min-1 
kcat-Rev 1.7 ± 0.85 min-1 
KM-NADH 180 ± 60 µM 
KM-NAD+ 190 ± 40 µM 
KI-NAD+ 185 ± 92.5 µM 
KI-NADH 185 ± 92.5 µM 
KM-Aldehyde 350 ± 120 µM 
KM-Alcohol 10,000 ± 5,000 
 
ttPpiase (Schomburg et al., 2013) 
 
kcat 4,400 ± 2,200 min-1 
KM-PPi (Schomburg et al., 2013) 500 ± 250 µM 
 
PTDH 
 
kcat-NAD+ 637 ± 16 min-1 
kcat-NADP+ 342 ± 16 min-1 
KM-NAD+ 85 ± 5 µM 
KM-NADP+ 220 ± 40 µM 
 
tnPAP 
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kcat 250 ± 60 min-1 
KM-AMP 280 ± 100 µM 
KM-PolyP 4,000 ± 1,400 µM 
 
tnAK (Perrier et al., 1998; Vieille et al., 2003) 
 
kcat-ADP (Vieille et al., 2003) 2,340 ± 1,170 min-1 
kcat-AMP-ATP (Vieille et al., 2003) 3,950 ± 1,975 min-1 
KM-ADP (Perrier et al., 1998) 91 ± 45.5 µM 
KM-AMP(Perrier et al., 1998) 38 ± 19 µM 
KM-ATP(Perrier et al., 1998) 51 ± 25.5 µM 
 
Aldehyde degradation 
 
k 0.00279 ± 0.001395 min-1 
 
Parameters were determined experimentally or obtained from 
the literature. Errors represent 95% confidence intervals where 
these could be experimentally determined. Where these could 
not be experimentally determined, errors of 50 % of the 
parameter value were conservatively assigned. 
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5.3.5 Esterase reaction 
afEst2 was recently characterised and kinetic parameters for the hydrolysis of methyl 
p-toluate at 30 oC reported (Sayer et al., 2016) (Table 5-2). The hydrolysis reaction is 
described by the one substrate Michaelis-Menten equation (Table 5-1).  The model 
was tested against a small scale batch reaction (Figure 5-4), which it was able to 
predict well. It was noted that the reaction proceeds only to approximately 95% 
completion, where there is a plateau. This was seen for several other reactions. 
 
Figure 5-4 - Validation of the esterase model. 
A reaction containing 10 µM afEst2 and 2,800 µM methyl p-toluate (ester) was used 
to validate the model for afEst2.  Ester and acid concentrations, measured every 30 
minutes by HPLC, are shown as red circles and blue squares respectively.  The 
model prediction is shown as the solid line in the same colours.  Dashed lines 
represent the 5th and 95th percentile of the uncertainty analysis. 
 
5.3.6 CAR reaction 
The CAR enzymes have three substrates: ATP, NADPH and a carboxylic acid.  
mpCAR has a low KM for NADPH (Finnigan et al., 2016) and it is expected that in the 
coupled reactions, the NADPH concentration will considerably exceed this at all 
times. This reaction was therefore modelled considering only the ATP and carboxylic 
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acid concentrations that are relevant for the rate limiting step (Finnigan et al., 2016).  
A steady state sequential ordered bi-substrate equation was used to model ATP and 
carboxylic acid concentration effects.  The ordered binding of ATP followed by a 
carboxylic acid has been shown previously for CAR enzymes (Finnigan et al., 2016), 
and is confirmed by the data in this study.   This was combined with a term equating 
to the Michaelis-Menten equation to model the effects of NADPH concentration.  
Parameters were determined experimentally (Table 5-2 - Supplementary Figure 3 
and Table 5-2 - Supplementary Figure 4). 
A reaction to test the CAR model was set up, predicting a fast turnover of the acid 
into its derivative aldehyde (shown in grey, Figure 5-5A).  Instead, after an initial 
burst, activity slowed considerably and the reaction was not complete even after four 
hours.  We investigated the possibility of product inhibition and found that all of the 
products of the CAR reaction (PPi, AMP and NADP+) act as inhibitors (discussed in 
more detail in (Finnigan et al., 2016)). While AMP and NADP+ both act as 
competitive inhibitors which may be overcome by increasing the substrate 
concentration, PPi acts as a mixed model inhibitor with respect to ATP, causing a 
large decrease in the apparent kcat.  When the inhibition by these products was taken 
into account the model fitted the data quite well (Figure 5-5A). We noted that 
modelling the inhibition resulted in a large level of uncertainty. 
5.3.7 ttPPiase removes CAR inhibition by PPI 
In order to alleviate inhibition by PPi on the CAR enzyme, an inorganic 
pyrophosphatase from Thermus thermophilus (ttPPiase) was added to the reaction. 
This enzyme shows exceptional thermostability and retained over 90 % activity after 
a 30 minute incubation at 95 oC (Figure 5-3).  Pyrophosphatase activity was 
measured at a saturating concentration of PPi (5 mM) and the rate taken to be the 
kcat.  The enzyme was modelled using the one substrate Michaelis-Menten equation, 
and using the KM determined in a recent work on this enzyme (Mu et al., 2009). The 
addition of the ttPPiase alleviated the majority of the inhibitory effects seen 
previously and the CAR reaction went to completion within one hour (Figure 5-5B). 
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5.3.8 Aldehyde degradation 
Once the CAR reaction was complete, aldehyde concentration decreased steadily 
over time (Figure 5-5B).  The product of this degradation could not be identified by 
HPLC, indicating that it was either lost from the reaction solution, or was not 
detectable in this HPLC mode.  A one phase decay equation was fitted to the 
decrease in aldehyde concentration, and an equation for the rate of aldehyde 
degradation constructed (Table 5-1 and Table 5-2). This resulted in a very good fit of 
the aldehyde concentration to the data. 
5.3.9 NAD(P)H regeneration using PTDH 
The regeneration of NADPH using PTDH was then added to the CAR step. Although 
PTDH shows sequential ordered kinetics, with NAD+ binding before phosphite, 
suitable parameters to use a two substrate equation are not reported in the literature.  
The phosphite concentration was not modelled, as all experiments will be performed 
at saturating phosphite concentrations throughout.  The one substrate Michaelis-
Menten equation was therefore used for reactions with either NAD+ or NADP+ as the 
substrate. NAD+ and NADP+ act as competitive inhibitors of each other with KI values 
equal to their respective KM values, and this inhibition was added to the model (Table 
5-1).  Kinetic parameters for NAD+, NADP+ were determined at assay conditions by 
following the generation of NADH or NADPH at 340 nm (Table 5-2; Table 5-2 - 
Supplementary Figure 13Table 5-2 - Supplementary Figure 14).  The KM for NAD+ 
was in good agreement with previously reported data for the thermostable mutant 
PTDH.  However our enzyme showed a substantially higher kcat for NAD+ than 
previously reported (McLachlan, Johannes and Zhao, 2007).   
The NADPH regeneration was tested by attempting reduction of 4000 µM p-toluic 
acid by CAR with only 500 µM or 50 µM NADPH, together with the PTDH 
regeneration system.  Both reactions went to completion and the reaction containing 
500 µM NADPH fit model predictions well (Figure 5-5C).  When only 50 µM NADPH 
was used, a much slower reaction was predicted by the model.  However, only a 
small difference was observed experimentally compared to the use of 500 µM 
NADPH (Figure 5-5D).  We considered that some form of substrate channelling (Lin, 
Palomec and Wheeldon, 2014; Wheeldon et al., 2016) may be taking place between 
the CAR and PTDH resulting in a lower apparent KM for NADP+ by PTDH.   
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5.3.10 ATP regeneration using tnPAP and tnAK. 
Both tvPAP and tnPAP showed good PAP activity (Figure 5-2 - Supplementary 
Figure 9). tnPAP showed the best activity and so was chosen for further 
characterisation.  Kinetic parameters for polyphosphate and AMP were determined 
experimentally (Table 5-2 - Supplementary Figure 17, Table 5-2 - Supplementary 
Figure 18, Table 5-2 - Supplementary Figure 19), and a bi-substrate equation 
constructed. 
An adenylate kinase from Thermotoga neapolitana has been reported to possess 
excellent thermostability, with kinetic parameters similar to those of the characterised 
E. coli adenylate kinase.  These parameters were used to model the adenylate 
kinase. However, testing of this enzyme in a CAR coupled reaction revealed a 
significantly lower turnover number (Table 5-2 - Supplementary Figure 21).  
Furthermore, magnesium concentration has been shown to be instrumental in 
controlling the equilibrium catalysed by AK.  Since the free magnesium concentration 
is not known due to chelation by polyphosphate, this effect could not be taken into 
account.  For this reason, the AK reaction is difficult to model accurately in the 
context of the multistep pathway. Therefore, a simple bi-substrate equation was used 
to describe it.  Large uncertainty bounds were used for all the parameters in the AK 
reaction as a consequence.  
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Figure 5-5 - Validation of mpCAR and related enzyme models. 
Reactions were performed to validate the model for mpCAR, and the addition of cofactor 
regenerating and PPi removing enzymes.  Acid and aldehyde concentrations measured 
every 30 minutes by HPLC are shown as blue squares and green upwards facing triangles 
respectively.  The model prediction is shown as the solid line in the same colours.  Dashed 
lines represent the 5th and 95th percentile of the uncertainty analysis. 
A.  mpCAR alone.  Reactions were initiated with 1 µM mpCAR, 8,000 µM ATP, 5,000 
µM NADPH, 20,000 µM MgCl2, 4,000 µM p-toluic acid.  The initial model prediction, 
which did not take in to account any product inhibition, is shown in grey. 
B.  mpCAR-ttPpiase.  Reactions were initiated with 1 µM mpCAR, 1 µM ttPpiase, 8,000 
µM ATP, 5,000 µM NADPH, 20,000 µM MgCl2, 4,000 µM p-toluic acid. 
C.  mpCAR-ttPpiase-PTDH.  Reactions were initiated with 1 µM mpCAR, 1 µM ttPpiase, 
1 µM PTDH,  8,000 µM ATP, 500 µM NADPH, 20,000 µM MgCl2, 20,000 µM PO3, 
4,000 µM p-toluic acid. 
D.  mpCAR-ttPpiase-PTDH (low NADPH).  Reactions were initiated with 1 µM mpCAR, 
1 µM ttPpiase, 1 µM PTDH,  8,000 µM ATP, 50 µM NADPH, 20,000 µM MgCl2, 
20,000 µM PO3, 4,000 µM p-toluic acid. 
E.  mpCAR-ttPpiase-PTDH-tnPAP-tnAK.  Reactions were initiated with 0.4 µM mpCAR, 
1 µM ttPpiase, 1 µM PTDH, 3 µM tnPAP, 1 µM tnAK, 1,250 µM ATP, 500 µM 
NADPH, 20,000 µM MgCl2, 20,000 µM PO3, 6,000 µM polyphosphate, 4,000 µM p-
toluic acid.  
	216	
5.3.11 ADH reaction 
Kinetic parameters for both the forward and reverse directions of the ApADH 
catalysed reactions were determined experimentally. The KM for p-tolyl alcohol (for 
the reverse oxidative reaction) could not be accurately determined, as it is likely 
outside the range which can be tested (Table 5-2 - Supplementary Figure 11 and 
Table 5-2 - Supplementary Figure 12). An estimated KM of 100 mM was used (Table 
5-2).  Consequently, kcat-Rev was also difficult to determine and a value similar to kcat-
Fwd was assumed.  A two substrate steady state sequential rate equation was used 
to describe both the forward and reverse reactions separately, using an estimated 
parameter for the KI for NAD+ and NADH based on their determined KM values. 
Reactions featuring only apADH as well as with PTDH for NADH regeneration were 
used to validate the model, which predicted the rate of reduction well in both cases 
(Figure 5-6).  A sensitivity analysis of the final alcohol concentration in both these 
reactions showed the KI for NAD+ and NADH, and kcat-Rev to have little effect (Figure 
5-6 - Supplementary Figure 1). 
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Figure 5-6 - Validation of ADH and ADH-PTDH modals  
Reactions used to validate the model for apADH, and cofactor regeneration by PTDH. 
Aldehyde and alcohol concentrations measured every 30 minutes are shown as green 
upwards facing triangles and orange downward facing triangles respectively.  The model 
prediction is shown as the solid line in the same colours.  Dashed lines represent the 5th and 
95th percentile of the uncertainty analysis. 
apADH only. Reactions were initiated with 10 µM apADH, 5,000 µM NADH, 3,500 µM p-
tolualdehyde. 
apADH-PTDH. Reactions were initiated with 10 µM apADH, 1 µM PTDH, 20,000 µM PO3, 
500 µM NADH, 3,500 µM p-tolualdehyde. 
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5.3.12 Building a multi-step enzyme cascade 
Once the models for each of the esterase, CAR and ADH steps were independently 
validated with cofactor regeneration, multi-step reactions were constructed.  The 
CAR step was tested in combination with first the esterase, and then ADH (Figure 
5-7A, B). In each case the model performed well in predicting the productivity of the 
reaction, although the hydrolysis reaction catalysed by afEst2 proceeded faster than 
was expected (Figure 5-7A). This might again reflect a substrate channelling effect 
speeding the afEst2 reaction when CAR is available to receive the product, or the 
activation of afEst2 by one of the substrates not included when afEst2 was tested 
alone. The full desired multistep reaction was then constructed (Figure 5-7C).  Again, 
the afEst2 reaction appeared to be proceeding at approximately twice the expected 
rate.  However the data showed an excellent fit in terms of the final product 
measurements.  
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Figure 5-7 - Validations of combinations of the esterase, CAR and ADH reactions. 
Reactions combining the CAR step with the esterase, ADH or both were constructed to test 
the model for these multi-step reactions.  Ester, acid, aldehyde and alcohol concentrations 
measured every 30 minutes are shown as red circles, blue squares, green upwards facing 
triangles and orange downward facing triangles respectively.  The model prediction is shown 
as the solid line in the same colours.  Dashed lines represent the 5th and 95th percentile of 
the uncertainty analysis. 
A. afEst2-mpCAR-ttPpiase-PTDH-tnPAP-tnAK. Reactions were initiated with 10 µM 
afEst2, 0.4 µM mpCAR, 1 µM ttPPiase, 1 µM PTDH, 3 µM tnPAP, 1 µM tnAK, 5,000 
µM methyl p-toluate, 500 µM NADPH, 1,250 µM ATP, 20,000 phosphite, 6,000 µM 
polyphosphate, 20,000 MgCl2. 
B.  mpCAR-ttPpiase-PTDH-tnPAP-tnAK-apADH. Reactions were initiated with 0.4 µM 
mpCAR, 1 µM ttPPiase, 1 µM PTDH, 3 µM tnPAP, 1 µM tnAK, 10 µM apADH, 4,500 
µM p-toluic acid, 500 µM NADPH, 500 µM NADH, 1,250 µM ATP, 20,000 phosphite, 
6,000 µM polyphosphate, 20,000 MgCl2. 
C.  afEst2-mpCAR-ttPpiase-PTDH-tnPAP-tnAK-apADH. Reactions were initiated with 
10 µM afEst2, 0.4 µM mpCAR, 1 µM ttPPiase, 1 µM PTDH, 3 µM tnPAP, 1 µM tnAK, 
10 µM apADH, 5,000 µM methyl p-toluate, 500 µM NADPH, 500 µM NADH, 1,250 
µM ATP, 20,000 phosphite, 6,000 µM polyphosphate, 20,000 MgCl2. 
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5.3.14 Optimisation of enzyme concentrations by a genetic 
algorithm 
For most industrial processes, the cost of inputs is a critical factor in determining the 
economic feasibility of an approach. We therefore aimed to demonstrate that this 
multistep cascade could be optimised using a model to deliver enhanced 
performance, at reduced input cost. A cost of $100 per kg of enzyme was chosen, 
assuming crude lysate is used and enzyme yield has been optimised (Tufvesson et 
al., 2011). The amount of each enzyme in the pathway was then optimised. The 
optimisation was required to achieve the lowest price whilst meeting a target of 90% 
conversion to the alcohol.  Substrate concentrations were set at 4,000 µM methyl p-
toluate, 1,250 µM ATP, 500 µM NADPH, 500 µM NADH, 20,000 µM phosphite and 
7,500 µM polyphosphate.   A custom built genetic algorithm was used to carry out 
the optimisation (Figure 5-8).  Enzyme concentrations of 9.65 µM Esterase, 0.73 µM 
CAR, 24.75 µM ADH, 0.07 µM PPiase, 0.43 µM PTDH 0.15 µM AK and 0.57 µM 
PAP were identified as the lowest cost pathway capable of achieving 90 % yield in 
four hours. 
To test the optimised pathway, reactions were set up at these concentrations.  Again 
the esterase reaction proceeded at approximately twice the expected rate (Figure 
5-9).  By taking this enhanced rate of esterase activity into account, the model fitted 
the rest of the data well. Alcohol production was slightly slower than expected 
reaching a final yield of only 3,000 µM as opposed to the 3,500 µM predicted by the 
model.  However, the optimised pathway performed significantly better in both 
productivity and cost compared to the non-optimised pathway. 
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Figure 5-8 - Flow diagram for genetic algorithm used to optimise the reaction 
A custom built genetic algorithm was used in the optimisation of a batch reaction, minimising 
total enzyme cost whilst achieving a target yield of 90 % or above.  The flow diagram 
describes the steps the genetic algorithm carries out to reach this goal.
Generate random population of 
400 individuals, each with set of 
enzyme concentration within 
defined bounds:
Est : 5 - 20
CAR : 0.01 - 5
ADH : 5 - 40
PTDH : 0.01 - 5
PPiase : 0.01 - 1
AK : 0.01 - 10
PAP : 0.01 - 10
Simulate each 
individual within the 
population.
Score and rank each individual 
within the population on objective 
function, which is the sum of…
1.  100 x normalised distance to 
target yield.
2.  1 x normalised total cost of 
enzyme
Remove the bottom 
300 of the population.
Add 25 random 
individuals to the 
population.
Generate new “children” 
individuals by mating the 
survivors, applying cross-over 
at random.
Apply mutations to the children 
with an 20 % chance of applying a 
variation of 20 % to each 
characteristic.
After 25 generations, take the 
top individual as optimised.
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Figure 5-9 - Validations of the optimised complete reaction 
A reaction using enzyme concentrations predicted by a genetic algorithm to give the lowest cost reaction, whilst hitting a target of 90 % alcohol 
yield, was performed.  Ester, acid, aldehyde and alcohol concentrations measured every 30 minutes are shown as red circles, blue squares, 
green upwards facing triangles and orange downward facing triangles respectively.  The model prediction is shown as the solid line in the same 
colours.  The original model prediction for the ester is shown in grey.  Dashed lines represent the 5th and 95th percentile of the uncertainty 
analysis.  Reactions were initiated with 9.65 µM afEst2, 0.73 µM mpCAR, 0.07 µM ttPPiase, 0.43 µM PTDH, 0.57 µM tnPAP, 0.15 µM tnAK, 
4,000 µM methyl p-toluate, 500 µM NADPH, 500 µM NADH, 1,250 µM ATP, 20,000 phosphite, 6,000 µM polyphosphate, 20,000 MgCl2
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5.3.15 Sensitivity analysis comparison of the optimised vs non-
optimised pathways 
As well as delivering optimal performance at lowest cost, it is important that industrial 
processes are robust, and not easily affected by issues with a single reagent. 
Therefore, a Sobol sensitivity analysis was carried out on the model for the optimised 
reaction to determine the main sources of the large uncertainty in the final alcohol 
concentration (Nossent, Elsen and Bauwens, 2011) (Figure 5-10).  This revealed 
that the parameters for tnAK had by far the largest impact on the uncertainty in this 
optimised reaction. Other parameters with a substantial contribution included CAR 
inhibition by PPi, the rate of aldehyde degradation and polyphosphate concentration. 
These parameters were very different from those observed in the non-optimised 
reaction (Figure 5-10). This indicated that, whilst the optimisation had been highly 
successful in delivering greater productivity at lower cost, this came at the cost of 
increased sensitivity to some parameters related to individual enzymes.
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Figure 5-10 - Sensitivity analysis of the modelled un-optimised and optimised batch reaction 
The total sensitivity indices (ST) are shown which take into account 1st order and all other interactions.  Sensitivity is in reference to the 
uncertainty in the final p-tolyl alcohol concentration.    Error bars show the 95 % confidence intervals.  The sum of all sensitivity indices should 
equal 1.  Parameters with a ST of less than 0.001 are not shown.  A:  Sensitivity analysis of the un-optimised complete reaction, shown in figure 
6C.  B:  Sensitivity analysis of the optimised complete reaction, shown in Figure 5-9. 
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5.4 Discussion 
5.4.1 Multi-step in vitro biocatalysis 
Isolated enzymes are one of the two main systems for industrial biocatalysis, offering 
several advantages. In particular, they allow reactions to be easily controlled, and so 
optimized quickly and easily (Hold and Panke, 2009; Bujara et al., 2010; Xue and 
Woodley, 2012; du Preez et al., 2015).  We have demonstrated the use of CARs for 
multi-step in vitro biocatalysis, making use of mechanistic modelling to understand 
the dynamics of multiple enzymes working in concert.  The modular nature of these 
models allows a systems biology approach to be taken for the creation of new 
cascades, with the effects of enzyme module addition or removal predictable in silico 
(du Preez et al., 2015). 
A critical paradigm for synthetic biology is that “What I cannot create, I do not 
understand” (Richard Feynman; quote was incorporated into the first chemically 
synthesized genome (Gibson et al., 2010)).  For the synthetic biologist, the building, 
testing and modelling of biological parts is essential to our understanding of biology 
(Benner, Yang and Chen, 2011).  The creation of a mathematical model for this 
seven enzyme in vitro cascade reaction facilitates its understanding.  It acts as a 
summary for all the available process knowledge for the reaction and allows it to be 
exploited for the evaluation of different process options, identification of bottlenecks 
and optimization of the reaction (Woodley, 2013; Ringborg and Woodley, 2016). 
5.4.2 Modelling drives hypothesis generation 
A most significant benefit of mechanistic modelling over a data driven approach is 
the ability of this form of modelling to generate new hypotheses and understanding 
of the system (Vasić-Rački, Findrik and Vrsalović Presečki, 2011). In this pathway, 
modelling was critical in realizing that the buildup of PPi slows the CAR reaction 
significantly. When our model for CAR activity differed from observation, we were 
able to design new experiments to understand why. Product inhibition of CARs was 
discovered and characterized (Finnigan et al., 2016), allowing the problem to be 
solved with the addition of a PPiase enzyme (Teplyakov et al., 1994).  This may not 
have been apparent had data driven modelling been used.  We were then able to 
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test the addition of the PPiase enzyme in silico and model that this restored the 
desired behavior solved the issue before committing to the time consuming process 
of cloning, expressing and characterizing the enzyme for inclusion in the cascade.   
Testing our observations against model predictions revealed some other interesting 
phenomena.  The inclusion of PTDH allowed the CAR reaction to proceed much 
more effectively than the model predicted at low NAPDH concentrations.  More 
detailed modelling would be required to fully understand this; however, this 
observation might be a result of substrate shuttling or channeling between PTDH 
and the reductase domain of the CAR enzyme (Tullman-Ercek, 2015).  It could be 
expected that the local concentration of NADP+ around the CAR enzyme might be 
higher, and that here PTDH would work more efficiently providing a larger local 
supply of NADPH (Zheng et al., 2011).  Possibly PTDH could even localize near the 
CAR for this reason.   Furthermore, the reaction catalyzed by afEst2 appears to 
proceed more quickly when included in the full cascade.  Possibly afEst2 could be 
activated by a compound such as MgCl2, PO3, polyphosphate or NAD(P)H 
(Tomlinson, Mutus and McLennan, 1981), not included during characterization of 
afEst2 or the trial batch reaction (Figure 5-4).  afEst2 is an unusual esterase in that it 
has a Coenzyme A molecule tightly bound near its active site, which could be playing 
a regulatory role, possibly modulated by one of these additional compounds (Sayer 
et al., 2016).  Alternatively substrate shuttling between afEst2 and mpCAR could be 
occurring, resulting in a faster afEst2 catalyzed reaction as the product removed 
more quickly (Tullman-Ercek, 2015). 
5.4.3 The use of CARs in vitro 
CARs have previously been used in whole-cell biocatalysis where ATP and NADPH 
can be regenerated by the host metabolism (Akhtar, Turner and Jones, 2013).  PPi 
inhibition has likely not been identified as a problem for CAR enzymes previously, 
due to the activity of native PPiase enzymes (Kankare et al., 1994).  However while 
the use of whole-cell biocatalysis for CAR reactions has its advantages, the 
optimization of whole-cell systems is challenging, and side reactions can be 
problematic.  For example, native ADH enzymes may cause reduction all the way to 
the alcohol product even when this isn’t desired (France et al., 2016).  The use of a 
CAR as an isolated enzyme allows a more efficient process to be designed, and the 
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inclusion of cofactor regeneration provides an economically competitive alternative to 
whole-cell biocatalysis (Zhao and Van Der Donk, 2003).  Importantly, modelling the 
use of a CAR in vitro has allowed a more thorough understanding of its reaction 
kinetics, useful not only in vitro, but also for informing in vivo design (Rios-Solis et 
al., 2015). 
5.4.4 Modelling NADH and NADPH regeneration 
PTDH accepts two substrates, NAD+ and NADP+, which are competing against each 
other for the enzyme’s active site (Woodyer, Van der Donk and Zhao, 2003).  
Increasing the concentration of one will increase the apparent KM for the other, as 
they are competitive inhibitors of each other (the reaction was modelled as such).  In 
our optimized reaction both NAD+ and NADP+ were set to 500 µM and only PTDH 
concentration optimized.  In this situation NAD+ is regenerated more effectively as 
PTDH has a lower KM and higher kcat for this substrate.  Possibly, the PTDH reaction 
could be optimized further by allowing the ratio of NAD+ : NADP+ to be altered in the 
optimization, such that rates of NADH and NADPH regeneration are balanced to the 
requirements of the reaction.  The reaction might be further improved by considering 
the evidence for substrate shuttling of cofactors between enzymes, possibly allowing 
expensive cofactor concentrations to be reduced significantly (Kragl et al., 1996). 
This would require substantial additional modelling, but would offer considerable 
advantages for in vitro biocatalysis. 
5.4.5 The ATP regeneration system is challenging to model 
AK catalyzes an equilibrium between MgADP + ADP <-> MgATP + AMP.  The free 
magnesium concentration is critical in regulating the position of this equilibrium 
(Blair, 1970).  While adenylate kinase has been shown to follow a random Bi Bi 
mechanism (Sheng, Li and Pan, 1999), in practice this is difficult to implement into a 
mathematical model as free magnesium concentration would also need to be 
modelled.  To further complicate this modelling, polyphosphate strongly chelates 
magnesium ions depending on the concentration and length of the polyphosphate 
chains, both of which can only be estimated (Strauss and Siegel, 1963).  Because of 
these challenges we were forced to only approximate the AK reaction using a bi 
substrate equation (Table 5-1), with high levels of uncertainty associated with each 
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parameter.  Previous work has suggested where the equilibrium constant for this 
reaction might lie, at a range of free magnesium concentrations (Blair, 1970).  These 
values are easily captured within the parameter bounds set for the uncertainty 
analysis of our approximation, indicating that our modelling is biochemically 
reasonable. However, when AK concentrations were optimized, this increased the 
overall uncertainty in the modelling significantly. It may be that the optimization 
strategy should be altered to use more than the minimum levels of enzymes with 
high uncertainties, to increase the robustness of the overall model. 
The reaction catalyzed by PAP is also difficult to model.  Initially it was hoped that 
polyphosphate concentration could be set at a high level such that its effects on 
reaction rate could be ignored.  However, polyphosphate strongly chelates Mg2+, and 
MgCl2 cannot be added at a high concentration due to the inhibitory effects this 
would cause on other enzymes (Strauss and Siegel, 1963).  This limited feasible 
polyphosphate concentrations to approximately 10 mM or less, with the inclusion of 
20 mM MgCl2.  Previous characterization of PAP enzymes is limited, and the 
reaction mechanism unknown (Bonting, Kortstee and Zehnder, 1991; Resnick and 
Zehnder, 2000; Kameda et al., 2001; Itoh and Shiba, 2004; Shiba et al., 2005). PAPs 
are thought to be processive, as tri- or di- phosphates are not accepted by the 
enzyme,  yet these are never detected following a reaction (Kameda et al., 2001).  
Both polyphosphate chain length and concentration affect reaction kinetics, making 
this challenging to model accurately (Shiba et al., 2005).  Because of this we used a 
bi substrate equation to approximate the PAP reaction. We acknowledge that this 
reduces the robustness of the overall model: again, this suggests that an optimized 
pathway might use more than the minimum concentration of this enzyme to mitigate 
this. 
5.4.6 The optimised reaction 
Optimization of the batch reaction used to validate the model demonstrates its 
potential for exploring new process options.  The optimization of the reaction resulted 
in just enough AfEst2 to hydrolyze all the methyl p-toluate in the time available, and 
just enough ApADH to produce 90 % p-tolyl alcohol within 4 hours (Figure 5-9).  In 
contrast, p-toluic acid and p-tolualdehyde concentrations were maintained at a low 
but steady concentration, allowing maximum productivity by all enzymes for the 
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entire reaction.  Enzyme concentrations were minimized and productivity maximized 
successfully.     
5.4.7 Comparing the optimised and un-optimised reactions. 
In comparing the uncertainty in the un-optimized (Figure 5-7C) and optimized (Figure 
5-9) complete reactions, it is clear that uncertainty in the optimized reaction has 
increased significantly.  Minimizing the concentration of all enzymes so that they are 
each close to being rate limiting has likely increased the uncertainty in substrate 
concentrations, as changes in a greater number of parameters can impact on the 
rates.   
The initial reaction still showed reasonably large uncertainty in p-toluic acid and p-
tolualdehyde concentrations. However, these do not translate to a high degree of 
uncertainty in the p-tolyl alcohol concentration.  When p-tolualdehyde concentration 
is high enough (well above its KM for ApADH), the main cause of uncertainty in p-
tolyl alcohol concentration is the rate of the ApADH reaction (primarily adh_kcat_fwd; 
Figure 5-10A).  However, when p-tolualdehyde is maintained at a lower 
concentration (as in the optimized reaction), p-tolualdehyde concentration has a 
greater impact on pathway efficiency.  In this case many of the parameters causing 
uncertainty in p-tolualdehyde concentration are also responsible for the larger 
degree of uncertainty in p-tolyl alcohol concentration, as shown in the sensitivity 
analysis (Figure 5-10B).  If p-tolualdehyde concentration were to be maintained well 
above its KM for apADH, p-tolyl alcohol production should only be sensitive to apADH 
parameters, regardless of uncertainty in the other steps.  However as p-tolualdehyde 
is shown not to be stable in the reaction (Figure 5-5), this compound is best kept at a 
low concentration. 
Future optimization could include an additional objective for the minimization of 
uncertainty in the final p-tolyl alcohol concentration.  This would allow cost to be 
minimized whilst also allowing a robust process to be designed.  However, the 
inclusion of two competing objective functions would make the optimization process 
more complex, likely requiring the generation and manual evaluation of a set of 
Pareto optimal solutions (Deb et al., 2000). 
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5.4.8 Evaluating other potential reaction configurations 
For the use of isolated enzymes to be economical, the reuse of the enzymes for 
multiple reactions should be considered.  The immobilization of enzymes is a 
powerful approach facilitating this (Sheldon and Van Pelt, 2013).  The use of 
membranes with low molecular weight cut-offs can allow an enzyme cocktail to be 
maintained while substrates and products can be easily added and removed.  An 
interesting example might be the use of an enzyme “teabag” (Wachtmeister et al., 
2014).   Diffusion across a membrane could be included in the model to help 
evaluate this option. 
Flow reactors are another popular option, in which immobilized enzymes (such as 
Cross-Linked Enzyme Aggregates - CLEAs (Sheldon, 2011)) are packed into 
reaction channels through which substrates and products flow (Hickey et al., 2007).  
For the construction of multistep reactions, using flow reactor modelling will be 
invaluable in informing the set-up of the reactor, allowing high productivity and 
conversion to be achieved.  A two phase system is another alternative (Woodley and 
Lilly, 1990).  Hydrophobic solvents can be used as a substrate and product sink for 
hydrophobic substrates, allowing high substrate concentrations to be used 
(Domínguez de María and Hollmann, 2015).  Diffusion between the phases could be 
modelled helping inform solvent selection and reaction set up.   
Isolated enzymes are often used as a crude lysate (Tufvesson et al., 2011).  An 
interesting approach for the construction of this multi enzyme reaction might be the 
expression of all seven enzymes in one host organism.  Expression levels could be 
balanced using synthetic biology techniques, for example using characterized 
ribosome binding sites to modulate expression of each enzyme in a single operon.  
The level of expression required could be determined using the model, to design an 
organism with the correct expression levels of each enzyme.  If a thermostable CAR 
enzyme were used, purification by differential thermal denaturation would also be 
possible (Ninh et al., 2015). 
5.4.9 Operational stability 
Data for enzyme degradation under operating conditions could be included in the 
model to allow evaluation of the reaction for extended operation.  This is an 
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important consideration in considering the overall cost and productivity of a reaction 
and could be included in the model (Vasić-Rački, Findrik and Vrsalović Presečki, 
2011).  Enzymes from thermophiles have been used as they are an excellent starting 
point in achieving high operational stability; although mpCAR is the weakest enzyme 
in this respect, it still has a long half-life at 30 °C (Finnigan et al., 2016).  The use of 
enzyme immobilisation or the identification of a more thermostable CAR could 
improve on the operational stability of the whole reaction.  The identification of the 
operational window for the reaction (Figure 5-3), is also an important step in 
designing an optimal reaction with good operational stability (Xue and Woodley, 
2012). 
5.4.10 Conclusions 
Multistep reactions are highly attractive to industry, with enzymes ideally suited for 
these processes given their ability to operate under similar reaction conditions, and 
offering specificity and selectivity in their reactions.  Here, we show that mechanistic 
modelling of a three-step reaction pathway with seven enzymes is not only possible, 
but faithfully predicts experimental results.  Furthermore, we demonstrate that the 
use of a mechanistic model allows bottlenecks and deviations from predicted 
behavior to be identified, providing opportunities to rapidly overcome blockages.  Our 
model allowed optimization of the reaction pathway to provide higher throughput at 
lower cost, highlighting the potential for application to industry. 
By using good modelling practice and considering the uncertainty of each step in the 
pathway (Sin, Gernaey and Lantz, 2009), we show which steps and parameters are 
of greatest importance to the reaction, guiding improvements to reaction robustness.  
Uncertainty analysis also facilitated the use of approximations where reactions were 
too prohibitively complex to model entirely faithfully, with the error associated with 
these approximations captured in the uncertainty and sensitivity analysis. 
Our model reaction is highly adaptable to a wide range of reactions, as the central 
CAR model is ideal for linking together pharmaceutically important chemical 
pathways.  An enzyme toolbox featuring well characterized enzyme parts and 
covering a network of reactions will drive multi-step biocatalysis process 
development forward.  The construction of models for enzymes in the toolbox allows 
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novel multi-step reactions to be quickly tested in silico, with the construction of a 
model early in the development process an invaluable asset.   
A parallel with the design, model, build and test cycle of synthetic biology may be 
drawn for the process of model construction, and the use of validated parts for the 
construction of future reactions both in vitro and in vivo.  The process of building and 
testing a model can drive hypothesis generation, and can be an invaluable exercise 
in developing a new process. 
5.5 Methods 
5.5.1 Materials and plasmids 
All chemicals were purchased from Sigma-Aldrich (Gillingham, UK), and were of the 
highest purity available.  Plasmid details are available as supplementary file 2. 
5.5.2 Enzyme preparation 
Genes for the expression of mpCAR, PTDH, tnAK, tnPAP, and ttPPiase were cloned 
into the NcoI and HindIII sites of pNIC28-Bsa4(Hansch et al., 1977).  The native 
ApADH gene sequence was cloned previously into pET-30 Xa/LIC (Hickey, 2008).  
The gene for mpCAR was obtained by PCR from genomic DNA; all others were 
codon optimized for E. coli and gene synthesized by IDT.  All contained a N-terminal 
6x histidine tag (Hansch et al., 1977).  Vectors were transformed into BL21 (DE3) E. 
coli for expression.  mpCAR was co-transformed with a pCDF-Duet1 vector 
containing a phosphopantetheine transferase from Bacillus subtilis.  A pET24-d 
plasmid containing afEst2 transformed into the E. coli strain BL21-CodonPlus (DE3)-
RIPL (Agilent) has been described previously (Sayer et al., 2016).  Expression was 
carried out in LB media with the addition of 50 µg/µl of appropriate antibiotics.   
Cells were grown to approximately 0.6 OD600nm at 37 °C with shaking at 225 rpm, at 
which point IPTG was added to a concentration of 100 µM.  Temperature was 
dropped to 20 °C for protein expression overnight, except in the case of afEst2 
where temperature was dropped to 30 oC.  Cells were harvested by centrifuging and 
re-suspended in 25 mM Tris-HCl pH 8.0, 0.5 M NaCl2.  
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Cell lysate was prepared by sonication on ice and clarified by centrifugation at 
20,000g at 4 °C.  Enzymes were purified from the cell lysate using a 1 ml His-Trap 
FF crude column (GE Healthcare) using an elution gradient from 10 to 250 mM 
imidazole in 25 mM Tris-HCl pH 8.0, 0.5 M NaCl.  The purified sample was then 
applied to a Superdex 200 HiLoad 16/60 size exclusion column (GE Healthcare) and 
eluted in 25 mM HEPES pH 7.5, 0.1 M NaCl at 1.0 ml/min.  Eluted fractions were 
analyzed by SDS-PAGE before being pooled and concentrated to between 1 and 8 
mg/ml.  To calculate protein concentration from OD280nm, an extinction coefficient and 
molecular weight for each enzyme was calculated using the ExPaSy ProtParam tool.  
Single use aliquots of protein were stored at -80 oC. 
5.5.3 Enzyme assays 
Unless otherwise stated, all reaction were performed in triplicate in a 96-well 
microtitre plate using a Tecan M200 Infinite plate reader.  All assays were carried out 
in a standard reaction buffer consisting of 100 mM Tris-HCl at pH 7.5, titrated to the 
correct pH whilst at 30 oC. 
5.5.4 Buffers for pH vs activity assays 
Buffers to measure activity across a range of pH values were prepared at 0.2 pH unit 
intervals at assay temperature. Buffers used were 50 mM citrate between pH 4.0 and 
5.8, 50 mM MES between pH 5.8 and 6.6, 50 mM PIPES between pH 6.4 and 7.4, 
50 mM MOPS between pH 6.8 and 7.8, 50 mM HEPES between pH 7.0 and 8.0, 50 
mM Tris between pH 7.8 and 9.0, and boric acid between pH 8.8 and 10.  HCl or 
NaOH was used to titrate the buffers to the correct pH as appropriate.  In some 
cases data were adapted from previous work as indicated in the relevant sections.   
5.5.5 Thermostability assays 
Thermostability was measured by heating enzyme samples for half an hour using the 
temperature gradient of a Bio-Rad thermocycler between 30 and 90 oC (or less 
where appropriate) before cooling on ice.  Activity was then measured using specific 
enzyme assays relative to a control sample kept on ice.  In some cases data were 
adapted from previous work as indicated in the relevant sections. 
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5.5.6 CAR assays 
To determine the two substrate kinetics of mpCAR with ATP and p-toluic acid, 
reactions were set up containing 11 µg / ml mpCAR enzyme, 0.25 mM NADPH, 10 
mM MgCl2, with a range of ATP and p-toluic acid concentrations.  The oxidation of 
NADPH was used to monitor reactions by measuring absorbance of NADPH at 
OD340 nm; production of aldehyde, measured by HPLC, correlates tightly with the 
NADPH oxidation (Finnigan et al., 2016). Reactions were carried out for 10 minutes 
after a 5 minute pre-incubation at 30 oC.  The appropriate equation was determined 
by fitting the initial rates of reaction at eight ATP concentrations around the expected 
KM including a blank, each at five p-toluic acid concentrations around its expected 
KM.  Data were fit by least squares non-linear regression using GraphPad Prism 5.0, 
and possible reaction mechanisms compared for goodness of fit.  A KM for NADPH 
was determined by setting up reactions containing 10 µg / ml mpCAR enzyme, 10 
mM MgCl2, 1 mM ATP, 10 mM p-toluic acid and a range of eight NADPH 
concentrations around its expected KM, after confirming NADPH concentration at 
OD340 nm.  Other characterization was carried out previously (Finnigan et al., 2016). 
5.5.7 ADH assays 
To determine kinetic parameters for apADH, assays were carried out in sealed PCR 
tubes using a Bio-Rad thermocycler.  After 15 to 30 minutes reactions were 
quenched by transfer into a 96-well microtitre plate containing 5 mM NaOH.  
Increase or decrease in NADH concentration was measured at OD340nm to determine 
activity, relative to a blank reaction.  Reactions to measure activity in the reductive 
direction were set up containing either 0.5 mM NADH or 10 mM p-tolualdehyde.  
Conversely, reactions to measure activity in the oxidative direction were set up 
containing either 2.5 mM NAD+ or 100 mM p-tolualdehyde.  In each case a range of 
concentrations were used for the other respective substrate around its expected KM, 
including a blank.  p-tolylaldehyde kinetics were measured at 30 oC in standard 
reaction buffer using 166.7 µg / ml apADH.  NAD+, NADH and p-tolyl alcohol kinetics 
were carried out at 70 oC in 100 mM Tris-HCl titrated to pH 7.5 at 70 oC, using 40 µg 
/ ml apADH.  Only KM constants were taken from data at 70 oC.  Data were fit by 
least squares non-linear regression using GraphPad Prism 5.0.  Data for the effects 
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of pH and temperature were adapted from previous work (Hirakawa, Kamiya and 
Kawarabayashi, 2004).     
5.5.8 PTDH assays 
To determine kinetic parameters for PTDH, assays were set up containing 20 mM 
Na2HPO3, 2.8 µg / ml PTDH, and a range of NAD+ or NADP+ concentrations around 
the expected KM.  The production of NADH or NADPH was monitored at OD340nm and 
data were fit by least squares non-linear regression using GraphPad Prism 5.0.  The 
thermostability of a sample containing 18 µg / ml PTDH was measured as described 
previously.  Activity at various pH values was determined using a range of buffers 
described previously, in place of the standard reaction buffer. 
5.5.9 PPIase 
PPiase activity was measured using the production of phosphomolybdate to 
measure phosphate content, as described (Heinonen and Lahti, 1981).  Using a 
standard curve, the rate of phosphate production by ttPPiase was determined using 
a high (5 mM) concentration of PPi in the presence of 10 mM MgCl2, in standard 
reaction buffer.  Five measurements were taken in triplicate over 20 minutes.  A 
conservative KM was estimated from the BRENDA database (Schomburg et al., 
2013) and the rate of PPi hydrolysis used to calculate kcat.   
Activity at pH was determined using the same phosphomolybdate method with 
reaction buffers covering a range of pH values, detailed previously.  The 
thermostability of a sample containing 0.44 µg / ml ttPPiase was measured as 
described previously, with the assay above used with readings at time points 0 and 
20 minutes taken.  10 mM MgCl2 was included in the heated sample. 
5.5.10 PAP assays 
ADP formation was measured using an ADP-Glo kinase assay kit (Promega) in a 
384-well solid white microtitre plate (Corning, 3572) following manufacturer’s 
instructions.  Assays were carried out in standard reaction buffer containing 20 or 40 
mM MgCl2, 12.5 mM polyphosphate, 3.25 mM AMP, 12.5 µg / ml or 125 µg / ml of 
tnPAP enzyme.  Reactions were carried out for 15 minutes before quenching with 
the ADP-Glo kit.  A range of polyphosphate, AMP and MgCl2 concentrations around 
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an expected KM were assayed in turn.  ADP production was calculated from a 
standard curve, and the data fit by least squares non-linear regression using 
GraphPad Prism 5.0.  Specific assay conditions are shown in Table 5-2 - 
Supplementary Figure 16 –Table 5-2 - Supplementary Figure 20.  Activity at pH was 
measured using a range of buffers described previously in place of the standard 
reaction buffer.  Thermostability was determined as described previously, using the 
ADP-Glo assay to measure residual relative activity. 
5.5.11 Mathematical modelling 
Mathematical modelling was carried out in Python 3.4 using the SciPy and SALib 
modules.  Outputs were exported to GraphPad Prism 5.0 for plotting.  The 
integrate.odeint function in SciPy was used to solve ordinary differential equations.   
Uncertainty analysis was carried out making use of the SALib module.  Input bounds 
for each parameter were defined as either the calculated 95 % confidence intervals, 
or where uncertainty was judged to be high by 25 or 50 % of the parameter value, as 
shown in Table 5-2.  Sampling of the possible inputs within these bounds was 
carried out by Latin hypercube sampling of 1,000 samples, with the model for each 
sample run.  At each time point the mean, 5th and 95th percentile of each substrate 
concentration was plotted to represent the uncertainty of the model.   
The method of Sobol was used for sensitivity analysis as part of the SALib module.  
Second order effects were not calculated, and the total sensitivity indices plotted to 
show the sensitivity of each parameter.  The sample number was set at 1,000.  
5.5.12 Optimisation using a genetic algorithm 
A custom built, single objective genetic algorithm was used to minimize enzyme cost, 
on the condition over 90 % alcohol yield was reached.  A general outline of the 
algorithm is shown in Figure 5-8, and the script is provided as a Supplementary File. 
5.5.13 Model validation reactions 
Standard curves of methyl p-toluate, p-toluic acid, p-tolylaldehyde and p-tolyl alcohol 
were prepared and analyzed by HPLC.  500 µl reactions were set up in triplicate in 
1.5 ml microcentrifuge tubes, and incubated in a thermoshaker at 30 oC with 500 rpm 
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shaking.  50 µl samples were taken every 30 minutes into 50 µl acetonitrile and 
centrifuged for 10 minutes.  Supernatant was removed and stored at 4 oC until 
analyzed by HPLC. 
5.5.14 HPLC 
An Eclipse Plus C18 column with a particle size of 3.5 µm, measuring 4.6 x 100 mm, 
was used.  The column was run at 60 oC on the following method using two buffers, 
buffer A: 95 % H2O, 5 % (v/v) acetonitrile, 0.1 % (v/v) trifluoroacetic acid, and buffer 
B: 5 % H20, 95 (v/v) % acetonitrile, 0.1 % (v/v) trifluoroacetic acid.  3 µl of sample 
was injected and eluted on a gradient from 0 to 100 % buffer B over 10 minutes.  
Buffer B was maintained at 100 % for a further 2 minutes before the column was re-
equilibrated with buffer A for 2 minutes before the next run.  
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5.6 Supplementary Figures 
 
 
Figure 5-2 - Supplementary Figure 1 - SDS-PAGE analysis of the AF-Est2 protein 
purification 
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate.  HT: Soluble lysate 
heat treated at 70 oC for 30 minutes before removal of precipitated proteins by 
centrifugation.  FT:  The flow through after loading the heat treated sample onto the nickel 
column.  B11-B5:  Fractions collected from the gel filtration column believed to be the 
purified AF-Est2 protein with an expected MW of 29kDa.   
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Figure 5-2 - Supplementary Figure 2 - SDS-PAGE analysis of the mpCAR protein 
purification.    
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate. Ni F/T:  The flow 
through after loading the sample onto the nickel column. Ni Elu:  Purified protein after the 
nickel purification step.  E4-E11:  Fractions collected from the gel filtration column believed 
to be the purified mpCAR protein with an expected MW of 128kDa  Fractions E9 – E11 
contained another unknown protein at approximately 60kDa.  These fractions were not 
pooled with the remaining fractions. 
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Figure 5-2 - Supplementary Figure 3 - SDS-PAGE analysis of the ApADH protein 
purification.   
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate.  HT: Soluble lysate 
heat treated at 70oC for 30 minutes before removal of precipitated proteins by centrifugation.  
FT:  The flow through after loading the heat treated sample onto the nickel column.  A2-A7:  
Fractions collected from the gel filtration column believed to be the purified ApADH protein 
with an expected MW of 41 kDa. 
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Figure 5-2 - Supplementary Figure 4 - SDS-PAGE analysis of the PTDH protein 
purification.   
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate. FT:  The flow 
through after loading the sample onto the nickel column.  A10-B9:  Fractions collected from 
the gel filtration column believed to be the purified PTDH protein with an expected MW of 
38.7 kDa.  Very little protein was detected by SDS-PAGE in lanes A11, A112, B11 and B10, 
however there was likely a problem in running in the gel as there was an unavoidable delay 
between preparing the samples and running them.  Samples at the extremes of the collected 
peak show pure protein so the entire peak was used. 
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Figure 5-2 - Supplementary Figure 5 - SDS-PAGE analysis of the ttPpiase protein 
purification.  
Ni F/T:  The flow through after loading the heat treated sample onto the nickel column.  C7-
D11:  Fractions collected from the gel filtration column believed to be the purified ttPpiase 
protein with an expected MW of 21.8kDa.   
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Figure 5-2 - Supplementary Figure 6 - SDS-PAGE analysis of the tnPAP protein 
purification.   
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate.  Ni F/T:  The flow 
through after loading the sample onto the nickel column.  A2-A10:  Fractions collected from 
the gel filtration column believed to be the purified tnPAP protein with an expected MW of 
61.1 kDa. 
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Figure 5-2 - Supplementary Figure 7 - SDS-PAGE analysis of the tnAK protein 
purification.   
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate.  Ni F/T:  The flow 
through after loading the sample onto the nickel column.  C3-D12:  Fractions collected from 
the gel filtration column believed to be the purified tnPPT protein with an expected MW of 
27.6 kDa. 
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Figure 5-2 - Supplementary Figure 8 - SDS-PAGE analysis of the tePPK protein 
purification.   
Sol: Soluble fraction of cell lysate.  Insol: Insoluble fraction of cell lysate.  Ni F/T:  The flow 
through after loading the sample onto the nickel column.  B7-B2:  Fractions collected from 
the gel filtration column believed to be the purified tePPK protein with an expected MW of 
87.5 kDa. 
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Figure 5-1 - Supplementary Figure 1 - Differential equations for modelling 
 
 
 
afEst2 !"#$%&'!( = −+1  !"-./0!( = +1  
 
mpCAR !"-./0!( = −+2  !"-23!( = −+2  !"4-536!( = −+2  !"-70&890&!( = +2  !"3:/!( = +2  !"-;3!( = +2  !"4-53<!( = +2  
 
mpCAR-ttPPiase !"-./0!( = −+2  !"-23!( = −+2  !"4-536!( = −+2  !"-70&890&!( = +2 − +11  !"3:/!( = +2 − +7   !"-;3!( = +2  !"4-53<!( = +2  
 
mpCAR-ttPPiase-PTDH !"-./0!( = −+2  !"-23!( = −+2  !"4-536!( = −+2 + +5  !"-70&890&!( = +2 − +11  !"3:/!( = +2 − +7   !"-;3!( = +2  !"4-53<!( = +2 − +5  !"3@A!( = −+5  !"3@B!( = −+5  
 
mpCAR-ttPPiase-PTDH-tnAK-tnPAP !"-./0!( = −+2  !"-23!( = −+2 + +9 − +10  !"4-536!( = −+2 + +5  !"-70&890&!( = +2 − +11  !"3:/!( = +2 − +7   !"-;3!( = +2 − +8 + +9 − +10  !"4-53<!( = +2 − +5  !"3@A!( = −+5  !"3@B!( = +5  !"3F793!( = −+8  !"-53!( = +8 − +9 + +10  
 
apADH !"-70&890&!( = −+3 + +4 − +11  !"-7.F8F7!( = +3 − +4  !"4-56!( = −+3 + +4  !"4-5<!( = +3 − +4  
	
 
apADH-PTDH !"-70&890&!( = −+3 + +4 − +11  !"-7.F8F7!( = +3 − +4  !"4-56!( = −+3 + +4 + +6  !"4-5<!( = +3 − +4 − +6  !"3@A!( = −+6  !"3@B!( = ++6  
 
afEst2-mpCAR-ttPPiase-PTDH-tnAK-tnPAP !"#$%&'!( = −+1  !"-./0!( = +1 − +2  !"-23!( = −+2 + +9 − +10  !"4-536!( = −+2 + +5  !"-70&890&!( = +2 − +11  !"3:/!( = +2 − +7   !"-;3!( = +2 − +8 + +9 − +10  !"4-53<!( = +2 − +5  !"3@A!( = −+5  !"3@B!( = +5  !"3F793!( = −+8  !"-53!( = +8 − +9 + +10  
 
mpCAR-ttPPiase-PTDH-tnAK-tnPAP-apADH !"-./0!( = −+2  !"-23!( = −+2 + +9 − +10  !"4-536!( = −+2 + +5  !"-70&890&!( = +2 − +11 − +3 + +4  !"3:/!( = +2 − +7   !"-;3!( = +2 − +8 + +9 − +10  !"4-53<!( = +2 − +5  !"3@A
 ( = −+5 − +6  !"3@B!( = +5 + +6  !"3F793!( = −+8  !"-53!( = +8 − +9 + +10  !"-7.F8F7!( = +3 − +4  !"4-56!( = −+3 + +4 + +6  !"4-5<!( = +3 − +4 − +6  
 
afEst2-mpCAR-ttPPiase-PTDH-tnAK-tnPAP-apADH !"#$%&'!( = −+1  !"-./0!( = +1 − +2  !"-23!( = −+2 + +9 − +10  !"4-536!( = −+2 + +5  !"-70&890&!( = +2 − +11 − +3 + +4  !"3:/!( = +2 − +7   !"-;3!( = +2 − +8 + +9 − +10  !"4-53<!( = +2 − +5  !"3@A!( = −+5 − +6  !"3@B!( = +5 + +6  !"3F793!( = −+8  !"-53!( = +8 − +9 + +10  !"-7.F8F7!( = +3 − +4  
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Figure 5-2 - Supplementary Figure 9 – Preliminary data on two PAP enzymes.   
A preliminary experiment to determine presence of PAP activity, and which enzyme was 
most promising.  ADP produced in 15 minutes divided by µg / ml enzyme used in the assay 
for comparison.  The preliminary assay contained 5 mM MgCl2, 1 mM AMP and 2.5 mM 
polyphosphate. 
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Figure 5-3 - Supplementary Figure 1 – PTDH activity at pH 
Activity of PTDH at various pH values, relative to the maximum activity detected.  Various 
buffers were used to cover the range of pH values as indicated.   
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Figure 5-3 - Supplementary Figure 2 – PTDH thermostability and temperature vs 
activity 
Red circles show PTDH activity at temperature, relative to the maximum activity at 51.4 oC.  
Blue circles show residual activity after incubating PTDH at various temperatures for 30 
minutes, relative to a control kept on ice. 
 
 
 
20 30 40 50 60 70 80
0
20
40
60
80
100
120
Temperature oC
R
el
at
iv
e 
ac
tiv
ity
 %
Temperature vs Activity
Thermostability
	252	
 
Figure 5-3 - Supplementary Figure 3 – tnPAP activity at pH 
Activity of tnPAP at various pH values, relative to the maximum activity detected.  Various 
buffers were used to cover the range of pH values as indicated.   
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Figure 5-3 - Supplementary Figure 4 – tnPAP thermostability 
Residual activity after incubating tnPAP at various temperatures for 30 minutes, relative to a 
control kept on ice. 
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Figure 5-3 - Supplementary Figure 5 – ttPPiase activity at pH 
Activity of ttPPiase at various pH values, relative to the maximum activity detected.  Various 
buffers were used to cover the range of pH values as indicated.   
 
 
 
 
 
2 3 4 5 6 7 8 9 10 11 12
0
20
40
60
80
100
120
pH
R
el
at
iv
e 
ac
tiv
ity
 %
MES
MOPS
Tris
HEPES
Boric acid
	 255	
 
Figure 5-3 - Supplementary Figure 6 - ttPPiase thermostability 
Residual activity after incubating ttPPiase at various temperatures for 30 minutes, relative to 
a control kept on ice. 
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Table 5-2 - Supplementary Figure 1 - The kinetics of mpCAR with varying 
concentrations of ATP and p-toluic acid.   
Data fit best to the equation for a steady-state sequential reaction.   
 
Table 5-2 - Supplementary Figure 2 – 
Parameters calculated fitting kinetics of 
mpCAR with varying concentrations of ATP 
and p-toluic acid to a sequential steady state 
equation. 
! = #$%& ∙ [)]∙[+](-./∙-01)3(-0/ ∙[+])3(-01∙[)])3([)]∙[+])  
 
Best-fit values  
VMAX (µmol / min / mg) 1.5 
KI ATP (µM) 50 
KM Acid (µM) 1500 
KM ATP (µM) 100 
Std. Error  
VMAX (µmol / min / mg) 0.07 
KI ATP (µM) 20 
KM Acid (µM) 200 
KM ATP (µM) 10 
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Table 5-2 - Supplementary Figure 3 – The kinetics of mpCAR with varying 
concentrations NADPH. 
Data have been fit to the Michaelis-Menten equation. 
 
Table 5-2 - Supplementary Figure 4 
-Parameters calculated fitting 
kinetics of mpCAR with varying 
concentrations of NADPH to the 
Michaelis-Menten equation. 
Best-fit values 
VMAX (µmol / min / mg) 0.35 
KM NADPH (µM) 30 
Std. Error  
VMAX (µmol / min / mg) 0.01 
KM NADPH (µM) 4 
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Table 5-2 - Supplementary Figure 5 - The kinetics of apADH in the reductive direction 
at 30 oC, pH 7.5  with varying concentrations of p-tolualdehyde.   
Two experiments were carried out shown as triangles and circles, with the data combined for 
fitting to the Michaelis-Menten equation. 
 
Table 5-2 - Supplementary Figure 6 - 
Parameters calculated fitting kinetics of 
apADH in the reductive direction at 30 oC, 
pH 7.5, with varying concentrations of p-
tolualdehyde to the Michaelis-Menten 
equation. 
Best-fit values 
VMAX (µmol / min / mg) 0.041 
KM p-tolualdehyde (µM) 350 
Std. Error 
VMAX (µmol / min / mg) 0.002 
KM p-tolualdehyde (µM) 60 
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Table 5-2 - Supplementary Figure 7 - The kinetics of apADH in the reductive direction 
at 70 oC, pH 7.5 with varying concentrations of NADH. 
Data have been fit to the Michaelis-Menten equation. 
 
Table 5-2 - Supplementary Figure 8 - 
Parameters calculated fitting kinetics of 
apADH in the reductive direction at 70 oC, 
pH 7.5, with varying concentrations of 
NADH, to the Michaelis-Menten equation. 
Only KM used in this work. 
Best-fit values 
VMAX (µmol / min / mg) 0.68 
KM NADH (µM) 180 
Std. Error 
VMAX (µmol / min / mg) 0.04 
KM NADH (µM) 30 
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Table 5-2 - Supplementary Figure 9 - The kinetics of apADH in the oxidative direction 
at 70 oC, pH 7.5 with varying concentrations of NAD+. 
Data have been fit to the Michaelis-Menten equation. 
 
Table 5-2 - Supplementary Figure 10 - 
Parameters calculated fitting kinetics of 
apADH in the oxidative direction at 70 oC, 
pH 7.5, with varying concentrations of 
NAD+, to the Michaelis-Menten equation. 
Only KM used in this work. 
Best-fit values 
VMAX (µmol / min / mg) 0.50 
KM NAD+ (µM) 195 
Std. Error  
VMAX (µmol / min / mg) 0.01 
KM NAD+ (µM) 16 
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Table 5-2 - Supplementary Figure 11 - The kinetics of apADH in the oxidative direction 
at 70 oC, pH 7.5 with varying concentrations of p-tolyl alcohol. 
Data fit to the Michaelis-Menten equation 
Table 5-2 - Supplementary Figure 12 - Parameters 
calculated fitting kinetics of apADH in the 
oxidative direction at 70 oC, pH 7.5, with varying 
concentrations of NAD+, to the Michaelis-Menten 
equation. 
As substrate concentration could not be taken high 
enough to calculate an accurate KM or VMAX this data 
was not used.  An approximate KM of 100 mM was 
used and kcat in the oxidative direction assumed to 
be approximately equal to the forward.   
Best-fit values 
VMAX (µmol / min / mg) 0.80 
KM p-tolyl alcohol (mM) 90 
Std. Error 
VMAX (µmol / min / mg) 0.06 
KM p-tolyl alcohol (mM) 15 
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Table 5-2 - Supplementary Figure 13 – The kinetics of PTDH with varying 
concentrations of NADP+ and NAD+. 
Data fit to the Michaelis-Menten equation 
Table 5-2 - Supplementary Figure 14 - Parameters calculated 
fitting kinetics of PTDH with varying concentrations of 
NADP+ and NAD+ to the Michaelis-Menten equation. 
Best-fit values NADP+ NAD+ 
VMAX (µmol / min / mg) 8.3 16.4 
KM NAD(P)+(mM) 180 85 
Std. Error 
VMAX (µmol / min / mg) 0.2 0.2 
KM p-tolyl alcohol (mM) 20 5 
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Table 5-2 - Supplementary Figure 15 – Determining kcat  for ttPPiase 
A:  A standard curve of phosphate concentration vs OD 335 nm was determined for the 
assay. 
B:  The rate of phosphate production was determined (green circles), along with a blank rate 
(blue circles).  Rate of blank subtracted phosphate production was calculated from the 
standard curve, from which kcat was calculated.   
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Table 5-2 - Supplementary Figure 16 – The kinetics of tnPAP with varying 
concentrations of AMP 
Data fit to the Michaelis-Menten equation 
Table 5-2 - Supplementary Figure 17 - 
Parameters calculated fitting kinetics 
of tnPAP with varying concentrations 
of AMP  to the Michaelis-Menten 
equation. 
Best-fit values 
VMAX (µmol / min / mg) 0.39 
KM AMP (mM) 0.28 
Std. Error 
VMAX (µmol / min / mg) 0.03 
KM AMP (mM) 0.05 
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Table 5-2 - Supplementary Figure 18 - The kinetics of tnPAP with varying 
concentrations of Polyphosphate (PolyP) 
Data fit to the Michaelis-Menten equation 
Table 5-2 - Supplementary Figure 
19 - Parameters calculated fitting 
kinetics of tnPAP with varying 
concentrations of polyphosphate 
to the Michaelis-Menten 
equation. 
Best-fit values  
Vmax 3.781 
Km 4.004 
Std. Error  
Vmax 0.3454 
Km 0.6808 
0 2 4 6 8
0.0
0.5
1.0
1.5
2.0
2.5
PolyP mM
µm
ol
 / 
m
in
 / 
m
g
20 mM MgCl, 
3.25 mM AMP, 
5 µg enzyme 
40 µl reaction vol
	266	
 
 
Table 5-2 - Supplementary Figure 20 - The kinetics of tnPAP with varying 
concentrations of MgCl 
Data fit to the Michaelis-Menten equation with substrate inhibition 
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Table 5-2 - Supplementary Figure 21 – tnAK – CAR coupled assay to estimate kcat 
tnAK was coupled to a CAR enzyme in order to estimate its kcat in the ADP to ATP direction.  
The rate obtained was significantly slower than previously reported.  The kcat for the reverse 
reaction was adjusted relative.  Red circles show the blank rate, blue squares show the rate 
with tnAK. 
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Figure 5-6 - Supplementary Figure 1 – Sensitivity analysis of apADH and apADH-PTDH 
modelled reactions.   
The total sensitivity indices (ST) are shown which take into account 1st order and all other 
interactions.  Sensitivity is in reference to the uncertainty in the final p-tolyl alcohol 
concentration.  Error bars show the 95 % confidence intervals.  The sum of all sensitivity 
indices’ should equal 1.  
A:  Sensitivity analysis of apADH only reaction, figure 6A. 
B:  Sensitivity analysis of the apADH-PTDH reaction, figure 6B. 
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Chapter 6 - Thermus thermophilus as a 
host organism for whole-cell 
biocatalysis  
	270	
6.1 Introduction 
6.1.1 Thermus thermophilus as a host organism for whole-cell 
biocatalysis 
6.1.1.1 Whole-cell biocatalysis using a thermophile as a host organism 
Whole-cell biocatalysis offers a number of attractive benefits such as cofactor 
regeneration from the host metabolism, improved stability of enzymes inside the cell 
and no need for enzyme isolation.  It can be particularly attractive for multi-step 
processes where multiple enzymes can be expressed in a single host organism, 
although these reactions are challenging to optimize (Ladkau, Schmid and Bühler, 
2014).  
Whole-cell biocatalysis using thermophiles as host organisms is a largely 
undeveloped area, with the potential to allow processes to be run at elevated 
temperatures (Taylor et al., 2011).  Elevated temperatures give a lower risk of 
contamination, potential for the recovery of volatile products, allows higher mass 
transfer rates with improved solubility of some substrates and can allow integration 
with chemical processes that require such temperatures (Frock and Kelly, 2012).   
6.1.1.2 T. thermophilus as an attractive host organism for whole-cell 
biocatalysis 
T. thermophilus makes an excellent candidate for development as a host organism 
for thermophilic whole-cell biocatalysis.  T. thermophilus is established as a model 
organism for the study of life at high temperatures (Cava, Hidalgo and Berenguer, 
2009), has fast growth rates on complex media (Koyama et al., 1986), and is 
naturally competent allowing easy transformation (Averhoff, 2009).  This ease of 
transformation has allowed the development of a number of genetic tools (Averhoff, 
2006).  T. thermophilus is a thermophilic, Gram-negative, bacterium with an optimum 
growth temperature of 70 oC (Cava, Hidalgo and Berenguer, 2009), although it can 
grow between 50 and 85 oC (Sakaki and Oshima, 1975). 
T. thermophilus HB27 is the strain most commonly investigated, as it demonstrates a 
higher transformation efficiency than other strains such as HB8, and maintains less 
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native plasmids.  This difference in transformation efficiency is thought to be related 
to a less efficient modification-restriction barrier (Cava, Hidalgo and Berenguer, 
2009).  The genome sequence is also available for this strain (Henne et al., 2004) 
and a structural genomics study has been carried out (Yokoyama et al., 2000). 
6.1.1.3 T. thermophilus in the tree of life 
T. thermophilus belongs to the phylum Thermi (Langille et al., 2013) (also known as 
Deinococcus-Thermus) which contains two distinct orders:  the Deinococcales 
containing several species which are resistant to radiation, and the Thermales which 
contain many genera resistant to heat.  T. thermophilus belongs to this latter order.  
While members of these two orders have evolved from a common ancestor and are 
both adapted to life in extreme environments, their mechanisms of resistance are 
thought to be largely independent (Omelchenko et al., 2005). 
6.1.1.4 Natural competence by T. thermophilus 
T. thermophilus is one of the few bacteria to possess natural competence over all 
stages of its growth and not to require any sort of stimulus to induce competence.  
This is due to the presence of a macromolecular DNA translocator assembly which 
mediates the entry of foreign DNA past the cell envelope into the cell (Averhoff, 
2009).  The ease with which T. thermophilus can be transformed has played a major 
role in its development as a model thermophilic organism (Cava, Hidalgo and 
Berenguer, 2009). 
A model for this DNA translocation process has been developed as detailed in 
Figure 6-5 (Averhoff, 2009).  Initially DNA is thought to bind to unknown DNA binding 
proteins on the cell surface or to proteins associated with a DNA translocator 
structure made up of pilin-like proteins.  DNA is transported through or along a DNA 
transformation shaft made up of pilin PilA4 and some other minor pilin-like proteins 
such as PilA1, PilA2 and PilA3.  PilQ proteins are thought to form a ring like structure 
and guide DNA translocator through the cell envelope.  PilF, a putative DNA traffic 
NTPase, is thought to power DNA transport through the ring structure, and is 
possibly involved in the retraction of the DNA translocator.  Once in the periplasmic 
space it is suggested that the DNA binds to the putative binding protein ComEA, 
which delivers the DNA to the inner membrane DNA transport complex.  DNA is 
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thought to be transported through an inner membrane channel generated by 
ComEC, an inner membrane protein (Averhoff, 2004, 2006).   
 
 
Figure 6-1 – A model of the DNA transporter of T. thermophilus 
DNA is transported along the DNA transformation shaft made up primarily of PilA4 and other 
pilin like proteins PilA1 to A3, guided through the outer membrane by the secretin ring (PilQ).  
Retraction of the DNA transformation shaft is powered by an ATPase PilF, which mediates 
transport into the periplasmic space.  DNA then binds to a receptor protein ComEA where it 
is then delivered to an inner membrane channel thought to be made up by ComEC.  Other 
proteins PilM, PilN, PilO and PilW are associated with the DNA transporter complex.  OM:  
Outer membrane, SCWPs: secondary cell wall polymers, PG: peptidoglycan, CM: 
cytoplasmic membrane.  The figure is adapted and redrawn from (Averhoff, 2009). 
 
6.1.1.5 Development of T. thermophilus as a host organism for whole-cell 
biocatalysis 
In order to develop and use T. thermophilus as a host organism for whole-cell 
biocatalysis, well defined synthetic biology parts are crucial (Rollié, Mangold and 
Sundmacher, 2012).  While a number of vectors have been developed for T. 
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thermophilus, often these possess limited multiple cloning sites (MCSs) or large 
areas of apparently unrequired DNA.  By identifying established vector parts, these 
can be combined for the creation of more efficient, well-designed vectors which 
facilitate standardized cloning approaches (Heinemann and Panke, 2006).  Other 
well characterized parts such as promoters are also essential to facilitate a synthetic 
biology approach for the expression of biocatalytic pathways in T. thermophilus 
(Figure 6-2) (Rollié, Mangold and Sundmacher, 2012). 
 
 
Figure 6-2 – Well defined parts are essential for the development of T. thermophilus 
as a host organism for whole-cell biocatalysis. 
Defined and characterized parts that can be combined in a predictable way must be 
developed for T. thermophilus to be attractive for whole-cell biocatalysis.  Regions of 
replication (Rep – yellow), selection markers (purple), multiple cloning sites (MCS – teal), 
coding sequences (CDS – green), ribosome binding sites (RBS – red) and promoters (blue) 
are all important for the construction of new pathways in T. thermophilus. 
6.1.2 Vectors for T. thermophilus 
6.1.2.1 Established vectors 
A number of vectors have been established for T. thermophilus by altering cryptic 
plasmids with the addition of thermostable antibiotic resistance cassettes, MCSs, 
and regions of replication for E. coli.  A good example and one of most commonly 
used or built upon vectors is pMK18. This consists of a fused region of replication 
from a cryptic plasmid of Thermus sp. ATCC27737, a thermostable kanamycin 
resistance cassette, and a replicative origin and MCS from pUC18 (de Grado and 
Casta, 1999).  Another commercially available vector is pMKE2, derived from pMK18 
Rep
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RBSCDS
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with the inclusion of the Pnar promoter for inducible protein expression in T. 
thermophilus (Moreno et al., 2003).  A number of other vectors have been 
constructed in a similar fashion (Averhoff, 2006).   
6.1.2.2 Selectable markers at elevated temperatures 
Selectable markers are essential for the use of a vector in T. thermophilus, or for 
insertions or deletions on the T. thermophilus genome.  The most commonly used is 
a thermostable kanamycin resistance cassette.  The promoter for the S-layer protein, 
PslpA, is commonly used to drive the expression in the cassette, and allows function 
in both T. thermophilus and E. coli.  A number of other selectable markers are also 
available which can also be used in conjunction with the kanamycin resistance 
marker (Table 6-1). 
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Table 6-1 – Selectable markers for T. thermophilus 
Gene Name NCBI 
Reference 
Media 
requirements 
Strain 
requirements 
Description 
kat Kanamycin resistance 
(thermostable) 
GI:363583404 20 - 40 µg / ml 
kanamycin 
None Antibiotic resistance.  Kanamycin adenyl 
transferase has been engineered for improved 
thermostability.  Expression from the PslpA 
promoter is common and allows resistance to 
kanamycin in both T. thermophilus, and E. coli  
(Matsumura and Aiba, 1985; Lasa et al., 1992). 
ble Bleomycin resistance 
(thermostable) 
GI:60594050 3 - 15 µg / ml 
bleomycin 
None Antibiotic resistance.  Bleomycin-binding protein 
is a small, highly negatively charged protein 
which can bind positively charged antibiotic 
molecules such as bleomycin.  It was been 
engineered by directed evolution for 
thermostability and can also function in E. coli 
when expressed from PslpA (Brouns et al., 
2005). 
	276	
hyg Hygromycin resistance 
(thermostable) 
GI:213020041 40 µg / ml 
hygromycin 
None Antibiotic resistance.  A thermostable E. coli 
hygromycin phosphotransferase was developed 
using directed evolution in T. thermophilus.  It is 
stable up to 65 oC and has been used in both a 
plasmid and as a selection marker for genome 
integration (Nakamura et al., 2005). 
pyrE Orotate 
phosphoribosyltransferase 
GI:499487123 Minimal media 
containing 50 µg / 
ml uracil, or 200 
µg / ml 5-FOA 
pyrE knockout 
strain 
A knockout of pyrE results in resistance against 
the bactericidal compound 5-fluroorotic acid (5-
FOA), and uracil auxotrophy.  Can be used 
effectively for iterative knock-ins or knock-outs 
(Tamakoshi et al., 1997, 1999). 
leuB 3-isopropyl-malate 
dehydrogenase 
GI:21262177 Minimal media 
containing 50 µg / 
ml leucine and 
isoleucine. 
Auxotrophic 
strain 
Auxotrophic strains can be complemented on a 
vector, or used as a marker for successful 
knock-ins.  The use of minimal media with or 
without the relevant amino acid is required.  The 
knockout of leuB, which codes for a 3-isopropyl-
malate dehydrogenase, causes leucine 
auxotrophy and has been used in this way 
(Tamakoshi, Yamagishi and Oshima, 1995). 
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mdh Malate dehydrogenase GI:46196098 None mdh knockout 
strain 
Malate dehydrogenase is a key enzyme in the 
tricarboxylic acid cycle and mdh deficient cells 
show a small colony phenotype, even after 5 
days of growth.  This can allow easy 
identification of colonies that have been 
successfully transformed or have had mdh 
knocked out (Kayser and Kilbane, 2001). 
Selectable markers are essential for the design of new vectors for protein expression in T. thermophilus.  However the use of standard markers is 
limited due to the requirement for thermostability.  Three antibiotic resistance cassettes have been developed as well as a number of other markers 
that can be used to select for successful transformants.  The most useful of these are detailed in the table. 
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6.1.2.3 Cryptic plasmids – regions of replication 
T. thermophilus HB8 has three plasmids, pTT8, pTT27 and pVV8, which can be 
used for the construction of new synthetic plasmids (Ohtani, Tomita and Itaya, 2013).  
In contrast T. thermophilus HB27 has only pTT27, and efforts to remove this plasmid 
have resulted in a plasmid free strain, better suited for industrial exploitation (Ohtani, 
Tomita and Itaya, 2016).  In addition to these plasmids, a region of replication taken 
from a Thermus sp. ATCC27727 plasmid has been used for the construction of 
synthetic vectors such as pMK18 for T. thermophilus (de Grado and Casta, 1999).  
More recently a small multi-copy cryptic plasmid from Thermus sp. TK10 has been 
used as a replication region for the creation of a T. thermophilus vector, pNHK101 
(Kobayashi et al., 2005).   
6.1.2.4 Region of replication from a cryptic plasmid of Thermus sp. 
ATCC27737 
The minimum replication region identified from the 16 kbp plasmid of Thermus sp. 
ATCC27737 is 1.8 kbp in size and encodes a RepA protein which is essential for 
replication of the plasmid.  The N-terminal fragment of RepA binds an AT rich area of 
DNA surrounded by GC rich sequences in its own coding sequence.  This is thought 
to be the origin of replication (De Grado, Lasa and Berenguer, 1998).  This region of 
replication was used for the construction of pMK18 and pMKE2, and was used for 
the construction of vectors in this study. 
6.1.2.5 Region of replication for the cryptic plasmid pTT8 
The replication region from the pTT8 9.3 kbp cryptic plasmid of T. thermophilus HB8 
was identified as a 1.6 kbp region.  This region shows homology to the replication 
regions of ColE2 related plasmids (Aoki and Itoh, 2007).  The region of replication 
contains the gene for a replication initiator protein Rep.  pTT8 also contains genes 
for PasA and PasB proteins, which function as a stability system for pTT8 
(Takayama et al., 2004).  The origin of replication recognized by Rep was identified 
as a region just downstream of the rep gene.  Rep expression is regulated by anti-
sense RNA just upstream of the rep gene (Aoki and Itoh, 2007).  A high copy 
number mutant of pTT8 was obtained in which this region was removed and 
replaced with a fragment of DNA containing two promoter-like elements and an RBS 
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just upstream of the rep ORF.  While the normal copy number of pTT8 is 
approximately eight, the mutant showed a copy number of 30 to 40, with very good 
stability (Takayama et al., 2004).   
6.1.2.6 Region of replication from the pVV8 mega-plasmid 
The replication region from the pVV8 81.2 kbp mega-plasmid was identified by 
stepwise deletion to a region containing a single ORF TTHV001, RepV.  RepV has 
been shown to bind to an inverted repeat in its own DNA sequence, triggering an 
unwinding of the DNA duplex at an AT rich region downstream of this site.  This 
replication region is thought to show promise for co-existence with other plasmids 
(Ohtani, Tomita and Itaya, 2013). 
6.1.2.7 A cryptic plasmid from Thermus sp. TK10 as a replication region 
A small 1.5 kbp multi-copy cryptic plasmid from Thermus sp. TK10 has been used as 
a replication region for the construction of a T. thermophilus expression vector 
pNHK101.  No significant similarities to other plasmids have been identified, and only 
four ORFs are found within it.  Three of these ORFs show small similarities to 
several replication proteins from other plasmids.  The vector showed a copy number 
of approximately 80 in T. thermophilus, which reduced to about 20 with the addition 
of a thermostable kanamycin resistance cassette.  pNHK101 was unstable above 60 
oC, but stability was improved with the addition of pTT8 at 70 oC.  This vector shows 
promise for co-existence with other plasmids, but more work is needed to 
understand its instability and replication mechanism (Kobayashi et al., 2005). 
6.1.2.8 Replication region of the pTT27 mega-plasmid 
pTT27 is a mega-plasmid of about 233 kbp found in both T. thermophilus HB8 and 
HB27, although there are number of differences between the plasmids of the two 
strains.  A minimal region for replication was identified as a 2.3 kbp region, which 
includes a single gene for a replication initiation protein RepT, which binds to direct 
repeats downstream of its ORF.  A region for the expression of subunits of a class I 
ribonucleotide reductase for deoxynucleoside triphosphate synthesis was also 
shown to be essential for plasmid maintenance.  For plasmids designed from pTT27 
to be used in T. thermophilus HB27, a strain which has had the natural pTT27 
plasmid removed is likely to be necessary (Ohtani, Tomita and Itaya, 2016).  
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6.1.3 Promoters for T. thermophilus 
6.1.3.1 Constitutive promoter - PslpA 
The promoter for the S-layer protein, PslpA (Figure 6-3), is a very strong constitutive 
promoter, however it is also tightly regulated.  The promoter is negatively regulated 
by the SlrA and SlpM proteins.  SlpA is also able to regulate its own translation by 
binding to a leader region of its own mRNA preventing translation initiation 
(Fernández-Herrero, Olabarría and Berenguer, 1997; Cava, Hidalgo and Berenguer, 
2009).  Fusions of PslpA to lacZ have shown regulation both transcriptionally and 
translationally to be dependent on the 5ʹ UTR [14].  Possibly the removal of this 
region would result in a better synthetic promoter, although it has been speculated 
that the 5ʹ UTR may have implications for mRNA stability [14].   The PslpA promoter 
is also able to function in E. coli, making this a very useful promoter for the 
expression of antibiotic resistance cassettes which can work in both T. thermophilus 
and E. coli (Moreno et al., 2003).  
 
Figure 6-3 – A map of PslpA promoter and the beginning of the slpA gene.   
-35 and -10 promoter regions are shown as well as the transcription start site.  Much of the 
region identified as the promoter is transcribed as an mRNA leader sequence.  This region 
has been shown be important in the regulation of PslpA.   This figure was made with 
SnapGene. 
6.1.3.2 Constitutive promoter - PrmpB 
The promoter for the RmpB 50S ribosomal protein, PrmpB, is a constitutive promoter 
that is weaker than PslpA, which offers a more moderate level of protein expression.  
It was identified as a useful promoter (personal communication with José Berenguer 
and Aurelio Hidalgo, Universidad Autónoma de Madrid, Spain). 
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6.1.3.3 Nitrate and anoxic conditions inducible promoter - Pnar 
The promoter region of the respiratory nitrate reductase operon from T. thermophilus 
HB8, Pnar, allows inducible expression by the addition of nitrate and anoxic 
conditions (Moreno et al., 2003).  Two transcriptional regulators, DnrS and DnrT 
responding to anoxia and nitrate respectively, are found in the nar operon and are 
essential for the induction of Pnar (Moreno et al., 2003).  The nar operon is not 
normally found in T. thermophilus HB27, however it can been transferred from HB8 
by conjugation (Cava et al., 2004).  Reasonably good levels of protein expression 
have been reported using the Pnar promoter (Hidalgo et al., 2004; Moreno et al., 
2005), although it requires the use of anoxic conditions severely stunting growth.   
6.1.3.4 Constitutive promoter – Pnqo 
The nqo operon encodes a type I NADH dehydrogenase that is the main electron 
donor during aerobic growth.  Its promoter Pnqo is constitutive but repressed by 
DnrT under anaerobic conditions and by the addition of nitrate (Cava et al., 2007).  
This promoter offers weaker constitutive expression than PslpA. 
6.1.3.5 Heat inducible promoter - PdnaK 
The promoter for the dnaK gene in T. thermophilus is activated by heat shock, 
specifically transferring cultures from 70 oC to 85 oC.  When this promoter was used 
in the expression of malate dehydrogenase as a reporter gene it was shown to give 
significantly high background levels, and an increase of ~38% on heat induction 
(Kayser et al., 2001).  In another study using β-galactosidase as a reporter the high 
background expression was confirmed, but a doubling of expression on heat shock 
was demonstrated (Park and Kilbane, 2004). 
6.1.3.6 Arginine and carbon source inducible promoters 
An arginine inducible promoter Parg, has been shown to be induced by the addition 
of 10 to 30 mM arginine.  However only a maximum of a three-fold increase in 
expression was detected using this promoter (Park and Kilbane, 2004).  Another 
promoter, Pscs-mdh, is induced by the addition of carbon sources such as malate, 
succinate, pyruvate, glutamine, glucose, yeast extract or peptone (Park and Kilbane, 
2004). 
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6.1.3.7 Potential cold shock promoter - Pcsp2 
The cold shock protein gene csp2 shows a rapid and large increase in mRNA 
following a temperature downshift in T. thermophilus HB8.  This is thought to be due 
to a temperature dependent secondary structure forming at 45 oC at the 5ʹ UTR of 
the mRNA, assumed to prevent degradation of the mRNA at this temperature (Mega 
et al., 2010).  This 5ʹ UTR or even the whole csp2 promoter could provide an 
interesting approach for the inducible expression of proteins in T. thermophilus, upon 
dropping temperature to 45 oC, causing the cell growth to slow considerably.  
However the use of Pcsp2 for the expression of other proteins has never been 
tested. 
6.1.3.8 Identification of promoters from genomic DNA fragments 
Other bifunctional constitutive promoters have been developed by using a promotor-
less kanamycin resistance gene on a promoter-probe vector, and ligating random 
chromosomal fragments from T. thermophilus or T. flavus into this vector, and 
screening for kanamycin resistant colonies.  Transformants capable of surviving on 
the high levels of kanamycin were selected.  Of those, two promoters termed J17 
and vv12 were selected that also conferred resistance in E. coli, although the 
sequences are not available (Kayser et al., 2001).   
6.1.4 Ribosome binding sites for T. thermophilus 
6.1.4.1 Ribosome binding site parts. 
The use of defined parts for the construction of new pathways is an attractive 
proposal (Ellis, Adie and Baldwin, 2011).  Ribosome binding sites (RBSs) are an 
essential part for the expression of proteins and can be very useful in modulating 
gene expression, especially in the construction of synthetic operons (Farasat et al., 
2014).  However while the core RBS sequence is small, the strength of an RBS can 
be very context dependent, with the initial ORF affecting the RBS (Espah Borujeni, 
Channarasappa and Salis, 2014).  For this reason having reusable RBS parts for 
multiple ORFs is challenging (Kaberdin and Bläsi, 2006).  The use of a bicistronic 
design can be used to work around the issue of RBS context dependence (Mutalik et 
al., 2013), but can cause toxicity issues when multiple bicistronic RBS parts are 
used. 
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One approach for creating predictable custom RBSs for each ORF is the use of a 
biophysical model for translation initiation.  This allows RBS strength to be predicted 
or designed in silico, and such a tool is available through a web portal as “the 
ribosome binding site calculator” (Salis, Mirsky and Voigt, 2009).  In practice this tool 
is not completely reliable, although it maybe allows design in the regions of strong, 
medium and low strength (Jeschek, Gerngross and Panke, 2016).  Another 
approach has been the use of this tool to facilitate the design of RBS libraries of 
reduced size which still cover the hypothetical RBS strength space which can be 
useful in pathway optimization (Jeschek, Gerngross and Panke, 2016).   
6.1.4.2 T. thermophilus Shine-Dalgarno sequence 
The anti-Shine-Dalgarno (SD) sequence found at the 3ʹ of the T. thermophilus 16S 
rRNA is ACCTCCTTT (Murzina, Vorozheykina and Matvienko, 1988).  
Complementarity can be seen with the RBS identified for the S-layer protein, SlpA.  
This has a sequence of AAGGAGGTG TGAGGCAT ATG, with the SD sequence and 
start codon shown in italics (Faraldo et al., 1992).  The anti-SD sequence of T. 
thermophilus is used in the design of custom RBSs using the RBS calculator (Salis, 
Mirsky and Voigt, 2009). 
6.1.5 Designing genes for expression in T. thermophilus 
6.1.5.1 Codon usage 
In most species synonymous codons are not used equally where there is a bias 
towards certain codons over others.  Codons that are not used frequently are 
classified as rare codons, and are often associated with rare tRNAs where their 
inclusion in CDS’s inhibits protein translation (Gould, Hendy and Papamichail, 2014).  
T. thermophilus has a large number of such rare codons, using 36 % of its codons 
less than 10 % of the time.  Initially in this study the level of codon bias by T. 
thermophilus was not appreciated and native genes were used.  No expression was 
detected for these constructs and codon optimization has proved to be important for 
protein expression in T. thermophilus.   
Codon optimisation is the process of trying to match the codon usage of a gene 
towards the preference of the host, and can be performed in a number of ways 
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(Gould, Hendy and Papamichail, 2014).  Some methods try to maximize the CAI 
(codon adaption index), although this generally leads to the selection of the most 
used codon at every position, which can be detrimental to protein expression if 
certain tRNA pools are exhausted (Gingold and Pilpel, 2011).  Another approach is 
try and emulate a given codon distribution, for example by randomly assigning 
codons to match the host bias (in many cases with the exception of rare codons 
which are ignored) (Gould, Hendy and Papamichail, 2014).  For the codon 
optimisation of genes for T. thermophilus the random selection of codons to match 
the host bias, with the removal of rare codons used less than 10 % of the time, was 
used.  
Codon context is also thought to play a role in translation efficiency (Gould, Hendy 
and Papamichail, 2014).  A number of prokaryotes have been shown to have bias 
towards specific combinations of codons, often referred to as codon pairing.  There 
is evidence that codon pair bias has an influence on translation efficiency (Coleman 
et al., 2011).  Codon reuse has also been observed, with the grouping of specific 
synonymous codons into distinct regions of some genes.  This is thought to allow 
tRNA recycling and there is evidence that genes that have groups of synonymous 
codons show better expression (Cannarrozzi et al., 2010).  Codon context may be an 
important consideration for the design of synthetic genes for expression in T. 
thermophilus, however to date this has not been explored. 
6.1.5.2 Other factors that may affect translation initiation or elongation in T. 
thermophilus. 
mRNA secondary structure is thought to play a role in translation efficiency.  Some 
secondary structures have been shown to stall ribosomes as they are required to 
unwind these sections of mRNA before translation elongation can occur (Buchan 
and Stansfield, 2007).  mRNA secondary structure around the area of translation 
initiation area has also been shown to be detrimental to gene expression (Tuller et 
al., 2010).   
Shine-Dalgarno like sequences inside the CDS have been shown to cause 
translational pausing in some prokaryotes, due to hybridization between the mRNA 
and 16S RNA of the ribosome (Li, Oh and Weissman, 2012).  Other factors such as 
repeated nucleotides, polyadenylation sites, nuclease cleavage sites, hidden stop 
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codons and GC content have also been suggested as factors to consider when 
designing genes for protein expression (Gould, Hendy and Papamichail, 2014).   
6.1.6 Assembly of parts using BioBricks cloning approach 
The BioBricks cloning approach makes use of four main restriction enzymes to allow 
modular and iterative cloning.  EcoRI and XbaI are placed upstream of each part, 
and SpeI and PstI are placed downstream of each part.  XbaI and SpeI cut sites can 
be ligated together forming a scar site which cannot be cut by either of these 
restriction enzymes.  This allows the same four restriction sites to be maintained 
either side of a new combined part for the next round of cloning, as shown in Figure 
6-4).  Using these restriction sites for all the DNA parts in this study allows their 
combination and reuse in any combination.  Specific BioBricks cloning steps have 
not been included in the results or methods sections, but all followed standard 
protocols described here and in the general materials and methods section (section 
1.1).  All vectors constructed in this study are also available as a supplementary file. 
 
Figure 6-4 – Standard BioBricks cloning method 
An example of a standard BioBricks cloning procedure.  E: EcoRI, X: XbaI, S: SpeI, P: PstI.  
The figure shows a promoter part cut with E and S, and a vector containing a CDS part cut 
with E and X.  These are ligated together to form a new vector containing a newly formed 
combined part, maintaining the unique restriction enzymes at each side. 
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X
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6.1.7 Summary of aims – a preliminary investigation into the use of 
T. thermophilus as a host organism for whole cell biocatalysis 
This study aims to develop and test the use of T. thermophilus as a host organism 
for whole-cell biocatalysis.  The construction of a T. thermophilus BioBricks vector 
will be investigated to facilitate the modular use of DNA parts.  Promoters of a range 
of strengths will be characterised using a reporter protein such as sfGFP.  The use of 
the RBS calculator for the design of custom RBSs for each CDS will be used, and 
the success of this approach evaluated. 
As a proof of principle to investigate the use of T. thermophilus for whole-cell 
biocatalysis, a pathway made up of an esterase from Archaeoglobus fulgidus 
(AfEst2), a carboxylic acid reductase from Mycobacterium pheli (mpCAR) and an 
alcohol dehydrogenase from Aeropyrum pernix (ApADH) will to be expressed in T. 
thermophilus (Figure 6-5), utilising the DNA parts described above.  Methyl p-toluate 
will be used as a substrate to be hydrolyzed and subsequently reduced through to p-
tolyl alcohol. 
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Figure 6-5 – A T. thermophilus cell expressing AfEst2, mpCAR and ApADH, catalyzing 
the hydrolysis and subsequent reduction of methyl p-toluate through to p-tolyl 
alcohol. 
AfEst2: an esterase from Archaeoglobus fulgidus, mpCAR: a carboxylic acid reductase from 
Mycobacterium pheli, ApADH: an alcohol dehydrogenase from Aeropyrum pernix.  
Expression of all three enzymes allows the cascade reaction to be carried out inside the cell 
with cofactors regenerated from the host metabolism.  Substrates and products must diffuse 
into and out of the cell. 
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6.2 Materials and methods 
6.2.1 Materials 
6.2.1.1 Bacterial strains 
Competent 5-alpha E. coli (NEB) were used in all DNA manipulations and plasmid 
preparations.  T. thermophilus HB27::nar, a strain of HB27 with the addition of the 
nar element transferred from T. thermophilus HB8, was used in all T. thermophilus 
work.  This strain was kindly gifted by José Berenguer, and is required for the use of 
the Pnar promoter in an HB27 strain.   
6.2.1.2 Vectors 
Template and cloning vectors used in this study are shown in Table 6-2.  Vectors 
constructed throughout this study for the expression of genes in T. thermophilus, are 
included as a supplementary file.  
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Table 6-2 – Template and cloning vectors used in this study 
Vector Description 
pMKE2 pMKE2 is a T. thermophilus-E. coli expression 
vector, purchased from Biotools (Madrid) and used 
as a template for the construction of pBBTth. 
pSB1C3, pSB1A3 and 
pSB1K3 
Established BioBricks plasmids for E. coli available 
from iGEM (iGEM website for part BBa_I13521, 
2016).  They include selectable markers for 
resistance against chloramphenicol, ampicillin or 
kanamycin respectively. 
pBBTTh The T. thermophilus-E. coli BioBricks vector 
constructed in this study and used in all T. 
thermophilus work. 
These vectors were either used as a template for the construction of new vectors, or used in 
the assembly of BioBrick parts.  Sequences for other vectors as well as these are available 
as a supplementary file. 
 
6.2.1.3 DNA BioBrick parts 
DNA BioBrick parts used in the study are detailed in Table 6-3.  Sequences are also 
available as a supplementary file. 
Table 6-3 – DNA BioBrick parts used throughout this study. 
Name Source Description 
PslpA PCR from pMKE2 A constitutive promoter 
Prmp PCR from T. 
thermophilus 
genomic DNA 
A constitutive promoter 
Pnqo PCR from T. 
thermophilus 
genomic DNA 
A constitutive promoter 
Pnar PCR from pMKE2 A nitrate and anoxic conditions 
inducible promoter 
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AfEst2* Gene synthesis (IDT) CDS for expression of AfEst2 protein 
ApADH PCR from a vector 
containing native 
ApADH sequence 
CDS for expression of ApADH 
protein.  Native sequence 
mpCAR PCR from pNIC28-
BSA vector 
containing mpCAR 
native sequence 
CDS for expression of mpCAR 
protein.  Native sequence. 
CtTran-His* Gene synthesis (IDT) CDS for expression of CtTran protein.  
Two copies of this gene were 
designed, one with a His tag and one 
with a FLAG tag. 
RBS for AfEst2 Primers (Invitrogen) RBS for AfEst2 
RBS for ApADH Primers (Invitrogen) RBS for ApADH 
RBS for mpCAR Primers (Invitrogen) RBS for mpCAR 
RBS for CtTran-His Primers (Invitrogen) RBS for CtTran-His 
ApADH* Gene synthesis (IDT) CDS for expression of ApADH.  An 
RBS is included. 
ApADH* (N	term	myc) Gene synthesis (IDT) CDS for expression of ApADH with 
the addition of a N terminal myc tag.  
An RBS is included. 
ATN1-ADH* Gene synthesis (IDT) CDS for expression of ATN1-ADH.  
An RBS is included. 
ss-!-lactamase* Gene synthesis (IDT) CDS for expression of ss-!-lactamase.  An RBS is included. 
CtTran-FLAG* 
Gene synthesis (IDT) CDS for expression of CtTran protein.  
Two copies of this gene were 
designed, one with a His tag and one 
with a FLAG tag. 
sfGFP* 
Gene synthesis (IDT) CDS for expression of sfGFP.  An 
RBS is included. 
mRFP* Gene synthesis (IDT) CDS for expression of mRFP.  An RBS is included. 
mpCAR* Gene synthesis (MWG) 
CDS for expression of mpCAR.  An 
RBS is included. 
ancCAR* Gene synthesis (MWG) 
CDS for expression of ancCAR.  An 
RBS is included. 
Cas9* Gene synthesis (Twist) 
CDS for expression of Cas9.  An RBS 
is included. 
Parts were assembled using BioBricks cloning method to develop and investigate the use of 
T. thermophilus for whole-cell biocatalysis. A * is used to indicate a codon optimized 
sequence was used. 
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6.2.2 Assembly of T. thermophilus BioBricks vector and BioBricks 
parts 
6.2.2.1 Vector creation 
Fragments with overhangs for Gibson assembly were designed using SnapGene.  
Fragments were generated by PCR and where appropriate DpnI treated.  Fragments 
were joined in a one hour Gibson assembly reaction at 50 oC, with equimolar 
concentrations of each fragment used.  A 20 µl reaction containing 10 µl of Gibson 
Assembly Master Mix from NEB was used, following manufacturer’s instructions.  
The assembly was transformed into 5-alpha E. coli cells (NEB) on LB agar plates 
containing 50 µg / ml kanamycin.  Red colonies were selected for plasmid 
purification, and the correct assembly confirmed by restriction digest, PCR and 
sequencing.   
6.2.2.2 BioBricks assembly of parts 
BioBrick parts are pieces of DNA with a defined function, such as a promoter, RBS 
or CDS.  BioBrick parts were assembled using standard restriction cloning or three 
antibiotic assembly (3A) assembly.  BioBricks assembly makes use of four restriction 
sites, two either side of each part.  EcoRI and XbaI are used prefixing a part, while 
SpeI and PstI are used suffixing a part.  XbaI and SpeI cut sites can be ligated 
together forming an uncuttable scar site, maintaining the same four restriction sites 
either side of a new assembly.  The standard prefix sequence is 
gaattcgcggccgcttctagag, although this is changed to gaattcgcggccgcttctag if the part 
starts with ATG and is a CDS.  The standard suffix sequence is 
tactagtagcggccgctgcag. 
6.2.2.3 Creation of RBS parts from primers 
Pairs of complementary forward and reverse primers were ordered from Invitrogen 
and re-suspended in distilled water at a concentration of 100 µM.  Primers were 
phosphorylated using a T4 polynucleotide kinase (NEB) following the manufacturer’s 
instructions.  Primers were mixed to a final concentration of 10 µM each in 30 µl, and 
4 µl of 0.5 M NaCl added.  Using a thermocycler samples were heated at 95 oC for 2 
minutes, followed by 75 cycles of 30 seconds with temperature dropping by 1 oC per 
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cycle.  A 1 in 10 dilution of the primer mix was made, equal to approximately 1 µg of 
DNA.   
6.2.2.4 Assembly of Cas9 by Gibson assembly 
The gene for Cas9 expression in T. thermophilus was assembled from three linear 
pieces of synthetic DNA (IDT), into pSB1C3.  Gibson assembly was carried out as 
described for vector assembly.  Cas9 was then cloned into pBBTTh with a range of 
promoters using standard BioBrick cloning techniques. 
6.2.2.5 Codon optimisation for T. thermophilus 
The codon optimisation tool from IDT was used to match the codon bias of T. 
thermophilus in the creation of synthetic genes.  Codons used less than 10 % of the 
time were ignored, with codons for each amino acid selected randomly weighted by 
their frequency in the T. thermophilus genome. 
6.2.3 T. thermophilus methods 
6.2.3.1 T. thermophilus complex media 
T. thermophilus was routinely grown on a complex media, often referred to as TM or 
TB media, as described in (Averhoff, 2006).  This was made up of 8 g/L trypticase, 4 
g/L yeast extract, 3 g/L NaCl.  For TB agar 20 g/L agar was added.  Media was 
titrated to pH 7.5 with HCl and NaOH and autoclaved.  A 1 in 1000 dilution of an 
autoclaved 1000x MgCl and CaCl2 solution containing 7.2 g/L MgCl.6H20 and 8.7 g/L 
CaCl2.2H20 was added, as these ions have been shown to be important in 
transformation efficiency (Averhoff, 2006). 
6.2.3.2 T. thermophilus minimal media 
For promoter characterization a minimal media was required to reduce background 
fluorescence. This was made up of 20 g/L sucrose, 20 g/L sodium glutamate, 0.5 g/L 
K2HPO4, 0.5 g/L KH2PO4, 0.25 g/L NaCl, 0.5 g/L (NH4)SO4 with pH titrated to 
between 7.0 - 7.2.  After autoclaving a 1 in 1000 dilution of the 1000x MgCl and 
CaCl2 solution described previously was added.  A 1 in 1000 dilution of a filter 
sterilised solution, made up in 0.01 N H2SO4 containing, 60 g/L FeSO4.7H20, 8 g/L 
CoCl2.6H2O, 0.2 g/L NiCl2.6H2O, was also added.  The addition of 0.1 mg/L biotin 
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and 1 mg/L thiamine is also suggested in some literature (Averhoff, 2006), however 
these were not added in this study. 
6.2.3.3 T. thermophilus growth 
As standard T. thermophilus was grown in 20 to 30 ml of TB media, in a 250 ml 
conical flask, at 70 oC with shaking at 200 RPM.  Where T. thermophilus was 
transformed with a plasmid containing a kanamycin resistance cassette, 30 µg/ml 
kanamycin was added.  Glycerol stocks were produced as they were for E. coli 
cultures, through the addition of 20 % glycerol to a culture before freezing at -80 oC.  
Confluent cultures could be obtained overnight through inoculation 30 ml TB media 
with a T. thermophilus colony or small scrape of a glycerol stock.  Complete 
coverage of the conical flask lid with tin foil over a bung was important to prevent 
high levels of evaporation. 
6.2.3.4 T. thermophilus transformation 
T. thermophilus was grown overnight in TB media at 70oC, 200 RPM before being 
diluted to OD600nm 0.1. 5 µl of plasmid DNA was added to 500 µl of T. thermophilus 
culture in 10 ml breather tubes and incubated for four hours at 70 oC, 200 RPM.  
Cultures were plated on TB agar with 30 µg/ml kanamycin.  Plates were incubated at 
70 oC inside a sealed plastic box to which a small volume of water was added in a 
Duran bottle lid, which is important to prevent the agar plates from becoming 
dehydrated.  
6.2.3.5 Promoter characterisation 
Overnight cultures of T. thermophilus transformed with plasmids for the expression 
of sfGFP from the range of promoters were set up in TB media as standard.  Minimal 
media cultures were inoculated with 500 µl of the overnight culture in 30 ml minimal 
media with 30 µg/ml kanamycin.  Cultures were incubated at 60 oC, 200 RPM.  200 
µl samples were taken in triplicate into a 96-well microtiter plate for OD600 and 
fluorescence readings.  Fluorescence settings were as follows:  Excitation 
wavelength 450 nm, excitation bandwidth 9 nm, emission wavelength 508 nm, 
emission bandwidth 20 nm, gain 120, 10 flashes, 10 µs integration time, lag time 0 
µs, settle time 0 µs, and an automatically calculated Z-position of 18268 µm.  
Population average GFP fluorescence was calculated.  This is blank subtracted 
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fluorescence divided by blank subtracted OD600nm.  Standard deviations for each 
reading were combined and shown as error bars. 
6.2.3.6 Whole-cell biocatalysis assays 
T. thermophilus was grown as specified previously.  250 mM stocks of each 
substrate was prepared in ethanol and added to give the desired concentration 
(usually 2 mM).  Conversion of substrates by T. thermophilus was determined by 
HPLC.  500 µl samples were taken and added to 500 µl of acetonitrile.  Samples 
were centrifuged at maximum speed for 10 minutes, and the supernatant collected.  
Samples were kept at 4 oC and analyzed by HPLC within 24 hours.  The standard 
HPLC method specified in the general materials and methods chapter was used. 
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6.3 Results 
6.3.1 Construction of a T. thermophilus BioBricks vector. 
6.3.1.1 Specifications for a T. thermophilus BioBricks vector 
In order to use the BioBricks cloning approach for the assembly of synthetic biology 
parts for expression in T. thermophilus, a BioBricks vector was needed.  A vector 
capable of replication and selection in both E. coli and T. thermophilus, with an 
insulated BioBricks cloning site, was required.  Minimization of vector size was also 
considered an important goal. 
6.3.1.2 Template vectors 
Two vectors were selected as templates for the construction of a new vector (Figure 
6-6).  pMKE2 is a commercially available vector derived from pMK18 (Figure 6-6A) 
which meets many of the criteria above.  However it contains a number of regions of 
apparently “junk” DNA and contains a limited cloning site only for the expression of 
genes from its Pnar2 promoter.  pSB1C3 (Figure 6-6B) is an established BioBricks 
vector for E. coli with a BioBricks cloning site flanked by two insulating terminator 
regions.  The BioBricks cloning site is supplied containing a stuffer gene for the 
expression of mRFP under the control of a lac promoter which helps identify 
successful cloning attempts.   
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Figure 6-6 – Template vectors used for the construction of both T. thermophilus 
BioBricks vectors 
These vectors were used for the construction of new T. thermophilus vectors by PCR and 
Gibson assembly.  Fragments amplified for the construction of T. thermophilus BioBricks 
vector 1 are shown by the red lines.  Fragments amplified for the construction of T. 
thermophilus BioBricks vector 2, called pBBTTh, are shown by green lines. 
A:  pMKE2 - An E. coli – T. thermophilus shuttle vector with a Pnar promoter for the 
expression of proteins in T. thermophilus.  Important features include: 
PslpA-KanR - A heat stable kanamycin resistance cassette, under the control of a bi-
functional PslpA promoter.    
RepA - A region for replication in T. thermophilus. 
Ori – Region of replication for E. coli. 
pNAR2 – A modified pNAR promoter for driving protein expression in T. thermophilus  
B:  pSB1C3 – A BioBricks vector for E. coli.  Important features include: 
 CmR – A chloramphenicol resistance casette 
 BioBricks cloning site:  Restriction sites EcoRI, XbaI, SpeI and PstI flanking 
stuffer gene for the expression of mRFP.  Terminators flank this cloning site. 
Ori – Region of replication for E. coli.  Identical to the same region in pMKE2 
 
6.3.1.3 T. thermophilus BioBricks vector 1 construction 
The first vector constructed (Figure 6-7) took the BioBricks cloning site and origin of 
replication for E. coli from pSB1C3 as one fragment (Figure 6-6B – Red line), and 
the RepA region for replication in T. thermophilus and bi-functional kanamycin 
resistance cassette as two separate fragments from pMKE2 (Figure 6-6A – Red 
lines).  Fragments were amplified by PCR with overhangs to allow Gibson assembly. 
This first vector had a minimized size and was able to function in E. coli.  Red 
colonies were selected from agar plates containing 50 µg / ml kanamycin, and the 
new vector confirmed by PCR and restriction digest (data not shown).  However this 
vector was unable to be transformed into T. thermophilus (data not shown).  The 
RepA region of this vector was also confirmed by sequencing.   
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Figure 6-7 – T. thermophilus BioBricks plasmid 1 
The first attempt at constructing a T. thermophilus BioBricks vector.  This vector has regions 
for replication in both E. coli and T. thermophilus, and a bi-functional and heat stable 
kanamycin resistance cassette. Vector size was minimized by not including sections of DNA 
from the template vectors with no apparent purpose.   This vector did not function in T. 
thermophilus.  
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6.3.1.4 T. thermophilus BioBricks vector 2 construction - pBBTTh 
A second vector was designed (Figure 6-9), without the removal of so much of the 
pMKE2 vector DNA, as this vector is known to function in T. thermophilus.  A 
fragment containing the BioBricks cloning site was taken from pSB1C3 (Figure 6-6B 
– Green line), and a fragment containing everything else from pMKE2 (Figure 6-6A – 
Green line).  Again these fragments were amplified by PCR with overhangs to allow 
Gibson assembly (Figure 6-8). 
Again red E. coli colonies were selected on 50 µg / ml kanamycin (Figure 6-10 – Part 
I).    This vector was also able to function in T. thermophilus, with transformants able 
to grow on 30 µg / ml kanamycin (Figure 6-10 – Part II).  The correct assembly was 
confirmed by restriction digest using XbaI and PstI, with bands at the correct size 
identified (Figure 6-11).  This vector was designated pBBTTh and used in 
subsequent work (Figure 6-9).  
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Figure 6-8 – PCR amplification of two fragments for the construction of a second T. 
thermophilus BioBricks vector by Gibson assembly. 
Fragments were amplified from pMKE2 and pSB1C3 (Figure 6-6 – Green lines) using a 
temperature gradient from 55 oC to 75 oC (left to right on for both fragments on the gel).  
However all temperatures resulted in equally selective PCR, as shown on the gel.  Bands 
are at the expected size for the fragments amplified, indicted by arrows in the figure.  
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Figure 6-9 – T. thermophilus BioBricks plasmid 2 - pBBTTh 
The second attempt at constructing a T. thermophilus BioBricks vector.  This vector was 
constructed by Gibson assembly by combining the PCR fragments in Figure 6-8.  Again, this 
vector has regions for replication in both E. coli and T. thermophilus, and a bifunctional and 
heat stable kanamycin resistance cassette. However sections of DNA from the pMKE2 with 
no apparent purpose were not removed, and this vector was functional in T. thermophilus, 
unlike the first vector.   
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Figure 6-10 – pBBTTh functioning in both E. coli and T. thermophilus.   
1. Four E. coli colonies were picked labelled A to D.  Each was red due to the 
expression of mRFP in the stuffer gene, and able to grow in the presence of 50 µg / 
ml kanamycin from the bifunctional kanamycin resistance cassette. 
2. Plasmids were isolated from E. coli colonies A to D and transformed into T. 
thermophilus.  Transformants were able to grow in the presence of 30 µg / ml 
kanamycin in all cases showing the vector was functional.  No growth was detected 
in a negative control of T. thermophilus without the addition of a plasmid.  
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Figure 6-11 – Restriction digest of pBBTTh by XbaI and PstI 
A restriction digest of pBBTTh was carried out using restriction enzymes XbaI and PstI.  
Bands of the correct sizes were identified on the gel confirming the successful construction 
of the second T. thermophilus BioBricks vector.  A-D shows four separate plasmid samples 
identical to those used in Figure 6-10, all digested with XbaI and PstI. 
 
6.3.2 Synthetic biology tools for controllable protein expression in 
T. thermophilus. 
6.3.2.1 Codon usage in T. thermophilus is limited due to high GC content. 
T. thermophilus has a GC content of 70 %, and as a result its codon usage is more 
limited than average.  The relative frequency a codon is used to code for a specific 
amino acid can be calculated as a fraction of use, summing to one for each amino 
acid (Figure 6-12).  Rare codons can arbitrarily be defined by specifying a 
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percentage usage cut-off, with 10 % being used by some gene synthesis companies, 
such as IDT, as rare codons to avoid in codon optimization.  Taking this cut-off for T. 
thermophilus codon usage, 36 % of the codons are classed as rare.  The strict codon 
usage of T. thermophilus makes codon optimization almost essential for successful 
heterologous gene expression.  In the initial design of some constructs this was not 
appreciated and the native genes used (Figure 6-16).  No expression was detected 
in these cases (Figure 6-19 and Figure 6-21)  
Figure 6-12 - Thermus thermophilus HB27 codon usage 
Codon usage was taken from the Kazusa database (Nakamura, Gojobori and Ikemura, 
1999).  Codon frequency per amino acid is shown, which equals a total of 1 for each amino 
acid.  A threshold of 0.1 is shown which equates to triplets which are used less than 10 % of 
the time.  Codons used less than this may be considered as “rare” and equate to 36 % of the 
possible triplets. 
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6.3.2.2 Ribosome binding site calculator for designing maximised RBS’s for T. 
thermophilus. 
Custom ribosome binding sites (RBS) were designed for each coding sequence 
(CDS), using the RBS calculator.  A maximization of RBS strength was set as the 
target objective.  Initially RBS’s were designed as BioBricks themselves, with the aim 
of being able to easily modulate RBS strength by swapping out the RBS part.  
However this proved to be an inefficient use of time, and moreover the resulting scar 
site between the RBS and CDS limited the ability of the RBS calculator in 
maximizing RBS strength.  RBS’s that were designed as BioBrick parts, and those 
that were designed with no scar site constraints, are indicated in Table 6-4.  In 
general the use of the RBS calculator for designing maximized RBS’s for T. 
thermophilus was quite successful.  
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Table 6-4 – Ribosome binding site strength 
Gene RBS strength (A.U.) 
AfEst2*C 69,963 
ApADHC 170,863 
ApADH*C 19,141 
ApADH* (N term myc) 626,778 
ATN1-ADH* 50,417 
ss-!-lactamase* 42,111 
mpCAR 40,768 
CtTran-His*C 50,417 
sfGFP* 243,592 
mRFP* 1,122,434 
CtTran-FLAG* 203,462 
mpCAR* 135,374 
ancCAR* 1,287,767 
Cas9* 305,063 
RBS strengths for all of the proteins expressed in T. 
thermophilus in this study, as calculated using the RBS 
(Salis, Mirsky and Voigt, 2009).  (A.U. - Arbitrary Units).  
The scale runs from 0 to 5,000,000.  * represents a codon 
optimized sequence.  Initial designs used individual 
BioBrick RBS parts, resulting in constraints on the RBS 
design, this is indicated by C.	
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6.3.2.3 Promoters for T. thermophilus 
Four promoters for T. thermophilus were identified as covering a range of strengths, 
partly through personal communication with Prof. José Berenguer and Prof. Aurelio 
Hidalgo.  PslpA and Pnar were cloned as BioBricks from pMKE2 by PCR, while 
Prmp and Pnqo were cloned from T. thermophilus genomic DNA.  In an effort to 
ensure promoters from the T. thermophilus genome were captured, 200 bp and 150 
bp regions upstream of the rmpB and nqo genes were used, although it is possible 
the actual promoter regions are smaller. 
6.3.2.4 Testing promoter strength using sfGFP 
In order to quantify promoter strength, a super-folder GFP (sfGFP) was used able to 
function at 70 oC (Cava et al., 2008).  Evidence that mRFP might function at elevated 
temperatures was also found through the iGEM website (iGEM website for part 
BBa_I13521, 2016), although efforts to use mRFP to quantify protein expression in 
T. thermophilus were not effective (data not shown).  T. thermophilus was 
transformed with constructs in pBBTth containing each promoter upstream of sfGFP 
or mRFP (Figure 6-13), as well as with no promoter, and grown in minimal media.  
Both sfGFP and mRFP were codon optimized for expression in T. thermophilus and 
featured a C-terminal FLAG tag. 
To confirm sfGFP and mRFP expression, an SDS-PAGE gel and western blot were 
run of total cell lysates of these T. thermophilus constructs.  FLAG tagged protein of 
the correct molecular weight was clearly detected by western blot analysis, and was 
faintly detectable by SDS-PAGE (Figure 6-14). To quantify sfGFP expression, 
cultures grown in minimal media were set up and incubated at 60 oC, 200 RPM.  200 
µl samples were taken in triplicate into a 96-well microtiter plate to allow reading of 
fluorescence and OD600nm.  At approximately OD600nm 0.15 population average 
sfGFP expression was determined, quantifying gene expression from each promoter 
(Figure 6-15).  Population average sfGFP expression after 24 hours incubation, with 
an OD600nm 1.1 showed similar results (data not shown).  The Pnar promoter was not 
induced and so showed no expression.  A blank reading of T. thermophilus 
containing empty pBBTTh was subtracted from the population average fluorescence 
of all other readings. 
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Figure 6-13 – The constructs used for measuring promoter strength 
From RBS-CDS parts, constructs were made for the expression of sfGFP or mRFP from a 
range of promoters, as well as without any promoter at all.  These constructs were cloned 
into pBBTTh to allowing testing of promoter strength by measuring sfGFP or mRFP 
expression by fluorescence.  Both CDS’s featured a C terminal FLAG tag to allow detection 
of expression by western blot.  * is used to indicate a codon optimized sequence.  Promoter:  
A promoter part, either PslpA, Pnar, Prmp, Pnqo, or no promoter at all.  RBS:  A custom 
RBS, designed using the RBS calculator. 
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Figure 6-14 – SDS-PAGE analysis and western blot of total cell lysate of T. thermophilus expressing sfGFP and mRFP under the 
control of a range of promoters. 
SDS-PAGE and western blot of total cell lysate from T. thermophilus expressing codon optimised sfGFP and mRFP, under the control of PslpA, 
Pnar, Prmp, Pnqo and without a promoter.  T. thermophilus containing empty pBBTthK and without a plasmid were included as negative 
controls.  A T. thermophilus cell lysate expressing FLAG tagged AfEst2 was included as a positive control.   The western blot was probed using 
a chicken anti-FLAG primary antibody and a goat anti-chicken IRDye 800CW secondary antibody.  The expected size of sfGFP and mRFP is 
shown by the green and red boxes respectively.
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Figure 6-15 – Population average sfGFP fluorescence as a measure of promoter 
strength 
sfGFP expression was measured by reading the fluorescence and OD600nm T. thermophilus 
were cultures grown in minimal media and 200 µl was taken in triplicate from a shake flask 
into a 96-well microtiter plate for reading using a plate reader.  Population average GFP 
expression was calculated as the Fluorescence recorder divided by OD600nm.  A blank was 
also measured using T. thermophilus cultures with no sfGFP expression, and subtracted 
from all readings.  Error bars shows the combined standard deviation for all readings.
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6.3.3 Initial trials for the expression of AfEst2, ApADH and a 
synthetic operon. 
6.3.3.1 Building constructs for the expression AfEst2, ApADH and a synthetic 
operon in T. thermophilus. 
Constructs for expression of AfEst2, ApADH and for the expression of a complete 
synthetic operon (Figure 6-16), were constructed using the BioBricks cloning 
approach into pBBTth (Figure 6-9).  In the synthetic operon a gene for the 
expression of a phosphopantetheine (PPT) transferase from the thermophile 
Clostridium thermocellum was included (CtTran), for transfer of the PPT group onto 
a CAR.  AfEst2 and CtTran were codon optimised and synthesised by Integrated 
DNA Technologies (IDT) to match the T. thermophilus codon usage, as the native 
sequences contained BioBricks restriction sites.  Native sequences were used for 
ApADH and mpCAR, although it was subsequently realized that codon optimization 
is almost essential for successful gene expression in T. thermophilus (Figure 6-12).  
The PslpA, Pnar, Prmp and Pnqo promoters were used for all constructs.  
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Figure 6-16 – Constructs for the expression of AfEst2, ApADH and a complete 
synthetic operon.  
From RBS-CDS parts constructs were made for the expression of AfEst2 or ApADH from a 
range of promoters.  A synthetic operon was also constructed for the expression of mpCAR, 
AfEst2, ApADH and CtTran from a single promoter.  * is used to indicate a codon optimized 
sequence. 
Promoter:  A promoter part, either PslpA, Pnar, Prmp or Pnqo. 
RBS:  A custom RBS, designed using the RBS calculator. 
AfEst2*:  Codon optimized gene for the expression of AfEst2, a C terminal FLAG tag was 
included. 
ApADH:  Natural gene for the expression of ApADH, a C terminal Myc tag was included. 
mpCAR:  Natural gene for the expression of mpCAR, a C terminal 6xHis tag was included 
CtTran*:  Codon optimized gene for the expression of CtTran, a C terminal 6xHis tag was 
included. 
 
6.3.3.2 Testing constructs for the expression AfEst2, ApADH. 
T. thermophilus transformed with constructs for the expression of AfEst2 or ApADH 
in pBBTTh were grown overnight in TB media + 30 µg / ml kanamycin at 70 oC at 
200 RPM.  Negative controls of T. thermophilus with an empty pBBTth plasmid, and 
without a plasmid were also set up (without kanamycin added where no plasmid was 
used). Fresh cultures were then inoculated at OD600nm 0.05 and growth followed 
using OD600nm (Figure 6-17 and Figure 6-18). 
After approximately 3.5 hours one of the cultures containing constructs featuring the 
Pnar promoter was placed in a sealed and para-filmed 50 ml falcon tube with the 
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addition of 40 mM potassium nitrate.  This was incubated at 70 oC with no shaking to 
bring about anaerobic conditions.  According to previous work this should cause 
induction of the Pnar promoter (Hidalgo et al., 2004).  In both cases a further culture 
featuring the Pnar promoter was kept shaking at 200 RPM.  At 6.5 hours 2 mM 
methyl p-toluate to test Af-Est2, or 2 mM p-tolualdehyde to test ApADH, was added 
as indicated (Figure 6-17 and Figure 6-18).  
After 21 hours 500 µl samples were taken for HPLC analysis, and added to 500 µl of 
acetonitrile.  The cell debris was removed by centrifugation, and the remaining 
supernatant quantified by HPLC against standard curves (Figure 6-17 and Figure 
6-18).  Samples were also taken at this time for SDS-PAGE and western blot 
analysis (Figure 6-19). 
6.3.3.3 AfEst2 expression in T. thermophilus, and the conversion of methyl p-
toluate. 
AfEst2 was expressed well by PslpA, Prmp and Pnqo, visable by both SDS-PAGE 
and western blot analysis (green bands).  A low level of expression by the induced 
Pnar promoter was also detected by western blot analysis (Figure 6-19).  The 
western blot was probed using a chicken anti-FLAG and mouse anti-myc primary 
antibodies.  Two secondary antibodies were used, rabbit anti-mouse IRDye 680 and 
goat anti-chicken IRDye 800CW.  T. thermophilus containing empty pBBTthK and 
without a plasmid were included as negative controls, and non-specific binding of 
multiple antibodies to a protein at approximately 100 kDa was detected in all T. 
thermophilus samples. 
Expression levels of AfEst2 seemed to match the promoter strengths determined 
using sfGFP expression (Figure 6-15), with PslpA showing the most expression 
followed by Prmp and Pnqo.   
While the negative controls showed some conversion of methyl p-toluate, T. 
thermophilus expressing AfEst2 showed a much higher conversion to p-toluic acid 
(Figure 6-17). Expression from Prmp gave the best conversion, followed by Pnqo 
and then PslpA.  Conversion of methyl p-toluate seems not only to be related to 
protein expression but also to cell density.  All of the initial 2 mM methyl p-toluate 
was not accounted for and it seems likely that a side reaction is occurring.   
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6.3.3.4 ApADH expression in T. thermophilus, and the conversion of p-
tolualdehyde 
No expression of ApADH was detected by either SDS-PAGE or western blot analysis 
(Figure 6-19), which is likely due to the strict codon usage of T. thermophilus (Figure 
6-12).  The western blot was probed as described for AfEst2 (section 6.3.3.3).  The 
p-tolualdehyde was converted predominantly into p-toluic acid, with some p-tolyl 
alcohol, by all the T. thermophilus cultures (Figure 6-18).  It was hoped that 
expression of ApADH could allow better conversion into p-tolyl alcohol rather than 
predominantly p-toluic acid.  The next step was therefore codon optimization of 
ApADH to match the T. thermophilus codon usage. 
6.3.3.5 Synthetic operon expression in T. thermophilus, and the conversion of 
methyl p-toluate. 
Cultures to test the expression of the synthetic operon (Figure 6-16) were set up in 
the same way as those to test AfEst2 and ApADH expression.  However induction of 
Pnar was carried out instead at 9 hours due to slower growth, at which point 2 mM 
methyl p-toluate was also added to all cultures.  Samples for HPLC, SDS-PAGE and 
western blot were taken as before, after 23 hours.   
Only expression of AfEst2 was detected by SDS-PAGE and western blot analysis 
(Figure 6-21).  The western blot was probed using chicken anti-flag, mouse anti-myc 
and mouse anti-6x-His primary antibodies.  Two secondary antibodies were used, 
rabbit anti-mouse IRDye 680 (shown in red) and goat anti-chicken IRDye 800CW 
(shown in green). A band at approximately 45 kDa was detected by the rabbit anti-
mouse IRDye 680 antibody in the PslpA sample, however this band is also faintly 
visible in the negative control suggesting it is not apADH.  Myc and 6x-his positive 
controls were included, although the 6x-his control was not detected. 
It is worth noting that the mpCAR gene is approximately 3.5 kbp in length, but that 
there is good translation of AfEst following this from the internal RBS.  AfEst2 
expression was to a similar level to AfEst2 expressed alone (Figure 6-19 and Figure 
6-21).  The mpCAR, ApADH or CtTran expression could not be detected by SDS-
PAGE or western blot.  However the positive 6x-His positive control was also poorly 
detected.  T. thermophilus containing empty pBBTth and without a plasmid were 
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included as negative controls, and non-specific binding of multiple antibodies to a 
protein at approximately 100 kDa was detected in all T. thermophilus samples.    
A significant amount of methyl p-toluate was converted to p-toluic acid by T. 
thermophilus expressing AfEst2, although low levels of p-toluic acid were also 
detected in the empty pBBTth and no plasmid controls (Figure 6-20). 
6.3.3.6 Growth rates of T. thermophilus expressing AfEst2, ApADH or the 
synthetic operon. 
Induction of the Pnar promoter by switching to anaerobic conditions with the addition 
of 40 mM potassium nitrite stalled growth nearly completely in all cases (Figure 6-17, 
Figure 6-18 and Figure 6-20).  T. thermophilus without the addition of the pBBTth 
plasmid and not challenged by kanamycin was generally able to grow more quickly 
and to a higher cell density than the other cultures.  Expression of AfEst2 or the 
synthetic operon from the strongest promoter PslpA resulted in much slower growth 
and lower final cell density.  In contrast the PslpA-ApADH culture did not show this to 
the same degree.  This was likely due to the fact that there was no protein 
expression, although the final cell density was still lower.  Expression from other 
constructs was comparable to empty pBBTTh in most cases. 
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Figure 6-17 - Growth curves of T. thermophilus constructs transformed with AfEst2 
constructs (left), and their conversion of methyl p-toluate into p-toluic acid (right). 
Left:  Growth curves of T. thermophilus transformed with pBBTth containing various 
constructs from Figure 6-16.  Two Pnar constructs representing a culture that was induced 
(I), and one which was not (NI).  pBBTth –ve refers to T. thermophilus transformed with an 
empty pBBTth plasmid.  No plasmid control refers to T. thermophilus with no plasmid, and 
no kanamycin in the growth media.  The points at which Pnar was induced, 2 mM methyl p-
toluate was added, and when samples were taken for analysis, are shown. 
Right:  Conversion of methyl p-toluate into p-toluic acid by T. thermophilus cells.  
Concentrations were calculated by reading HPLC peak areas and using standard curves. 
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Figure 6-18 - Growth curves of T. thermophilus constructs transformed with ApADH 
constructs (left), and their conversion of p-tolualdehyde (right). 
Left:  Growth curves of T. thermophilus transformed with pBBTth containing various 
constructs from Figure 6-16.  Two Pnar constructs representing a culture that was induced 
(I), and one which was not (NI).  pBBTth –ve refers to T. thermophilus transformed with an 
empty pBBTth plasmid.  No plasmid control refers to T. thermophilus with no plasmid, and 
no kanamycin in the growth media.  The points at which Pnar was induced, 2 mM p-
tolualdehyde was added, and when samples were taken for analysis, as shown. 
Right:  Conversion of p-tolualdehyde into p-toluic acid or p-tolyl alcohol by T. thermophilus 
cells.  Concentrations were calculated by reading HPLC peak areas and using standard 
curves. 
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Figure 6-19 - SDS-PAGE and western blot on T. thermophilus total cell lysate, 
transformed with constructs for the expression of AfEst2 or ApADH only. 
SDS-PAGE and Western blot analysis of the total cell lysate from T. thermophilus 
expressing ApADH (myc tagged) or codon optimised AfEst (FLAG tagged), under the control 
of PslpA, Pnar, Prmp and Pnqo.  Two cultures for Pnar were included, one which was 
induced (I), and one which was not (NI). Expected sizes of AfEst and ApADH are shown by 
the green and red boxes respectively. 
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Figure 6-20 - Growth curves of T. thermophilus constructs transformed with synthetic 
operon constructs (left), and their conversion of methyl p-toluate (right). 
Left:  Growth curves of T. thermophilus transformed with pBBTth containing various 
constructs from Figure 6-16.  Two Pnar constructs representing a culture that was induced 
(I), and one which was not (NI).  pBBTth –ve refers to T. thermophilus transformed with an 
empty pBBTth plasmid.  No plasmid control refers to T. thermophilus with no plasmid, and 
no kanamycin in the growth media.  The points at which Pnar was induced, 2 mM methyl p-
toluate was added, and when samples were taken for analysis, are shown. 
Right:  Conversion of p-tolualdehyde into p-toluic acid or p-tolyl alcohol by T. thermophilus 
cells.  Concentrations were calculated by reading HPLC peak areas and referring to 
standard curves. 
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Figure 6-21 - SDS-PAGE and Western blot of T. thermophilus total cell lysate, 
transformed with the constructs for the expression of a synthetic operon containing 
mpCAR, AfEst, ApADH and CtTran 
SDS-PAGE and western blot of total cell lysate from T. thermophilus expressing a synthetic 
operon for the expression of mpCAR (6x-His tagged), AfEst2 (FLAG tagged), ApADH (myc 
tagged) and CtTran (6x-His tagged), under the control of PslpA, Pnar, Prmp and Pnqo.  Two 
cultures for Pnar were included, one which was induced by anaerobic conditions and 40 mM 
potassium nitrite (I), and one which was not (NI).  T. thermophilus containing empty 
pBBTthK and without a plasmid were included as negative controls. Expected sizes of 
mpCAR, AfEst, ApADH and CtTran are shown by the blue, green, red and yellow boxes 
respectively.   
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6.3.5 Conversion of p-tolualdehyde into p-toluic acid by native T. 
thermophilus enzymes 
6.3.5.1 Three aldehyde ferredoxin oxidoreductases (AFOs) in the T. 
thermophilus genome 
Conversion of p-tolualdehyde into p-toluic acid by T. thermophilus is likely due to one 
or more AFO enzymes found in T. thermophilus.  These enzymes have been shown 
to carry out the oxidation of aromatic aldehydes into their corresponding acids, with 
oxidized ferredoxin as an electron acceptor (Heider, Ma and Adams, 1995).  There 
are three afo genes in the T. thermophilus genome, showing good similarity to well-
studied afo genes from Pyrococcus furiosus (Chan et al., 1995; Heider, Ma and 
Adams, 1995; Van Den Ban et al., 1999; Ni et al., 2013). 
6.3.5.2 Testing the rate of p-tolualdehyde oxidation by T. thermophilus. 
T. thermophilus was grown to plateau phase at approximately OD600nm 4.0 and the 
rate of p-tolualdehyde oxidation by these cells measured.  Three p-tolualdehyde 
concentrations were tested: 1000, 2500 and 5000 µM.  The rate of p-toluic acid 
production was measured by taking samples every 15 minutes for analysis by HPLC.  
Oxidation of p-tolualdehyde was relatively fast in all samples.  The presence of these 
enzymes will be problematic in using T. thermophilus for the reduction of p-toluic 
acid or other aromatic compounds.  Strategies to delete these enzymes should be 
considered if the use of a CAR in T. thermophilus is to be successful.   
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Figure 6-22 – Oxidation of p-tolualdehyde by T. thermophilus at OD600nm 4.0 
T. thermophilus was grown to OD600nm 4.0 before the addition of a p-tolualdehyde between 
1000 and 5000 µM.  Samples were taken every 15 minutes into an equal volume of 
acetonitrile, followed by centrifugation to remove cellular debris.  Samples were analyzed by 
HPLC and quantified against standard curves of p-toluic acid and p-tolualdehyde.   
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6.3.7 Improving ADH expression in T. thermophilus, and the 
expression of a g-lactamase. 
6.3.7.1 Codon optimisation of ApADH and redesign of 5ʹ CDS for an improved 
RBS 
ApADH was codon optimized the match the T. thermophilus codon usage, and a 
new RBS designed using the RBS calculator (Table 6-4) (Salis, Mirsky and Voigt, 
2009).  Due to the specific ApADH sequence, codon optimization was limited by the 
capabilities of gene synthesis for high GC sequences (IDT was used), and so some 
compromises had to be made.  Also the RBS strength designed was very low, 
possibly inhibiting successful protein expression.  The 5ʹ of the ApADH sequence 
and RBS was redesigned with the inclusion of an N-terminal myc tag, allowing a 
much stronger RBS to be designed (Table 6-4).  The PslpA promoter and a construct 
with no promoter were used to test protein expression in T. thermophilus (Figure 
6-23). 
6.3.7.2 Constructs for the expression of an ADH from Thermus sp. ATN1, and 
a g-lactamase from Sulfolobus solfataricus 
An ADH from Thermus sp. ATN1 has been shown to turnover benzaldehyde into 
benzyl alcohol (Höllrigl et al., 2008), and it was assumed it would therefore show 
good activity with p-tolualdehyde. As this enzyme is from a related Thermus species 
it was also hoped it would show better expression than ApADH.  A g-lactamase from 
Sulfolobus solfataricus (ss-g-lactamase) (Toogood et al., 2004; Hickey et al., 2009),  
was also identified as an interesting target for expression in T. thermophilus, possibly 
replacing AfEst2 in the cascade reaction and catalyzing a reaction of industrial 
interest to GSK.  Codon optimized C-terminally FLAG tagged sequences were 
designed with custom RBSs, and cloned under the control of a PslpA or Prmp 
promoters, as well as without a promoter, to test expression in T. thermophilus 
(Figure 6-23).   
6.3.7.3 Expression of codon optimised ApADH, ATN1-ADH and ss-g-lactamase 
T. thermophilus cells were transformed with constructs for the expression of ApADH, 
ATN1-ADH and ss-g-lactamase in pBBTth (Figure 6-23).  Overnight cultures were 
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grown at 70 oC, 200 RPM in TB media with 30 µg / ml kanamycin, following which 
samples taken for SDS-PAGE and western blot analysis.  Expression could not be 
detected by SDS-PAGE, but all proteins were detected by western blot (Figure 6-24).  
The western blot was probed using chicken anti-flag and mouse anti-myc primary 
antibodies.  Two secondary antibodies were used, rabbit anti-mouse IRDye 680 and 
goat anti-chicken IRDye 800CW.  Positive controls for myc and FLAG were included, 
showing up as a strong red or green band respectively.  T. thermophilus containing 
an empty pBBTth plasmid was included as a negative control, and non-specific 
binding of multiple antibodies to a protein at approximately 100 kDa was detected in 
all T. thermophilus samples.  
As ApADH showed good expression, and preliminary data suggested ATN1-ADH did 
not perform any better than ApADH for conversion of p-tolualdehyde into p-tolyl 
alcohol.  The use of ATN1-ADH in T. thermophilus was therefore not investigated 
further. 
6.3.7.4 Testing p-tolualdehyde and p-toluic acid conversion by T. 
thermophilus cells expressing ApADH. 
It was hoped that the expression of ApADH in T. thermophilus would improve the 
conversion of p-tolualdehyde into p-tolyl alcohol, and even that p-toluic acid might be 
converted to p-tolyl alcohol if native AFOs showed any reductive activity.  The 
equilibrium catalyzed by the native AFO and ADH enzymes will be dependent on the 
oxidative state of the ferredoxin and NAD(P)H pools, which may be influenced by the 
growth phase of T. thermophilus. 
For this reason the growth of the three T. thermophilus cultures tested (ApADH with 
no promoter (NP), PslpA-ApADH and an empty pBBTth –ve control) were 
synchronized by dilutions to a similar OD600nm, followed by growth at 70 oC 200 RPM 
before another dilution to OD600nm 0.1 (shown as hour 0 - Figure 6-25).  Growth was 
followed at OD600nm, and was fairly consistent between the cultures. 
At 4.5 hours, 2 mM p-toluic acid (Figure 6-25-A) or p-tolualdehyde (Figure 6-25-B) 
was added.  p-toluic acid concentration remained fairly constant at 2 mM, with very 
small amounts of p-tolualdehyde and p-tolyl alcohol detected.  The p-tolualdehyde 
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concentration very quickly decreased to around 500 µM after only one hour, and was 
almost completely converted to p-toluic acid 7.5 hours after its addition.   
6.3.7.5 Preliminary test for conversion of p-toluamide by T. thermophilus cells 
expressing ss-g-lactamase. 
Overnight cultures of T. thermophilus containing Prmp-ss-g-lactamase, ss-g-
lactamase only and an empty pBBTth –ve control were set up in TB media + 30 µg / 
ml kanamycin at 70 oC 200 RPM.    2 mM p-toluamide was added and the cultures 
incubated for a further 8 hours before samples were taken for analysis by HPLC. 
Between 260 and 290 mM p-toluic acid was detected in all the T. thermophilus 
cultures expressing ss-g-lactamase, with very low levels found in the empty pBBTth 
–ve control (Figure 6-26). 
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Figure 6-23 – New constructs for the expression of codon optimized ApADH, ATN1-
AND and ss-g-lactamase 
From RBS-CDS parts, constructs were made for the expression of ApADH, ATN1-ADH or 
ss-g-lactamase.  * is used to indicate a codon optimized sequence. 
Promoter:  A promoter part, either PslpA, Pnar, Prmp, Pnqo or no promoter relying on read 
through on plasmid. 
RBS:  A custom RBS for each CDS, designed using the RBS calculator. 
ApADH*:  Codon optimized gene for the expression of ApADH, a C- and N-terminal Myc tag 
was included. 
ATN1-ADH*:  Codon optimized gene for the expression of ATN1-ADH, a C-terminal FLAG 
tag was included. 
ss-g-lactamase*:  Codon ptimized gene for the expression ss-g-lactamase, a C-
terminal FLAG tag was included. 
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Figure 6-24 - SDS-PAGE and western blot analysis of T. thermophilus total cell lysate, 
transformed with constructs for the expression of codon optimized ApADH, ATN1-
ADH and ss-g-lactamase. 
SDS-PAGE and western blot analysis of total cell lysate from T. thermophilus expressing 
codon optimised ApADH (N- and C-terminally myc tagged), codon optimised ATN1-ADH 
(FLAG tagged), or codon optimised ss-g-lactamase (FLAG tagged).  Proteins were 
expressed under the control of the PslpA promoter, or without a promoter (NP). Expected 
sizes for ApADH, ATN1-ADH and ss-g-lactamase are shown by the red, green and orange 
boxes respectively.   
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Figure 6-25 - Conversion of p-toluic acid or p-tolualdehyde by T. thermophilus cells 
expressing ApADH 
The optical density of T. thermophilus cultures and concentrations of p-toluic acid, p-
tolualdehyde and p-tolyl alcohol are shown.  A. shows the addition of 2 mM p-toluic acid to 
growing T. thermophilus cells.  B. shows the addition of 2 mM p-tolualdehyde to growing T. 
thermophilus cells.  OD600nm is shown in black, and is on the right hand axis of both A and B.  
p-toluic acid is shown in blue, p-tolualdehyde in red and p-tolyl alcohol in green.  T. 
thermophilus cultures transformed with an empty pBBTth is shown by the circles, containing 
only ApADH by the squares and ApADH under the control of PslpA by triangles.  Error bars 
so the standard deviation of three readings. 
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Figure 6-26 – Conversion of p-toluamide by T. thermophilus cells expressing ss-g-
lactamase. 
Concentrations of p-toluamide (purple) and p-toluic acid (blue) are shown following 
incubation of 2 mM p-toluamide with cultures of T. thermophilus expressing ss-g-lactamase.  
T. thermophilus containing an empty pBBTth vector was used as the control.  T. 
thermophilus expressing ss-g-lactamase was able to transform between 265 and 290 9µM p-
toluamide into p-toluic acid, while the control showed only a very low concentration of p-
toluic acid.  Error bars show the standard deviation of two repeats. 
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6.3.8 Improving CAR expression in T. thermophilus 
6.3.8.1 Ancestral gene reconstruction for a more thermostable CAR 
A thermostable CAR is necessary for expression in T. thermophilus, but to date no 
thermostable CARs have been identified.  Efforts to find a CAR from a thermophilic 
source were also unsuccessful (data not shown).  mpCAR, as discussed in chapter 
4, comes from the moderate thermophile Mycobacterium phlei and is stable up to 
approximately 47 oC in vitro (Figure 6-27).  It was hoped in vivo stability might be 
greater, allowing some CAR activity at lower T. thermophilus growth temperatures.  
However ideally a more thermostable CAR would be used for expression in T. 
thermophilus. 
Adam Thomas (University of Exeter) investigated the use of ancestral sequence 
reconstruction to produce a more thermostable CAR (ancCAR), which was stable up 
to 59 oC (Figure 6-27). 
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Figure 6-27 - Thermostability of a number CAR proteins in comparison to ancCAR 
The residual activity after incubation for half an hour at a range of temperatures, relative to a 
control kept on ice, is shown.  mpCAR: CAR from Mycobacerium phlei, msCAR: CAR from 
M. smegmatis, tpCAR: CAR from Tsukamurella paurometabola, noCAR: CAR from Nocardia 
otitidiscaviarum, niCAR: N. iowensis, mmCAR: M. marinum, ancCAR:  Ancestrally 
reconstructed CAR. 
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6.3.8.2 Design and expression of codon optimised ancCAR, mpCAR, and a re-
optimised CtTran. 
Codon optimized sequences for the expression of mpCAR (CAR from Mycobacerium 
phlei), ancCAR (Ancestrally reconstructed CAR) and CtTran were designed, 
featuring N-terminal FLAG tags.  RBSs were designed using the RBS calculator set 
to maximize RBS strength.  The PslpA promoter was placed ahead of these genes 
for their expression in T. thermophilus in pBBTth (Figure 6-28-A). 
T. thermophilus containing these constructs were grown overnight in TB media + 30 
µg / ml kanamycin at 70 oC, 200 RPM.  The temperature was then dropped to 60 oC 
for a further 6 hours (given the lower thermostability of the CARs) before samples 
were taken for SDS-PAGE and Western blot analysis.  FLAG tagged protein was 
detected at the expected molecular weight for all proteins by western blot analysis, 
but were not detectable by SDS-PAGE (Figure 6-29).  The western blot was probed 
using a chicken anti-flag primary antibody, and a goat anti-chicken IRDye 800CW 
secondary antibody.  A positive FLAG control was used, although was only weakly 
detected.  T. thermophilus containing an empty pBBTth plasmid was included as a 
negative control, and non-specific binding of multiple antibodies to a protein at 
approximately 100 kDa was detected in all T. thermophilus samples. 
6.3.8.3 Expression of CAR-CtTran operons for testing CAR activity in T. 
thermophilus 
Having shown successful expression of mpCAR, ancCAR and CtTran, CtTran was 
cloned downstream each of the CARs creating two protein operons (Figure 6-28-B).  
Expression of the CARs with CtTran was tested as before, with 2 mM p-toluic acid 
added upon reducing temperature to 60 oC.  Approximatly 6 hours after reducing the 
temperature to 60 oC samples were taken for western blot analysis and HPLC.  
Western blot analysis of the cell lysates did not provide conclusive results, although 
suggests the CARs and CtTran were expressed together (Figure 6-30).  No 
conversion of 2 mM p-toluic acid into p-tolualdehyde or p-tolyl alcohol was detected 
by these constructs when analyzed by HPLC (data not shown).   
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Figure 6-28 – Constructs for the expression of codon optimized mpCAR, ancCAR and 
CtTran from the PslpA promoter 
From RBS-CDS parts, constructs were made for the expression of A:  mpCAR, ancCAR or 
CtTran, or B: mpCAR or ancCAR in combination with CtTran.  * is used to indicate a codon 
optimized sequence. 
PslpA:  The PslpA promoter. 
RBS:  A custom RBS for each CDS, designed using the RBS calculator. 
mpCAR*:  Codon optimized gene for the expression of mpCAR, a C-terminal FLAG tag was 
included. 
ancCAR*:  Codon optimized gene for the expression of ancCAR, a C-terminal FLAG tag was 
included. 
CtTran*:  Codon optimized gene for the expression of CtTran, a C-terminal FLAG tag was 
included. 
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Figure 6-29 – SDS-PAGE and western blot analysis of T. thermophilus total cell lysate with soluble and insoluble fractions, 
transformed with constructs for the expression of codon optimized ancCAR, mpCAR and CtTran only, under the control of the PslpA 
promoter. 
SDS-PAGE and western blot of total cell lysate from T. thermophilus expressing codon optimised mpCAR (FLAG tagged and shown as pCAR), 
codon optimised ancCAR (FLAG tagged and shown as aCAR), or codon optimised CtTran (FLAG tagged and shown as CT) from the PslpA 
promoter.  Expected sizes for mpCAR and ancCAR are shown by the red boxes, and for CtTran by the yellow boxes.  
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6.3.9 Expression of a Cas9 in T. thermophilus 
6.3.9.1 Designing constructs for the expression of Cas9 in T. thermophilus 
A codon optimized and N-terminal FLAG tagged sequences for the expression of the 
Cas9 protein from Streptococcus thermophilus were designed assembled by Gibson 
assembly.   
6.3.9.2 Strong Cas9 expression appears to be toxic to T. thermophilus 
Cas9 under the control of PslpA, Prmp and Pnqo were transformed into T. 
thermophilus.  With expression of Cas9 under the control of PslpA no colonies were 
found.  Expression from Prmp gave two or three colonies, while Pnqo resulted in 
many colonies. It is clear that high levels of Cas9 expression is toxic to T. 
thermophilus growth.   
Overnight cultures containing Prmp and Pnqo Cas9 constructs were grown overnight 
in TB media + 30 µg / ml kanamycin.  The total cell lysate was analyzed by western 
blot, showing expression of a FLAG tagged protein of the correct molecular weight of 
Cas9, under the control of Pnqo.  No protein was detected from the Prmp construct 
(Figure 6-30).  The western blot was probed using a chicken anti-flag primary 
antibody, and a goat anti-chicken IRDye 800CW secondary antibody.  A positive 
FLAG control was used, although was only weakly detected.  T. thermophilus 
containing an empty pBBTth plasmid was included as a negative control and non-
specific binding of multiple antibodies to a protein at approximately 100 kDa was 
detected in all T. thermophilus samples. 
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Figure 6-30 – Western blot on T. thermophilus total cell lysate, transformed with 
constructs for the expression of codon optimized ancCAR or mpCAR in combination 
CtTran (all FLAG tagged).  And for expression of a Cas9 protein (FLAG tagged) from 
S. thermophilus. 
SDS-PAGE and western blot of total cell lysate from T. thermophilus expressing codon 
optimised mpCAR or ancCAR in combination with CtTran (all FLAG tagged), under the 
control of the PslpA promoter, or codon optimised Cas9 from S. thermophilus (FLAG tagged) 
under the control of the Prmp or Pnqo promoters.  Expected sizes for mpCAR and ancCAR 
are shown by the red boxes, for CtTran by the blue boxes and for Cas9 by the yellow box. 
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6.3.10 Summary of Results 
This study aimed to develop and test the use of T. thermophilus HB27 as a host 
organism for whole-cell biocatalysis.  To facilitate the modular construction of DNA 
parts, a T. thermophilus BioBricks vector was constructed.  Using this vector and a 
sfGFP reporter we were able to characterize a number of constitutive promoters 
based on their sfGFP expression, providing a panel of promoters with a range of 
known strengths.  The use of the Pnar promoter was also investigated although the 
requirement for anaerobic conditions limited its usefulness.  
The RBS calculator was used to design strong RBSs for all of the proteins expressed 
in T. thermophilus throughout this study.  We have demonstrated this to be an 
effective method for creating custom RBSs for T. thermophilus for maximum protein 
expression. 
The pathway shown in Figure 6-5 was to be carried out in T. thermophilus to 
demonstrate its use for whole-cell biocatalysis.  However in practice, while all the 
enzymes could be expressed, only the hydrolysis of methyl p-toluate was achieved 
in T. thermophilus, due to the strong oxidation of p-tolualdehyde to p-toluic acid by 
native enzymes. 
In summary we have demonstrated the use of T. thermophilus for whole-cell 
biocatalysis, but more work is needed to complete the pathway shown in Figure 6-5.  
We have also started the process of designing and characterizing well-defined parts 
for the predictable construction of new pathways in T. thermophilus. 
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6.4 Discussion 
6.4.1 Designing new T. thermophilus vectors 
6.4.1.1 Minimisation of vector size inhibited transformation into T. 
thermophilus 
The first BioBricks vector featured a minimum of apparently junk DNA but was 
unable to replicate in T. thermophilus (Figure 6-7).  Reasons were that either some 
unknown essential piece of DNA was removed in this design, or a problem with the 
close proximity of parts such as the replication region for T. thermophilus and 
kanamycin resistance cassette inhibited antibiotic resistance or plasmid replication in 
T. thermophilus.  Possibly the inclusion of the antibiotic resistance cassette ahead of 
the region of replication rather than after it may have offered a better design. 
The inclusion of a larger section of DNA taken directly from pMKE2 allowed a 
second plasmid to replicate in T. thermophilus (Figure 6-9), although it is unclear 
whether this is due to the inclusion of a piece of DNA that was missing previously, or 
because the parts are better separated from each other. 
6.4.1.2 Defined vector parts can be combined in a number of ways for the 
assembly of new vectors. 
Recent work on a modular system for Clostridium-E. coli shuttle plasmids allows the 
combination of many of the components from disparate plasmids to be combined to 
create new vectors suitable for specific hosts and applications.  Using a system of 
type II restriction enzymes, components can be combined easily as modules, 
allowing a large number of different vectors to be constructed (Heap et al., 2009).  A 
similar system could be envisaged for the construction of new T. thermophilus 
vectors, using the parts already established and described in the introduction.  An 
example of how much a system might operate is shown in Figure 6-31. 
 
	346	
 
Figure 6-31 – Hypothetical modular system for the creation of T. thermophilus vectors 
from established parts. 
A modular system for the assembly of DNA parts for the construction of new T. thermophilus 
vectors - inspired from (Heap et al., 2009).  A number of regions of replication for T. 
thermophilus and thermostable antibiotic resistance markers are available which could be 
combined in a number of combination.  Different selectable markers, origins of replication for 
E. coli and multiple cloning sites (MCSs) could be used.  A system of type II restriction 
enzymes suggested for the modular construction of Clostridium-E. coli shuttle plasmids 
(Heap et al., 2009), could be used for a similar approach in T. thermophilus. 
6.4.2 Designing genes for expression in T. thermophilus 
6.4.2.1 Codon optimisation was essential for protein expression in T. 
thermophilus 
Codon optimization proved to be essential for protein expression in T. thermophilus.  
Initially native genes for mpCAR and ApADH were used and no expression was 
detected (Figure 6-19 and Figure 6-21).  When codon optimized constructs were 
used protein was detected by western blot analysis (Figure 6-24 and Figure 6-29), 
however expression was still at a relatively low level compared to the more highly 
Re
pA
Re
pT
Re
p
Re
pV
pN
HK
101
Ka
nH
ygB
le
MCS
E. coli 
ori and 
marker
AscI
FseI
PmeI
SbfI
	 347	
expressed AfEst2 (Figure 6-19).  Clearly codon optimization is important for gene 
expression in T. thermophilus, but the process of optimization itself is in need of 
optimization.  As discussed previously, many other factors can be considered other 
than codon usage and these may be relevant for optimal expression in T. 
thermophilus. 
6.4.2.2 Using the RBS calculator for RBS design for expression in T. 
thermophilus 
The RBS calculator was used to design custom RBSs for all the genes in this study, 
set to maximize RBS strength.  Initially RBS BioBrick parts were created to allow 
modulation of RBS strength through the introduction of new RBS BioBrick parts.  
However BioBrick cloning results in a scar sequence between the SD and start 
codon, constraining the design space available to the RBS calculator.  This limitation 
along with the extra time required to clone RBS sites meant it was much more 
efficient to have RBS sites gene synthesized in front of new genes directly.  However 
this limits their reuse with new RBSs. 
A range of RBS strengths were predicted by the calculator for the RBSs designed 
(Table 6-4).  However these do not seem to correlate well with the observed protein 
expression.  Arguably the best protein expression was observed for AfEst2, with a 
predicted RBS strength of only 69,963 (Figure 6-19).  In contrast the RBS designed 
for ancCAR had a predicted strength of 1,287,767 yet was not detected by SDS-
PAGE, and only weakly by western blot analysis (Figure 6-29).  Possibly the 
predictive power of the RBS calculator for T. thermophilus is not reliable, or other 
factors have a greater influence on protein expression.  However it is clear that the 
RBS calculator can be used for the design of functional RBSs for T. thermophilus. 
6.4.3 Promoter characterisation 
6.4.3.1 A range of promoters of varying strength were characterised using 
sfGFP as a reporter. 
Promoters were successfully characterized in terms of their strength using sfGFP as 
a reporter (Figure 6-15).  As expected PslpA was by far the strongest promoter, 
useful where high levels of expression are required.  However in some cases 
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promoters can be too strong, for example when the expressed protein is toxic to the 
cell, or strong expression inhibits reasonable growth rates.  In these cases it is useful 
to have a characterized set of promoters covering a range of strengths.  Prmp offers 
a more moderate level of protein expression for these cases, followed by Pnqo. 
Characterization of the promoters would be better achieved looking at sfGFP 
expression over all phases of growth, as protein expression is dependent on growth 
phase.  For example it is likely that the regulation of PslpA by SlrA and SlpM is not 
consistent across all phases of growth.  Using E. coli this can be achieved using a 
plate reader with shaking and heating capabilities, with OD and fluorescence 
readings taken automatically at regular time intervals (Hirst, 2014).  This is more 
challenging for a thermophile as most plate readers do not have the ability to heat to 
the required temperature, and evaporation becomes more of a problem than it 
already is at 30 or 37 oC. 
6.4.3.2 Read-through from the PslpA-Kanamycin antibiotic resistance 
cassette. 
Promoter characterization using sfGFP shows weak expression with no promoter 
present, using the pBBTTh vector (Figure 6-14 and Figure 6-15).  This is likely a 
result of transcriptional read through from the PslpA promoter driving the kanamycin 
resistance cassette (Figure 6-9).  While the BioBricks cloning site is insulated by two 
terminators, these are designed for use in E. coli and may be less functional in T. 
thermophilus.  There is also a possible terminator region downstream of the kan 
gene.  Future vector designs should take this into account.  However the weak level 
of expression detected with no promoter present could prove useful where low levels 
of expression are desirable.   
6.4.3.3 An ideal promoter would be a strong inducible promoter. 
A strong inducible promoter would be a powerful tool for the use of T. thermophilus 
for whole-cell biocatalysis.  This would allow the accumulation of biomass before 
induction, and the optimization of expression conditions.  Unfortunately the currently 
available inducible promoters have a number of disadvantages making them 
unattractive for this purpose.   
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A system mirroring the T7 system used in E. coli would be attractive (Tabor, 2001), 
but requires a suitable thermostable viral RNA polymerase and a tightly controlled 
inducible promoter such as the lac promoter.  It is tempting to look in the genome of 
T. thermophilus for systems resembling the lac operon (Jacob and Monod, 1961).  
On the pTT27 plasmid of T. thermophilus, a gene for a LacI family transcription 
regulator is followed by an operon ending in a gene for a beta-glucosidase (Figure 
6-32).  Possibly a promoter for this operon is regulated by the LacI family 
transcription regulator and may be inducible.  The presence of non-coding regions 
and predicted promoter regions using bioinformatics tools identifies three potential 
areas which could contain such a promoter, which would be interesting to test using 
the sfGFP reporter system. 
 
Figure 6-32 – A lac like operon on the pTT27 plasmid of T. thermophilus HB27 
An area of the T. thermophilus HB27 pTT27 plasmid (bp 33,740 to 40,570 is shown), 
contains a region with a number of similarities to the lac operon.  A gene for the expression 
of a LacI family transcription regulator is followed by an operon ending in the gene for a 
beta-glucosidase.  It is unclear if the LacI family transcription regulator regulates a promoter 
for this operon, or indeed where this promoter is.  However there are a number of likely 
options and regions that are identified as promoters using various bioinformatics tools 
available online (Molbiol-Tools Web Portal, 2016), or as they are non-coding regions.  This 
figure was made with SnapGene. 
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6.4.4 Using T. thermophilus for the hydrolysis of methyl p-toluate 
or p-toluamide by whole-cell biocatalysis. 
6.4.4.1 Expression of AfEst2 in T. thermophilus for whole-cell biocatalysis 
Expression of AfEst2 in T. thermophilus was strong with the protein clearly visible by 
both SDS-PAGE and western blot analysis when expressed alone or as part of a 
synthetic operon (Figure 6-19 and Figure 6-21).  In the synthetic operon the AfEst2 
gene was approximately 3.5 kbp from the beginning of the mRNA transcript (Figure 
6-16), yet a similar level of expression was detected compared to AfEst2 expressed 
alone.  Translation initiation via the RBS in the middle of the operon mRNA transcript 
is equally as efficient as initiation from the same RBS near the beginning of the 
transcript for AfEst2 alone.  This suggests the construction of a large synthetic 
operon for expression in T. thermophilus is a reasonable approach for the 
expression of multiple genes. 
Slower growth by constructs designed for expression from PslpA is likely due to the 
burden of high expression on the T. thermophilus cells.  Lower cell densities in these 
constructs also resulted in a poorer conversion of methyl p-toluate than expression 
from the weaker Prmp promoter.  Induction of Pnar resulted in very slow growth 
rates and demonstrates this promoter to be unsuitable for the use of T. thermophilus 
for whole-cell biocatalysis. 
T. thermophilus has a number of native esterase enzymes (Henne et al., 2004), and 
it likely one or more of these have some activity against methyl p-toluate, as some p-
toluic acid was detected in the control experiments. 
6.4.4.2 Expression of ss-g-lactamase in T. thermophilus   
A preliminary test for the expression of ss-g-lactamase in T. thermophilus showed 
good expression of the enzyme (Figure 6-24), and that it could be used for the 
whole-cell conversion of p-toluamide to p-toluic acid, although yields were low 
(Figure 6-26).  This further demonstrates the use of T. thermophilus for whole-cell 
biocatalysis although a more thorough characterization of the expression of ss-g-
lactamase would be useful. 
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6.4.5 Aldehyde ferredoxin oxidoreductases limit the potential of T. 
thermophilus for the reduction of acids or aldehydes. 
6.4.5.1 Aldehyde ferredoxin oxidoreductases 
The T. thermophilus genome contains three tungsten containing aldehyde ferredoxin 
oxidoreductases.  These enzymes catalyze the reversible oxidation of aldehydes into 
carboxylic acids, generally using ferredoxin as a redox partner (Bevers, 2008).  They 
are part of a group of pyranopterin containing molydbo- or tunsto enzymes, in which 
tungsten is always part of the active site, held by two pyranopterin cofactors and an 
oxo group.  These enzymes contain an iron-sulphur cluster which is responsible for 
the transfer of electrons from the pyranopterin cofactor to an electron acceptor, 
usually ferredoxin (Omelchenko et al., 2005).  While the reaction is reversible it has 
been shown to strongly favor the oxidative direction in vitro (Heider, Ma and Adams, 
1995).  
The AFOs in T. thermophilus have the ascension numbers: GI:499487549, 
GI:499485830 and GI:499487802 (labelled as TTh Afo 1 to 3 respectively in Table 
6-5).  Some of the best studied AFOs are found in Pyrococcus furious which has five 
AFOs.  These are labelled as:  AOR -  most active on aldehydes derived from amino 
acids, FOR – active against small C1-C3 aldehydes, GAPOR - only active against 
glyceraldehyde-3-phosphate, WOR4 – no known function and WOR5 - with high 
affinity for several substituted and non-substituted aliphatic and aromatic aldehydes 
with variable chain lengths (Bevers, 2008).  The percentage identity similarities of 
these AFOs compared to the T. thermophilus AFOs is compared in Table 6-5, 
determined using the Clustal Omega multiple sequence alignment tool (McWilliam et 
al., 2013). 
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Table 6-5 – Percentage identity matrix comparing the AFO’s from P. furiosus with 
those of T. thermophilus. 
 WOR5	 FOR	 WOR4	 AOR	 GAPOR	 TTh	AFO	1	
TTh	AFO	
2	
TTh	AFO	
3	
TTh 
AFO 1 20.96 27.51 30.97 35.71 34.52 100 39.39 34.3 
TTh 
AFO 2 22.49 32.84 35.55 36.49 40.03 39.39 100 44.2 
TTh 
AFO 3 23.93 30.11 29.95 33.97 38.15 34.3 44.2 100 
AFO’s from P. furiosus have been labelled as they are referred to in the literature as AOR, 
FOR, GAPOR, WOR4 and WOR5 (Bevers, 2008).  T. thermophilus AFO’s are labelled as 
TTH Afo 1 to 3.  Determined using the Clustal Omega multiple sequence alignment tool 
(McWilliam et al., 2013). 
 
6.4.5.2 Expression of ApADH in T. thermophilus for the reduction of p-
tolualdehyde or p-toluic acid. 
P. furious has been used previously for the reduction of aromatic carboxylic acids 
through the action of its native AFOs, relying on an ADH to pull the equilibrium 
towards the alcohol product (Van Den Ban et al., 1999).  The redox state of the 
ferredoxin pool has been shown to be a critical factor in achieving reduction with 
AFOs, with higher levels of reduced ferredoxin favoring the reduction of acids (Van 
Den Ban et al., 1999).  Feeding P. furious hydrogen allowed hydrogenase enzymes 
to regenerate reduced ferredoxin improving this reaction (Ni et al., 2013).  It was 
hoped that the expression of ApADH might pull the equilibrium catalyzed by the 
AFOs through to p-tolyl alcohol, or at least compete with the AFOs allowing more p-
tolualdehyde to be converted to p-tolyl alcohol rather than p-toluic acid.  As the 
ferredoxin pool has been shown to be important for the AFO enzymes, and it is likely 
dependent on the growth phase of T. thermophilus, efforts were made to 
synchronize the growth of T. thermophilus cultures expressing ApADH and an empty 
plasmid control. 
p-toluic acid and p-tolualdehyde were added in the early exponential phase in the 
hope growing cultures would be producing more reduced ferredoxin (Figure 6-25).  
Negligible conversion of p-toluic acid was seen suggesting that the AFOs had very 
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little reductive activity.  The expression of ApADH in T. thermophilus had little impact 
on its conversion of p-tolualdehyde, with native ADH enzymes responsible for the 
most of conversion to p-tolyl alcohol observed (however the majority was still 
oxidized to p-toluic acid).  ApADH has an optimum temperature > 90 oC so may not 
be as active at 70 oC as native T. thermophilus ADH enzymes (Hirakawa, Kamiya 
and Kawarabayashi, 2004).  Marginally more p-tolualdehyde was converted to p-tolyl 
alcohol by the T. thermophilus expressing ApADH from the PslpA promoter, possibly 
as a result of the expression of this enzyme. 
6.4.5.3 Could the reduced ferredoxin pool be increased in T. thermophilus? 
For P. furious to reduce carboxylic acids, maintaining high levels of reduced 
ferredoxin was shown to be important (Ni et al., 2013).  If high levels of reduced 
ferredoxin could be maintained in T. thermophilus, possibly the AFOs could be used 
in a similar way, in the reductive direction rather than the oxidative.  A genome scale 
flux balance model of T. thermophilus has been developed and is available (Lee et 
al., 2014).  This may offer potential routes for metabolic engineering to try and 
increase the reduced ferredoxin pool.   
A NADH-ferredoxin oxidoreductase from Trichomonas vaginalis has previously been 
expressed in E. coli for production of reduced ferredoxin using NADH as an electron 
donor (Do et al., 2009).  Possibly a similar enzyme might be used in T. thermophilus 
to produce more reduced ferredoxin.  
6.4.6 Gene deletion techniques for T. thermophilus 
6.4.6.1 Deletion of afo genes may be required for the pathway to function in T. 
thermophilus. 
For effective incorporation of any reductive biotransformation using T. thermophilus 
and featuring aldehydes in the pathway, the deletion of the three afo genes may be 
essential to stop oxidation of the aldehyde into its corresponding carboxylic acid.  
Cas9 may offer an interesting alternative for gene deletion to the more conventional 
use of the homologous recombination with pyrE gene used as a marker. 
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6.4.6.2 Cas9 could offer an efficient method for gene deletion in T. 
thermophilus. 
Recently CRISPR-Cas9 has received much attention as an efficient method for gene 
deletion, among other things (Mali, Esvelt and Church, 2013).  Possibly the CRISPR-
Cas9 system may be used for the deletion of the afo genes from T. thermophilus.  In 
order to begin exploring this possibility we have looked at expressing a well 
characterized Cas9 from Streptococcus thermophilus (Xu et al., 2015).  Interestingly, 
when constructs were created for the expression of Cas9 from strong promoters 
PslpA and Prmp, either no colonies, or only a couple of colonies, were recovered 
following transformation into T. thermophilus.  However many colonies were 
recovered when a construct for the expression of Cas9 from the much weaker Pnqo 
promoter was transformed into T. thermophilus.  It seems likely that high levels of 
Cas9 expression is toxic to T. thermophilus, possibly due to non-specific cutting of 
DNA by the Cas9 protein (Hsu, Lander and Zhang, 2014).  The expression Cas9 
was detected by western blot analysis when expressed from Pnqo (Figure 6-30).  
The next steps will be the design of an RNA to allow Cas9 targeting, and validation 
of the Cas9 gene deletion approach.  A good initial target may be the pyrE gene 
which would result in uracil autotrophy but resistance to 5-fluoroorotic acid (5-FOA) 
(Tamakoshi et al., 1997), facilitating screening for a successful gene deletion.   
6.4.6.3 PyrE gene deletion technique 
An approach known to work with T. thermophilus is homologous recombination using 
the pyrE gene as a marker, shown in Figure 6-33.  A pyrE knockout is first prepared.  
Regions of homology to the target gene, 500 bp in size, are prepared either side of 
the pyrE gene on a vector, with homologous recombination replacing the target gene 
with the pyrE gene in the chromosome.  The pyrE gene is then deleted again to 
allow subsequent rounds of gene deletion.   
This technique makes use of the uracil autotrophy and resistance 5-FOA that occurs 
upon pyrE gene deletion, with growth in the absence of uracil restored with the 
knock-in of pyrE  (Tamakoshi et al., 1999).   
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Figure 6-33 – The pyrE gene deletion method. 
500 bp regions of homology to a target gene (GOI) are prepared flanking a pyrE gene on a 
vector.  Homologous recombination restores growth in the absence of uracil of a pyeE 
knockout strain of T. thermophilus, with the target gene (GOI) replaced with the pyrE gene. 
The pyrE gene is deleted by homologous recombination allowing the next round of gene 
deletion making use of pyrE. 
Target gene (GOI) is deleted and the pyrE knockout is maintained. 
6.4.7 Conclusions 
The ease with which T. thermophilus can be transformed has driven its use as a 
model organism for understanding life at high temperatures (Cava, Hidalgo and 
Berenguer, 2009), and could also drive its uptake as the host organism of choice for 
whole-cell biocatalysis at elevated temperatures.  Having a number of genetic parts 
that can be combined predictably is an important step in developing T. thermophilus 
as a host organism.   
Better characterization of a wider range of promoters should be performed, in order 
to better understand the regulation on the current constitutive promoters, and in an 
GOI
pyrE
pyrE
A
B
C
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Vector
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effort to find an industrially useful inducible promoter.  The RBS calculator allows 
strong RBSs to be designed for each CDS.  Codon optimization is essential for the 
expression of genes in T. thermophilus. However more work is needed to 
understand translation efficiency determinants, although this is a not a problem 
unique to T. thermophilus.  The approach taken by DNA 2.0 for E. coli and other 
organisms may offer a better approach for designing genes for T. thermophilus 
(Welch et al., 2009). 
Whole-cell biocatalysis by T. thermophilus cells expressing AfEst2 and ss-g-
lactamase has been demonstrated.  However the completion of the entire pathway 
shown in Figure 6-5 would offer a much better demonstration.  The three afo genes 
in T. thermophilus can be deleted to allow this pathway to be completed, either using 
a Cas9 approach or using the pyrE gene deletion method (Tamakoshi et al., 1999) 
(Figure 6-33).  
This study highlights the potential of T. thermophilus is an organism for synthetic 
biology and whole-cell biocatalysis at elevated temperatures.  The development of 
well characterized parts and tools, and the completion of the pathway in Figure 6-5 
would help that potential be realized. 
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Chapter 7 - General Discussion 
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7.1 Multistep pathways in biocatalysis 
This study has sought to characterise a number of enzymes before incorporating 
them into a multistep enzyme reaction.  This multistep reaction has then been 
carried out in vitro using isolated enzymes, and in vivo exploring the use of the 
thermophile T. thermophilus as a host organism. 
Currently single step enzyme reactions are most commonly used for industrial 
biocatalysis.  However as the uptake of enzymes for synthetic chemistry continues, 
multistep reactions are likely to become more prominent (Bruggink, Schoevaart and 
Kieboom, 2003; Wohlgemuth, 2010). The complexity of these reactions increases 
substantially as more steps are added, requiring more of a synthetic biology 
approach to their design and optimization than a single step reaction might require 
(Ricca, Brucher and Schrittwieser, 2011).    
Synthetic biology is inspired by engineering disciplines demanding the use of well 
characterized “parts” (Ellis, Adie and Baldwin, 2011).  In a similar vein, the enzyme 
toolbox is an image often invoked to describe the enzymes which have established 
themselves as tools for synthetic chemistry (Meyer et al., 2013).  Possibly the 
enzymes in the enzyme toolbox could be thought of as “parts” for combination into 
predictable multistep cascade reactions, although the thorough biochemical 
characterization of each enzyme would first be necessary.  The characterisation of 
enzymes for their incorporation into a multistep reaction is the approach taken 
throughout this study. A lesson that has been learnt in synthetic biology is that each 
“part” must be robustly characterized before it is used in a larger “device” (Cheng 
and Lu, 2012). In the same way, each enzyme in a toolbox needs thorough 
characterization before it can be incorporated into a larger pathway.  
7.2 Characterising enzymes 
Possibly the most important characterisation of enzymes is that of their substrate 
specificity.  However, before assays examining substrate specificity can be carried 
out, constraints on the assay conditions such as pH and temperature must be 
determined.  Furthermore, some substrates may only be accepted at higher 
temperatures or different pH values, with some enzymes catalysing different 
reactions entirely at extremes of pH (Höllrigl et al., 2008). 
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Often substrate specificity is reported as the relative activity at a single substrate 
concentration, or the percentage conversion in a specified time period.  Arguably this 
provides little more than a yes/no analysis of whether a substrate is turned over by 
an enzyme. Far more meaningful information can be gained looking at the kinetics of 
the enzyme with changing substrate concentration. This is particularly important for 
modelling complex reactions, as some substrates may only have industrially relevant 
rates at high concentrations. 
Testing all available substrates for an enzyme is unfeasible, so some predictions on 
substrate specificity must be made.  Given enough data, quantitative structure 
activity relationship (QSAR) models might be constructed to help extrapolate 
substrate specificity (Damborsky and Brezovsky, 2014).  Alternatively, some 
progress is being made on predicting substrate specificity from the crystal structures 
of some enzymes, although protein flexibility must be taken into account (Tyagi and 
Pleiss, 2006). 
Characterisation of product inhibition is also important, as we showed for the CAR 
enzymes.  Enzymes should be tested for product inhibition, as well as the effects of 
other compounds likely to be included in a multistep reaction such as cofactors or 
metal ions. 
Other important considerations when characterizing enzymes are the effects of pH 
and temperature.  Characterizing the effect of pH on the activity of enzymes is often 
reported at a single substrate concentration, and the enzymes in this study were 
characterized in this way.  However, the effect of pH on enzyme activity is more 
complex than this, as it is a result of the changing protonation of various amino acid 
residues in the protein, or even the protonation of substrate itself.  It must be borne 
in mind that accurately reporting these effects requires a prohibitively large number 
of experiments to determine Michaelis-Menten parameters at each pH.  Furthermore, 
substrates may be affected in different ways at varying pH values (Stryer, 1995).  
These issues mean that characterization of pH effects on enzymes must necessarily 
be a compromise of data range and practicality. The effects of temperature on 
enzyme activity is also often reported at a single substrate concentration.  However, 
unless changing temperature causes a conformational change in the enzyme, 
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activity will generally follow the Arrhenius equation which can be incorporated into 
Michalis-Menten-like equations in the place of kcat (Laidler, 1984). 
Thermostability can be reported in a number of ways, such as looking at residual 
activity after heating the enzyme at a range of temperatures, or looking for the 
melting temperature using techniques such as dynamic scanning fluorimetry (DSF) 
(Vivoli et al., 2014).  In practice, enzymes are generally used at temperatures well 
below these limits.  What is often more relevant is operational stability, which 
temperature will often play a large role in.  Operational stability is generally reported 
as the half-life of the enzyme in a certain condition.  This might be considered as a 
simplified view of enzyme degradation, which is itself a complex process (Polizzi et 
al., 2007).   
Possibly the creation of enzyme specification sheets, similar to specification sheets 
produced on DNA parts for synthetic biology, might aid the design of novel multistep 
pathways (Cooling et al., 2010; Sainz de Murieta, Bultelle and Kitney, 2016).   
Such a sheet might seek to contain information on changing activity with pH and 
temperature, any inhibition by commonly used buffers, metal ions or cofactors and 
information on stability at extremes of temperature, pH or in solvents, as well as 
operational stability in more commonly used conditions.  Where structural 
information on an enzyme is available, limitations on the size and shapes of 
molecules which might fit in the active site could be provided.  Providing information 
on substrate specificity in terms of a structure-activity relationship would also be 
valuable in allowing chemists to select suitable enzymes for specific reactions with 
greater confidence.   
7.3 The characterisation of the thermostable esterase Af-
Est2 for inclusion in the multistep reaction. 
The first step in the multistep reaction shown in Figure 1-8 was filled with a novel 
esterase, Af-Est2, from the hyperthermophile A. fulgidus.  While hydrolase enzymes 
are the most studied of the six main enzymes classes, thermostable hydrolase 
enzymes offer unparalleled stability with novel thermostable hydrolase enzymes still 
sought after industrially (Littlechild, 2015).  In this respect, Af-Est2 showed not only 
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excellent thermostability but maintained high levels of activity in extremes of pH and 
at high solvent concentrations, making this enzyme very industrially attractive.  The 
excellent solvent stability of Af-Est2 is particularly intriguing as this may facilitate the 
use of Af-Est2 in the absence of water for bond forming condensation reactions 
(Klibanov, 2001).   
Characterization of the substrate specificity of Af-Est2 is limited only to methyl p-
toluate and the standard p-nitrophenyl esters which are often used to examine the 
substrate specificity of esterase or lipase enzymes.  A more thorough 
characterization of substrate specificity could be beneficial in characterizing this 
enzyme for industrial use.  The crystal structure of Af-Est2 might be useful in 
selecting a panel of substrates for this purpose, and possibly in predicting other 
substrate specificities.  Furthermore, the crystal structure, biochemical 
characterization and high stability of Af-Est2 provides an excellent starting point for 
engineering of the enzyme for industrial use, such as expanding substrate specificity 
(Dalby, 2007). 
7.4 Characterisation of carboxylic acid reductase 
enzymes. 
The second step in the multistep reaction was filled by a CAR enzyme (Figure 1-8).  
Previous work on CARs has mostly focused on the CAR from Nocardia iowensis (He 
et al., 2004), and to a lesser extent the CAR from Mycobacterium marinum (Akhtar, 
Turner and Jones, 2013).  Recently, some characterization was carried out on two 
other CARs, but this was limited to a yes/no screen of only a few substrates, with 
products confirmed by GC/MS analysis (Moura et al., 2015).  Since only a few CARs 
have been explored, with often a limited biochemical characterization, we sought to 
characterize a number of CARs from across the CAR family. 
Our work identified a large number of CAR sequences by bioinformatics, with a 
careful phylogenetic analysis carried out to examine the relationship between these 
sequences.  CARs from across the family were selected for characterization.  Kinetic 
characterization of these CARs strongly suggested that the first step in the proposed 
reaction scheme is crucial for substrate specificity, and that while substrate 
specificity is fairly broad, it is similar across all the CARs.  We also showed ordered 
	362	
binding of substrates at the adenylation domain, similar to other members of the ANL 
superfamily which we identified CARs to be a member of (Gulick, 2009).   
CARs offer the reduction of carboxylic acids in mild conditions in stark contrast to 
chemical methods typically requiring harsh reducing agents in stoichiometric 
quantities.  Moreover they offer selective reduction to only the aldehyde product 
rather than complete reduction to the alcohol product as is generally the case using 
chemical methods (Napora-Wijata, Strohmeier and Winkler, 2014).  For these 
reasons CARs are promising enzymes and could be thought of as one the next 
enzymes to achieve a place in the enzyme toolbox.   
For example, CARs are already being used in the construction of numerous 
multistep enzymes pathways, both for biotransformations and for fermentations 
(Hansen et al., 2009; Kallio et al., 2014; Napora-Wijata et al., 2014).  Furthermore 
CARs join up a number of established enzymes in the enzyme toolbox, and are a 
crucial link in constructing a network of biocatalysis reactions, important for the 
construction of industrial multistep reactions.  
However, while CARs are very attractive enzymes for synthetic chemistry, other 
enzyme classes in the enzyme toolbox feature a number of distinct enzymes able to 
meet a wide range of requirements (Turner and O’Reilly, 2013).  The CARs we 
tested cover most of the known family of CARs, all from the Actinomyces.  The 
similarities of substrate specificity and operating conditions between these enzymes 
could be a limitation in the CARs ability to meet the wide range of requirements the 
other enzymes classes in the toolbox are capable of.  Future efforts to engineer 
CARs are likely to expand the substrate specificity and operating conditions.  
Additionally, a CAR from the fungus Syncephalastrum racemosum was recently 
identified (Brenna et al., 2015), and possibly more CARs from other sources will 
follow, resulting in more diverse set of CAR enzymes.   
7.5 Completion of a multistep enzymatic reaction 
Af-Est and mpCAR, the most naturally thermostable CAR identified, were used to 
make up the first two steps of the three enzyme pathway outlined in Figure 1-8.  An 
ADH from the hyperthermophile A. pernix, apADH, has been characterized 
previously and filled the final step in this pathway (Guy, Isupov and Littlechild, 2003; 
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Hirakawa, Kamiya and Kawarabayashi, 2004).  With a pathway of well characterized 
enzymes, the in vitro and in vivo reaction were both investigated.    
7.6 The use of isolated enzymes with mathematical 
modelling and cofactor regeneration 
One of the ambitions of synthetic biology is the in silico design of organisms.  This 
ambition might be shared with the field of biocatalysis for the design of multistep 
pathways for synthetic chemistry.  This is probably most achievable in the design of 
reactions featuring isolated enzymes, as the unpredictable components of whole-
cells are removed.   
The optimization of multistep reactions is challenging and will generally require some 
form of modelling. This can be either a data driven approach such as the generation 
of a response surface, or mechanistic modelling using parameters determined 
experimentally to fit equations such as the Michaelis-Menten equation (Santacoloma 
et al., 2011).  The use of mechanistic modelling also facilitates understanding of the 
reaction being modelled, as we demonstrated with the identification product inhibition 
in the CAR step and its removal with the addition of an inorganic pyrophosphatase 
enzyme.  Mechanistic models might also be reused in other reactions, something 
that is not possible using data driven modelling.  A further three enzymes were 
included for the regeneration of NADPH, NADH and ATP.  This included the 
identification and characterization of a novel thermostable AMP polyphosphate 
phosphotransferase enzyme (PAP).  However, characterization of these enzymes 
was fairly limited, with the scope for a much more thorough characterization. 
Modelling of the ATP regeneration system posed the most challenges and could not 
be achieved entirely faithfully.  It would be interesting if the modelling of free and 
bound magnesium ions could be achieved, and how this might affect the model 
predictions.  A more efficient ATP regeneration system might seek to mimic the way 
ATP is more commonly regenerated in nature, through the use of an ATP synthase 
embedded in a synthetic membrane separating a pH gradient (Nam, Struck and 
Holtzapple, 1996). 
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This work used “good modelling practice” which included uncertainty and sensitivity 
analysis (Sin, Gernaey and Lantz, 2009), often omitted in other similar work.  This 
allowed the impact of assumptions and unknowns to be evaluated and taken into 
account.  Using uncertainty and sensitivity analysis offers a very useful approach to 
building models quickly from limited data.  Even if a mechanistic model will ultimately 
not be used, with appropriate bounds for unknown parameters they can help identify 
which experiments should be carried out.  For example this approach might be used 
to inform which variables should be tested using a response surface methodology. 
Where a mechanistic model has been developed for a process, it can be exploited to 
optimise the reaction towards a desired goal.  Numerous methods for global 
optimisation are available, with genetic algorithms offering a powerful tool for 
avoiding local minima or maxima, and for multi-objective problems likely to arise for 
biocatalysis.  In this study the model constructed was used in this way to minimize 
enzyme concentrations while reaching a target product concentration in a specified 
time, demonstrating the power of this approach. 
Whether for in vitro or in vivo biotransformations, modelling offers a powerful tool for 
the design and optimisation of reactions.  For in vivo models, ideally enzyme 
characterisation could be carried out in a buffer mimicking the cellular environment.  
However the use of in vivo models to realise optimised reactions is limited by our 
inability to accurately predict protein production rates, mostly at the level of 
transcription.   
Reaching an optimised process is an important goal for biocatalysis, but where this 
is the only goal and the process is relatively well understood, it is likely faster and 
simpler to use a data driven approach such as response surface methodology.  
However the use of a mechanistic model offers a number of advantages if a process 
is under active development, as it allows options to be explored quickly in silico.  
Both methods have their place for process modelling of biocatalysis reactions. 
7.7 Whole-cell biocatalysis at elevated temperatures. 
T. thermophilus is an attractive host organism for whole-cell biocatalysis at elevated 
temperatures primarily due to its natural competence (Cava, Hidalgo and Berenguer, 
2009), making transformations much easier to achieve than in other thermophilic 
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organisms.  The main competitor for this role is likely Geobacillus stearothermophilus 
(or other Geobacillus species), which is being actively pursued as a thermophilic 
host organism for various synthetic biology applications (French, 2009).  An ability to 
grow at a wide range of growth temperatures, utilizing a range of carbon sources and 
being a relative to the well-studied mesophilic bacteria Bacillus subtilis make this an 
attractive host organism (Takami et al., 2004; Olson et al., 2012; Kananavičiute and 
Čitavičius, 2015).  However in many cases development has been slowed 
substantially by difficulties in transforming the organism, often requiring complex 
protocols including electroporation (Kananavičiute and Čitavičius, 2015).   
For both T. thermophilus and G. stearothermophilus the development of synthetic 
biology tools and parts is critical to their success (Kuhn et al., 2010).  In this work the 
available genetic tools and parts for T. thermophilus were reviewed.  sfGFP 
expression allowed three constitutive promoters to be easily characterized.  A robust 
protocol should be set up to allow the characterization of more promoters to cover a 
range of expression strengths, with the development of synthetic promoters another 
possibility.  Ideally a strong but inducible promoter would allow the accumulation of 
biomass followed by high levels of protein expression, with some potential promoters 
identified in this study.   
While a good start was made on the development of synthetic biology tools for T. 
thermophilus, a demonstration of its use as a host for whole-cell biocatalysis was 
more limited.  Due to the presence of native AFO enzymes for the oxidation of 
aromatic aldehydes in T. thermophilus, the transformation was limited to only 
hydrolysis of methyl p-toluate.  Potentially the native AFO enzymes might be made 
to work in the reverse direction, but it is more likely that their deletion will be 
necessary for the complete transformation to be successful.  Exploring the use of 
Cas9 in T. thermophilus would be an interesting approach for the deletion of these 
genes. 
Possibly a more achievable short term goal might be the expression of the three 
enzymes making up the multistep reaction in E. coli.  An interesting proposal might 
be the use of the mathematical model developed for the in vitro reaction, in informing 
the design of a new synthetic operon for expression in E. coli. 
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7.8 Biocatalysis and synthetic biology in the future 
Biology is said to be going through a reproducibility crisis, but is also changing at a 
fast pace.  One positive change is that some journals are now asking that all data 
associated with publications be uploaded along with the manuscript.  Automation is 
becoming more accessible, both in-house automation and cloud labs such as 
Transcriptic, offering more reproducible experiments.  Programming languages for 
biology such as Antha are being developed, aimed at describing protocols in an 
exact way and integrating with liquid handling robots.  Companies such as Biobright 
are producing hardware and software tools aimed to change the way biology is done 
in the lab, collecting data from new sensors or lab equipment in an integrated way. 
For both biocatalysis and synthetic biology, high-throughput experiments are 
becoming more routine.  The falling price of synthetic DNA means it’s easy for large 
numbers of genes, or even synthetic sequences such as ancCAR, to be tested 
quickly and cheaply, especially with increasing levels of lab automation. 
It has been remarked that biocatalysis often constitutes the second generation 
choice for synthetic chemistry processes, generally due to slower development 
times.  The use of characterised parts could take out some of the trial and error 
present in the approach of screening large numbers of enzymes to fit a reaction.  
Furthermore as the enzyme toolbox grows, possibly there will be less need to 
engineer enzymes to fit specific roles, as a suitable enzyme may already be present.   
The design of multistep pathways could be aided greatly using computer tools armed 
with knowledge of the enzyme reactions available, and their strengths and 
limitations.  Such a tool would be useful in suggesting to chemists where biocatalysis 
might offer a powerful solution to a synthesis. 
7.9 Conclusions 
With the increasing uptake of enzymes for synthetic chemistry, and a number of 
advantages to be gained from combining multiple enzyme reactions into a single 
process, multistep reactions are likely to become more common in the future.  
However multistep reactions are generally more complex than single step reactions 
with many variables to consider.  Thorough characterization of enzymes such as has 
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been performed in this study will be critical in the future design of novel multistep 
enzyme reactions.  Mathematical modelling offers a powerful tool for the optimization 
and understanding of these reactions, which the work in this study demonstrates well 
with the use of good modelling practice.  Finally where there is a need to use 
enzymes at elevated temperatures, the use of a well-developed thermophilic host 
organism for whole-cell biocatalysis such as T. thermophilus will allow these types of 
reactions to be considered.  The work in this study is a strong start in developing T. 
thermophilus as a host organism.   
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